,compound_chembl_id,canonical_smiles,standard_type,standard_relation,standard_value,standard_units,target_name,organism,assay_description,assay_type,Ki [nM]
35,CHEMBL269004,CCCN(CCC)[C@H]1CCc2c(O)cccc2C1,Ki,=,6.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,B,6.0
36,CHEMBL269004,CCCN(CCC)[C@H]1CCc2c(O)cccc2C1,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,B,14.0
38,CHEMBL269004,CCCN(CCC)[C@H]1CCc2c(O)cccc2C1,EC50,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human cloned dopamine D2 receptor expressed in CHO cells by [35S]GTP gammaS binding assay,F,20.5
39,CHEMBL269004,CCCN(CCC)[C@H]1CCc2c(O)cccc2C1,Ki,=,7.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,7.1
88,CHEMBL26,CCN1CCCC1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N,Ki,=,68.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,68.0
91,CHEMBL26,CCN1CCCC1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N,Ki,=,7.6,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin),B,7.6
92,CHEMBL26,CCN1CCCC1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N,Kb,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at D2 long receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine induced beta-arrestin recruitment after 90 mins by DiscoveRx PathHunter assay,B,3.0
93,CHEMBL26,CCN1CCCC1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N,Kd,=,2.818,nM,Dopamine D2 receptor,Homo sapiens,Competitive antagonist activity at D2 long receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine induced beta-arrestin recruitment after 90 mins by DiscoveRx PathHunter assay,B,2.818
132,CHEMBL268799,Clc1ccc(cc1)N2CCN(Cc3c[nH]c4ccccc34)CC2,Ki,=,71.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,B,71.0
133,CHEMBL442,CN1C[C@@H](C=C2[C@H]1Cc3c[nH]c4cccc2c34)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](Cc8ccccc8)N6C5=O,IC50,=,4.3,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,2.15
134,CHEMBL442,CN1C[C@@H](C=C2[C@H]1Cc3c[nH]c4cccc2c34)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](Cc8ccccc8)N6C5=O,Ki,=,1.433,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,1.433
170,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,74.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,74.0
172,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity for Dopamine receptor D2,B,31.62
175,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,B,41.0
176,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,B,28.0
177,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,74.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,B,74.0
178,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,74.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,74.0
179,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2L stably expressed in Chinese hamster ovary (CHO) cells was determined.,B,39.0
180,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2S stably expressed in Chinese hamster ovary (CHO) cells was determined.,B,28.0
181,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,B,39.0
182,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,B,28.0
185,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,69.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,69.0
186,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,74.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,B,74.0
187,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,91.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,B,91.0
188,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,B,41.0
189,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,B,28.0
191,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,74.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,74.0
196,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,41.0
197,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,B,28.0
200,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,IC50,=,113.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,56.5
201,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,91.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,B,91.0
202,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,41.0
203,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Competitive binding affinity against human Dopamine receptor D2S by displacing [3H]spiperone from CHO cells,B,28.0
209,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,B,41.0
210,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,B,28.0
217,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,77.62,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2,B,77.62
219,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,IC50,=,9.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory concentration against dopamine receptor D2,B,4.5
220,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,B,28.0
221,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,41.0
228,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,83.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,83.0
229,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,B,41.0
230,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,B,28.0
240,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,72.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,72.0
241,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,7.11,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,7.11
246,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,88.65,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from wild-type human dopamine D2S receptor expressed in CHO-K1 cell membrane after 2 hrs by beta counting,B,88.65
247,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,89.13,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from wild-type human dopamine D2S receptor expressed in CHO-K1 cell membrane after 2 hrs by beta counting,B,89.13
252,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,72.0,nM,Dopamine D2 receptor,Homo sapiens,Competitive antagonist activity against human dopamine D2 receptor short isoform by R-SAT assay,B,72.0
280,CHEMBL415300,CN1CCN(CC1)C2=Nc3ccccc3Nc4ccc(Cl)cc24,IC50,=,34.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2,B,17.0
281,CHEMBL415300,CN1CCN(CC1)C2=Nc3ccccc3Nc4ccc(Cl)cc24,Ki,=,47.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,B,47.0
290,CHEMBL7806,CCCN(CCc1ccsc1)C2CCc3c(O)cccc3C2,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,B,24.0
291,CHEMBL7806,CCCN(CCc1ccsc1)C2CCc3c(O)cccc3C2,Ki,=,0.14,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,B,0.14
296,CHEMBL7549,CCCN1CCC[C@H](C1)c2cccc(O)c2,Ki,=,9.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity of compound measured using [3H]spiperone for the cloned human dopamine receptor D2 long (high/low affinity is given as 9.0/1800),B,9.0
297,CHEMBL7549,CCCN1CCC[C@H](C1)c2cccc(O)c2,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity of compound measured using [3H]spiperone for the cloned human dopamine receptor D2 short (high/low affinity is given as 27/1800),B,27.0
298,CHEMBL7549,CCCN1CCC[C@H](C1)c2cccc(O)c2,Ki,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",B,39.0
299,CHEMBL7549,CCCN1CCC[C@H](C1)c2cccc(O)c2,Ki,=,8.5,nM,Dopamine D2 receptor,Homo sapiens,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",B,8.5
302,CHEMBL7549,CCCN1CCC[C@H](C1)c2cccc(O)c2,Ki,=,17.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,B,17.4
305,CHEMBL7549,CCCN1CCC[C@H](C1)c2cccc(O)c2,EC50,=,163.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,B,81.5
318,CHEMBL7617,CN1CCN(CC1)C2=Cc3ccccc3Cc4ccc(Cl)cc24,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,B,1.0
329,CHEMBL49,O=C1CC2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)c4ncccn4,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,B,13.0
330,CHEMBL49,O=C1CC2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)c4ncccn4,Ki,=,90.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for DA2 receptor,B,90.0
332,CHEMBL49,O=C1CC2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)c4ncccn4,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 receptor by radioligand binding assay,B,13.0
340,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,"Compound was evaluated for the binding affinity against [3H]U-86,170-labeled D2 sites in cloned CHO cells",B,26.0
342,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,"Compound was evaluated for the binding affinity against [3H]U-86,170-labeled D2 sites in cloned CHO cells",B,26.0
344,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Kd,=,0.66,nM,Dopamine D2 receptor,Homo sapiens,Compound was evaluated for the ability to displace [3H]spiperone at Dopamine receptor D2 in porcine anterior pituitary gland as high affinity state,B,0.66
346,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,41.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,B,41.9
347,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,41.6,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,B,41.6
349,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,41.9,nM,Dopamine D2 receptor,Homo sapiens,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,B,41.9
350,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,41.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human Dopamine receptor D2A,B,41.9
351,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Tested for binding affinity towards human D2L receptor using [3H]spiperone as radioligand,B,28.0
353,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,41.6,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,B,41.6
354,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,EC50,=,5.8,nM,Dopamine D2 receptor,Homo sapiens,In vitro effective concentration tested on HEK293 cells co-transfected with human Dopamine receptor D2 using FLIPR assay,B,2.9
356,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,41.9,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]raclopride binding to cloned human Dopamine receptor D2A,B,41.9
357,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Kd,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Equilibrium dissociation constant against recombinant Dopamine receptor D2A expressed in COS7 cells,B,24.0
359,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,EC50,=,5.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor in HEK293 cells coexpressing G-alpha-qo5 by FLIPR,F,2.9
360,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,EC50,=,1.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ferret D2 receptor in HEK293 cells coexpressing Galphaqo5 by FLIPR,F,0.9
363,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,3.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]7-OH-PIPAT from human D2L receptor expressed in HEK293 cell membrane,B,3.6
364,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,EC50,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,10.0
365,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,EC50,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production,F,2.0
367,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human cloned dopamine D2 receptor expressed in CHO cell membrane,B,32.0
369,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,98.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in HEK293 cells,B,98.0
371,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,0.62,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,B,0.62
374,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,50.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,B,50.0
375,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,EC50,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in HEK293 cells assessed as forskolin-stimulated cAMP accumulation after 15 mins,F,2.0
376,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,53.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,B,53.0
378,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,IC50,=,117.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,B,58.5
379,CHEMBL53,CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,EC50,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2L receptor expressed in CHOFlpIn cells assessed as ERK1/2 phosphorylation by alphascreen assay,B,0.85
384,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,3.6,nM,Dopamine D2 receptor,Homo sapiens,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,B,3.6
385,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2,B,1.4
386,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.7943,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity for Dopamine receptor D2,B,0.7943
389,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,B,18.0
390,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,B,1.4
391,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,1.4
392,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.16,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,B,0.16
393,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.44,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,B,0.44
402,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards mouse LtK- cells transfected with human D2 receptor using [3H]spiperone,B,1.0
403,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,IC50,=,4.9,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2,B,2.45
404,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,1.4
405,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,B,1.4
406,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,B,1.6
408,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,5.6,nM,Dopamine D2 receptor,Homo sapiens,"In vitro binding affinity towards Dopamine receptor D2L, using [3H]spiroperidol radioligand in Sf9 baculovirus expression.",B,5.6
409,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,4.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,B,4.8
410,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,B,1.0
411,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.5,nM,Dopamine D2 receptor,Homo sapiens,Tested for binding affinity towards human D2L receptor using [3H]spiperone as radioligand,B,0.5
413,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.89,nM,Dopamine D2 receptor,Homo sapiens,In vitro ability to inhibit the binding of [3H]spiperone to cloned human Dopamine receptor D2 using apomorphine induced climbing test in male Swiss mice,B,0.89
414,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.8913,nM,Dopamine D2 receptor,Homo sapiens,Cataleptogenic effect against cloned human Dopamine receptor D2 in male Sprague-Dawley rats in a bar test,B,0.8913
415,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,IC50,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,2.0
416,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,7.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonism of dopamine-stimulated [35S]GTP-gamma-S binding against human Dopamine receptor D2 in CHO cells,F,7.0
417,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.44,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from CHO-K1 cell membranes expressing human dopamine receptor D2,B,0.44
418,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,B,1.6
419,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,B,3.0
420,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.16,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]quinpirole from Dopamine receptor D2,B,0.16
421,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.66,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]raclopride binding to Dopamine receptor D2,B,0.66
424,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,IC50,=,4.1,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,2.05
426,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,B,1.5
427,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,8.5,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,B,8.5
428,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.12,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,B,0.12
429,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.6026,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine receptor D2,B,0.6026
430,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.84,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,B,0.84
431,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,3.7,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards Dopamine receptor D2 in human using [3H]-spiperone as radioligand,B,3.7
432,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 long,B,1.3
433,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,2.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human recombinant dopamine D2 receptor,B,2.2
434,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,B,2.5
435,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,2.0
436,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.122,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,1.122
438,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,3.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cells,B,3.3
439,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,B,2.0
440,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,2.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,B,2.6
441,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,5.012,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,B,5.012
442,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.6026,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone human cloned dopamine D2 receptor,B,0.6026
443,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,4.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,B,4.2
444,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.6026,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,0.6026
445,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,1.4
446,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,5.09,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]YM-09151-2 from human dopamine D2S receptor in membrane suspensions by liquid scintillation counter,B,5.09
447,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,4.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,B,4.2
449,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,1.1
450,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.6026,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,0.6026
451,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2 receptor,B,3.0
452,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,B,1.9
453,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,B,1.0
456,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,B,3.0
457,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,1.1
458,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,1.1
459,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.87,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,0.87
462,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEK cells,B,1.0
463,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,B,1.5
464,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,1.1
465,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,IC50,=,6.5920000000000005,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,3.2960000000000003
466,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,2.197,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,2.197
467,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,B,1.1
468,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,B,1.5
469,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,3.0
470,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,2.84,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 receptor,B,2.84
473,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,3.548,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-Methylspiperone from dopamine D2 receptor (unknown origin),B,3.548
474,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,3.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-Methylspiperone from dopamine D2 receptor (unknown origin),B,3.5
475,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.6026,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor,B,0.6026
476,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.6026,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,B,0.6026
477,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,B,1.4
478,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.85,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,0.85
479,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,IC50,=,0.7079,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,0.35395
480,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,IC50,=,0.7,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,0.35
482,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,4.0
485,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,0.89
486,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.81,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,0.81
487,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.85,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,0.85
488,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,IC50,=,0.16,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,0.08
489,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,4.0
492,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.96,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,B,0.96
493,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.7,nM,Dopamine D2 receptor,Homo sapiens,"Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, ¿A1, 5-HT2C and H1 Receptors.",B,0.7
494,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,9.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,9.6
495,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,1.4
496,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.42,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cell membranes by radioligand binding assay,B,0.42
497,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.25,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cell membranes by radioligand binding assay,B,0.25
502,CHEMBL56,CCCN(CCC)C1CCc2cccc(O)c2C1,Ki,=,86.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",B,86.0
503,CHEMBL56,CCCN(CCC)C1CCc2cccc(O)c2C1,Ki,=,86.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",B,86.0
506,CHEMBL56,CCCN(CCC)C1CCc2cccc(O)c2C1,Ki,=,84.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2,B,84.0
507,CHEMBL8514,CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc5cccc([C@@H]2C1)c35,Ki,=,0.04,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human recombinant D2S receptor expressed in HEK293 cells,B,0.04
509,CHEMBL8514,CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc5cccc([C@@H]2C1)c35,Ki,=,0.04,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human D2S receptor expressed in HEK293 cells,B,0.04
510,CHEMBL8514,CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc5cccc([C@@H]2C1)c35,IC50,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human recombinant Dopamine D2S receptor expressed in HEK293 cells,B,0.55
511,CHEMBL8514,CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc5cccc([C@@H]2C1)c35,IC50,=,0.81,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methyl-spiperone from human recombinant D2S receptor in HEK293 cells after 60 mins by scintillation counting,B,0.405
512,CHEMBL8514,CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc5cccc([C@@H]2C1)c35,Ki,=,0.27,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methyl-spiperone from human recombinant D2S receptor in HEK293 cells after 60 mins by scintillation counting,B,0.27
519,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,1.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,B,1.89
526,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,170.0,nM,Dopamine D2 receptor,Homo sapiens,Adenylate cyclase assay carried out in LTK cells transfected with human Dopamine receptor D2,B,85.0
528,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro effective concentration tested on HEK293 cells co-transfected with human Dopamine receptor D2 using FLIPR assay,B,9.0
532,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,1.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]quinpirole from Dopamine receptor D2,B,1.89
536,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity on High Affinity Site of Dopamine receptor D2L,B,20.0
537,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity on High Affinity Site of Dopamine receptor D2S,B,17.0
540,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,42.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity was tested on relative proportion of High Affinity Site of Dopamine receptor D2L,B,42.0
541,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,34.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity was tested on relative proportion of High Affinity Site of Dopamine receptor D2S,B,34.0
545,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor in HEK293 cells coexpressing G-alpha-qo5 by FLIPR,F,9.0
546,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ferret D2 receptor in HEK293 cells coexpressing Galphaqo5 by FLIPR,F,4.0
548,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,43.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production,F,21.5
556,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,2.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,B,2.9
565,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,65.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as stimulation of mitogenesis incubated for 24 hrs by [3H]thymidine incorporation assay,F,32.5
570,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,6.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at dopamine D2 receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 by FLIPR assay,B,3.35
577,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-NPA from dopamine D2L receptor (unknown origin) expressed in CHO cell membranes,B,8.0
578,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,36.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase of forskolin-induced cAMP production after 20 mins,F,18.0
590,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,183.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,B,91.5
592,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,8.73,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,8.73
594,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,B,2.5
596,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,7.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,B,3.85
598,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,48.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,48.0
600,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,0.69,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 by fluo-4 dye based FLIPR assay,B,0.345
602,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,3.9810000000000003,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at dopamine D2 receptor short isoform (unknown origin) expressed in mouse NIH/3T3 cells by R-SAT assay,B,1.9905
603,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,2.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,B,1.4
605,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,3.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,B,1.95
607,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,4.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,B,2.25
609,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,0.67,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,B,0.335
611,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,0.78,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,B,0.39
615,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,163.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,B,81.5
617,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,156.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ARMS2-PK2 tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin-2 recruitment incubated for 5 hrs measured after 60 mins by PathHunter assay,B,78.0
623,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,B,16.0
628,CHEMBL59,NCCc1ccc(O)c(O)c1,EC50,=,160.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 and GRK2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,B,80.0
631,CHEMBL267930,Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4,Ki,=,0.2,nM,Dopamine D2 receptor,Homo sapiens,Tested for binding affinity against dopamine receptor D2,B,0.2
632,CHEMBL267930,Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4,Ki,=,0.06,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,B,0.06
634,CHEMBL267930,Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4,Ki,=,0.12,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 long,B,0.12
636,CHEMBL267930,Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4,Ki,=,0.44,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in HEK293 cells,B,0.44
637,CHEMBL267930,Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4,Ki,=,0.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]sulpiride from dopamine D2 receptor,B,0.1
639,CHEMBL267930,Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4,IC50,=,1.27,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,B,0.635
640,CHEMBL267930,Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4,Ki,=,0.28,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,B,0.28
641,CHEMBL267930,Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4,Ki,=,1.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,B,1.2
643,CHEMBL267930,Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4,Ki,=,0.08900000000000001,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human recombinant dopamine D2S receptor expressed in CHO cells after 2 hrs,B,0.08900000000000001
644,CHEMBL267930,Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4,IC50,=,0.25,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human recombinant dopamine D2S receptor expressed in CHO cells after 2 hrs,B,0.125
646,CHEMBL267930,Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4,Ki,=,1.08,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from dopamine D2 receptor (unknown origin) expressed in HEK293 cell membranes incubated for 15 mins by liquid scintillation spectrometry,B,1.08
647,CHEMBL267930,Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4,Kd,=,0.16,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor in human brain caudate nucleus,B,0.16
648,CHEMBL267930,Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4,Ki,=,0.5,nM,Dopamine D2 receptor,Homo sapiens,"Reception Binding Assay: Different concentrations (10^¿5 M-10^¿11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 ¿L liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",B,0.5
649,CHEMBL267930,Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4,IC50,=,2.56,nM,Dopamine D2 receptor,Homo sapiens,"Reception Binding Assay: Different concentrations (10^¿5 M-10^¿11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 ¿L liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",B,1.28
650,CHEMBL267930,Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4,EC50,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,"Affinity Assay: Each medicament was dissolved in serum-free F12 culture medium containing 100 ¿M of IBMX. CHO cells which can stably express D2 receptor were pre-incubated at 37° C. for 10 min, and then 10 ¿M Forskoline and 10 ¿M Dopanie were added at the same time to react for 10 min. 100 ¿L, of pre-cooled 1 M of HClO4 was added and the reaction was terminated at 4° C. for 1 hour. 20 ¿L of 2 M K2CO3 was added to neutralize the reaction. The resulting mixture was centrifugated at 3000 rpm for 15 min, and the precipitate KClO4 was discarded. A certain amount of the supernatant was taken for cAMP detection. Spiperone and Quinpirole were used as positive control.",B,0.7
651,CHEMBL267930,Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4,Ki,=,0.06,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,B,0.06
657,CHEMBL267044,CCN1CCC[C@H]1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N,Ki,=,51.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,B,51.0
660,CHEMBL267044,CCN1CCC[C@H]1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N,Ki,=,51.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,B,51.0
661,CHEMBL267044,CCN1CCC[C@H]1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N,IC50,=,128.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,64.0
662,CHEMBL267044,CCN1CCC[C@H]1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N,Ki,=,43.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,43.0
663,CHEMBL8809,CCN1CCC[C@H]1CNC(=O)c2c(O)c(Cl)cc(Cl)c2OC,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,B,17.0
664,CHEMBL8809,CCN1CCC[C@H]1CNC(=O)c2c(O)c(Cl)cc(Cl)c2OC,Ki,=,31.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,B,31.0
665,CHEMBL8809,CCN1CCC[C@H]1CNC(=O)c2c(O)c(Cl)cc(Cl)c2OC,Ki,=,12.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,B,12.7
666,CHEMBL8809,CCN1CCC[C@H]1CNC(=O)c2c(O)c(Cl)cc(Cl)c2OC,Ki,=,1.21,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,1.21
671,CHEMBL8946,CCN1CCC[C@H]1CNC(=O)c2c(O)c(CC)cc(Cl)c2OC,Ki,=,0.086,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,B,0.086
673,CHEMBL8946,CCN1CCC[C@H]1CNC(=O)c2c(O)c(CC)cc(Cl)c2OC,Ki,=,0.26,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2R expressed in HEK293 cell membranes incubated for 1 hr by radioligand binding assay,B,0.26
674,CHEMBL267723,CCN1CCC[C@H]1CNC(=O)c2c(O)c(I)ccc2OC,Ki,=,4.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,B,4.2
675,CHEMBL267723,CCN1CCC[C@H]1CNC(=O)c2c(O)c(I)ccc2OC,Ki,=,4.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,B,4.2
676,CHEMBL267932,CN1CN(c2ccccc2)C3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)C1=O,Kd,=,0.09699999999999999,nM,Dopamine D2 receptor,Homo sapiens,Affinity constant of compound was evaluated in human brain,B,0.09699999999999999
678,CHEMBL267932,CN1CN(c2ccccc2)C3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)C1=O,Ki,=,0.133,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,B,0.133
718,CHEMBL479,CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2,B,27.0
719,CHEMBL479,CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1,IC50,=,35.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,17.5
720,CHEMBL479,CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,12.0
728,CHEMBL71,CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13,Ki,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2-like receptor in porcine striata homogenate,B,8.0
729,CHEMBL71,CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,B,10.0
730,CHEMBL71,CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13,Ki,=,4.06,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,4.06
731,CHEMBL71,CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13,IC50,=,54.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,27.0
732,CHEMBL71,CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,18.0
733,CHEMBL71,CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13,Ki,=,1.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2long receptor expressed in HEK293 cells after 30 mins by scintillation counting,B,1.2
734,CHEMBL71,CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13,IC50,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,B,6.0
735,CHEMBL71,CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13,Ki,=,6.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,6.1
736,CHEMBL71,CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13,Kb,=,1.3,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human recombinant D2 receptor expressed in CHO-K1 cells assessed as inhibition of apomorphine-induced response treated 15 to 30 mins before agonist challenge by luminescence analysis,B,1.3
737,CHEMBL71,CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13,IC50,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity against human recombinant dopmaine D2L receptor expressed in CHOK1 cells assessed as reduction in apomorphine-induced increase in intracellular Ca2+ levels by aequorin based radiometric and luminescence plate counting method,B,0.5
746,CHEMBL10085,CC(C)Oc1ccccc1N2CCN(Cc3cccc(c3)C(=O)N4CCCCC4)CC2,Ki,=,2.2,nM,Dopamine D2 receptor,Homo sapiens,Compound was measured in vivo for its binding affinity at Dopamine receptor D2 using [3H]spiperone as radioligand.,B,2.2
747,CHEMBL10085,CC(C)Oc1ccccc1N2CCN(Cc3cccc(c3)C(=O)N4CCCCC4)CC2,Ki,<,4.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,4.0
758,CHEMBL493,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,B,10.0
759,CHEMBL493,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,IC50,=,1.5819999999999999,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,0.7909999999999999
760,CHEMBL493,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,Ki,=,0.527,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,0.527
761,CHEMBL493,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125]iodosulpride from human recombinant dopamine D2L receptor expressed in CHO cells after 30 mins,B,15.0
763,CHEMBL493,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,Ki,=,14.79,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125]iodosulpride from human recombinant dopamine D2L receptor expressed in CHO cells after 30 mins,B,14.79
765,CHEMBL493,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,EC50,=,0.5012,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at dopamine D2 receptor short isoform (unknown origin) expressed in mouse NIH/3T3 cells by R-SAT assay,B,0.2506
767,CHEMBL10207,CCCN1CCC2C1CCc3c(O)cccc23,Ki,=,93.0,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,93.0
771,CHEMBL418705,COc1cccc2CC[C@H]3C(CCN3CC=C)c12,Ki,=,77.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",B,77.0
773,CHEMBL276825,COc1cccc2C3CCN(CC=C)[C@H]3CCc12,Ki,=,50.0,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,50.0
775,CHEMBL10289,Oc1cccc2C3CCN(CC=C)C3CCc12,Ki,=,75.0,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,75.0
777,CHEMBL10289,Oc1cccc2C3CCN(CC=C)C3CCc12,Ki,=,4.1,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,4.1
780,CHEMBL273412,COc1cccc2CCC3C(CCN3CC=C)c12,Ki,=,8.5,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,8.5
782,CHEMBL275543,Oc1cccc2C3CCN(CC=C)[C@H]3CCc12,Ki,=,59.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",B,59.0
784,CHEMBL10270,COc1cccc2CC[C@@H]3C(CCN3CC=C)c12,Ki,=,6.7,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",B,6.7
789,CHEMBL10570,COc1cccc2C3CCN(CC=C)[C@@H]3CCc12,Ki,=,78.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",B,78.0
791,CHEMBL10570,COc1cccc2C3CCN(CC=C)[C@@H]3CCc12,Ki,=,78.0,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,78.0
795,CHEMBL85,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,Ki,=,3.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2,B,3.3
796,CHEMBL85,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,Ki,=,3.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,3.1
797,CHEMBL85,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,Ki,=,0.44,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human D2 dopamine receptor.,B,0.44
799,CHEMBL85,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,Ki,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,B,1.4
800,CHEMBL85,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,Ki,=,6.4,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,B,6.4
801,CHEMBL85,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,Ki,=,6.31,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,B,6.31
802,CHEMBL85,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,Ki,=,2.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,2.2
803,CHEMBL85,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,Ki,=,6.166,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,6.166
805,CHEMBL85,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,IC50,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,10.0
806,CHEMBL85,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,Ki,=,6.545,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,6.545
808,CHEMBL85,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,Ki,=,2.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,B,2.7
809,CHEMBL85,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,Ki,=,6.166,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor,B,6.166
810,CHEMBL85,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin) by PDSP assay,B,10.0
811,CHEMBL85,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,Ki,=,6.166,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,B,6.166
812,CHEMBL85,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,Ki,=,3.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,3.8
813,CHEMBL85,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,Ki,=,5.9,nM,Dopamine D2 receptor,Homo sapiens,"Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, ¿A1, 5-HT2C and H1 Receptors.",B,5.9
814,CHEMBL85,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,IC50,=,7.09,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,3.545
817,CHEMBL86,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,IC50,=,127.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,63.5
818,CHEMBL86,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,Ki,=,42.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,42.0
819,CHEMBL86,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,Ki,=,64.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The pharmacological profile of metopimazine, metopimazine acid (MPZA), domperidone, and metoclopramide were assessed by radioligand binding and by a functional antagonist assay. For the radioligand binding assay, cell membranes of dopamine D2 receptor expressing cells were incubated with [3H]spiperone and competing drugs in buffer. The assay was terminated by rapid filtration, and the bound radioactive signal was determined by liquid scintillation counting.",B,64.0
827,CHEMBL11425,O=C1CC2(CCCC2)CC(=O)N1CCCCNCC3COc4ccccc4C3,IC50,=,67.61,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 by displacement of [3H]-Raclopride.,B,33.805
835,CHEMBL416523,COc1cccc2OCC(CNCCCCN3C(=O)CC4(CCCC4)CC3=O)Cc12,IC50,=,29.51,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 by displacement of [3H]-Raclopride.,B,14.755
836,CHEMBL11592,CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C3COc4cccc(OC)c4C3,IC50,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 by displacement of [3H]-Raclopride.,B,5.0
842,CHEMBL11363,Oc1cccc2C[C@@H]3[C@H](CCN3CC=C)Cc12,Ki,=,0.3,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",B,0.3
844,CHEMBL11363,Oc1cccc2C[C@@H]3[C@H](CCN3CC=C)Cc12,Ki,=,0.3,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,0.3
848,CHEMBL11066,CCCN1CC[C@@H]2Cc3c(O)cccc3C[C@@H]12,Ki,=,2.4,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",B,2.4
850,CHEMBL11066,CCCN1CC[C@@H]2Cc3c(O)cccc3C[C@@H]12,Ki,=,0.5,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",B,0.5
852,CHEMBL11066,CCCN1CC[C@@H]2Cc3c(O)cccc3C[C@@H]12,Ki,=,0.5,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,0.5
865,CHEMBL11388,CCCN1CC[C@@H]2Cc3c(C[C@@H]12)cccc3OC,Ki,=,75.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",B,75.0
869,CHEMBL11388,CCCN1CC[C@@H]2Cc3c(C[C@@H]12)cccc3OC,Ki,=,75.0,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,75.0
875,CHEMBL273273,CCCN(CCC)C1CCc2c(O)cccc2C1,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity is the ability to displace [3H]spiperone from human Dopamine receptor D2 expressed in CHO-K1 cells,B,26.0
876,CHEMBL273273,CCCN(CCC)C1CCc2c(O)cccc2C1,Ki,=,6.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity is the ability to displace [3H]N-0437 from human Dopamine receptor D2 expressed in CHO-K1 cells,B,6.0
877,CHEMBL273273,CCCN(CCC)C1CCc2c(O)cccc2C1,EC50,=,10.4,nM,Dopamine D2 receptor,Homo sapiens,Activity at human dopamine D2L receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding,F,5.2
879,CHEMBL273273,CCCN(CCC)C1CCc2c(O)cccc2C1,EC50,=,41.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cells assessed as stimulation of [35S]GTPgamma binding,F,20.6
881,CHEMBL273273,CCCN(CCC)C1CCc2c(O)cccc2C1,Ki,=,58.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,58.8
882,CHEMBL273273,CCCN(CCC)C1CCc2c(O)cccc2C1,Ki,=,58.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,B,58.8
885,CHEMBL11845,CCCN(CCC)C1CCc2c(O)c(O)ccc2C1,EC50,=,0.7,nM,Dopamine D2 receptor,Homo sapiens,Tested for intrinsic activity towards Dopamine receptor D2 in CHO cells,B,0.35
901,CHEMBL11493,CCCCN1C2CCC1CC(C2)OC(c3ccc(F)cc3)c4ccc(F)cc4,Ki,=,68.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2R expressed in HEK293 cell membranes incubated for 1 hr by radioligand binding assay,B,68.1
917,CHEMBL12713,Fc1ccc(cc1)n2cc(C3CCN(CCN4CCNC4=O)CC3)c5cc(Cl)ccc25,Ki,=,7.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2,B,7.4
918,CHEMBL12713,Fc1ccc(cc1)n2cc(C3CCN(CCN4CCNC4=O)CC3)c5cc(Cl)ccc25,Ki,=,0.45,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,0.45
919,CHEMBL12713,Fc1ccc(cc1)n2cc(C3CCN(CCN4CCNC4=O)CC3)c5cc(Cl)ccc25,Ki,=,0.45,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,B,0.45
933,CHEMBL516,CN1CCC(=C2c3ccccc3C=Cc4ccccc24)CC1,IC50,=,164.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,82.0
934,CHEMBL516,CN1CCC(=C2c3ccccc3C=Cc4ccccc24)CC1,Ki,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,55.0
962,CHEMBL531,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34,Ki,=,50.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards Dopamine receptor D2,B,50.0
963,CHEMBL531,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34,Ki,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,B,4.0
964,CHEMBL531,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34,IC50,=,111.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,55.5
965,CHEMBL531,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34,Ki,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,37.0
966,CHEMBL531,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125]iodosulpride from human recombinant dopamine D2L receptor expressed in CHO cells after 30 mins,B,26.0
968,CHEMBL531,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34,Ki,=,25.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125]iodosulpride from human recombinant dopamine D2L receptor expressed in CHO cells after 30 mins,B,25.7
970,CHEMBL531,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34,EC50,=,0.3548,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at dopamine D2 receptor short isoform (unknown origin) expressed in mouse NIH/3T3 cells by R-SAT assay,B,0.1774
976,CHEMBL13647,COc1ccccc1N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2,B,14.0
999,CHEMBL14376,COc1cc(ccc1OCCCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)C,IC50,=,110.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 was determined using [ [3H]-spiperone radioligand,B,55.0
1006,CHEMBL15270,Cc1nc(Cl)c(Sc2ccc(Cl)cc2)c(NC3CCN(Cc4ccccc4)CC3)n1,Ki,=,62.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to Dopamine receptor D2 was determined,B,62.0
1008,CHEMBL15136,CCCN(CCC)[C@@H]1Cc2cccc(O)c2C[C@H]1C,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,B,14.0
1009,CHEMBL15146,CCCN(CCC)[C@@H]1CCc2c(O)cccc2C1,Ki,=,90.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,B,90.0
1010,CHEMBL15146,CCCN(CCC)[C@@H]1CCc2c(O)cccc2C1,Ki,=,55.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,B,55.1
1011,CHEMBL407641,CNc1nc(Cl)c(SC)c(n1)N2CCN(C)CC2,Ki,=,5.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to Dopamine receptor D2 was determined,B,5.4
1012,CHEMBL15242,CN1CCN(CC1)c2nc3ccccc3c(Cl)c2Sc4ccccc4,Ki,=,31.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to Dopamine receptor D2 was determined,B,31.0
1016,CHEMBL14998,CN1CCN(CC1)c2nc(C)nc(Cl)c2Sc3ccc(Cl)cc3,Ki,=,62.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to Dopamine receptor D2 was determined,B,62.0
1049,CHEMBL567,OCCN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1,IC50,=,0.3,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 assessed as inhibition of agonist-induced response incubated for 60 mins in incubator followed by 15 mins at room temperature by FLIPR assay,B,0.15
1089,CHEMBL589,CCCN(CCC)CCc1cccc2NC(=O)Cc12,Ki,=,7.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,B,7.2
1090,CHEMBL589,CCCN(CCC)CCc1cccc2NC(=O)Cc12,EC50,=,83.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,41.5
1101,CHEMBL589,CCCN(CCC)CCc1cccc2NC(=O)Cc12,Ki,=,3.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,3.7
1103,CHEMBL589,CCCN(CCC)CCc1cccc2NC(=O)Cc12,EC50,=,6.457000000000001,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at dopamine D2 receptor short isoform (unknown origin) expressed in mouse NIH/3T3 cells by R-SAT assay,B,3.2285
1104,CHEMBL589,CCCN(CCC)CCc1cccc2NC(=O)Cc12,EC50,=,89.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,B,44.5
1108,CHEMBL589,CCCN(CCC)CCc1cccc2NC(=O)Cc12,EC50,=,30.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 and GRK2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,B,15.0
1110,CHEMBL589,CCCN(CCC)CCc1cccc2NC(=O)Cc12,EC50,=,89.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,B,44.5
1143,CHEMBL276042,CN1CCc2cc(N)cc3c2[C@H]1Cc4ccc(O)c(O)c34,Kd,=,19.9,nM,Dopamine D2 receptor,Homo sapiens,Compound was evaluated for the ability to displace [3H]spiperone at Dopamine receptor D2 in porcine anterior pituitary gland as high affinity state,B,19.9
1145,CHEMBL19130,CN1CCc2cc(O)cc3c2[C@H]1Cc4ccc(O)c(O)c34,Kd,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Compound was evaluated for the ability to displace [3H]spiperone at Dopamine receptor D2 in porcine anterior pituitary gland as high affinity state,B,1.1
1146,CHEMBL18598,CN1CCc2cc(F)cc3c2[C@H]1Cc4ccc(O)c(O)c34,Kd,=,0.43,nM,Dopamine D2 receptor,Homo sapiens,Compound was evaluated for the ability to displace [3H]spiperone at dopamine receptor in porcine anterior pituitary gland as high affinity state,B,0.43
1147,CHEMBL18598,CN1CCc2cc(F)cc3c2[C@H]1Cc4ccc(O)c(O)c34,Kd,=,94.3,nM,Dopamine D2 receptor,Homo sapiens,Compound was evaluated for the ability to displace [3H]spiperone at Dopamine receptor D2 in porcine anterior pituitary gland as high affinity state,B,94.3
1148,CHEMBL276326,CN1CCc2cc(Br)cc3c2[C@H]1Cc4ccc(O)c(O)c34,Kd,=,6.75,nM,Dopamine D2 receptor,Homo sapiens,Compound was evaluated for the ability to displace [3H]spiperone at Dopamine receptor D2 in porcine anterior pituitary gland as high affinity state,B,6.75
1151,CHEMBL19215,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@H]3[C@H]1Cc4cn(C)c5cccc3c45,IC50,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,31.5
1152,CHEMBL19215,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@H]3[C@H]1Cc4cn(C)c5cccc3c45,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,21.0
1185,CHEMBL283142,CC(C)(C)C(=O)NCCCCN1CCN(CC1)c2ccccc2Cl,Ki,=,63.1,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",B,63.1
1192,CHEMBL21008,COc1ccccc1N2CCN(CCCCNC(=O)C(C)(C)C)CC2,Ki,=,19.95,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",B,19.95
1198,CHEMBL20763,CCN1CCCCC1c2ccc([nH]2)c3cc(ccc3OC)S(=O)(=O)CC,Ki,=,7.943,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,B,7.943
1199,CHEMBL277631,CCN1CCCC1c2ccc([nH]2)c3cc(ccc3OC)S(=O)(=O)CC,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,B,25.12
1200,CHEMBL277945,CCN1CCCC1CNC(=O)c2cc(ccc2OC)S(=O)(=O)CC,Ki,=,6.31,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,B,6.31
1201,CHEMBL280961,CCS(=O)(=O)c1ccc(OC)c(c1)c2ccc(CN3CCCC3c4ccccc4)[nH]2,Ki,=,15.85,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,B,15.85
1202,CHEMBL21967,CCN(Cc1ccccc1)Cc2ccc([nH]2)c3cc(ccc3OC)S(=O)(=O)CC,Ki,=,0.7943,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,B,0.7943
1203,CHEMBL21967,CCN(Cc1ccccc1)Cc2ccc([nH]2)c3cc(ccc3OC)S(=O)(=O)CC,Ki,=,0.7943,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,0.7943
1204,CHEMBL22022,CCS(=O)(=O)c1ccc(OC)c(c1)c2ccc([nH]2)C(C)N3CCCCCC3,Ki,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,B,79.43
1205,CHEMBL280177,CCN1CCCCCC1c2ccc([nH]2)c3cc(ccc3OC)S(=O)(=O)CC,Ki,=,7.943,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,B,7.943
1211,CHEMBL22156,CCS(=O)(=O)c1ccc(OC)c(c1)c2ccc(CN3CCCCCC3c4ccccc4)[nH]2,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,B,39.81
1212,CHEMBL22156,CCS(=O)(=O)c1ccc(OC)c(c1)c2ccc(CN3CCCCCC3c4ccccc4)[nH]2,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,39.81
1213,CHEMBL22156,CCS(=O)(=O)c1ccc(OC)c(c1)c2ccc(CN3CCCCCC3c4ccccc4)[nH]2,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",B,39.81
1216,CHEMBL281177,CCS(=O)(=O)c1ccc(OC)c(c1)c2ccc(CN3CCCCC3c4ccccc4)[nH]2,Ki,=,12.59,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,B,12.59
1233,CHEMBL283528,CCCCN1CCC[C@H]1CNC(=O)c2cc(Cl)cc3N(C)CCOc23,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,B,12.0
1253,CHEMBL279937,CN1CCOc2c1cc(Cl)cc2C(=O)NC[C@H]3CCCN3CCc4ccccc4,Ki,=,57.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,B,57.0
1267,CHEMBL643,CC(CN1c2ccccc2Sc3ccccc13)N(C)C,IC50,=,100.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,B,50.0
1325,CHEMBL25938,C(N1CCC(CC1)c2cc([nH]n2)c3ccccc3)c4ccccc4,Ki,=,66.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,66.0
1326,CHEMBL25938,C(N1CCC(CC1)c2cc([nH]n2)c3ccccc3)c4ccccc4,Ki,=,66.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,B,66.0
1333,CHEMBL279247,Cc1nn(cc1c2ccccc2)C3CCN(Cc4ccccc4)CC3,Ki,=,6.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,6.1
1334,CHEMBL279247,Cc1nn(cc1c2ccccc2)C3CCN(Cc4ccccc4)CC3,Ki,=,6.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,6.1
1336,CHEMBL287412,Cc1nn(cc1c2ccccc2)C3CCN(Cc4cccc(Cl)c4)CC3,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,15.0
1337,CHEMBL26120,Cc1nn(cc1c2ccccc2)C3CCN(Cc4cccc(c4)C#N)CC3,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,15.0
1343,CHEMBL281195,Cc1c(n[nH]c1c2ccccc2)C3CCN(Cc4ccccc4)CC3,Ki,=,90.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,90.0
1351,CHEMBL24588,CCCN1CC[C@H]2[C@H]1CCc3c(O)cccc23,Ki,=,93.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",B,93.0
1353,CHEMBL283738,Oc1cccc2CC[C@@H]3[C@H](CCN3CC=C)c12,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",B,25.0
1355,CHEMBL286205,COc1cccc2CC[C@@H]3[C@H](CCN3CC=C)c12,Ki,=,8.5,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",B,8.5
1358,CHEMBL24222,COc1cccc2[C@H]3CCN(CC=C)[C@@H]3CCc12,Ki,=,50.0,nM,Dopamine D2 receptor,Homo sapiens,"Compound was evaluated for the binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in rat striatum",B,50.0
1361,CHEMBL24222,COc1cccc2[C@H]3CCN(CC=C)[C@@H]3CCc12,Ki,=,50.0,nM,Dopamine D2 receptor,Homo sapiens,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",B,50.0
1362,CHEMBL26181,CCCN(CCC)[C@@H]1Cc2cccc3nc(O)n(C1)c23,Ki,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,1.7
1363,CHEMBL26181,CCCN(CCC)[C@@H]1Cc2cccc3nc(O)n(C1)c23,Ki,=,11.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,11.4
1365,CHEMBL26181,CCCN(CCC)[C@@H]1Cc2cccc3nc(O)n(C1)c23,EC50,=,2.53,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,B,1.265
1369,CHEMBL24110,CCCN(CCC)[C@H]1CN2C(=O)NCc3cccc(C1)c23,Ki,=,58.0,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,58.0
1376,CHEMBL26118,COc1cccc2CC[C@@H]3[C@@H](CCN3CC=C)c12,Ki,=,6.7,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,6.7
1378,CHEMBL26118,COc1cccc2CC[C@@H]3[C@@H](CCN3CC=C)c12,Ki,=,7.0,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,7.0
1380,CHEMBL26118,COc1cccc2CC[C@@H]3[C@@H](CCN3CC=C)c12,Ki,=,77.0,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,77.0
1384,CHEMBL280955,COc1cccc2[C@@H]3CCN(CC=C)[C@@H]3CCc12,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",B,18.0
1386,CHEMBL280955,COc1cccc2[C@@H]3CCN(CC=C)[C@@H]3CCc12,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,18.0
1389,CHEMBL280955,COc1cccc2[C@@H]3CCN(CC=C)[C@@H]3CCc12,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",B,18.0
1390,CHEMBL25483,Oc1cccc2[C@H]3CCN(CC=C)[C@@H]3CCc12,Ki,=,4.1,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",B,4.1
1398,CHEMBL430332,CCCN1CC[C@@H]2[C@H]1CCc3cccc(O)c23,Ki,<,50.0,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,50.0
1405,CHEMBL25074,CN1C[C@H](CC2[C@H]1Cc3c(Cl)[nH]c4cccc2c34)NC(=O)C(C)(C)C,Ki,=,3.6,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,3.6
1421,CHEMBL25359,CCCN1CCC2Cc3c(O)cccc3C[C@@H]12,Ki,=,2.4,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,2.4
1431,CHEMBL285873,Oc1cccc2[C@@H]3CCN(CC=C)[C@@H]3CCc12,Ki,=,75.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",B,75.0
1435,CHEMBL25013,CN1C[C@H](CC2[C@H]1Cc3c(C)[nH]c4cccc2c34)NC(=O)C(C)(C)C,Ki,=,3.1,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,3.1
1437,CHEMBL708,Clc1cc2NC(=O)Cc2cc1CCN3CCN(CC3)c4nsc5ccccc45,Ki,=,9.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2,B,9.7
1438,CHEMBL708,Clc1cc2NC(=O)Cc2cc1CCN3CCN(CC3)c4nsc5ccccc45,Ki,=,2.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human D2 dopamine receptor.,B,2.8
1439,CHEMBL708,Clc1cc2NC(=O)Cc2cc1CCN3CCN(CC3)c4nsc5ccccc45,IC50,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory concentration against dopamine receptor D2,B,2.5
1440,CHEMBL708,Clc1cc2NC(=O)Cc2cc1CCN3CCN(CC3)c4nsc5ccccc45,Ki,=,12.59,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,B,12.59
1441,CHEMBL708,Clc1cc2NC(=O)Cc2cc1CCN3CCN(CC3)c4nsc5ccccc45,Ki,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,5.0
1442,CHEMBL708,Clc1cc2NC(=O)Cc2cc1CCN3CCN(CC3)c4nsc5ccccc45,Ki,=,3.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,3.1
1444,CHEMBL708,Clc1cc2NC(=O)Cc2cc1CCN3CCN(CC3)c4nsc5ccccc45,Ki,=,8.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,B,8.5
1445,CHEMBL708,Clc1cc2NC(=O)Cc2cc1CCN3CCN(CC3)c4nsc5ccccc45,Ki,=,4.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,B,4.8
1446,CHEMBL708,Clc1cc2NC(=O)Cc2cc1CCN3CCN(CC3)c4nsc5ccccc45,Ki,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, ¿A1, 5-HT2C and H1 Receptors.",B,5.0
1447,CHEMBL708,Clc1cc2NC(=O)Cc2cc1CCN3CCN(CC3)c4nsc5ccccc45,Ki,=,2.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),B,2.1
1450,CHEMBL278751,CCCN(CCC)[C@@H]1CCc2c(OC)cccc2[C@@H]1C,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,13.0
1452,CHEMBL278751,CCCN(CCC)[C@@H]1CCc2c(OC)cccc2[C@@H]1C,Ki,=,63.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,B,63.1
1453,CHEMBL278751,CCCN(CCC)[C@@H]1CCc2c(OC)cccc2[C@@H]1C,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was measured at cloned mammalian dopamine D2 receptor expressed in CHO-K1 cells (using [3H]U-86170),B,15.0
1461,CHEMBL278285,Oc1cccc2C[C@@H]3C(CCN3CC=C)Cc12,Ki,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,1.4
1463,CHEMBL25236,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2,Ki,=,61.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,61.0
1466,CHEMBL25236,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2,Ki,=,61.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2 receptor expressed in CHO cells,B,61.0
1470,CHEMBL25236,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2,Ki,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,B,52.0
1472,CHEMBL25236,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2,Ki,=,33.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,B,33.6
1478,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2,B,17.0
1479,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity of compound against neuronal Dopamine receptor D2,B,20.0
1480,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,Ki,=,2.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human D2 dopamine receptor.,B,2.1
1481,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,Ki,=,78.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,B,78.0
1482,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,Ki,=,19.95,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,B,19.95
1483,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,20.0
1484,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,Ki,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,B,32.0
1485,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,Ki,=,6.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,B,6.1
1488,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,IC50,=,118.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,59.0
1489,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,Ki,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,39.0
1490,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,Ki,=,7.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,7.0
1491,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,IC50,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from D2 receptor in human corpus striatum after 30 mins by scintillation counting,B,5.0
1492,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from D2 receptor in human corpus striatum after 30 mins by scintillation counting,B,11.0
1494,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,Ki,=,23.45,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from wild-type human dopamine D2S receptor expressed in CHO-K1 cell membrane after 2 hrs by beta counting,B,23.45
1495,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,Ki,=,23.44,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from wild-type human dopamine D2S receptor expressed in CHO-K1 cell membrane after 2 hrs by beta counting,B,23.44
1496,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,Ki,<,10.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human recombinant at D2S receptor assessed as inhibition of dopamine-induced cAMP accumulation,F,10.0
1497,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,20.0
1498,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,20.0
1499,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,Ki,=,31.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, ¿A1, 5-HT2C and H1 Receptors.",B,31.0
1500,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,Ki,=,53.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human cloned D2 dopamine receptor expressed in human fibroblasts incubated for 90 mins by scintillation counting based radioligand binding assay,B,53.0
1501,CHEMBL715,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,Ki,=,9.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,B,9.0
1503,CHEMBL716,OCCOCCN1CCN(CC1)C2=Nc3ccccc3Sc4ccccc24,Ki,=,63.1,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity for Dopamine receptor D2,B,63.1
1506,CHEMBL716,OCCOCCN1CCN(CC1)C2=Nc3ccccc3Sc4ccccc24,Ki,=,69.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human D2 dopamine receptor.,B,69.0
1514,CHEMBL285802,CN(C)CCOC1=Cc2ccccc2Sc3ccc(Cl)cc13,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2,B,13.0
1515,CHEMBL285802,CN(C)CCOC1=Cc2ccccc2Sc3ccc(Cl)cc13,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human D2 dopamine receptor.,B,11.0
1516,CHEMBL24978,CCCN(CCC)[C@H]1CN2C(=O)C=Cc3cccc(C1)c23,Ki,=,3.5,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,3.5
1519,CHEMBL281248,CCCN(CCC)[C@@H]1Cc2cccc3nc(S)n(C1)c23,Ki,=,0.6,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,0.6
1522,CHEMBL27441,CCCN[C@@H]1CCc2c(OC)cccc2[C@@H]1C,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,14.0
1527,CHEMBL285341,CCN(CC)C(=O)N[C@@H]1C[C@H]2[C@@H](CC3=CCc4cccc2c34)N(C)C1,Ki,=,0.8,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,0.8
1534,CHEMBL28437,CCCN(CCC)C1CCc2cccc(OS(=O)(=O)C(F)(F)F)c2C1,Ki,=,62.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards Dopamine receptor D2 by using [3H]U-86170 as radioligand,B,62.0
1545,CHEMBL26998,CCCN(CCC)[C@@H]1CCc2cccc(O)c2C1,Ki,=,90.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards Dopamine receptor D2 by using [3H]U-86170 as radioligand,B,90.0
1547,CHEMBL26998,CCCN(CCC)[C@@H]1CCc2cccc(O)c2C1,Ki,=,93.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,B,93.0
1550,CHEMBL26929,COc1cccc2C(CCCN3CCN(CC3)c4ccccc4OC)CCCc12,IC50,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,10.0
1553,CHEMBL26677,COc1cccc(c1)C(=O)CCCN2CCN(CC2)c3ccccc3OC,IC50,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,6.5
1554,CHEMBL28321,COc1ccccc1N2CCN(Cc3ccn(c3)c4ccccc4)CC2,Ki,=,1.3,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity was measured at the cloned human Dopamine receptor D2 using [3H]spiroperidol as radioligand.,B,1.3
1560,CHEMBL26789,CCCCN1CCN(CC1)c2ccccc2OC,Ki,=,20.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,B,20.6
1563,CHEMBL26188,COc1ccccc1N2CCN(CCCCNC(=O)c3ccccc3)CC2,Ki,=,90.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 short receptor,B,90.0
1596,CHEMBL25856,Oc1cc2CC[C@H]3NCc4ccccc4[C@@H]3c2cc1O,Ki,=,58.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,58.0
1603,CHEMBL723,COc1ccccc1OCCNCC(O)COc2cccc3[nH]c4ccccc4c23,IC50,=,146.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,73.0
1604,CHEMBL723,COc1ccccc1OCCNCC(O)COc2cccc3[nH]c4ccccc4c23,Ki,=,49.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,49.0
1608,CHEMBL726,OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1,Ki,=,1.44,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,1.44
1609,CHEMBL726,OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1,IC50,=,1.6159999999999999,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,0.8079999999999999
1610,CHEMBL726,OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1,Ki,=,0.539,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,0.539
1620,CHEMBL280804,CCO[C@@]1(CC)c2cccc3C[C@H]4N(C)CCc5ccc1c(c45)c23,Ki,=,24.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human Dopamine receptor D2A,B,24.5
1621,CHEMBL417473,CN1CCc2ccc3c4c2[C@H]1Cc5cccc(c45)[C@]3(C)O,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human Dopamine receptor D2A,B,26.0
1626,CHEMBL728,CN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1,IC50,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,5.5
1627,CHEMBL728,CN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1,Ki,=,3.608,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,3.608
1628,CHEMBL284586,CN1CCc2ccc3Cc4cccc5C[C@@H]1c2c3c45,Ki,=,83.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,B,83.2
1629,CHEMBL284586,CN1CCc2ccc3Cc4cccc5C[C@@H]1c2c3c45,Ki,=,83.2,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,B,83.2
1630,CHEMBL26751,CN1CCc2ccc3[C@H](O)c4cccc5C[C@@H]1c2c3c45,Ki,=,23.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human Dopamine receptor D2A,B,23.8
1632,CHEMBL282863,C[C@@H]1c2cccc3C[C@H]4N(C)CCc5ccc1c(c45)c23,Ki,=,19.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,B,19.4
1633,CHEMBL27132,C[C@H]1c2cccc3C[C@H]4N(C)CCc5ccc1c(c45)c23,Ki,=,39.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,B,39.2
1635,CHEMBL281923,CO[C@@]1(C)c2cccc3C[C@H]4N(C)CCc5ccc1c(c45)c23,Ki,=,71.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human Dopamine receptor D2A,B,71.0
1636,CHEMBL281923,CO[C@@]1(C)c2cccc3C[C@H]4N(C)CCc5ccc1c(c45)c23,Ki,=,71.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2,B,71.0
1637,CHEMBL281924,CO[C@]1(C)c2cccc3C[C@H]4N(C)CCc5ccc1c(c45)c23,Ki,=,7.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human Dopamine receptor D2A,B,7.1
1638,CHEMBL281924,CO[C@]1(C)c2cccc3C[C@H]4N(C)CCc5ccc1c(c45)c23,Ki,=,7.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2,B,7.1
1639,CHEMBL281554,CCO[C@]1(CC)c2cccc3C[C@H]4N(C)CCc5ccc1c(c45)c23,Ki,=,70.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human Dopamine receptor D2A,B,70.8
1658,CHEMBL282083,COc1c(cc(C#N)c2ccccc12)C(=O)NCCN3CCN(CC3)c4ccccc4,Ki,=,71.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,B,71.0
1693,CHEMBL27559,CCCN1CCc2cccc3c2[C@H]1Cc4cccc(O)c34,Ki,=,12.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human Dopamine receptor D2A,B,12.7
1745,CHEMBL284092,CC1(C)CC(=O)N(CCCCN2CCN(CC2)c3ncccn3)C(=O)C1,Ki,=,58.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 receptor by radioligand binding assay,B,58.0
1779,CHEMBL285755,CCCN(CCC)C1CCc2ccc(O)cc2C1,EC50,=,39.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding,F,19.9
1782,CHEMBL285755,CCCN(CCC)C1CCc2ccc(O)cc2C1,Ki,=,2.27,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,2.27
1815,CHEMBL43475,CCCN(CCC)[C@@H]1CCc2cccc(O)c2[C@@H]1C,Ki,=,30.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,B,30.0
1816,CHEMBL38580,CCCN(CCC)C1COc2c(C1)cccc2c3cocc3,Ki,=,47.5,nM,Dopamine D2 receptor,Homo sapiens,In vitro ability to inhibit [3H]raclopride binding to cloned human D2A receptors expressed in mouse fibroblast (LtK-) cells,B,47.5
1822,CHEMBL831,CN1CCN(CC1)C2=Nc3ccccc3Oc4ccc(Cl)cc24,IC50,=,54.0,nM,Dopamine D2 receptor,Homo sapiens,Compound was tested in vitro for its binding affinity towards human Dopamine receptor D2,B,27.0
1823,CHEMBL831,CN1CCN(CC1)C2=Nc3ccccc3Oc4ccc(Cl)cc24,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,B,21.0
1824,CHEMBL831,CN1CCN(CC1)C2=Nc3ccccc3Oc4ccc(Cl)cc24,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,B,21.0
1842,CHEMBL40634,CCCN(CCC)[C@@H]1CCc2cccc(C(=O)OC)c2[C@@H]1C,Ki,=,58.8,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,B,58.8
1850,CHEMBL290091,CCCN(CCC)[C@@H]1CCc2cccc(C(=O)C)c2[C@@H]1C,Ki,=,40.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,B,40.0
1851,CHEMBL290446,CCCN(CCC)[C@@H]1CCc2cccc(OC)c2[C@@H]1C,Ki,=,33.9,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,B,33.9
1852,CHEMBL40650,COc1cccc2[C@@H]3CN(CCN4C(=O)Nc5c(sc6cccnc56)C4=O)C[C@@H]3CCc12,Ki,=,19.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 using [3H]spiroperidol as radioligand,B,19.7
1853,CHEMBL41802,CCCN(CCC)[C@@H]1CCc2ccccc2[C@@H]1C,Ki,=,87.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,B,87.0
1858,CHEMBL836,CCOc1ccccc1OCCN[C@H](C)Cc2ccc(OC)c(c2)S(=O)(=O)N,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards recombinant human Dopamine receptor D2L was determined using [3H]spiperone as radioligand,B,13.0
1860,CHEMBL836,CCOc1ccccc1OCCN[C@H](C)Cc2ccc(OC)c(c2)S(=O)(=O)N,Ki,=,78.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards recombinant human Dopamine receptor D2S was determined using [3H]spiperone as radioligand,B,78.0
1874,CHEMBL296512,Fc1ccc(cc1)c2[nH]c3cc(F)ccc3c2C4CCCNC4,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,28.0
1885,CHEMBL43819,CN1CCCC(C1)c2c([nH]c3ccccc23)c4ccccc4,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,28.0
1886,CHEMBL289330,CCN1CCC[C@H]1CNC(=O)c2cc(Br)cc(OC)c2OC,Ki,=,0.003,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,0.003
1891,CHEMBL294951,CN1CCC(=C2c3ccccc3CCc4sccc24)CC1,Ki,=,2.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,2.4
1894,CHEMBL297302,Oc1nc2ccccc2n1C3CCN(CCCC(=O)c4ccc(F)cc4)CC3,Ki,=,0.027000000000000003,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor by radioligand displacement assay,B,0.027000000000000003
1951,CHEMBL300647,CN(C)C1CCC2(C=C1)c3ccccc3C=Cc4ccc(Cl)cc24,Ki,=,6.5,nM,Dopamine D2 receptor,Homo sapiens,The compound was tested for binding affinity against Dopamine receptor D2 using raclopride as radioligand,B,6.5
1952,CHEMBL300647,CN(C)C1CCC2(C=C1)c3ccccc3C=Cc4ccc(Cl)cc24,Ki,=,0.66,nM,Dopamine D2 receptor,Homo sapiens,The compound was tested for binding affinity against dopamine receptor D2 using raclopride as radioligand,B,0.66
1953,CHEMBL45491,CN(C)C1CCC2(C=C1)c3ccccc3CCc4ccc(Cl)cc24,Ki,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,The compound was tested for binding affinity against dopamine receptor D2 using raclopride as radioligand,B,2.0
1976,CHEMBL52096,CC1=CC(=O)Oc2cc(OCCCN3CCN(CC3)c4ccccc4)ccc12,Ki,=,13.7,nM,Dopamine D2 receptor,Homo sapiens,Compound was measured for the binding affinity in homogenated mouse fibroblast (LTK) cells transfected with human Dopamine receptor D2A using [3H]raclopride as radioligand.,B,13.7
1977,CHEMBL52096,CC1=CC(=O)Oc2cc(OCCCN3CCN(CC3)c4ccccc4)ccc12,Ki,=,10.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,10.8
1989,CHEMBL296953,Clc1ccc(cc1)C(=O)NCN2CCN(CC2)c3ccccc3Cl,Ki,=,66.07,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,B,66.07
1990,CHEMBL299879,[O-][N+](=O)c1ccccc1S(=O)(=O)NC[C@@H]2CC[C@@H](CNCC3CCc4ccccc4C3)CC2,Ki,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human Dopamine receptor D2 was evaluated,B,63.0
2000,CHEMBL51536,Cc1ccc(cc1)C(=O)NCN2CCN(CC2)c3ccccc3Cl,Ki,=,48.98,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,B,48.98
2001,CHEMBL51767,COc1ccccc1N2CCN(CCCOc3ccc4C(=CC(=O)Oc4c3)C)CC2,Ki,=,11.75,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,11.75
2019,CHEMBL51433,COc1ccccc1N2CCN(CCN3C(=O)Nc4ccccc4C3=O)CC2,Ki,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,Compound is evaluated for binding affinity towards Dopamine receptor D2 using [3H]spiperone in CHO cells at 10 uM,B,32.0
2024,CHEMBL432713,Oc1ccc2[nH]cc(C3CCN(CCCCCNC(=O)\C=C\c4ccc(Cl)c(Cl)c4)CC3)c2c1,Ki,=,15.85,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for Dopamine receptor D2 was determined,B,15.85
2039,CHEMBL908,CN(C)CC\C=C/1\c2ccccc2Sc3ccc(Cl)cc13,Ki,=,2.96,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,2.96
2051,CHEMBL301559,CCCN(CCC)[C@@H]1CCc2ccc(O)cc2C1,Ki,=,0.5,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,0.5
2052,CHEMBL301559,CCCN(CCC)[C@@H]1CCc2ccc(O)cc2C1,Ki,=,34.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,B,34.0
2053,CHEMBL301559,CCCN(CCC)[C@@H]1CCc2ccc(O)cc2C1,Ki,=,56.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,B,56.0
2054,CHEMBL301559,CCCN(CCC)[C@@H]1CCc2ccc(O)cc2C1,Ki,=,34.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,B,34.0
2057,CHEMBL301559,CCCN(CCC)[C@@H]1CCc2ccc(O)cc2C1,Ki,=,40.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,40.0
2099,CHEMBL54786,O=C1Cc2cc(CCN3CCN(CC3)c4cccc5ccccc45)ccc2N1,IC50,=,44.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory concentration against dopamine receptor D2,B,22.0
2112,CHEMBL56519,Oc1cccc2[C@@H]3CCCN[C@H]3CCc12,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,11.0
2129,CHEMBL301265,CCCN[C@H]1CCc2nc(N)sc2C1,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity of compound measured using [3H]-spiperone for the cloned human dopamine receptor D2 long (high/low affinity is given as 27/5400),B,27.0
2130,CHEMBL301265,CCCN[C@H]1CCc2nc(N)sc2C1,Ki,=,40.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity of compound measured using [3H]spiperone for the cloned human dopamine receptor D2 short (high/low affinity is given as 40/3600),B,40.0
2133,CHEMBL301265,CCCN[C@H]1CCc2nc(N)sc2C1,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,B,21.0
2135,CHEMBL301265,CCCN[C@H]1CCc2nc(N)sc2C1,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,B,21.0
2137,CHEMBL301265,CCCN[C@H]1CCc2nc(N)sc2C1,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,High binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,21.0
2138,CHEMBL301265,CCCN[C@H]1CCc2nc(N)sc2C1,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,High binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,21.0
2141,CHEMBL301265,CCCN[C@H]1CCc2nc(N)sc2C1,EC50,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,13.5
2143,CHEMBL301265,CCCN[C@H]1CCc2nc(N)sc2C1,EC50,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production,F,2.5
2149,CHEMBL301265,CCCN[C@H]1CCc2nc(N)sc2C1,EC50,=,7.079,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at dopamine D2 receptor short isoform (unknown origin) expressed in mouse NIH/3T3 cells by R-SAT assay,B,3.5395
2150,CHEMBL301265,CCCN[C@H]1CCc2nc(N)sc2C1,EC50,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,B,13.5
2152,CHEMBL301265,CCCN[C@H]1CCc2nc(N)sc2C1,EC50,=,100.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2S receptor expressed in HEK293T cell membranes coexpressing Galphao1 assessed as induction of nucleotide exchange preincubated for 30 mins followed by addition of [35S]GTPgammaS measured after 30 mins by [35S]GTPgammaS binding assay,B,50.0
2154,CHEMBL301265,CCCN[C@H]1CCc2nc(N)sc2C1,EC50,=,9.6,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 and GRK2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,B,4.8
2163,CHEMBL58377,COc1ccccc1N2CCN(CCNC(=O)c3ccc(F)cc3)CC2,Ki,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,5.0
2170,CHEMBL292187,Fc1ccc(cc1)c2ccc(CN3CCN(CC3)c4cccc5ccoc45)[nH]2,Ki,=,0.42,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,0.42
2189,CHEMBL445102,OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4,Ki,=,2.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,B,2.4
2190,CHEMBL445102,OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4,Ki,=,11.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,11.2
2191,CHEMBL445102,OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4,EC50,=,4.46,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole stimulated mitogenesis,F,2.23
2192,CHEMBL445102,OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4,Ki,=,11.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,11.2
2194,CHEMBL445102,OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4,Ki,=,11.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,11.2
2195,CHEMBL445102,OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,10.0
2196,CHEMBL445102,OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4,Ki,=,7.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,B,7.5
2199,CHEMBL60708,COc1cc2ccccc2cc1C(=O)NC3CCN(Cc4ccccc4)C3,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,B,39.81
2241,CHEMBL294747,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)c4ccc(cc4)C(=O)C)CC2,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,B,39.81
2242,CHEMBL294747,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)c4ccc(cc4)C(=O)C)CC2,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards mouse LtK- cells transfected with human D2 receptor using [3H]spiperone,B,39.81
2245,CHEMBL58669,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)C3CCc4c(O)cccc4C3,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,B,25.12
2256,CHEMBL64553,Oc1ccc2CC[C@H](CNCc3ccccc3)Oc2c1,Ki,=,10.4,nM,Dopamine D2 receptor,Homo sapiens,Affinity for the Dopamine receptor D2S was determined using membranes from CHO cells labeled with [3H]spiperone,B,10.4
2258,CHEMBL64553,Oc1ccc2CC[C@H](CNCc3ccccc3)Oc2c1,Ki,=,10.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,B,10.4
2262,CHEMBL59752,O=C1Cc2c(N1)cccc2OCCNCc3ccccc3,Ki,=,4.25,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,B,4.25
2264,CHEMBL300571,Oc1ccc2OC[C@H](CNCc3ccccc3)Oc2c1,Ki,=,7.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,B,7.2
2266,CHEMBL59713,COc1cc(Br)cc(C(=O)NCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)c1OC,Ki,=,58.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,B,58.8
2267,CHEMBL59713,COc1cc(Br)cc(C(=O)NCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)c1OC,Ki,=,58.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,B,58.8
2268,CHEMBL301242,Clc1cccc(N2CCN(CCCCNC(=O)c3cccc4C(=O)c5ccccc5c34)CC2)c1Cl,Ki,=,89.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human dopamine receptor D2,B,89.0
2270,CHEMBL301242,Clc1cccc(N2CCN(CCCCNC(=O)c3cccc4C(=O)c5ccccc5c34)CC2)c1Cl,Ki,=,19.4,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,B,19.4
2271,CHEMBL301242,Clc1cccc(N2CCN(CCCCNC(=O)c3cccc4C(=O)c5ccccc5c34)CC2)c1Cl,Ki,=,70.1,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,B,70.1
2274,CHEMBL64283,C(COc1cccc2[nH]ccc12)NCc3ccccc3,Ki,=,81.8,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,B,81.8
2285,CHEMBL300780,Clc1cccc(N2CCN(CCCCNC(=O)c3ccc4c(Cc5ccccc45)c3)CC2)c1Cl,Ki,=,54.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells,B,54.7
2289,CHEMBL64508,Oc1cccc(OCCNCc2ccccc2)c1,Ki,=,75.8,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,B,75.8
2291,CHEMBL64508,Oc1cccc(OCCNCc2ccccc2)c1,Ki,=,75.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,B,75.8
2300,CHEMBL59725,Clc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)c1Cl,Ki,=,64.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,64.7
2304,CHEMBL59725,Clc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)c1Cl,Ki,=,42.5,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,B,42.5
2306,CHEMBL59725,Clc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)c1Cl,Ki,=,64.7,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,B,64.7
2313,CHEMBL303556,O=C1Cc2c(N1)ccc3CC[C@H](CNCc4ccccc4)Oc23,Ki,=,9.3,nM,Dopamine D2 receptor,Homo sapiens,Affinity for the Dopamine receptor D2S was determined using membranes from CHO cells labeled with [3H]spiperone,B,9.3
2314,CHEMBL64249,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(Cl)cc24,Ki,=,0.67,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,0.67
2315,CHEMBL303313,CN1CCN(CC1)[C@H]2Cc3ccccc3Sc4ccc(Cl)cc24,Ki,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,1.1
2318,CHEMBL64875,CN1CCN(CC1)[C@@H]2Cc3ccccc3Sc4ccc(Cl)cc24,Ki,=,7.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,7.3
2320,CHEMBL302904,Fc1ccc(cc1)c2cncc(CN3CCN(CC3)c4ccccc4)c2,IC50,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,11.5
2323,CHEMBL302183,Fc1ccc(cc1)c2cncc(CN3CCN(CC3)c4ncccn4)c2,IC50,=,120.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,60.0
2324,CHEMBL61682,Fc1ccc(cc1)c2cncc(CN3CCN(CC3)c4ccccc4F)c2,IC50,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,12.5
2325,CHEMBL62829,Fc1cccc(c1)c2cccc(CN3CCN(CC3)c4ncccn4)c2,IC50,=,81.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,40.5
2326,CHEMBL291824,Fc1ccc(cc1)N2CCN(Cc3cncc(c3)c4ccc(F)cc4)CC2,IC50,=,70.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,35.0
2327,CHEMBL61657,Fc1ccc(cc1)c2cncc(CN3CCN(CC3)c4ccccn4)c2,IC50,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,30.0
2330,CHEMBL59942,Fc1ccc(cc1)c2cccc(CN3CCN(CC3)c4ncccn4)c2,IC50,=,49.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,24.5
2332,CHEMBL292943,COc1ccc(cc1)c2cccc(CN3CCN(CC3)c4ncccn4)c2,IC50,=,50.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,25.0
2334,CHEMBL63321,CN1CCc2cc(Cl)c(O)cc2[C@@H](C1)c3ccccc3,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to partially antagonise [3H]-SCH- 23388 binding to the Dopamine receptor D2,B,20.0
2373,CHEMBL293645,COc1ccc(Br)cc1c2nc(CN3CCN(Cc4ccccc4)CC3)cs2,Ki,=,85.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,B,85.0
2398,CHEMBL302416,N#Cc1ccc2OCC3CN(Cc4ccccc4)CC3c2c1,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,25.12
2399,CHEMBL294515,N#Cc1ccc2OC[C@@H]3CN(Cc4ccccc4)C[C@H]3c2c1,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,31.62
2401,CHEMBL418321,Brc1ccc2OCC3CN(Cc4ccccc4)CC3c2c1,Ki,=,50.12,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,50.12
2402,CHEMBL303979,Fc1ccc2OCC3CN(Cc4ccccc4)CC3c2c1,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,25.12
2405,CHEMBL291417,Clc1ccc2OCC3CN(Cc4ccccc4)CC3c2c1,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,31.62
2407,CHEMBL293159,N#Cc1ccc2OC[C@H]3CN(Cc4ccccc4)C[C@@H]3c2c1,Ki,=,19.95,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,19.95
2409,CHEMBL413275,CC(=O)Nc1ccc(CN2C[C@H]3COc4ccc(cc4[C@@H]3C2)C#N)cc1,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,31.62
2410,CHEMBL61565,CC(=O)Nc1ccc(CCN2CC3COc4ccc(cc4C3C2)C#N)cc1,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,39.81
2411,CHEMBL62416,CC(=O)Nc1ccc(CN2C[C@@H]3COc4ccc(cc4[C@H]3C2)C#N)cc1,Ki,=,12.59,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,12.59
2413,CHEMBL65122,Fc1ccc(CN2C[C@H]3COc4ccc(cc4[C@@H]3C2)C#N)cc1,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,39.81
2415,CHEMBL277790,O=C(NCCCCN1CC2COc3ccc(cc3C2C1)C#N)c4ccc(cc4)c5ccccc5,Ki,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,79.43
2416,CHEMBL64157,Fc1ccc(CN2C[C@@H]3COc4ccc(cc4[C@H]3C2)C#N)cc1,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,25.12
2417,CHEMBL64721,Fc1ccc(CN2CC3COc4ccc(cc4C3C2)C#N)cc1,Ki,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,79.43
2418,CHEMBL65274,CCCN(CCC)[C@@H]1CCc2ccc3[nH]cc(C(=O)C)c3c2C1,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity against dopamine receptor D2 using [3H]raclopride as radioligand in CHO cells (sc),B,17.0
2419,CHEMBL65280,O=C(NCCCCN1C[C@@H]2COc3ccc(cc3[C@H]2C1)C#N)c4ccc(cc4)c5ccccc5,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,31.62
2421,CHEMBL305392,N#Cc1ccc2CCC3CN(Cc4ccccc4)CC3c2c1,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,10.0
2424,CHEMBL434403,CC(=O)c1ccc(cc1)C(=O)Nc2ccc(CCN3CC4COc5ccc(cc5C4C3)C#N)cc2,Ki,=,19.95,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,19.95
2425,CHEMBL443006,CS(=O)(=O)Nc1ccc(CCN2CC3COc4ccc(cc4C3C2)C#N)cc1,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,25.12
2426,CHEMBL62823,CC(=O)Nc1ccc(CCN2C[C@H]3COc4ccc(cc4[C@@H]3C2)C#N)cc1,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,39.81
2427,CHEMBL418671,CC(=O)Nc1ccc(CCN2C[C@@H]3COc4ccc(cc4[C@H]3C2)C#N)cc1,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,31.62
2428,CHEMBL65071,CC(=O)Nc1ccc(CN2CC3COc4ccc(cc4C3C2)C#N)cc1,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,25.12
2429,CHEMBL66080,O=C(NCCCCN1C[C@H]2COc3ccc(cc3[C@@H]2C1)C#N)c4ccc(cc4)c5ccccc5,Ki,=,50.12,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,50.12
2432,CHEMBL441618,CN1CCc2ccccc2Cc3[nH]c4ccccc4c3CC1,Ki,=,44.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2L dopamine receptor,B,44.7
2433,CHEMBL441618,CN1CCc2ccccc2Cc3[nH]c4ccccc4c3CC1,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,F,19.0
2434,CHEMBL441618,CN1CCc2ccccc2Cc3[nH]c4ccccc4c3CC1,Ki,=,44.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L dopamine receptor expressed in CHO cells,B,44.5
2435,CHEMBL441618,CN1CCc2ccccc2Cc3[nH]c4ccccc4c3CC1,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,Activity at human D2L dopamine receptor expressed in HEK293 cells by calcium fluorescence assay,B,19.0
2436,CHEMBL441618,CN1CCc2ccccc2Cc3[nH]c4ccccc4c3CC1,Ki,=,44.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,B,44.5
2439,CHEMBL441618,CN1CCc2ccccc2Cc3[nH]c4ccccc4c3CC1,Ki,=,41.69,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,B,41.69
2441,CHEMBL441618,CN1CCc2ccccc2Cc3[nH]c4ccccc4c3CC1,Ki,=,44.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned D2 dopamine receptor incubated for 90 mins by radioligand binding assay,B,44.5
2443,CHEMBL62919,Fc1ccc(cc1)C(=O)C2CCN(CCN3C(=S)Nc4ccccc4C3=O)CC2,Ki,=,62.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor by competitive binding experiment,B,62.0
2448,CHEMBL304902,CN1CCN(CC1)C2=Nc3ccccc3Sc4ccc(Cl)cc24,Ki,=,0.49,nM,Dopamine D2 receptor,Homo sapiens,"Binding Assay: The ability of test compounds to displace 3H-raclopride at the D2s receptor can be determined on membranes from D2s-transfected CHO cells (Bmax 13 pmol/mg protein). An assay can use a standard 96-well glass-fiber filter plate to retain radioligand bound by the receptor. Retained 3H can be determined in a TopCount scintillation plate counter following the addition of a liquid scintillant to each well. Compounds can be evaluated for their potency using competition curve analysis, resulting in calculated Ki values.",B,0.49
2477,CHEMBL302075,Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c4ccccc4)CC2)c(Cl)c1,Ki,=,93.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human Dopamine receptor D2 by [3H]- YM 09151 displacement.,B,93.0
2487,CHEMBL68191,CCN1C(=O)C(Cc2ccccc12)N3CCN(Cc4ccc(Cl)cc4)CC3,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human Dopamine receptor D2 by [3H]- YM 09151 displacement.,B,21.0
2488,CHEMBL68191,CCN1C(=O)C(Cc2ccccc12)N3CCN(Cc4ccc(Cl)cc4)CC3,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-YM 09151 from D2 receptor,B,21.0
2516,CHEMBL68573,CCCN(CCC)[C@@H]1CCc2c(C1)cccc2OC,Ki,=,6.35,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,B,6.35
2517,CHEMBL68573,CCCN(CCC)[C@@H]1CCc2c(C1)cccc2OC,Ki,=,46.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,B,46.0
2526,CHEMBL67923,CCCN(Cc1ccc(OC)cc1)[C@@H]2CCc3c(C2)cccc3OC,Ki,=,64.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,B,64.1
2527,CHEMBL67923,CCCN(Cc1ccc(OC)cc1)[C@@H]2CCc3c(C2)cccc3OC,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,B,22.0
2553,CHEMBL433121,CCCN(Cc1ccc(cc1)[N+](=O)[O-])[C@@H]2CCc3c(C2)cccc3OC,Ki,=,59.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,B,59.2
2562,CHEMBL69985,CCCN(CCC)[C@@H]1CCc2c(F)cccc2C1,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,B,26.0
2568,CHEMBL69985,CCCN(CCC)[C@@H]1CCc2c(F)cccc2C1,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]quinpirole from Dopamine receptor D2,B,26.0
2593,CHEMBL71599,CCCN(Cc1ccc(F)cc1)[C@@H]2CCc3c(C2)cccc3OC,Ki,=,69.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,B,69.7
2594,CHEMBL71599,CCCN(Cc1ccc(F)cc1)[C@@H]2CCc3c(C2)cccc3OC,Ki,=,43.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,B,43.8
2606,CHEMBL68545,CCCN(Cc1ccccc1)[C@@H]2CCc3c(C2)cccc3OC,Ki,=,75.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,B,75.0
2607,CHEMBL68545,CCCN(Cc1ccccc1)[C@@H]2CCc3c(C2)cccc3OC,Ki,=,65.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,B,65.6
2616,CHEMBL71275,CCCN[C@@H]1CCc2c(C1)cccc2OC,Ki,=,82.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,B,82.3
2628,CHEMBL309106,CC(C)Oc1ccccc1N2CCN(C[C@@H](O)CNC(=O)c3ccc4C(=O)N(C(=O)c4c3)c5ccc(cc5)N(C)C)CC2,Ki,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards recombinant human Dopamine receptor D2L was determined using [3H]spiperone as radioligand,B,23.0
2630,CHEMBL309106,CC(C)Oc1ccccc1N2CCN(C[C@@H](O)CNC(=O)c3ccc4C(=O)N(C(=O)c4c3)c5ccc(cc5)N(C)C)CC2,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards recombinant human Dopamine receptor D2S was determined using [3H]spiperone as radioligand,B,25.0
2636,CHEMBL307800,Clc1cccc(N2CCN(CCCCNC(=O)C3c4ccccc4c5ccccc35)CC2)c1Cl,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human dopamine receptor D2,B,10.0
2642,CHEMBL70565,CCCN1CCO[C@H]2[C@H]1COc3ccc(O)cc23,Ki,=,42.0,nM,Dopamine D2 receptor,Homo sapiens,"Human Dopamine receptor D2L affinities to determine agonist activity, using [3H]N-0437 as radioligand",F,42.0
2646,CHEMBL69271,CCCN1CCO[C@H]2[C@H]1CCc3ccc(O)cc23,Ki,=,6.24,nM,Dopamine D2 receptor,Homo sapiens,"Human Dopamine receptor D2L affinities to determine agonist activity, using [3H]spip as radioligand",F,6.24
2648,CHEMBL69271,CCCN1CCO[C@H]2[C@H]1CCc3ccc(O)cc23,Ki,=,6.31,nM,Dopamine D2 receptor,Homo sapiens,Agonistic activity at DRD2 receptor,F,6.31
2654,CHEMBL262724,Clc1cccc(N2CCN(CCCCNC(=O)c3cnc4ccccc4n3)CC2)c1Cl,Ki,=,29.6,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,29.6
2656,CHEMBL262724,Clc1cccc(N2CCN(CCCCNC(=O)c3cnc4ccccc4n3)CC2)c1Cl,Ki,=,29.6,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,B,29.6
2657,CHEMBL262724,Clc1cccc(N2CCN(CCCCNC(=O)c3cnc4ccccc4n3)CC2)c1Cl,Ki,=,58.3,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,B,58.3
2658,CHEMBL302374,Clc1cccc(N2CCN(CCCCNC(=O)c3ccc(I)cc3)CC2)c1Cl,Ki,=,39.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,39.3
2660,CHEMBL302374,Clc1cccc(N2CCN(CCCCNC(=O)c3ccc(I)cc3)CC2)c1Cl,Ki,=,39.3,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,B,39.3
2661,CHEMBL302374,Clc1cccc(N2CCN(CCCCNC(=O)c3ccc(I)cc3)CC2)c1Cl,Ki,=,51.4,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,B,51.4
2667,CHEMBL306672,Clc1cccc(N2CCN(CCCCCN3C(=O)c4ccccc4C3=O)CC2)c1Cl,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human dopamine receptor D2,B,11.0
2670,CHEMBL69571,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3cccc4Cc5ccccc5c34)CC2)c1Cl,Ki,=,62.9,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,B,62.9
2671,CHEMBL68720,Clc1cccc(N2CCN(CCCCCNC(=O)c3cccc4C(=O)c5ccccc5c34)CC2)c1Cl,Ki,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human dopamine receptor D2,B,5.0
2672,CHEMBL69451,Clc1cccc(N2CCN(CCCCNC(=O)c3ccc(cc3)c4ccccn4)CC2)c1Cl,Ki,=,24.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,24.8
2675,CHEMBL69451,Clc1cccc(N2CCN(CCCCNC(=O)c3ccc(cc3)c4ccccn4)CC2)c1Cl,Ki,=,24.8,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,B,24.8
2676,CHEMBL69451,Clc1cccc(N2CCN(CCCCNC(=O)c3ccc(cc3)c4ccccn4)CC2)c1Cl,Ki,=,61.2,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,B,61.2
2677,CHEMBL69451,Clc1cccc(N2CCN(CCCCNC(=O)c3ccc(cc3)c4ccccn4)CC2)c1Cl,Ki,=,24.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,B,24.8
2678,CHEMBL69451,Clc1cccc(N2CCN(CCCCNC(=O)c3ccc(cc3)c4ccccn4)CC2)c1Cl,EC50,=,92.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,46.0
2681,CHEMBL71865,Clc1cccc(N2CCN(C\C=C/CNC(=O)c3ccccc3)CC2)c1Cl,Ki,=,15.2,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,B,15.2
2682,CHEMBL71865,Clc1cccc(N2CCN(C\C=C/CNC(=O)c3ccccc3)CC2)c1Cl,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,B,2.5
2683,CHEMBL71327,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccccc3)CC2)c1Cl,Ki,=,2.9,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,2.9
2686,CHEMBL71327,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccccc3)CC2)c1Cl,Ki,=,23.4,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,B,23.4
2687,CHEMBL71327,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccccc3)CC2)c1Cl,Ki,=,2.9,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,B,2.9
2695,CHEMBL68740,Fc1ccc2[nH]c(cc2c1)C(=O)NCCCCN3CCN(CC3)c4cccc(Cl)c4Cl,Ki,=,36.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,B,36.8
2702,CHEMBL305660,CC(C)(C)c1ccc(cc1)C(=O)CCCN2CCC(CC2)OC(c3ccccc3)c4ccccc4,IC50,=,61.0,nM,Dopamine D2 receptor,Homo sapiens,Compound is evaluated for in vitro receptor binding affinity against Dopamine receptor D2,B,30.5
2706,CHEMBL431367,Oc1ccc2[nH]cc(CCCCN3CCC(=CC3)c4ccccc4)c2c1,EC50,=,0.37,nM,Dopamine D2 receptor,Homo sapiens,Compound was evaluated for effective concentration in vivo for Dopamine receptor D2 mitogenesis. (95% confidence intervals),F,0.185
2709,CHEMBL71920,CCCN(CCC)[C@@H]1CCc2ccc3[nH]c(cc3c2C1)C#N,Ki,=,35.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,B,35.0
2713,CHEMBL71960,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(Br)cc3)CC2,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards mouse LtK- cells transfected with human D2 receptor using [3H]spiperone,B,39.81
2714,CHEMBL423671,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)c4ccc(cc4)S(=O)(=O)C)CC2,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards mouse LtK- cells transfected with human D2 receptor using [3H]spiperone,B,25.12
2715,CHEMBL73665,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)c4ccc(N)cc4)CC2,Ki,=,19.95,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards mouse LtK- cells transfected with human D2 receptor using [3H]spiperone,B,19.95
2736,CHEMBL72292,CN1CCN(CC1)C2=Nc3ccccc3Nc4ccc(OS(=O)(=O)C(F)(F)F)cc24,IC50,=,140.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2,B,70.0
2740,CHEMBL73589,CN1CCN(CC1)C2=Nc3ccccc3Sc4ccc(OS(=O)(=O)C(F)(F)F)cc24,IC50,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2,B,11.5
2741,CHEMBL430798,CN1CCN(CC1)C2=Nc3ccccc3Oc4ccc(OS(=O)(=O)C(F)(F)F)cc24,IC50,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2,B,26.0
2745,CHEMBL70319,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccc(OS(=O)(=O)C(F)(F)F)cc24,IC50,=,30.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2,B,15.0
2772,CHEMBL76402,CCN1CCC[C@H]1CNC(=O)c2c(O)c(Br)cc(OC)c2OC,Ki,=,0.65,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,B,0.65
2773,CHEMBL76402,CCN1CCC[C@H]1CNC(=O)c2c(O)c(Br)cc(OC)c2OC,Ki,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,B,1.6
2780,CHEMBL308345,Oc1oc2c(cccc2n1)N3CCN(Cc4cc(ccn4)c5ccc(F)cc5)CC3,Ki,=,0.47,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,0.47
2781,CHEMBL76990,Oc1oc2c(cccc2n1)N3CCN(Cc4cncc(c4)c5ccccc5)CC3,Ki,=,1.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,1.8
2782,CHEMBL74805,Oc1oc2c(cccc2n1)N3CCN(Cc4ccnc(c4)c5ccc(F)cc5)CC3,Ki,=,2.9,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,2.9
2783,CHEMBL419275,Oc1oc2c(cccc2n1)N3CCN(Cc4cccc(n4)c5ccc(F)cc5)CC3,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,3.0
2784,CHEMBL310045,Oc1oc2c(cccc2n1)N3CCN(Cc4cccc(c4)c5ccsc5)CC3,Ki,=,1.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,1.3
2785,CHEMBL306634,CN1C(=O)Oc2c(cccc12)N3CCN(Cc4cccc(c4)c5ccccc5)CC3,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,10.0
2786,CHEMBL77334,Oc1oc2c(cccc2n1)N3CCN(Cc4cc(ccc4F)c5ccccc5)CC3,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,12.0
2806,CHEMBL75621,Oc1oc2c(cccc2n1)N3CCN(Cc4cccc(c4)c5cccs5)CC3,Ki,=,2.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,2.2
2807,CHEMBL310048,C(N1CCN(CC1)c2cccc3NCCOc23)c4cccc(c4)c5ccccc5,Ki,=,0.93,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,0.93
2808,CHEMBL305920,O=C1COc2c(N1)cccc2N3CCN(Cc4cccc(c4)c5ccccc5)CC3,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,1.0
2809,CHEMBL308476,C(N1CCN(CC1)c2cccc3NCCCc23)c4cccc(c4)c5ccccc5,Ki,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,4.0
2810,CHEMBL78241,C(N1CCN(CC1)c2cccc3OCOc23)c4cccc(c4)c5ccccc5,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,10.0
2812,CHEMBL80230,Oc1oc2c(cccc2n1)N3CCN(Cc4ccc(O)c(c4)c5ccccc5)CC3,Ki,=,0.41,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,0.41
2813,CHEMBL309215,COc1cccc(c1)c2cccc(CN3CCN(CC3)c4cccc5nc(O)oc45)c2,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,10.0
2814,CHEMBL77934,Oc1oc2c(cccc2n1)N3CCN(Cc4cccc(c4)c5cccc(Cl)c5)CC3,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,18.0
2815,CHEMBL306830,Oc1oc2c(cccc2n1)N3CCN(Cc4cccc(c4)c5ccc(F)cc5)CC3,Ki,=,8.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,8.1
2816,CHEMBL420016,Oc1oc2c(cccc2n1)N3CCN(Cc4cccc(c4)c5ccccc5C#N)CC3,Ki,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,2.0
2817,CHEMBL77472,C(N1CCN(CC1)c2cccc3OCCOc23)c4cccc(c4)c5ccccc5,Ki,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,1.7
2818,CHEMBL80156,Oc1oc2c(cccc2n1)N3CCN(Cc4cccc(c4)c5cccc(c5)C#N)CC3,Ki,=,6.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,6.0
2833,CHEMBL78058,Oc1oc2c(cccc2n1)N3CCN(CCNC(=O)c4ccc(F)cc4)CC3,Ki,=,4.6,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,4.6
2838,CHEMBL308875,C(N1CCN(CC1)c2cccc3ccoc23)c4cccc(c4)c5ccccc5,Ki,=,8.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,8.1
2839,CHEMBL305834,Cc1cccc(c1)c2cccc(CN3CCN(CC3)c4cccc5nc(O)oc45)c2,Ki,=,9.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,9.3
2863,CHEMBL77743,C(Cc1ccccc1)N2CCC(CC2)c3cc([nH]n3)c4cccs4,Ki,=,65.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,B,65.0
2864,CHEMBL77744,C(Cc1ccccc1)N2CCC(CC2)c3cc(n[nH]3)C4CCCCC4,Ki,=,61.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,B,61.0
2869,CHEMBL310867,CCCN(CCC)[C@H]1CCc2nn3ccccc3c2C1,Ki,=,85.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity of compound measured using [3H]spiperone for the cloned human Dopamine receptor D2L (high/low affinity is given as 85/6400),B,85.0
2870,CHEMBL310867,CCCN(CCC)[C@H]1CCc2nn3ccccc3c2C1,Ki,=,35.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity of compound measured using [3H]spiperone for the cloned human dopamine receptor D2 short (high/low affinity is given as 35/3700),B,35.0
2873,CHEMBL78923,Nc1nc(cc(n1)c2ccc(Cl)cc2)C3CCN(Cc4ccccc4)CC3,Ki,=,8.6,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,B,8.6
2885,CHEMBL80318,Cc1c(n[nH]c1C2=CCN(CCc3ccccc3)CC2)c4ccccc4,Ki,=,90.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,B,90.0
2890,CHEMBL78933,CCc1c(n[nH]c1c2ccc(Cl)cc2)C3CCN(Cc4ccccc4)CC3,Ki,=,35.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,B,35.0
2898,CHEMBL76908,Cc1ccc(s1)C(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4cccc(Cl)c4Cl)CC2,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,10.0
2899,CHEMBL312752,Cc1csc(c1)C(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4cccc(Cl)c4Cl)CC2,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,19.0
2900,CHEMBL309336,Cc1ccsc1C(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4cccc(Cl)c4Cl)CC2,Ki,=,11.4,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,11.4
2901,CHEMBL311575,Cc1ccc(cc1)N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)c4cccs4)CC2,Ki,=,16.5,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,16.5
2902,CHEMBL80875,Cc1cccc(c1)N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)c4cccs4)CC2,Ki,=,6.3,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,6.3
2903,CHEMBL78368,Clc1cccc(c1)N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)c4cccs4)CC2,Ki,=,6.5,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,6.5
2904,CHEMBL309501,Cc1ccccc1N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)c4cccs4)CC2,Ki,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,5.0
2905,CHEMBL309459,Clc1ccc(cc1)N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)c4cccs4)CC2,Ki,=,34.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,34.0
2906,CHEMBL78800,Clc1ccccc1N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)c4cccs4)CC2,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,1.0
2910,CHEMBL78406,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3ccccn3)CC1)c4cccs4,Ki,=,71.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,71.0
2912,CHEMBL80315,CN([C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1)C(=O)c4cccs4,Ki,=,16.5,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,16.5
2913,CHEMBL310401,Clc1cccc(c1)N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)C4CCCCC4)CC2,Ki,=,37.5,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,37.5
2914,CHEMBL310680,Clc1ccc(cc1)N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)C4CCCCC4)CC2,Ki,=,81.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,81.0
2915,CHEMBL430439,Clc1cccc(N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)c4ccccc4)CC2)c1Cl,Ki,=,4.5,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,4.5
2916,CHEMBL310204,Clc1ccccc1N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)C4CCCCC4)CC2,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,15.0
2917,CHEMBL309727,Clc1cccc(N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)c4ccsc4)CC2)c1Cl,Ki,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,5.0
2918,CHEMBL80615,Cc1ccc(cc1C)N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)C4CCCCC4)CC2,Ki,=,5.6,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,5.6
2919,CHEMBL309979,Clc1cccc(N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)C4CCCCC4)CC2)c1Cl,Ki,=,7.4,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,7.4
2920,CHEMBL80919,Clc1cccc(N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)c4cccs4)CC2)c1Cl,Ki,=,0.6,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,0.6
2922,CHEMBL309623,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3ccccc3)CC1)C4CCCCC4,Ki,=,38.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,38.0
2923,CHEMBL309623,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3ccccc3)CC1)C4CCCCC4,Ki,=,38.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,38.0
2924,CHEMBL310158,Clc1cccc(N2CCN(CCC3CCC(CC3)NC(=O)c4ccccc4)CC2)c1Cl,Ki,=,41.5,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,41.5
2925,CHEMBL310577,COc1cccc(c1)N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)c4cccs4)CC2,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,12.0
2926,CHEMBL78950,COc1ccccc1N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)c4cccs4)CC2,Ki,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,1.4
2927,CHEMBL78655,Clc1cccc(N2CCN(CCC3CCC(CC3)NC(=O)c4cccs4)CC2)c1Cl,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,18.0
2928,CHEMBL311772,O=C(NC1CCC(CCN2CCN(CC2)c3ccccc3)CC1)c4cccs4,Ki,=,40.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,40.0
2929,CHEMBL78916,CC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3ccccc3)CC1,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,10.0
2930,CHEMBL78195,Clc1cccc(N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)C4CCCCCC4)CC2)c1Cl,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,12.0
2931,CHEMBL78791,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3ccccc3)CC1)c4cccs4,Ki,=,3.4,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,3.4
2932,CHEMBL78791,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3ccccc3)CC1)c4cccs4,Ki,=,3.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,3.4
2933,CHEMBL78617,Clc1cccc(N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)C4CCCC4)CC2)c1Cl,Ki,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,1.7
2934,CHEMBL312430,Clc1cccc(N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)c4occc4)CC2)c1Cl,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,B,3.0
2943,CHEMBL82663,Oc1ccc(CCNCCS(=O)(=O)CCCOCCc2ccccc2)c3sc(O)nc13,IC50,=,100.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine 2 receptor,B,50.0
2944,CHEMBL82663,Oc1ccc(CCNCCS(=O)(=O)CCCOCCc2ccccc2)c3sc(O)nc13,EC50,=,4.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase in GTPgamma35S binding by scintillation proximity assay,B,2.25
2946,CHEMBL82663,Oc1ccc(CCNCCS(=O)(=O)CCCOCCc2ccccc2)c3sc(O)nc13,EC50,=,1.995,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2S receptor expressed in HEK cells by GTPgammaS binding assay,B,0.9975
2948,CHEMBL79834,Fc1ccc(OCCCN2CCC3(CC2)N(CNC3=O)c4ccccc4)cc1,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Tested for binding affinity against dopamine receptor D2,B,3.0
2959,CHEMBL83617,NC(=O)c1ccc2C(CCN3CCC(=CC3)c4c[nH]c5cc(F)ccc45)OCCc2c1,Ki,=,4.7,nM,Dopamine D2 receptor,Homo sapiens,Inhibition constant against dopamine receptor D2,B,4.7
2980,CHEMBL84931,CN(C)CC1CC2N(O1)c3cc(F)ccc3Cc4ccccc24,IC50,=,36.31,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human cloned Dopamine receptor D2L,B,18.155
2981,CHEMBL315772,CN(C)CC1CC2N(O1)c3cc(Cl)ccc3Cc4ccccc24,IC50,=,8.71,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human cloned Dopamine receptor D2L,B,4.355
2982,CHEMBL315772,CN(C)CC1CC2N(O1)c3cc(Cl)ccc3Cc4ccccc24,IC50,=,8.71,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2L,B,4.355
2987,CHEMBL85735,CN(C)CC1CC2N(O1)c3cc(C)ccc3Cc4ccccc24,IC50,=,54.95,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human cloned Dopamine receptor D2L,B,27.475
3024,CHEMBL313620,COc1ccccc1N2CCN(CCCOc3ccc(cc3)c4nc5ccccc5[nH]4)CC2,Ki,=,8.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,B,8.8
3025,CHEMBL313620,COc1ccccc1N2CCN(CCCOc3ccc(cc3)c4nc5ccccc5[nH]4)CC2,Ki,=,8.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,8.8
3026,CHEMBL313620,COc1ccccc1N2CCN(CCCOc3ccc(cc3)c4nc5ccccc5[nH]4)CC2,Ki,=,8.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopaminergic D2 receptor (unknown origin),B,8.8
3030,CHEMBL314663,C(COc1ccc(cc1)c2nc3ccccc3n2C\C=C\Cn4c(nc5ccccc45)c6ccc(OCCCN7CCCC7)cc6)CN8CCCC8,Ki,=,56.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,B,56.0
3035,CHEMBL314983,C(COc1ccc(cc1)c2nc3ccccc3[nH]2)CN4CCN(CC4)c5ccccn5,Ki,=,70.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,B,70.0
3036,CHEMBL314983,C(COc1ccc(cc1)c2nc3ccccc3[nH]2)CN4CCN(CC4)c5ccccn5,Ki,=,70.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,70.0
3037,CHEMBL87478,CCCSc1ccccc1N2CCN(CCCOc3ccc(cc3)c4nc5ccccc5[nH]4)CC2,Ki,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,B,8.0
3038,CHEMBL87478,CCCSc1ccccc1N2CCN(CCCOc3ccc(cc3)c4nc5ccccc5[nH]4)CC2,Ki,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,8.0
3091,CHEMBL87187,Nc1cccc(n1)c2ccc(CCN3CCN(CC3)c4cccc5cccnc45)cc2,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Binding ability of compound to human Dopamine receptor D2,B,11.0
3109,CHEMBL423499,C(CN1CCN(CC1)c2ccccn2)[C@@H]3CC[C@H](CC3)c4c[nH]c5ccccc45,EC50,=,2.8,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]thymidine uptake by Dopamine receptor D2,F,1.4
3112,CHEMBL89420,C(COc1cccc2[nH]cnc12)NCc3ccccc3,Ki,=,85.6,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,B,85.6
3113,CHEMBL87137,C(COc1cccc2[nH]ncc12)NCc3ccccc3,Ki,=,79.8,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,B,79.8
3114,CHEMBL87192,FC(F)(F)c1nc2c(OCCNCc3ccccc3)cccc2[nH]1,Ki,=,1.75,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,B,1.75
3115,CHEMBL86504,FC(F)(F)c1nc2c(OCCNCc3ccccc3)cc(Cl)cc2[nH]1,Ki,=,32.4,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,B,32.4
3116,CHEMBL87067,Cc1nc2c(OCCNCc3ccccc3)cccc2[nH]1,Ki,=,15.2,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,B,15.2
3117,CHEMBL314174,Oc1nc2c(OCCNCc3ccccc3)cccc2[nH]1,Ki,=,3.9,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,B,3.9
3118,CHEMBL327782,Sc1nc2c(OCCNCc3ccccc3)cccc2[nH]1,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,B,3.0
3119,CHEMBL329398,Oc1nc2c(OCCNCc3ccccc3)cc(Cl)cc2[nH]1,Ki,=,2.6,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,B,2.6
3120,CHEMBL89037,Sc1nc2c(OCCNCc3ccccc3)cc(Cl)cc2[nH]1,Ki,=,6.5,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,B,6.5
3126,CHEMBL90882,CN1CCN(CC1)C2=Cc3ccccc3Oc4ccc(Cl)cc24,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,B,2.5
3127,CHEMBL90882,CN1CCN(CC1)C2=Cc3ccccc3Oc4ccc(Cl)cc24,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,B,2.5
3128,CHEMBL88464,CN1CCN(CC1)C2=Cc3cc(Cl)ccc3Oc4ccccc24,Ki,=,8.7,nM,Dopamine D2 receptor,Homo sapiens,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,B,8.7
3132,CHEMBL88289,FC(F)(F)c1nc2c(cccc2[nH]1)N3CCN(Cc4ccccc4)CC3,Ki,=,4.1,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,B,4.1
3138,CHEMBL89970,CN1CCN(CC1)C2=Cc3ccccc3Oc4ccccc24,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,B,21.0
3139,CHEMBL89970,CN1CCN(CC1)C2=Cc3ccccc3Oc4ccccc24,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,B,21.0
3142,CHEMBL91310,CN1CCN(CC1)C2=Cc3ccccc3C(=C)c4ccccc24,Ki,=,57.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,B,57.0
3147,CHEMBL432762,CC1c2ccccc2C=C(N3CCN(C)CC3)c4ccccc14,Ki,=,94.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,B,94.0
3148,CHEMBL432762,CC1c2ccccc2C=C(N3CCN(C)CC3)c4ccccc14,Ki,=,94.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to inhibit the binding of [3H]spiperone to the D2L dopamine receptor in COS7 cells,B,94.0
3156,CHEMBL314952,O=C1Cc2c(N1)cccc2N3CCN(Cc4ccccc4)CC3,Ki,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,B,8.0
3163,CHEMBL88365,Oc1cccc(c1)N2CCN(Cc3ccccc3)CC2,Ki,=,4.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,B,4.6
3166,CHEMBL90476,Brc1ccc(N2CCN(Cc3ccccc3)CC2)c4cc[nH]c14,Ki,=,47.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,B,47.0
3168,CHEMBL328051,C(N1CCN(CC1)c2cccc3[nH]ccc23)c4ccccc4,Ki,=,53.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,B,53.0
3171,CHEMBL315864,Oc1nc2c(cccc2[nH]1)N3CCN(Cc4ccccc4)CC3,Ki,=,87.3,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,B,87.3
3173,CHEMBL311539,Clc1ccc2[nH]ccc2c1N3CCN(Cc4ccccc4)CC3,Ki,=,81.3,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,B,81.3
3176,CHEMBL91549,CCN(C)CCc1c([nH]c2ccccc12)c3ccccc3,Ki,=,85.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,B,85.0
3179,CHEMBL90837,CCN(C)CCc1c([nH]c2ccccc12)c3cccc(c3)[N+](=O)[O-],Ki,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,B,39.0
3180,CHEMBL328595,CCN(C)CCc1c([nH]c2ccccc12)c3cccc(F)c3,Ki,=,68.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,B,68.0
3181,CHEMBL328459,CCN(C)CCc1c([nH]c2ccccc12)c3ccc(F)cc3,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,B,17.0
3182,CHEMBL91542,CCN(C)CCc1c([nH]c2ccccc12)c3ccc(cc3)C#N,Ki,=,0.42,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,B,0.42
3186,CHEMBL90911,CCN(C)CCc1c([nH]c2ccccc12)c3cccc(c3)C(F)(F)F,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,B,17.0
3190,CHEMBL91446,COC[C@@H]1CCCN1CCc2c([nH]c3ccccc23)c4ccccc4,Ki,=,92.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,B,92.0
3192,CHEMBL92416,CCN(C)CCc1c([nH]c2ccccc12)c3cccs3,Ki,=,78.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,B,78.0
3204,CHEMBL90263,C[C@@H]1CCCCN1CCc2c([nH]c3ccccc23)c4ccccc4,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,B,21.0
3225,CHEMBL91498,CCc1c(nc(O)n1C2CCN(Cc3ccccc3)CC2)c4ccccc4,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,26.0
3226,CHEMBL91669,CN1C(=O)N(C=C1c2ccccc2)C3CCN(Cc4ccccc4)CC3,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,11.0
3233,CHEMBL89971,Cc1c(nc(O)n1C2CCN(Cc3ccccc3)CC2)c4ccccc4Cl,Ki,=,38.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,38.0
3235,CHEMBL93958,Oc1nc(cn1C2CCN(Cc3ccccc3)CC2)c4ccccc4,Ki,=,82.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,82.0
3236,CHEMBL263162,Cc1ccc(cc1)c2nc(O)n(C3CCN(Cc4ccccc4)CC3)c2C,Ki,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,52.0
3239,CHEMBL91162,Cc1c(nc(O)n1C2CCN(Cc3ccccc3)CC2)c4ccccc4,Ki,=,56.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,56.0
3240,CHEMBL94283,Cc1c(nc(O)n1C2CCN(Cc3ccccc3)CC2)c4cccc(Cl)c4,Ki,=,73.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,73.0
3242,CHEMBL93432,CC1=C(N(C(=O)N1C2CCN(Cc3ccccc3)CC2)c4ccccc4)c5ccccc5,Ki,=,8.8,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,8.8
3243,CHEMBL328739,CN1C(=O)N(C2CCN(Cc3ccccc3)CC2)C(=C1c4ccccc4)C,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,15.0
3246,CHEMBL91621,O=C(NC1CCN(Cc2ccccc2)CC1)Nc3ccccc3,Ki,=,86.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,86.0
3251,CHEMBL316125,Cc1c(nc(O)n1C2CCN(CC3CCCCC3)CC2)c4ccccc4,Ki,=,83.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,83.0
3256,CHEMBL90005,Cc1c(nc(O)n1C2CCN(Cc3ccccc3)CC2)c4cccs4,Ki,=,7.8,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,7.8
3262,CHEMBL92859,Cc1cccc(CN2CCC(CC2)n3c(C)c(nc3O)c4ccccc4)c1,Ki,=,95.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,95.0
3264,CHEMBL93969,Cc1c(nc(O)n1C2CCN(Cc3ccc(Cl)cc3)CC2)c4ccccc4,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,60.0
3272,CHEMBL94015,CCCN1COC[C@H]2[C@H]1COc3ccc(O)cc23,Ki,=,42.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,B,42.0
3280,CHEMBL420986,Oc1nc2c3O[C@@H](CNCc4ccccc4)CCc3ccc2[nH]1,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity for the Dopamine receptor D2S was determined using membranes from CHO cells labeled with [3H]spiperone,B,3.0
3282,CHEMBL93753,Oc1nc2c3O[C@H](CNCc4ccccc4)CCc3ccc2[nH]1,Ki,=,67.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity for the Dopamine receptor D2S was determined using membranes from CHO cells labeled with [3H]spiperone,B,67.0
3286,CHEMBL93779,Oc1nc2c3OC(CNCc4ccccc4)CCc3ccc2[nH]1,Ki,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity for the Dopamine receptor D2S was determined using membranes from CHO cells labeled with [3H]spiperone,B,5.0
3313,CHEMBL90359,CCCN1CCC[C@H](C1)c2cccc(OS(=O)(=O)C(F)(F)F)c2,Ki,=,48.0,nM,Dopamine D2 receptor,Homo sapiens,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",B,48.0
3325,CHEMBL93917,CCCN1CCC[C@H](C1)c2cccc(CC#N)c2,Ki,=,69.0,nM,Dopamine D2 receptor,Homo sapiens,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",B,69.0
3326,CHEMBL328119,FC(F)(F)S(=O)(=O)Oc1cccc(c1)[C@@H]2CCCN(CCc3ccccc3)C2,Ki,=,73.0,nM,Dopamine D2 receptor,Homo sapiens,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",B,73.0
3333,CHEMBL329443,CCCN1CCC[C@H](C1)c2cccc(c2)S(=O)(=O)N(C)C,Ki,=,91.0,nM,Dopamine D2 receptor,Homo sapiens,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",B,91.0
3343,CHEMBL93646,N#Cc1cccc(c1)[C@@H]2CCCN(CCc3ccccc3)C2,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",B,22.0
3344,CHEMBL413483,CCC(C)N1CCC[C@H](C1)c2cccc(c2)C#N,Ki,=,98.0,nM,Dopamine D2 receptor,Homo sapiens,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",B,98.0
3346,CHEMBL92887,CCCN1CCN(CC1)c2ccccc2OC,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,B,22.0
3347,CHEMBL92887,CCCN1CCN(CC1)c2ccccc2OC,Ki,=,19.95,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,B,19.95
3354,CHEMBL94811,N#Cc1cccc(c1)[C@@H]2CCCN(CCCc3ccccc3)C2,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",B,60.0
3355,CHEMBL94811,N#Cc1cccc(c1)[C@@H]2CCCN(CCCc3ccccc3)C2,Ki,=,29.0,nM,Dopamine D2 receptor,Homo sapiens,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",B,29.0
3361,CHEMBL93570,CCc1sccc1N2CCC[C@H](C2)c3cccc(c3)C#N,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",B,11.0
3368,CHEMBL329566,CN(C)C[C@H]1C[C@H]2[C@H](O1)c3ccccc3Cc4ccccc24,Ki,=,61.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,B,61.0
3382,CHEMBL1108,Fc1ccc(cc1)C(=O)CCCN2CCC(=CC2)N3C(=O)Nc4ccccc34,IC50,=,2.407,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,1.2035
3383,CHEMBL1108,Fc1ccc(cc1)C(=O)CCCN2CCC(=CC2)N3C(=O)Nc4ccccc34,Ki,=,0.802,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,0.802
3417,CHEMBL93868,CN(C)CCc1cn(c2ccccc12)S(=O)(=O)c3ccccc3,Ki,=,62.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 using [3H]spiperone radioligand in CHO cells,B,62.0
3419,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,1.82,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,1.82
3420,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,5.012,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,B,5.012
3421,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,2.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,B,2.6
3422,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,2.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,B,2.8
3426,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,4.0
3429,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,1.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,1.8
3430,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,3.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,B,3.1
3432,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,2.0
3434,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2L receptor expressed in HEK293T cells coexpressing Gi subunit assessed as inhibition of isoproterenol-stimulated cAMP production by luminescence assay,F,0.5
3435,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,3.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,3.9
3436,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,0.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 after 1 hr,B,0.8
3439,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,0.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,0.2
3440,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,<,1.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin) by PDSP assay,B,1.0
3441,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,0.54,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,0.54
3442,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,0.45,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,0.45
3444,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,158.49,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells co-expressing Galphai2 after 30 mins by [35S]GTPgammaS binding assay,F,79.245
3445,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,160.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells co-expressing Galphai2 after 30 mins by [35S]GTPgammaS binding assay,F,80.0
3447,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,IC50,=,11.22,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,5.61
3448,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,IC50,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,5.5
3457,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,0.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,0.8
3458,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,0.34299999999999997,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells,B,0.34299999999999997
3459,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,0.48,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,0.48
3460,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,38.9,nM,Dopamine D2 receptor,Homo sapiens,Activity at dopamine D2S receptor (unknown origin) expressed in HEK293 cell membranes co-expressing Galpha protein subunit Galphao1 by [35S]GTPgammaS binding assay,B,19.45
3462,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,158.49,nM,Dopamine D2 receptor,Homo sapiens,Activity at dopamine D2S receptor (unknown origin) expressed in HEK293 cell membranes co-expressing Galpha protein subunit Galphai2 by [35S]GTPgammaS binding assay,B,79.245
3465,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,"Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, ¿A1, 5-HT2C and H1 Receptors.",B,1.6
3467,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,IC50,=,17.2,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,8.6
3468,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,3.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,B,3.3
3469,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,8.0
3470,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,0.53,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.53
3471,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,0.45,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.45
3472,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,19.5
3475,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,158.49,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,79.245
3477,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,14.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,B,7.45
3479,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,19.4,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,B,9.7
3481,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,17.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,B,8.75
3483,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,8.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,B,4.35
3485,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,4.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,B,2.4
3499,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,160.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,80.0
3500,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,38.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,19.45
3503,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,0.48,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,B,0.48
3510,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,0.52,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,B,0.52
3511,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,0.38,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,B,0.38
3514,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,130.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2S receptor expressed in HEK293T cell membranes coexpressing Galphao1 assessed as induction of nucleotide exchange preincubated for 30 mins followed by addition of [35S]GTPgammaS measured after 30 mins by [35S]GTPgammaS binding assay,B,65.0
3529,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,0.52,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,B,0.52
3530,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,0.38,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,B,0.38
3532,CHEMBL1113,Clc1ccc2Oc3ccccc3N=C(N4CCNCC4)c2c1,Ki,=,67.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,67.0
3539,CHEMBL317535,CCOC(=O)c1[nH]c2ccccc2c1CCN(C)C,Ki,=,59.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 using [3H]spiperone radioligand in CHO cells,B,59.0
3562,CHEMBL319116,Oc1cccc2[C@@H]3CCN(CCCCNC(=O)c4ccc(cc4)c5ccccc5)[C@H]3CCc12,Ki,=,63.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,B,63.1
3566,CHEMBL316983,CCCN(CCC)[C@H]1CCn2c(C1)ccc2C=O,Ki,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,B,52.0
3568,CHEMBL316983,CCCN(CCC)[C@H]1CCn2c(C1)ccc2C=O,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,B,41.0
3570,CHEMBL316983,CCCN(CCC)[C@H]1CCn2c(C1)ccc2C=O,Ki,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,High binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,52.0
3571,CHEMBL316983,CCCN(CCC)[C@H]1CCn2c(C1)ccc2C=O,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,High binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,41.0
3584,CHEMBL99198,Oc1cccc2[C@@H]3CCCN(CCCCNC(=O)c4ccc(cc4)c5ccccc5)[C@H]3CCc12,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,B,25.12
3585,CHEMBL99198,Oc1cccc2[C@@H]3CCCN(CCCCNC(=O)c4ccc(cc4)c5ccccc5)[C@H]3CCc12,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,25.0
3590,CHEMBL317488,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(=O)N,Ki,=,0.09,nM,Dopamine D2 receptor,Homo sapiens,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p,B,0.09
3591,CHEMBL317488,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(=O)N,Ki,=,73.2,nM,Dopamine D2 receptor,Homo sapiens,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p,B,73.2
3594,CHEMBL317488,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(=O)N,Ki,=,0.13,nM,Dopamine D2 receptor,Homo sapiens,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,B,0.13
3595,CHEMBL317488,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(=O)N,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,B,60.0
3598,CHEMBL317488,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(=O)N,Ki,=,0.04,nM,Dopamine D2 receptor,Homo sapiens,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p (pretreatment with 100 nM of compound),B,0.04
3599,CHEMBL317488,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(=O)N,Ki,=,60.1,nM,Dopamine D2 receptor,Homo sapiens,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p (pretreatment with 100 nM of compound),B,60.1
3602,CHEMBL317488,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(=O)N,Ki,=,0.06,nM,Dopamine D2 receptor,Homo sapiens,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p (pretreatment with 100 nM of compound),B,0.06
3603,CHEMBL317488,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(=O)N,Ki,=,78.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,B,78.0
3617,CHEMBL98836,CCCN1CCO[C@H]2[C@@H]1CSc3ccc(O)cc23,Ki,=,74.0,nM,Dopamine D2 receptor,Homo sapiens,Tested for agonist binding affinity by measuring displacement of [3H]NPA from Human Dopamine receptor D2L expressed in CHO K-1 cells,B,74.0
3621,CHEMBL98305,CCCN1CCO[C@H]2[C@H]1CSc3ccc(O)cc23,Ki,=,1.14,nM,Dopamine D2 receptor,Homo sapiens,Tested for agonist binding affinity by measuring displacement of [3H]NPA from Human Dopamine receptor D2L expressed in CHO K-1 cells,B,1.14
3641,CHEMBL433376,Cc1oc(C)c2c1CCCc3cnn(C)c23,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 was determined,B,28.0
3667,CHEMBL1125,Cc1cc2C(=Nc3ccccc3Nc2s1)N4CCNCC4,Ki,=,9.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity of compound against neuronal Dopamine receptor D2,B,9.0
3669,CHEMBL99913,CS(=O)(=O)Nc1cc(OCCNCc2ccccc2)ccc1Cl,Ki,=,75.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,B,75.8
3672,CHEMBL100454,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(CO)cc24,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity of compound against neuronal Dopamine receptor D2,B,22.0
3695,CHEMBL99849,CS(=O)(=O)Nc1cccc(OCCNCc2ccccc2)c1,Ki,=,37.6,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,B,37.6
3697,CHEMBL102490,CS(=O)(=O)Nc1cc(OCCNCc2cccs2)ccc1Cl,Ki,=,9.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,B,9.0
3703,CHEMBL103622,CCCN(CCC)C1CCc2sccc2C1,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,B,20.0
3705,CHEMBL102582,CCCN1CCOC2C1CCc3ccc(O)cc23,Ki,=,6.24,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,B,6.24
3708,CHEMBL103857,CCCN(CCC)C1CCc2ccsc2C1,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,B,27.0
3717,CHEMBL102175,CCCCOC(=O)c1cc2c3OC(CN4CCC5(CC4)N(CNC5=O)c6ccccc6)COc3ccc2[nH]1,Ki,=,5.7,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",B,5.7
3718,CHEMBL101535,O=C1NCN(c2ccccc2)C13CCN(CC4COc5ccc6[nH]c(cc6c5O4)C#N)CC3,Ki,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",B,1.5
3719,CHEMBL320173,COC(=O)c1cc2c3OC(CN4CCC5(CC4)N(CNC5=O)c6ccccc6)COc3ccc2[nH]1,Ki,=,3.1,nM,Dopamine D2 receptor,Homo sapiens,Compound was evaluated for the binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using [3H]U-86170 as radioligand,B,3.1
3720,CHEMBL103983,O=C(NCCCc1ccccc1)c2cc3c4OC(CNCCCc5ccccc5)COc4ccc3[nH]2,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",B,41.0
3721,CHEMBL318374,COC(=O)c1cc2c3OC(CNCCCc4ccccc4)COc3ccc2[nH]1,Ki,=,15.9,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",B,15.9
3724,CHEMBL418802,COC(=O)c1cc2c3OC(CN4CCC(CC4)n5c(O)nc6ccccc56)COc3ccc2[nH]1,Ki,=,6.7,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",B,6.7
3726,CHEMBL317433,O=C1NCN(c2ccccc2)C13CCN(CC4COc5ccc6[nH]ccc6c5O4)CC3,Ki,=,0.2,nM,Dopamine D2 receptor,Homo sapiens,"Compound was evaluated for the binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",B,0.2
3727,CHEMBL323088,OCc1cc2c3OC(CN4CCC5(CC4)N(CNC5=O)c6ccccc6)COc3ccc2[nH]1,Ki,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",B,2.0
3728,CHEMBL320880,NC(=O)c1cc2c3OC(CN4CCC5(CC4)N(CNC5=O)c6ccccc6)COc3ccc2[nH]1,Ki,=,1.8,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",B,1.8
3729,CHEMBL106283,OC(=O)c1cc2c3OC(CN4CCC5(CC4)N(CNC5=O)c6ccccc6)COc3ccc2[nH]1,Ki,=,58.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",B,58.0
3730,CHEMBL318166,O=C(OCc1ccccc1)c2cc3c4OC(CN5CCC6(CC5)N(CNC6=O)c7ccccc7)COc4ccc3[nH]2,Ki,=,5.8,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",B,5.8
3768,CHEMBL104273,CC1Cc2ccccc2N1C(=O)CC3CCN(Cc4ccc(C)c(F)c4)CC3,Ki,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,23.0
3774,CHEMBL104832,CC1Cc2ccccc2N1C(=O)CC3CCN(Cc4cccc(Cl)c4)CC3,Ki,=,62.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,62.0
3778,CHEMBL104716,CC1Cc2ccccc2N1C(=O)CC3CCN(Cc4ccc(C)cc4)CC3,Ki,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,39.0
3798,CHEMBL419356,CC1Cc2ccccc2N1C(=O)CC3CCN(Cc4ccc(F)cc4)CC3,Ki,=,71.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,71.0
3799,CHEMBL104719,CC1Cc2ccccc2N1C(=O)CC3CCN(Cc4cccc(F)c4)CC3,Ki,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,52.0
3808,CHEMBL107742,CC1Cc2ccccc2N1C(=O)CN3CCN(Cc4ccc(C)cc4)CC3,IC50,=,188.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory concentration against dopamine receptor D2,B,94.0
3811,CHEMBL319043,COc1ccc(OC)c(CN2CCN(CC(=O)N3[C@H](C)Cc4ccccc34)CC2)c1,Ki,=,59.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,B,59.0
3813,CHEMBL321121,CC[C@@H]1Cc2ccccc2N1C(=O)CN3CCN(Cc4ccc(C)cc4)CC3,Ki,=,96.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,B,96.0
3816,CHEMBL104751,COc1ccc(Cl)cc1CN2CCN(CC(=O)N3[C@H](C)Cc4ccccc34)CC2,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,B,28.0
3827,CHEMBL105172,C[C@@H]1Cc2ccccc2N1C(=O)CN3CCN(Cc4cc(Cl)ccc4Cl)CC3,Ki,=,95.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,B,95.0
3829,CHEMBL104160,CC1CC(C)(C)N(C(=O)CN2CCN(Cc3ccc(Cl)cc3)CC2)c4ccccc14,Ki,=,35.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,B,35.0
3832,CHEMBL104678,C[C@@H]1Cc2ccccc2N1C(=O)CN3CCN(Cc4ccc(Cl)c(Cl)c4)CC3,Ki,=,43.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,B,43.0
3856,CHEMBL104788,CC1Cc2ccccc2N1C(=O)CC3CCN(Cc4ccc(Cl)cc4)CC3,Ki,=,92.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,92.0
3859,CHEMBL320597,C[C@@H]1Cc2ccccc2N1C(=O)CN3CCN(Cc4ccc(C)cc4)CC3,IC50,=,113.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory concentration against dopamine receptor D2,B,56.5
3883,CHEMBL106916,CC1Cc2ccccc2N1C(=O)CN3CCN(Cc4ccc(Cl)cc4)CC3,Ki,=,9.0,nM,Dopamine D2 receptor,Homo sapiens,Dopamine receptor D2 functional activity was assessed via inhibition of forskolin stimulated cAMP production from Whole cells,F,9.0
3900,CHEMBL110888,CCCN(CCC)C1CCc2nc(N)ccc2C1,Ki,=,17.1,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity is the ability to displace [3H]spiperone from human Dopamine receptor D2 expressed in CHO-K1 cells,B,17.1
3901,CHEMBL110888,CCCN(CCC)C1CCc2nc(N)ccc2C1,Ki,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity is the ability to displace [3H]N-0437 from human Dopamine receptor D2 expressed in CHO-K1 cells,B,5.0
3909,CHEMBL105512,CCCN(CCC)C1CCc2nc(N)sc2C1,Ki,=,57.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity is the ability to displace [3H]N-0437 from human Dopamine receptor D2 expressed in CHO-K1 cells,B,57.0
3938,CHEMBL110239,CCCN(C\C=C\I)C1CCc2ccc(O)cc2C1,Ki,=,6.6,nM,Dopamine D2 receptor,Homo sapiens,Tested for the inhibitory activity against D2H (high-affinity states) receptor in infected HEK 293 cells.,B,6.6
3941,CHEMBL106660,Clc1cccc(c1)C(OC2CC3CCC(C2)N3CCCc4ccccc4)c5ccccc5,Ki,=,59.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human dopamine receptor D2,B,59.0
3948,CHEMBL108463,C(CN1CCC(=CC1)c2ccccc2)C#Cc3cccnc3,EC50,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,In vivo Dopamine receptor D2 mitogenesis measured as [3H]thymidine incorporation in CHO p-5 cells expressing human D2 receptors,B,0.85
3950,CHEMBL109101,Nc1ccc(nc1)C#CCCN2CCC(=CC2)c3ccccc3,EC50,=,1.3,nM,Dopamine D2 receptor,Homo sapiens,In vivo Dopamine receptor D2 mitogenesis measured as [3H]thymidine incorporation in CHO p-5 cells expressing human D2 receptors,B,0.65
3952,CHEMBL109063,Nc1ccc(cn1)C#CCCN2CCC(=CC2)c3ccccc3,EC50,=,0.5,nM,Dopamine D2 receptor,Homo sapiens,In vivo Dopamine receptor D2 mitogenesis measured as [3H]thymidine incorporation in CHO p-5 cells expressing human D2 receptors,B,0.25
3954,CHEMBL108531,Nc1ccc(cc1)C#CCCN2CCC(=CC2)c3ccccc3,EC50,=,0.5,nM,Dopamine D2 receptor,Homo sapiens,Compound was evaluated for effective concentration in vivo for Dopamine receptor D2 mitogenesis. (95% confidence intervals),B,0.25
3956,CHEMBL108532,Nc1cccc(c1)C#CCCN2CCC(=CC2)c3ccccc3,EC50,=,9.8,nM,Dopamine D2 receptor,Homo sapiens,Compound was evaluated for effective concentration in vivo for Dopamine receptor D2 mitogenesis. (95% confidence intervals),B,4.9
3958,CHEMBL110489,C(CN1CCC(=CC1)c2ccccc2)C#Cc3ccncc3,EC50,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,In vivo Dopamine receptor D2 mitogenesis measured as [3H]thymidine incorporation in CHO p-5 cells expressing human D2 receptors,B,0.5
3975,CHEMBL108856,Cc1onc(n1)c2ccc(CSc3nc4ccccc4n3Cc5ccc(Cl)cc5)cc2,Ki,=,96.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,B,96.0
3987,CHEMBL111054,COC(=O)c1ccc(\C=C\c2nc3ccccc3n2Cc4ccc(Cl)cc4)cc1,Ki,=,38.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,B,38.0
3988,CHEMBL111054,COC(=O)c1ccc(\C=C\c2nc3ccccc3n2Cc4ccc(Cl)cc4)cc1,Ki,=,67.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 in presence of 0.5% human serum albumin,B,67.0
3991,CHEMBL108289,COC(=O)c1ccc(CCc2nc3ccccc3n2Cc4ccc(Cl)cc4)cc1,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,B,24.0
3995,CHEMBL324619,COC(=O)c1ccc(CSc2nc3ccccc3n2Cc4ccc(Cl)cc4)cc1,Ki,=,73.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,B,73.0
4014,CHEMBL111532,CCCN(CCc1ccc(N)cc1)C2CCc3c(O)cccc3C2,Ki,=,6.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,B,6.8
4016,CHEMBL109684,CCCN(CCc1ccccc1)C2CCc3c(O)cccc3C2,Ki,=,13.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,B,13.3
4017,CHEMBL109684,CCCN(CCc1ccccc1)C2CCc3c(O)cccc3C2,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,B,19.0
4018,CHEMBL109684,CCCN(CCc1ccccc1)C2CCc3c(O)cccc3C2,Ki,=,0.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,B,0.5
4019,CHEMBL109787,CCCN(CCc1ccc(Nc2ccc(c3nonc23)[N+](=O)[O-])cc1)C4CCc5c(O)cccc5C4,Ki,=,0.45,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,B,0.45
4021,CHEMBL113527,CCCN(CCc1ccc(Nc2ccc(c3nonc23)[N+](=O)[O-])cc1)[C@@H]4CCc5c(O)cccc5C4,Ki,=,3.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,B,3.2
4022,CHEMBL113196,CCCN(CCc1ccc(Nc2ccc(c3nonc23)[N+](=O)[O-])cc1)[C@H]4CCc5c(O)cccc5C4,Ki,=,0.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,B,0.3
4024,CHEMBL109897,CCCN(CCc1ccc(N\C(=N\c2ccc3c(c2)C(=O)OC34c5ccc(O)cc5Oc6cc(O)ccc46)\S)cc1)[C@H]7CCc8c(O)cccc8C7,Ki,=,4.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,B,4.8
4025,CHEMBL320526,CCCN(CCc1ccc(N\C(=N\c2ccc3c(c2)C(=O)OC34c5ccc(O)cc5Oc6cc(O)ccc46)\S)cc1)C7CCc8c(O)cccc8C7,Ki,=,7.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,B,7.0
4026,CHEMBL92649,[O-][N+](=O)c1ccc(Nc2ccc(CCN3CN(c4ccccc4)C5(CCN(CCCC(=O)c6ccc(F)cc6)CC5)C3=O)cc2)c7nonc17,Ki,=,0.66,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,B,0.66
4038,CHEMBL322802,COc1cc(N)c(Cl)cc1C(=O)N[C@H]2CCN(Cc3ccccc3)C[C@@H]2C,Ki,=,8.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,B,8.6
4039,CHEMBL322802,COc1cc(N)c(Cl)cc1C(=O)N[C@H]2CCN(Cc3ccccc3)C[C@@H]2C,Ki,=,7.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,B,7.4
4050,CHEMBL326454,CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]2CN(Cc3ccccc3)C[C@H]2C,Ki,=,2.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,B,2.3
4051,CHEMBL326454,CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]2CN(Cc3ccccc3)C[C@H]2C,Ki,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,B,2.0
4052,CHEMBL326454,CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]2CN(Cc3ccccc3)C[C@H]2C,Ki,=,3.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,B,3.7
4053,CHEMBL326454,CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]2CN(Cc3ccccc3)C[C@H]2C,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,B,3.0
4054,CHEMBL325109,COc1cc(N)c(Cl)cc1C(=O)NC2CCN(Cc3ccccc3)CC2,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,B,18.0
4055,CHEMBL325109,COc1cc(N)c(Cl)cc1C(=O)NC2CCN(Cc3ccccc3)CC2,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,B,12.0
4060,CHEMBL109912,CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]2CCN(Cc3ccccc3)C[C@@H]2C,Ki,=,54.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,B,54.0
4061,CHEMBL109912,CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]2CCN(Cc3ccccc3)C[C@@H]2C,Ki,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,B,39.0
4062,CHEMBL109912,CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]2CCN(Cc3ccccc3)C[C@@H]2C,Ki,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,B,8.0
4063,CHEMBL109912,CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]2CCN(Cc3ccccc3)C[C@@H]2C,Ki,=,6.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,B,6.4
4064,CHEMBL111749,CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]2CN(Cc3ccccc3)C[C@@H]2C,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,B,21.0
4065,CHEMBL111749,CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]2CN(Cc3ccccc3)C[C@@H]2C,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,B,19.0
4066,CHEMBL111749,CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]2CN(Cc3ccccc3)C[C@@H]2C,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,B,15.0
4067,CHEMBL111749,CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]2CN(Cc3ccccc3)C[C@@H]2C,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,B,11.0
4072,CHEMBL112395,CNc1cc(OC)c(cc1Cl)C(=O)NC2CCN(Cc3ccccc3)CC2,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,B,24.0
4073,CHEMBL112395,CNc1cc(OC)c(cc1Cl)C(=O)NC2CCN(Cc3ccccc3)CC2,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,B,15.0
4075,CHEMBL325772,COc1c(cc(I)c2ccccc12)C(=O)N[C@@H]3CCN(Cc4ccccc4)C3,Ki,=,70.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,B,70.0
4076,CHEMBL325772,COc1c(cc(I)c2ccccc12)C(=O)N[C@@H]3CCN(Cc4ccccc4)C3,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,B,60.0
4077,CHEMBL325772,COc1c(cc(I)c2ccccc12)C(=O)N[C@@H]3CCN(Cc4ccccc4)C3,Ki,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,B,23.0
4078,CHEMBL109532,CCN(Cc1ccc([nH]1)c2cc(ccc2OC)S(=O)(=O)CC)[C@H](C)c3ccccc3,Ki,=,7.943,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,7.943
4079,CHEMBL326662,CCS(=O)(=O)c1ccc(OC)c(c1)c2ccc([nH]2)C3CCCN3Cc4ccccc4,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,39.81
4080,CHEMBL113523,CCN(Cc1ccc([nH]1)c2cc(ccc2OC)S(=O)(=O)CC)Cc3ccccc3C,Ki,=,6.31,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,6.31
4081,CHEMBL113524,CCN(Cc1ccc([nH]1)c2cc(ccc2OC)S(=O)(=O)CC)C3CCCc4ccccc34,Ki,=,12.59,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,12.59
4090,CHEMBL112833,COc1c(cc(C#C)c2ccccc12)C(=O)N[C@@H]3CCN(Cc4ccccc4)C3,Ki,=,82.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,B,82.0
4091,CHEMBL110793,CCN(Cc1ccc([nH]1)c2cc(ccc2OC)S(=O)(=O)CC)Cc3ccccc3OC,Ki,=,15.85,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,15.85
4092,CHEMBL112268,CCN(Cc1cccc(C)c1)Cc2ccc([nH]2)c3cc(ccc3OC)S(=O)(=O)CC,Ki,=,7.943,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,7.943
4093,CHEMBL111884,CCN1[C@@H](CC[C@H]1c2ccc([nH]2)c3cc(ccc3OC)S(=O)(=O)CC)c4ccccc4,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,39.81
4094,CHEMBL321244,CCN(Cc1ccc([nH]1)c2cc(ccc2OC)S(=O)(=O)CC)[C@@H](C)c3ccccc3,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,25.12
4095,CHEMBL113606,CCN(Cc1ccc([nH]1)c2cc(ccc2OC)S(=O)(=O)CC)Cc3ccccc3Cl,Ki,=,19.95,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,19.95
4096,CHEMBL323817,CCN(Cc1ccc([nH]1)c2cc(ccc2OC)S(=O)(=O)CC)C3CCc4ccccc34,Ki,=,0.7943,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,0.7943
4105,CHEMBL112219,CCS(=O)(=O)c1ccc(OC)c(c1)c2ccc(CN3CCCCCC3c4ccc(C)cc4)[nH]2,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,25.12
4106,CHEMBL325859,CCS(=O)(=O)c1ccc(OC)c(c1)c2ccc(CN3CCCCCC3c4ccc(OC)cc4)[nH]2,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,25.12
4111,CHEMBL332270,CCN(Cc1cccc(Cl)c1)Cc2ccc([nH]2)c3cc(ccc3OC)S(=O)(=O)CC,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,10.0
4113,CHEMBL113229,CCN(Cc1ccc2OCOc2c1)Cc3ccc([nH]3)c4cc(ccc4OC)S(=O)(=O)CC,Ki,=,3.162,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,3.162
4114,CHEMBL324044,CCN(Cc1ccc(OC)c(OC)c1)Cc2ccc([nH]2)c3cc(ccc3OC)S(=O)(=O)CC,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,31.62
4115,CHEMBL112735,CCN(Cc1ccc(OC)cc1)Cc2ccc([nH]2)c3cc(ccc3OC)S(=O)(=O)CC,Ki,=,1.995,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,1.995
4124,CHEMBL112705,CCN(Cc1ccc(C)cc1)Cc2ccc([nH]2)c3cc(ccc3OC)S(=O)(=O)CC,Ki,=,0.3981,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,0.3981
4125,CHEMBL322070,CCN(Cc1ccc(Cl)cc1)Cc2ccc([nH]2)c3cc(ccc3OC)S(=O)(=O)CC,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,1.0
4126,CHEMBL112505,CCN(Cc1cccc(OC)c1)Cc2ccc([nH]2)c3cc(ccc3OC)S(=O)(=O)CC,Ki,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,79.43
4136,CHEMBL418854,COc1ccccc1N2CCC(CNCC3COc4ccc(Cl)cc4O3)CC2,Ki,=,13.2,nM,Dopamine D2 receptor,Homo sapiens,The compound was tested for binding affinity against human Dopamine receptor D2L,B,13.2
4138,CHEMBL325750,O=C1NCN(c2ccccc2)C13CCN(Cc4ccc5nsnc5c4)CC3,IC50,=,123.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine receptor D2,B,61.5
4170,CHEMBL119455,CN1CCc2cccc3c2[C@H]1Cc4cccc(O)c34,Ki,=,58.5,nM,Dopamine D2 receptor,Homo sapiens,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,B,58.5
4171,CHEMBL119455,CN1CCc2cccc3c2[C@H]1Cc4cccc(O)c34,Ki,=,58.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human Dopamine receptor D2A,B,58.5
4172,CHEMBL119455,CN1CCc2cccc3c2[C@H]1Cc4cccc(O)c34,Ki,=,58.5,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]raclopride binding to cloned human Dopamine receptor D2A,B,58.5
4202,CHEMBL118254,CCc1cccc2C[C@H]3N(C)CCc4cccc(c34)c12,Ki,=,79.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human Dopamine receptor D2A,B,79.2
4207,CHEMBL325710,CCCN(CCC)C1Cc2cc3nc(N)sc3cc2C1,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,in vitro binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]NPA as radioligand.,B,27.0
4219,CHEMBL120590,O=C1Oc2cc(OCCCN3CCN(CC3)c4ccccc4)ccc2C=C1,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Compound was measured for the binding affinity in homogenated mouse fibroblast (LTK) cells transfected with human Dopamine receptor D2A using [3H]raclopride as radioligand.,B,16.0
4220,CHEMBL120661,CC1=C(C)c2ccc(OCCCN3CCN(CC3)c4ccccc4)cc2OC1=O,Ki,=,5.92,nM,Dopamine D2 receptor,Homo sapiens,Compound was measured for the binding affinity in homogenated mouse fibroblast (LTK) cells transfected with human Dopamine receptor D2A using [3H]raclopride as radioligand.,B,5.92
4221,CHEMBL422788,CC1=Cc2ccc(OCCCN3CCN(CC3)c4ccccc4)cc2OC1=O,Ki,=,10.8,nM,Dopamine D2 receptor,Homo sapiens,Compound was measured for the binding affinity in homogenated mouse fibroblast (LTK) cells transfected with human Dopamine receptor D2A using [3H]raclopride as radioligand.,B,10.8
4222,CHEMBL116372,CCCN(CCC)C1COc2ccc3nc(N)sc3c2C1,Ki,=,47.0,nM,Dopamine D2 receptor,Homo sapiens,in vitro binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]-0437 as radioligand.,B,47.0
4231,CHEMBL124234,O.Cc1ccc(CN2CCC(CC2)C3CCc4ccccc4C3=O)cc1,Ki,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,37.0
4232,CHEMBL122538,Fc1ccc2C(=O)C(CCc2c1)C3CCN(Cc4ccccc4)CC3,Ki,=,62.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,62.0
4246,CHEMBL122533,COc1cc(N)c(Cl)cc1C(=O)NC2CC3CCCC(C2)N3Cc4ccccc4,Ki,=,0.2512,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor,B,0.2512
4253,CHEMBL124444,COc1ccccc1N2CCN(CCCCNC(=O)c3oc4ccccc4c3)CC2,Ki,=,84.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,B,84.0
4258,CHEMBL127317,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc4ccccc4n3)CC2,Ki,=,66.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,B,66.8
4261,CHEMBL125916,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4ccccc4[nH]3)CC2,Ki,=,37.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from D2 receptor,B,37.4
4263,CHEMBL125916,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4ccccc4[nH]3)CC2,Ki,=,37.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,B,37.4
4265,CHEMBL419792,CN[C@H]1CN2C(=O)Nc3cccc(C1)c23,EC50,=,165.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro effective concentration tested on HEK293 cells co-transfected with human Dopamine receptor D2 using FLIPR assay,F,82.5
4267,CHEMBL419792,CN[C@H]1CN2C(=O)Nc3cccc(C1)c23,Ki,=,9.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,B,9.0
4268,CHEMBL419792,CN[C@H]1CN2C(=O)Nc3cccc(C1)c23,Ki,=,17.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,17.1
4270,CHEMBL419792,CN[C@H]1CN2C(=O)Nc3cccc(C1)c23,EC50,=,60.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,B,30.05
4272,CHEMBL419792,CN[C@H]1CN2C(=O)Nc3cccc(C1)c23,EC50,=,64.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,B,32.35
4274,CHEMBL419792,CN[C@H]1CN2C(=O)Nc3cccc(C1)c23,EC50,=,4.6,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at recombinant human D2 receptor expressing in CHO cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation by beta plate counter,B,2.3
4276,CHEMBL419792,CN[C@H]1CN2C(=O)Nc3cccc(C1)c23,EC50,=,32.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as cAMP inhibition by BRET assay,B,16.1
4277,CHEMBL419792,CN[C@H]1CN2C(=O)Nc3cccc(C1)c23,Ki,=,46.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,B,46.3
4282,CHEMBL419792,CN[C@H]1CN2C(=O)Nc3cccc(C1)c23,EC50,=,74.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,B,37.4
4291,CHEMBL341299,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3occc3)CC2.OC(=O)C(=O)O,Ki,=,11.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,11.1
4292,CHEMBL126749,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc4ccccc4c3)CC2,Ki,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,32.0
4293,CHEMBL341542,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3cccnc3)CC2.OC(=O)C(=O)O,Ki,=,14.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,14.5
4295,CHEMBL126474,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)C(=O)C)CC2,Ki,=,17.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,17.5
4296,CHEMBL338552,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3cccs3)CC2.OC(=O)C(=O)O,Ki,=,9.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,9.5
4298,CHEMBL127288,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)C(C)(C)C)CC2,Ki,=,26.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,26.5
4299,CHEMBL126280,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccsc3)CC2,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,13.0
4301,CHEMBL127230,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc(Oc4ccccc4)cc3)CC2,Ki,=,65.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,65.2
4302,CHEMBL126312,COc1ccccc1N2CCN(Cc3ccccc3CNC(=O)c4ccc5ccccc5c4)CC2.OC(=O)C(=O)O,Ki,=,28.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,28.4
4303,CHEMBL127807,COc1ccccc1N2CCN(Cc3cccc(CNC(=O)c4ccc5ccccc5c4)c3)CC2.OC(=O)C(=O)O,Ki,=,45.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,45.0
4304,CHEMBL129035,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc(\C=C\C(=O)NCCCCN4CCN(CC4)c5ccccc5OC)cc3)CC2,Ki,=,7.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,7.2
4305,CHEMBL126632,COc1ccccc1N2CCN(CCCCN3C(=O)c4ccccc4C3=O)CC2.OC(=O)C(=O)O,Ki,=,50.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,50.0
4306,CHEMBL129767,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\C=C\c3ccccc3)CC2,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,19.0
4307,CHEMBL127311,COc1ccc(\C=C\C(=O)NCCCCN2CCN(CC2)c3ccccc3OC)cc1,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,12.0
4310,CHEMBL126331,COc1ccc2cc(ccc2c1)[C@H](C)C(=O)NCCCN3CCN(CC3)c4ccccc4OC.OC(=O)C(=O)O,Ki,=,94.6,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,94.6
4311,CHEMBL340608,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccccc3I)CC2,Ki,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,63.0
4312,CHEMBL127654,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccccc3Cl)CC2.OC(=O)C(=O)O,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,15.0
4320,CHEMBL127912,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3cccc(Cl)c3)CC2.OC(=O)C(=O)O,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,20.0
4321,CHEMBL126285,COc1ccccc1N2CCN(CCCCN3C(=O)c4cccc5cccc(C3=O)c45)CC2,Ki,=,40.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,40.0
4323,CHEMBL127923,COc1cc(\C=C\C(=O)NCCCCN2CCN(CC2)c3ccccc3OC)cc(I)c1OC.OC(=O)C(=O)O,Ki,=,38.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,38.5
4325,CHEMBL340851,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc(OCc4ccccc4)cc3)CC2,Ki,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,32.0
4326,CHEMBL415520,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3cccc(c3)C(F)(F)F)CC2.OC(=O)C(=O)O,Ki,=,50.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,50.2
4327,CHEMBL126258,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(Cl)cc3)CC2.OC(=O)C(=O)O,Ki,=,19.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,19.5
4330,CHEMBL126948,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)C(=O)c4ccccc4)CC2.OC(=O)C(=O)O,Ki,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,63.0
4331,CHEMBL421085,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc(Cl)c(Cl)c3)CC2.OC(=O)C(=O)O,Ki,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,23.0
4333,CHEMBL125459,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3cccc4OCOc34)CC2,Ki,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,8.0
4334,CHEMBL127038,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc4OCOc4c3)CC2,Ki,=,10.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,10.3
4335,CHEMBL338063,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc(Cl)cc3Cl)CC2.OC(=O)C(=O)O,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,21.0
4336,CHEMBL126441,COc1ccccc1\C=C\C(=O)NCCCCN2CCN(CC2)c3ccccc3OC,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,14.0
4337,CHEMBL126746,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc(cc3)c4ccccc4)CC2,Ki,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,37.0
4338,CHEMBL127234,COc1ccccc1N2CCN(Cc3ccccc3CNC(=O)\C=C\c4ccccc4)CC2,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,18.0
4341,CHEMBL126892,COc1ccccc1N2CCN(CCCCNC(=O)c3nccc4ccccc34)CC2.OC(=O)C(=O)O,Ki,=,20.9,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,20.9
4342,CHEMBL126439,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc4ccccc4n3)CC2.OC(=O)C(=O)O,Ki,=,53.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,53.2
4344,CHEMBL339062,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc(C=O)cc3)CC2.OC(=O)C(=O)O,Ki,=,11.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,11.5
4345,CHEMBL129465,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc(cc3)[N+](=O)[O-])CC2.OC(=O)C(=O)O,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,14.0
4346,CHEMBL341241,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc(cc3)C#N)CC2.OC(=O)C(=O)O,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,10.0
4347,CHEMBL126502,COc1ccccc1N2CCN(CCCCNC(=O)c3cccc(I)c3)CC2.OC(=O)C(=O)O,Ki,=,68.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,68.0
4348,CHEMBL129483,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)c4ccccc4)CC2.OC(=O)C(=O)O,Ki,=,75.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,75.0
4350,CHEMBL126136,COc1ccccc1N2CCN(CCCCNC(=O)c3ccccc3I)CC2,Ki,=,15.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,15.2
4351,CHEMBL129429,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc(cc3)C(F)(F)F)CC2,Ki,=,36.79,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,36.79
4352,CHEMBL128133,COc1ccccc1N2CCN(CCCNC(=O)Cc3ccc4ccccc4c3)CC2.OC(=O)C(=O)O,Ki,=,56.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,56.0
4353,CHEMBL340712,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc(I)cc3)CC2,Ki,=,76.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,76.4
4354,CHEMBL126834,COc1ccccc1N2CCN(CCCCNC(=O)c3cccc4C(=O)c5ccccc5c34)CC2,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,18.0
4356,CHEMBL126656,COc1ccccc1N2CCN(CCCNC(=O)Cc3cccc4ccccc34)CC2.OC(=O)C(=O)O,Ki,=,44.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,44.0
4357,CHEMBL341134,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc(Br)cc3)CC2.OC(=O)C(=O)O,Ki,=,23.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,23.7
4358,CHEMBL339103,COc1ccccc1N2CCN(CCCCNC(=O)Cc3ccc4ccccc4c3)CC2.OC(=O)C(=O)O,Ki,=,35.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,35.0
4359,CHEMBL126725,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc(Cl)cc3)CC2.OC(=O)C(=O)O,Ki,=,22.6,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,22.6
4361,CHEMBL126725,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc(Cl)cc3)CC2.OC(=O)C(=O)O,EC50,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Effective concentration for Dopamine receptor D3 was determined,F,5.0
4362,CHEMBL338606,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc(F)cc3)CC2,Ki,=,20.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,20.7
4363,CHEMBL338606,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc(F)cc3)CC2,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,B,27.0
4364,CHEMBL338606,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc(F)cc3)CC2,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,B,21.0
4365,CHEMBL338606,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc(F)cc3)CC2,EC50,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine receptor D2long expressed in CHO10001 cells assessed as stimulation of incorporation [3H]-thymidine incorporation,F,0.85
4368,CHEMBL126128,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccccc3)CC2.OC(=O)C(=O)O,Ki,=,13.54,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,13.54
4369,CHEMBL126313,COc1ccccc1N2CCN(CCCCNC(=O)c3sc4ccccc4c3Cl)CC2,Ki,=,71.9,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,71.9
4370,CHEMBL126780,COc1ccccc1N2CCN(CCCCNC(=O)C3=Cc4ccccc4OC3=O)CC2,Ki,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,23.0
4372,CHEMBL340211,Fc1ccc(cc1)C(=O)CCCN2CCN(CC2)c3ccccn3,Ki,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from CHO-K1 cell membranes expressing human dopamine receptor D2,B,52.0
4373,CHEMBL340173,COc1ccccc1N2CCN(CCCCNC(=O)CCc3ccccc3)CC2.OC(=O)C(=O)O,Ki,=,48.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,48.7
4374,CHEMBL125525,COc1ccccc1N2CCN(CCCCNC(=O)C3=COc4ccccc4C3=O)CC2.OC(=O)C(=O)O,Ki,=,47.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,47.0
4375,CHEMBL127114,COc1ccccc1N2CCN(CCCCNC(=O)C3CC3c4ccccc4)CC2.OC(=O)C(=O)O,Ki,=,81.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,81.0
4376,CHEMBL127080,COc1ccccc1N2CCN(CCCCNC(=O)C3(CCCC3)c4ccc(Cl)cc4)CC2.OC(=O)C(=O)O,Ki,=,56.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,56.0
4378,CHEMBL129237,O[C@@H](CCCN1CCC(O)(CC1)c2ccc(Cl)cc2)c3ccc(F)cc3,Ki,=,73.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from CHO-K1 cell membranes expressing human dopamine receptor D2,B,73.0
4383,CHEMBL129022,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4ccccc4cn3)CC2.OC(=O)C(=O)O,Ki,=,27.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,B,27.5
4385,CHEMBL129022,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4ccccc4cn3)CC2.OC(=O)C(=O)O,EC50,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Effective concentration for Dopamine receptor D3 was determined,F,1.25
4387,CHEMBL125455,Clc1ccc(N2CCN(C[C@@H]3C[C@H]3c4ccccc4)CC2)c(Cl)c1,IC50,=,64.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,32.0
4388,CHEMBL126429,Clc1ccc(cc1Cl)N2CCN(C[C@H]3C[C@@H]3c4ccccc4)CC2,Ki,=,93.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 receptor,B,93.0
4389,CHEMBL341497,C([C@H]1C[C@@H]1c2ccccc2)N3CCN(CC3)c4ccccc4,IC50,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,18.5
4390,CHEMBL130795,CS(=O)(=O)O.Oc1ccc(cc1)C2CN(CC=C)CCc3c(Cl)c(O)c(O)cc23,EC50,=,122.0,nM,Dopamine D2 receptor,Homo sapiens,Dopamine receptor D2 agonist activity was determined for inhibition of release of NE in an isolated perfused rabbit ear artery preparation,F,61.0
4391,CHEMBL131313,CS(=O)(=O)O.Oc1ccc(cc1)C2CN(CC=C)CCc3c(Br)c(O)c(O)cc23,EC50,=,174.0,nM,Dopamine D2 receptor,Homo sapiens,Dopamine receptor D2 agonist activity was determined for inhibition of the constrictor response to electrical stimulation in an isolated perfused rabbit ear artery preparation,F,87.0
4392,CHEMBL129634,CS(=O)(=O)O.Oc1ccc(cc1)C2CN(CC=C)CCc3c(F)c(O)c(O)cc23,EC50,=,137.0,nM,Dopamine D2 receptor,Homo sapiens,Dopamine receptor D2 agonist activity was determined for inhibition of the constrictor response to electrical stimulation in an isolated perfused rabbit ear artery preparation,F,68.5
4397,CHEMBL129534,Clc1cccc(OCCNCCCOc2ccccc2)c1,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,B,22.0
4398,CHEMBL129534,Clc1cccc(OCCNCCCOc2ccccc2)c1,Ki,=,21.88,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,B,21.88
4403,CHEMBL128232,Cc1cccc(OCCNCCCOc2ccccc2)c1,Ki,=,61.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,B,61.0
4404,CHEMBL128232,Cc1cccc(OCCNCCCOc2ccccc2)c1,Ki,=,61.66,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,B,61.66
4405,CHEMBL128313,Cc1ccccc1OCCNCCCOc2ccccc2,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,B,20.0
4406,CHEMBL128313,Cc1ccccc1OCCNCCCOc2ccccc2,Ki,=,19.95,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,B,19.95
4411,CHEMBL338611,CN1C(=O)N(C)c2ncn(CCCN3CCC(CC3)C(c4ccccc4)c5ccccc5)c2C1=O.OC(=O)\C=C\C(=O)O,IC50,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,Compound is evaluated for in vitro receptor binding affinity against Dopamine receptor D2,B,20.5
4419,CHEMBL131299,Cc1ccc(OCCCNCCOc2ccccc2)cc1,Ki,=,64.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,B,64.0
4420,CHEMBL131299,Cc1ccc(OCCCNCCOc2ccccc2)cc1,Ki,=,64.57,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,B,64.57
4439,CHEMBL129979,Clc1ccc2[nH]cc(C3=CCN(CCCCCN4C(=O)c5ccccc5C4=O)CC3)c2c1,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,B,20.0
4440,CHEMBL340220,Cc1ccc2C(=O)N(CCCCCN3CCC(=CC3)c4c[nH]c5ccc(F)cc45)C(=O)c2c1,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,B,20.0
4441,CHEMBL335259,Cc1cccc2C(=O)N(CCCCCN3CCC(=CC3)c4c[nH]c5ccc(F)cc45)C(=O)c12,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,B,25.0
4442,CHEMBL334956,Fc1ccc2[nH]cc(C3=CCN(CCCN4C(=O)c5ccccc5C4=O)CC3)c2c1,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,B,20.0
4443,CHEMBL422618,Cc1cccc2c(c[nH]c12)C3=CCN(CCCCCN4C(=O)c5ccccc5C4=O)CC3,Ki,=,40.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,B,40.0
4445,CHEMBL414433,O=C1N(CCCCCN2CCC(=CC2)c3c[nH]c4ccccc34)C(=O)c5ccccc15,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,B,25.0
4446,CHEMBL133524,Fc1ccc2[nH]cc(C3=CCN(CCCCCN4C(=O)c5ccccc5C4=O)CC3)c2c1,Ki,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,B,5.0
4447,CHEMBL423706,Fc1ccc(cc1)C(=O)CCCN2CCC(CCc3c[nH]c4ccccc34)CC2,Ki,=,40.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,B,40.0
4464,CHEMBL339098,Fc1cccc2C(=O)N(CCCCCN3CCC(=CC3)c4c[nH]c5ccccc45)C(=O)c12,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,B,25.0
4465,CHEMBL338270,Fc1ccc2[nH]cc(C3=CCN(CCCCCCCN4C(=O)c5ccccc5C4=O)CC3)c2c1,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,B,25.0
4466,CHEMBL131495,Fc1ccc2[nH]cc(C3=CCN(CCCCN4C(=O)c5ccccc5C4=O)CC3)c2c1,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,B,16.0
4467,CHEMBL131495,Fc1ccc2[nH]cc(C3=CCN(CCCCN4C(=O)c5ccccc5C4=O)CC3)c2c1,Ki,=,3.162,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,B,3.162
4474,CHEMBL336771,Fc1ccc2C(=O)N(CCCCCN3CCC(=CC3)c4c[nH]c5ccc(F)cc45)C(=O)c2c1,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,B,10.0
4475,CHEMBL335844,Fc1ccc2[nH]cc(C3=CCN(CCCCCN4C(=O)c5cccc(F)c5C4=O)CC3)c2c1,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,B,12.0
4476,CHEMBL130261,Cc1ccc2C(=O)N(CCCCCN3CCC(=CC3)c4c[nH]c5ccccc45)C(=O)c2c1,Ki,=,40.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,B,40.0
4484,CHEMBL421902,Fc1ccc2C(=O)N(CCCCCN3CCC(=CC3)c4c[nH]c5ccccc45)C(=O)c2c1,Ki,=,40.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,B,40.0
4492,CHEMBL132575,CCCN(CCC)C1CCC2=C(CCC/C/2=N\O)C1,EC50,=,170.0,nM,Dopamine D2 receptor,Homo sapiens,Tested for intrinsic activity towards Dopamine receptor D2 in CHO cells,B,85.0
4493,CHEMBL131926,COc1nc(N)c(Cl)cc1C(=O)NC2CC3CCCC(C2)N3Cc4ccccc4,Ki,=,1.2590000000000001,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor,B,1.2590000000000001
4494,CHEMBL134423,Fc1ccc(cc1)[Si]2(CCC(C2)N3CCN(CC3)c4ccccc4)c5ccc(F)cc5,IC50,=,140.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor,B,70.0
4495,CHEMBL134423,Fc1ccc(cc1)[Si]2(CCC(C2)N3CCN(CC3)c4ccccc4)c5ccc(F)cc5,IC50,=,100.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor,B,50.0
4497,CHEMBL336652,CCCNC1CCc2ccc(O)cc2C1,Ki,=,3.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,B,3.8
4502,CHEMBL133830,NC1CCc2ccc(O)cc2C1,Ki,=,78.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,B,78.0
4503,CHEMBL133830,NC1CCc2ccc(O)cc2C1,Ki,=,3.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,B,3.3
4507,CHEMBL334472,CCCNC1CCc2c(O)cccc2C1,Ki,=,0.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,B,0.5
4517,CHEMBL335392,CCCN(C)C1CCc2ccc(O)cc2C1,Ki,=,0.67,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,B,0.67
4519,CHEMBL134571,CCN(C)C1CCc2ccc(O)cc2C1,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,B,2.5
4520,CHEMBL135932,CN(C)C1CCc2ccc(O)cc2C1,Ki,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,B,55.0
4521,CHEMBL135932,CN(C)C1CCc2ccc(O)cc2C1,Ki,=,5.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,B,5.4
4569,CHEMBL135044,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CN3CCc4ccccc4C3)Oc2c1,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,B,2.5
4571,CHEMBL135954,CCCN(CCc1cccs1)C2CCc3ccc(O)cc3C2,Ki,=,59.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,B,59.0
4572,CHEMBL135954,CCCN(CCc1cccs1)C2CCc3ccc(O)cc3C2,Ki,=,0.76,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,B,0.76
4579,CHEMBL134343,OC(=O)C(=O)O.Oc1cc2O[C@H](CNCc3ccccc3)CCc2cc1Cl,Ki,=,77.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,B,77.0
4581,CHEMBL135357,OC(=O)C(=O)O.Oc1cc2O[C@@H](CNCc3ccccc3)CCc2cc1Cl,Ki,=,7.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,B,7.0
4583,CHEMBL423890,OC(=O)C(=O)O.Oc1ccc2OC[C@H](CNCc3ccccc3)Oc2c1,Ki,=,7.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,B,7.2
4586,CHEMBL133085,CCCN(C\C=C\I)C1COc2c(O)cccc2C1,Ki,=,10.8,nM,Dopamine D2 receptor,Homo sapiens,Tested for the inhibitory activity against D2H (high-affinity states) receptor in infected HEK 293 cells.,B,10.8
4588,CHEMBL134807,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccccc3)Oc2c1,Ki,=,10.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,B,10.4
4591,CHEMBL134807,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccccc3)Oc2c1,EC50,=,0.01995,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by LANCE assay,F,0.009975
4593,CHEMBL134807,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccccc3)Oc2c1,Ki,=,70.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,70.2
4594,CHEMBL134807,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccccc3)Oc2c1,Ki,=,2.98,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,2.98
4596,CHEMBL134807,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccccc3)Oc2c1,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,39.81
4597,CHEMBL134807,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccccc3)Oc2c1,Ki,=,1.23,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,1.23
4598,CHEMBL134808,OC(=O)C(=O)O.Oc1ccc2CCC(CN3CCc4ccccc4C3)Oc2c1,Ki,=,4.3,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested to inhibit Dopa accumulation in to Dopamine receptor D2 at 10 mg/kg, sc",B,4.3
4600,CHEMBL135725,OC(=O)C(=O)O.Oc1ccc2CC[C@@H](CN3CCc4ccccc4C3)Oc2c1,Ki,=,73.9,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,B,73.9
4603,CHEMBL263282,CCCN(C\C=C\I)C1CCc2c(O)cccc2C1,Ki,=,3.6,nM,Dopamine D2 receptor,Homo sapiens,Tested for the inhibitory activity against D2H (high-affinity states) receptor in infected HEK 293 cells.,B,3.6
4605,CHEMBL336851,CCCN(C\C=C\I)C1CCc2cc(O)ccc2C1,Ki,=,9.7,nM,Dopamine D2 receptor,Homo sapiens,Tested for the inhibitory activity against D2H (high-affinity states) receptor in infected HEK 293 cells.,B,9.7
4613,CHEMBL135395,OC(=O)C(=O)O.Oc1ccc2CCC(CNCc3ccccc3)Oc2c1,Ki,=,9.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,B,9.7
4617,CHEMBL337228,OC(=O)C(=O)O.Oc1cc2OC(CNCc3ccccc3)CCc2cc1Cl,Ki,=,5.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity in humans to Dopamine receptor D2 expressed in CHO cells was determined using the agonist [3H]-spiperone.,B,5.2
4627,CHEMBL335403,O=C(N[C@@H]1CC[C@H]2C[C@H](CC[C@@H]2C1)N3CCN(CC3)c4ccccn4)c5ccccc5,EC50,=,10.4,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibition of forskolin-stimulated cAMP accumulation in GH4C1 cells transfected with the human Dopamine D2 receptor,F,5.2
4630,CHEMBL135387,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3ccccn3)CC1)c4ccccc4,EC50,=,4.9,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibition of forskolin-stimulated cAMP accumulation in GH4C1 cells transfected with the human Dopamine D2 receptor,F,2.45
4634,CHEMBL137781,C[C@@H]1C[C@H](C)N1C(=O)[C@H]2CN(C)C3Cc4c[nH]c5cccc(C3=C2)c45,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2,B,60.0
4637,CHEMBL335545,C([C@@H]1CCC=C(C1)c2ccccc2)N3CCC(=CC3)c4ccccc4,Ki,=,25.5,nM,Dopamine D2 receptor,Homo sapiens,Tested for binding affinity towards human D2L receptor using [3H]spiperone as radioligand,B,25.5
4639,CHEMBL335545,C([C@@H]1CCC=C(C1)c2ccccc2)N3CCC(=CC3)c4ccccc4,Ki,=,25.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]spiperone,B,25.5
4640,CHEMBL335545,C([C@@H]1CCC=C(C1)c2ccccc2)N3CCC(=CC3)c4ccccc4,Ki,=,8.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]N-0437,B,8.4
4646,CHEMBL141510,CCCCN(CCC)[C@@H]1CCc2c(F)cccc2C1,Ki,=,45.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]quinpirole from Dopamine receptor D2,B,45.6
4681,CHEMBL138998,CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)[C@@H]3CCc4c(F)cccc4C3,Ki,=,4.94,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]quinpirole from Dopamine receptor D2,B,4.94
4682,CHEMBL138998,CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)[C@@H]3CCc4c(F)cccc4C3,Ki,=,16.9,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]raclopride binding to Dopamine receptor D2,B,16.9
4686,CHEMBL139089,Fc1cccc2C[C@@H](CCc12)NCCCCN3C(=O)CC4(CCCC4)CC3=O,Ki,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]quinpirole from Dopamine receptor D2,B,37.0
4687,CHEMBL139089,Fc1cccc2C[C@@H](CCc12)NCCCCN3C(=O)CC4(CCCC4)CC3=O,Ki,=,68.2,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]raclopride binding to Dopamine receptor D2,B,68.2
4695,CHEMBL140872,Fc1ccc(cc1)C(=O)CCCN2CCN(CC2)c3ncccn3,Ki,=,98.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,98.0
4696,CHEMBL140872,Fc1ccc(cc1)C(=O)CCCN2CCN(CC2)c3ncccn3,Ki,=,98.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,98.0
4699,CHEMBL337531,Clc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4[te]3)CC2)c1Cl,Ki,=,91.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,B,91.0
4700,CHEMBL337531,Clc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4[te]3)CC2)c1Cl,Ki,=,48.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,B,48.0
4707,CHEMBL140612,COc1ccccc1N2CCN(CCCNC(=O)c3cnn4ccccc34)CC2,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,B,11.0
4708,CHEMBL140612,COc1ccccc1N2CCN(CCCNC(=O)c3cnn4ccccc34)CC2,Ki,=,3.9,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,B,3.9
4709,CHEMBL140612,COc1ccccc1N2CCN(CCCNC(=O)c3cnn4ccccc34)CC2,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from wild type human cloned dopamine D2L receptor expressed in HEK293 cells,B,13.0
4710,CHEMBL140612,COc1ccccc1N2CCN(CCCNC(=O)c3cnn4ccccc34)CC2,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,B,11.0
4711,CHEMBL139600,COc1ccccc1N2CCN(CCCCCNC(=O)c3cnn4ccccc34)CC2,Ki,=,30.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,B,30.0
4712,CHEMBL139600,COc1ccccc1N2CCN(CCCCCNC(=O)c3cnn4ccccc34)CC2,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,B,25.0
4713,CHEMBL139600,COc1ccccc1N2CCN(CCCCCNC(=O)c3cnn4ccccc34)CC2,Ki,=,30.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,30.2
4714,CHEMBL139600,COc1ccccc1N2CCN(CCCCCNC(=O)c3cnn4ccccc34)CC2,Ki,=,7.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,7.1
4744,CHEMBL142020,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4ccccn4n3)CC2,Ki,=,99.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,99.0
4747,CHEMBL140968,COc1ccccc1N2CCN(CCCCCNC(=O)c3cc4ccccn4n3)CC2,Ki,=,71.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,B,71.0
4748,CHEMBL140968,COc1ccccc1N2CCN(CCCCCNC(=O)c3cc4ccccn4n3)CC2,Ki,=,76.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,B,76.0
4749,CHEMBL140968,COc1ccccc1N2CCN(CCCCCNC(=O)c3cc4ccccn4n3)CC2,Ki,=,70.79,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,70.79
4750,CHEMBL140968,COc1ccccc1N2CCN(CCCCCNC(=O)c3cc4ccccn4n3)CC2,Ki,=,35.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,35.0
4759,CHEMBL423735,COc1ccccc1N2CCN(CCCCNC(=O)c3cnn4ccccc34)CC2,Ki,=,65.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,B,65.0
4764,CHEMBL141845,COc1ccccc1N2CCN(CCNC(=O)c3cnn4ccccc34)CC2,Ki,=,85.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,85.0
4770,CHEMBL139926,Clc1cccc(N2CCN(CCCCNC(=O)c3oc4ccccc4c3)CC2)c1Cl,Ki,=,80.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,B,80.0
4771,CHEMBL139926,Clc1cccc(N2CCN(CCCCNC(=O)c3oc4ccccc4c3)CC2)c1Cl,Ki,=,44.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,44.8
4775,CHEMBL139926,Clc1cccc(N2CCN(CCCCNC(=O)c3oc4ccccc4c3)CC2)c1Cl,Ki,=,44.8,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,B,44.8
4777,CHEMBL139926,Clc1cccc(N2CCN(CCCCNC(=O)c3oc4ccccc4c3)CC2)c1Cl,Ki,=,44.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,B,44.8
4778,CHEMBL139926,Clc1cccc(N2CCN(CCCCNC(=O)c3oc4ccccc4c3)CC2)c1Cl,Ki,=,82.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,82.0
4780,CHEMBL344677,COc1ccccc1N2CCN(CCCCNC(=O)c3cccc4ccnn34)CC2,Ki,=,98.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,B,98.0
4782,CHEMBL344677,COc1ccccc1N2CCN(CCCCNC(=O)c3cccc4ccnn34)CC2,Ki,=,34.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,34.0
4784,CHEMBL336930,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc4ccnn4c3)CC2,Ki,=,84.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,B,84.0
4788,CHEMBL342060,COc1ccccc1N2CCN(CCCCNC(=O)c3ccn4nccc4c3)CC2,Ki,=,58.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,58.0
4789,CHEMBL141419,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4ccccc4[te]3)CC2,Ki,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,B,63.0
4790,CHEMBL141419,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4ccccc4[te]3)CC2,Ki,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,B,39.0
4797,CHEMBL424294,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2,Ki,=,87.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,B,87.0
4798,CHEMBL424294,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2,Ki,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,B,52.0
4799,CHEMBL424294,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2,Ki,=,87.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,87.1
4800,CHEMBL424294,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2,Ki,=,95.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,95.0
4801,CHEMBL424294,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2,Ki,=,72.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,72.0
4803,CHEMBL424294,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,25.0
4814,CHEMBL143027,Fc1ccc2c(noc2c1)C3CCN(CC4CC(=O)c5ccoc5C4)CC3,Ki,=,16.22,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,16.22
4844,CHEMBL424125,COc1ccc2CCCC(CCCN3CCN(CC3)c4ccccc4OC)c2c1,IC50,=,150.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,75.0
4854,CHEMBL357416,Oc1ccc(cc1)C2=CCC[C@@H](CN3CCC(=CC3)c4ccccc4)C2,Ki,=,3.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]spiperone,B,3.5
4855,CHEMBL357416,Oc1ccc(cc1)C2=CCC[C@@H](CN3CCC(=CC3)c4ccccc4)C2,Ki,=,0.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]N-0437,B,0.2
4858,CHEMBL147159,Oc1ccc(cc1)C2=CCN(C[C@@H]3CCC=C(C3)c4ccc(O)cc4)CC2,Ki,=,10.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]spiperone,B,10.3
4859,CHEMBL147159,Oc1ccc(cc1)C2=CCN(C[C@@H]3CCC=C(C3)c4ccc(O)cc4)CC2,Ki,=,2.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]N-0437,B,2.2
4867,CHEMBL356269,Oc1ccc(cc1)C2=CCN(C[C@@H]3CCC=C(C3)c4ccccc4)CC2,Ki,=,94.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]spiperone,B,94.0
4868,CHEMBL356269,Oc1ccc(cc1)C2=CCN(C[C@@H]3CCC=C(C3)c4ccccc4)CC2,Ki,=,5.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]N-0437,B,5.7
4894,CHEMBL357807,COc1ccc2OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)CCc2c1,Ki,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,B,2.0
4898,CHEMBL150161,OC1(CCN(CCCC(=O)c2ccc(F)cc2)C1)c3ccc(Cl)cc3,Ki,=,51.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor by radioligand binding assay,B,51.1
4900,CHEMBL150161,OC1(CCN(CCCC(=O)c2ccc(F)cc2)C1)c3ccc(Cl)cc3,Ki,=,51.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,51.1
4902,CHEMBL150161,OC1(CCN(CCCC(=O)c2ccc(F)cc2)C1)c3ccc(Cl)cc3,Ki,=,33.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,33.0
4921,CHEMBL149723,CSc1cc2CCOc2c(c1)C(=O)NC[C@H]3CCCN3CCc4ccccc4,Ki,=,6.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,B,6.7
4948,CHEMBL346398,Cc1ccc(cc1)C2CCN(Cc3ccc4OCC(=O)Nc4c3)CC2,Ki,=,52.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,B,52.5
5006,CHEMBL152262,Clc1cccc(N2CCN(CCCCNC(=O)c3c[nH]c4ccccc34)CC2)c1Cl,Ki,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,B,63.0
5022,CHEMBL433741,COc1cccc(c1)C(=O)NCCCCN2CCN(CC2)c3cccc(C)c3C,Ki,=,77.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,B,77.0
5048,CHEMBL155486,Fc1ccc2c(noc2c1)C3CCN(CC4CC(=O)c5ccccc5C4)CC3,Ki,=,57.54,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine receptor D2,B,57.54
5049,CHEMBL155486,Fc1ccc2c(noc2c1)C3CCN(CC4CC(=O)c5ccccc5C4)CC3,Ki,=,64.57,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine receptor D2,B,64.57
5051,CHEMBL1303,CCCN(CCc1cccs1)[C@H]2CCc3c(O)cccc3C2,Ki,=,0.06,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,B,0.06
5052,CHEMBL1303,CCCN(CCc1cccs1)[C@H]2CCc3c(O)cccc3C2,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,B,20.0
5053,CHEMBL1303,CCCN(CCc1cccs1)[C@H]2CCc3c(O)cccc3C2,Ki,=,0.06,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,B,0.06
5055,CHEMBL1303,CCCN(CCc1cccs1)[C@H]2CCc3c(O)cccc3C2,EC50,=,0.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase of forskolin-induced cAMP production after 20 mins,F,0.35
5056,CHEMBL1303,CCCN(CCc1cccs1)[C@H]2CCc3c(O)cccc3C2,EC50,=,4.1,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,B,2.05
5058,CHEMBL1303,CCCN(CCc1cccs1)[C@H]2CCc3c(O)cccc3C2,EC50,=,3.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2S receptor expressed in HEK293T cell membranes coexpressing Galphao1 assessed as induction of nucleotide exchange preincubated for 30 mins followed by addition of [35S]GTPgammaS measured after 30 mins by [35S]GTPgammaS binding assay,B,1.6
5060,CHEMBL1303,CCCN(CCc1cccs1)[C@H]2CCc3c(O)cccc3C2,EC50,=,4.4,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 and GRK2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,B,2.2
5065,CHEMBL155731,CCCN1CCC[C@@H]2Cc3nc(N)ncc3C[C@@H]12,EC50,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,1.0
5066,CHEMBL155731,CCCN1CCC[C@@H]2Cc3nc(N)ncc3C[C@@H]12,EC50,=,45.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,22.5
5067,CHEMBL155731,CCCN1CCC[C@@H]2Cc3nc(N)ncc3C[C@@H]12,EC50,=,44.67,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,22.335
5068,CHEMBL155731,CCCN1CCC[C@@H]2Cc3nc(N)ncc3C[C@@H]12,EC50,=,44.67,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,22.335
5069,CHEMBL155731,CCCN1CCC[C@@H]2Cc3nc(N)ncc3C[C@@H]12,EC50,=,45.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,22.5
5073,CHEMBL156689,CCCN(CCN1CCN(CC1)c2cccc(Cl)c2Cl)C3CCc4ccc(O)cc4C3,Ki,=,27.4,nM,Dopamine D2 receptor,Homo sapiens,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,B,27.4
5075,CHEMBL155826,CCCN(CCCCN1CCN(CC1)c2ccccc2)C3CCc4ccc(O)cc4C3,Ki,=,19.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,B,19.4
5076,CHEMBL155826,CCCN(CCCCN1CCN(CC1)c2ccccc2)C3CCc4ccc(O)cc4C3,Ki,=,19.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,B,19.3
5077,CHEMBL157035,Oc1ccc2CCC(Cc2c1)N(CCCCN3CCN(CC3)c4cccc(Cl)c4Cl)CC#C,Ki,=,7.37,nM,Dopamine D2 receptor,Homo sapiens,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,B,7.37
5078,CHEMBL157036,CCCN(CCCCN1CCN(CC1)c2cccc(Cl)c2Cl)C3CCc4ccc(O)cc4C3,Ki,=,8.78,nM,Dopamine D2 receptor,Homo sapiens,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,B,8.78
5081,CHEMBL156639,CCCN(CCN1CCN(CC1)c2ccccc2)C3CCc4ccc(O)cc4C3,EC50,=,12.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human cloned dopamine D2L receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding,F,6.1
5085,CHEMBL157293,Oc1ccc2CCC(Cc2c1)N(CCCCN3CCN(CC3)c4ccccc4)CC#C,Ki,=,68.4,nM,Dopamine D2 receptor,Homo sapiens,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,B,68.4
5086,CHEMBL157293,Oc1ccc2CCC(Cc2c1)N(CCCCN3CCN(CC3)c4ccccc4)CC#C,Ki,=,25.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,B,25.2
5087,CHEMBL157293,Oc1ccc2CCC(Cc2c1)N(CCCCN3CCN(CC3)c4ccccc4)CC#C,Ki,=,32.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,B,32.9
5098,CHEMBL156651,NC(=O)[C@H]1CS[C@@H]2CC[C@]3(CCCN3C(=O)[C@@H]4CCCN4)C(=O)N12,Ki,=,0.067,nM,Dopamine D2 receptor,Homo sapiens,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p,B,0.067
5102,CHEMBL156651,NC(=O)[C@H]1CS[C@@H]2CC[C@]3(CCCN3C(=O)[C@@H]4CCCN4)C(=O)N12,Ki,=,0.196,nM,Dopamine D2 receptor,Homo sapiens,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,B,0.196
5106,CHEMBL156651,NC(=O)[C@H]1CS[C@@H]2CC[C@]3(CCCN3C(=O)[C@@H]4CCCN4)C(=O)N12,Ki,=,0.05,nM,Dopamine D2 receptor,Homo sapiens,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p (pretreatment with 100 nM of compound),B,0.05
5110,CHEMBL156651,NC(=O)[C@H]1CS[C@@H]2CC[C@]3(CCCN3C(=O)[C@@H]4CCCN4)C(=O)N12,Ki,=,0.09,nM,Dopamine D2 receptor,Homo sapiens,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p (pretreatment with 100 nM of compound),B,0.09
5138,CHEMBL156164,NC(=O)C1CCS[C@@H]2C[C@]3(CCCN3C(=O)[C@@H]4CCCN4)C(=O)N12,Ki,=,0.071,nM,Dopamine D2 receptor,Homo sapiens,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p,B,0.071
5142,CHEMBL156164,NC(=O)C1CCS[C@@H]2C[C@]3(CCCN3C(=O)[C@@H]4CCCN4)C(=O)N12,Ki,=,0.122,nM,Dopamine D2 receptor,Homo sapiens,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,B,0.122
5146,CHEMBL156164,NC(=O)C1CCS[C@@H]2C[C@]3(CCCN3C(=O)[C@@H]4CCCN4)C(=O)N12,Ki,=,0.031,nM,Dopamine D2 receptor,Homo sapiens,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p (pretreatment with 100 nM of compound),B,0.031
5150,CHEMBL156164,NC(=O)C1CCS[C@@H]2C[C@]3(CCCN3C(=O)[C@@H]4CCCN4)C(=O)N12,Ki,=,0.064,nM,Dopamine D2 receptor,Homo sapiens,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p (pretreatment with 100 nM of compound),B,0.064
5171,CHEMBL157138,CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,Ki,=,0.8,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards Dopamine receptor D2,B,0.8
5172,CHEMBL157138,CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,Ki,=,0.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,B,0.5
5173,CHEMBL157138,CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,IC50,=,2.86,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,1.43
5174,CHEMBL157138,CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,Ki,=,0.953,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,0.953
5175,CHEMBL157138,CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,Ki,=,0.66,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125]iodosulpride from human recombinant dopamine D2L receptor expressed in CHO cells after 30 mins,B,0.66
5177,CHEMBL157138,CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,Ki,=,0.6607,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125]iodosulpride from human recombinant dopamine D2L receptor expressed in CHO cells after 30 mins,B,0.6607
5180,CHEMBL434665,CCCN[C@@H]1Cc2cccc3nc(O)n(C1)c23,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,B,2.5
5181,CHEMBL434665,CCCN[C@@H]1Cc2cccc3nc(O)n(C1)c23,Ki,=,2.78,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,2.78
5183,CHEMBL434665,CCCN[C@@H]1Cc2cccc3nc(O)n(C1)c23,EC50,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,B,8.0
5185,CHEMBL434665,CCCN[C@@H]1Cc2cccc3nc(O)n(C1)c23,EC50,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,B,0.5
5188,CHEMBL434665,CCCN[C@@H]1Cc2cccc3nc(O)n(C1)c23,EC50,=,9.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as cAMP inhibition by BRET assay,B,4.55
5189,CHEMBL434665,CCCN[C@@H]1Cc2cccc3nc(O)n(C1)c23,EC50,=,121.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,B,60.95
5191,CHEMBL434665,CCCN[C@@H]1Cc2cccc3nc(O)n(C1)c23,EC50,=,111.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,B,55.6
5193,CHEMBL434665,CCCN[C@@H]1Cc2cccc3nc(O)n(C1)c23,EC50,=,17.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,B,8.55
5195,CHEMBL422344,CN(C)[C@@H]1Cc2cccc3nc(O)n(C1)c23,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,B,12.0
5197,CHEMBL159022,COc1ccccc1C(=O)CCCCCN2CCN(CC2)c3noc4ccccc34,Ki,=,78.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity of compound was tested for Dopamine receptor D2L,B,78.1
5203,CHEMBL160744,Cc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1C,EC50,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,2.5
5206,CHEMBL160744,Cc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1C,Ki,=,8.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,8.1
5208,CHEMBL160921,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4ccccc4C#N)cc2N1,EC50,=,0.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,0.4
5210,CHEMBL160921,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4ccccc4C#N)cc2N1,EC50,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2L receptor expressed in HEK293T cells coexpressing Gi subunit assessed as inhibition of isoproterenol-stimulated cAMP production by luminescence assay,F,2.5
5211,CHEMBL160921,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4ccccc4C#N)cc2N1,Ki,=,2.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,2.9
5214,CHEMBL160296,COc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2L receptor expressed in HEK293T cells coexpressing Gi subunit assessed as inhibition of isoproterenol-stimulated cAMP production by luminescence assay,F,1.25
5215,CHEMBL160296,COc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,Ki,=,0.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,0.3
5217,CHEMBL160296,COc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,0.6,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,0.3
5218,CHEMBL160296,COc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,Ki,=,0.32,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,0.32
5219,CHEMBL160296,COc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,0.5,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,0.25
5221,CHEMBL443034,CCOc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,0.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,0.4
5223,CHEMBL443034,CCOc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,7.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2L receptor expressed in HEK293T cells coexpressing Gi subunit assessed as inhibition of isoproterenol-stimulated cAMP production by luminescence assay,F,3.95
5224,CHEMBL443034,CCOc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,Ki,=,2.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,2.8
5226,CHEMBL346129,Cc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,3.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,1.6
5228,CHEMBL346129,Cc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2L receptor expressed in HEK293T cells coexpressing Gi subunit assessed as inhibition of isoproterenol-stimulated cAMP production by luminescence assay,F,8.0
5229,CHEMBL346129,Cc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,Ki,=,5.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,5.9
5231,CHEMBL160630,Fc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,0.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,0.4
5233,CHEMBL160630,Fc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,0.3,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2L receptor expressed in HEK293T cells coexpressing Gi subunit assessed as inhibition of isoproterenol-stimulated cAMP production by luminescence assay,F,0.15
5234,CHEMBL160630,Fc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,Ki,=,5.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,5.5
5236,CHEMBL160357,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4ccccc4)cc2N1,EC50,=,0.4,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,0.2
5238,CHEMBL160357,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4ccccc4)cc2N1,EC50,=,0.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2L receptor expressed in HEK293T cells coexpressing Gi subunit assessed as inhibition of isoproterenol-stimulated cAMP production by luminescence assay,F,0.4
5239,CHEMBL160357,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4ccccc4)cc2N1,Ki,=,4.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,4.3
5241,CHEMBL161792,Oc1ccc2ccc(OCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)cc2n1,EC50,=,6.3,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,3.15
5243,CHEMBL161792,Oc1ccc2ccc(OCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)cc2n1,EC50,=,158.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2L receptor expressed in HEK293T cells coexpressing Gi subunit assessed as inhibition of isoproterenol-stimulated cAMP production by luminescence assay,F,79.0
5244,CHEMBL161792,Oc1ccc2ccc(OCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)cc2n1,Ki,=,7.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,7.3
5246,CHEMBL157923,Clc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,1.0
5248,CHEMBL157923,Clc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,7.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2L receptor expressed in HEK293T cells coexpressing Gi subunit assessed as inhibition of isoproterenol-stimulated cAMP production by luminescence assay,F,3.95
5249,CHEMBL157923,Clc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,Ki,=,3.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,3.7
5279,CHEMBL345438,CC1Cc2cccc3CCC(N4CCN(Cc5ccc(C)cc5)CC4)C(=O)N1c23,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-YM 09151 from D2 receptor,B,26.0
5285,CHEMBL352207,Clc1ccc(CN2CCN(CC2)C3CCc4cccc5CCN(C3=O)c45)cc1,Ki,=,62.0,nM,Dopamine D2 receptor,Homo sapiens,"D2 receptor functional activity was measured through reversal of quinpirole inhibited, forskolin stimulated cAMP production from whole cells",F,62.0
5291,CHEMBL164471,Fc1ccc2c(noc2c1)C3CCN(CCC4CCc5occc5C4=O)CC3,Ki,=,45.71,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,45.71
5292,CHEMBL163009,Fc1ccc(OC[C@H]2CC[C@H]3CN(CCN3C2)c4ncc(F)cn4)cc1,Ki,=,68.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,B,68.0
5301,CHEMBL165504,C(Oc1ccccc1)[C@H]2CC[C@H]3CN(CCN3C2)c4ncccn4,Ki,=,66.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,B,66.0
5302,CHEMBL165504,C(Oc1ccccc1)[C@H]2CC[C@H]3CN(CCN3C2)c4ncccn4,Ki,=,38.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,B,38.0
5304,CHEMBL351611,C(Oc1ccccc1)[C@@H]2CC[C@H]3CN(CCN3C2)c4ccccc4,Ki,=,44.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,B,44.0
5312,CHEMBL163087,CCCN(CCC)C1CCC(=CC1)C#C[Si](C)(C)C,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity was tested on relative proportion of High Affinity Site of Dopamine receptor D2L,B,16.0
5313,CHEMBL163087,CCCN(CCC)C1CCC(=CC1)C#C[Si](C)(C)C,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity was tested on relative proportion of High Affinity Site of Dopamine receptor D2S,B,17.0
5318,CHEMBL163087,CCCN(CCC)C1CCC(=CC1)C#C[Si](C)(C)C,Ki,=,-0.46,nM,Dopamine D2 receptor,Homo sapiens,Dissociation constant on two binding sites of Dopamine receptor D2L,B,-0.46
5319,CHEMBL163087,CCCN(CCC)C1CCC(=CC1)C#C[Si](C)(C)C,Ki,=,-0.63,nM,Dopamine D2 receptor,Homo sapiens,Dissociation constant on two binding sites of Dopamine receptor D2S,B,-0.63
5324,CHEMBL162762,CCCN(CCC)C1CCC(=CC1)C#C,Ki,=,38.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity was tested on relative proportion of High Affinity Site of Dopamine receptor D2L,B,38.0
5325,CHEMBL162762,CCCN(CCC)C1CCC(=CC1)C#C,Ki,=,34.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity was tested on relative proportion of High Affinity Site of Dopamine receptor D2S,B,34.0
5330,CHEMBL162762,CCCN(CCC)C1CCC(=CC1)C#C,Ki,=,-0.51,nM,Dopamine D2 receptor,Homo sapiens,Dissociation constant of compound on two binding sites of Dopamine receptor D2L,B,-0.51
5331,CHEMBL162762,CCCN(CCC)C1CCC(=CC1)C#C,Ki,=,-0.55,nM,Dopamine D2 receptor,Homo sapiens,Dissociation constant of compound on two binding sites of Dopamine receptor D2S,B,-0.55
5340,CHEMBL162102,CS(=O)(=O)Nc1cc(F)ccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5SCCCN3c45,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,18.0
5342,CHEMBL354005,Nc1cc(F)ccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5SCCN3c45,Ki,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,4.0
5343,CHEMBL163742,Nc1ccccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5SCCN3c45,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,41.0
5344,CHEMBL164744,Fc1ccc(C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5SCCCN3c45)c(NC=O)c1,Ki,=,7.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,7.7
5345,CHEMBL168051,CNc1ccccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5SCCCN3c45,Ki,=,31.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,31.0
5350,CHEMBL162768,CC(=O)Nc1cc(F)ccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5SCCCN3c45,Ki,=,3.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,3.4
5351,CHEMBL165679,C(CN1CCN(CC1)c2ccccc2)[C@@H]3CC[C@H](CC3)Nc4ncccn4,Ki,=,5.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,5.2
5352,CHEMBL165679,C(CN1CCN(CC1)c2ccccc2)[C@@H]3CC[C@H](CC3)Nc4ncccn4,EC50,=,29.0,nM,Dopamine D2 receptor,Homo sapiens,The in vitro intrinsic activity was measured at DA D2 receptor by measuring its ability to increase [3H]thymidine uptake in CHO-K1 cells transfected with the Dopamine receptor D2,B,14.5
5358,CHEMBL164338,CCOC(=O)Nc1cc(F)ccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5SCCCN3c45,Ki,=,15.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,15.1
5359,CHEMBL164792,COc1ccccc1N2CCN(CC[C@@H]3CC[C@H](CC3)Nc4ncccn4)CC2,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,3.0
5360,CHEMBL164792,COc1ccccc1N2CCN(CC[C@@H]3CC[C@H](CC3)Nc4ncccn4)CC2,IC50,=,9.9,nM,Dopamine D2 receptor,Homo sapiens,The in vitro intrinsic activity was measured at DA D2 receptor by measuring its ability to increase [3H]thymidine uptake in CHO-K1 cells transfected with the Dopamine receptor D2,B,4.95
5362,CHEMBL165047,CN([C@@H]1CC[C@@H](CCN2CCN(CC2)c3ccccc3)CC1)c4ncccn4,Ki,=,4.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,4.8
5363,CHEMBL349426,C(CN1CCN(CC1)c2ccccc2)[C@@H]3CC[C@H](CC3)Nc4ncnc5ccccc45,Ki,=,3.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,3.2
5364,CHEMBL163904,Nc1cc(F)ccc1C(=O)CCCN2CC[C@@H]3[C@H](C2)c4cccc5CCCN3c45,Ki,=,29.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,29.0
5365,CHEMBL352686,Nc1ccccc1C(=O)CCCN2CC[C@@H]3[C@H](C2)c4cccc5CCCN3c45,Ki,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,63.0
5366,CHEMBL351592,Nc1cc(F)ccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5CCCN3c45,Ki,=,5.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,5.2
5367,CHEMBL165056,FC(F)(F)c1cccc(c1)N2CCN(CC[C@@H]3CC[C@H](CC3)Nc4ncccn4)CC2,Ki,=,6.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,6.0
5368,CHEMBL351617,COc1ccc(cc1)N2CCN(CC[C@@H]3CC[C@H](CC3)Nc4ncccn4)CC2,Ki,=,6.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,6.0
5369,CHEMBL350352,Clc1cccc(N2CCN(CC[C@@H]3CC[C@H](CC3)Nc4ncccn4)CC2)c1Cl,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,11.0
5370,CHEMBL348977,Nc1ccccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5CCCN3c45,Ki,=,68.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,68.0
5371,CHEMBL424384,Nc1cc(Cl)ccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5SCCCN3c45,Ki,=,2.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,2.3
5372,CHEMBL352648,Fc1ccc(cc1)C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5SCCCN3c45,Ki,=,8.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,8.8
5373,CHEMBL164909,Nc1cc(O)ccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5SCCCN3c45,Ki,=,50.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,50.0
5374,CHEMBL166366,Nc1ccccc1C(=O)CCCN2CC[C@@H]3[C@H](C2)c4cccc5OCCN3c45,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,60.0
5375,CHEMBL165780,Nc1cc(F)ccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5OCCN3c45,Ki,=,2.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,2.3
5376,CHEMBL351708,Nc1ccccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5OCCN3c45,Ki,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,23.0
5377,CHEMBL165664,C([C@@H]1CC[C@H](CC1)Nc2ncccn2)N3CCN(CC3)c4ccccc4,Ki,=,5.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,5.7
5378,CHEMBL351247,Nc1cc(F)ccc1C(=O)CCCN2CC[C@@H]3[C@H](C2)c4cccc5SCCN3c45,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,14.0
5379,CHEMBL351459,Nc1ccccc1C(=O)CCCN2CC[C@@H]3[C@H](C2)c4cccc5SCCN3c45,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,19.0
5380,CHEMBL444342,Nc1ccccc1C(=O)CCCN2CC[C@@H]3[C@H](C2)c4cccc5SCCCN3c45,Ki,=,5.9,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,5.9
5381,CHEMBL166310,Nc1cc(F)ccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5SCCCN3c45,Ki,=,2.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,2.7
5382,CHEMBL166310,Nc1cc(F)ccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5SCCCN3c45,Ki,=,4.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,4.1
5383,CHEMBL164979,CN(CC[C@@H]1CC[C@H](CC1)Nc2ncccn2)CCc3ccccc3,Ki,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,39.0
5384,CHEMBL164604,C(CN1CCC(=CC1)c2ccccc2)[C@@H]3CC[C@H](CC3)Nc4ncccn4,Ki,=,4.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,4.7
5385,CHEMBL164185,Nc1ccccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5SCCCN3c45,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,15.0
5386,CHEMBL164185,Nc1ccccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5SCCCN3c45,Ki,=,6.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,6.0
5391,CHEMBL349057,Nc1cc(F)ccc1C(=O)CCCN2CC[C@@H]3[C@H](C2)c4cccc5OCCN3c45,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,16.0
5392,CHEMBL165126,Nc1c(F)cccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5SCCCN3c45,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,14.0
5393,CHEMBL165723,Nc1ccc(F)cc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5SCCCN3c45,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,15.0
5394,CHEMBL164723,C(CN1CCN(CC1)c2cccnc2)[C@@H]3CC[C@H](CC3)Nc4ncccn4,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,25.0
5395,CHEMBL355371,C(CN1CCN(CC1)c2ccccn2)[C@@H]3CC[C@H](CC3)Nc4ncccn4,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,12.0
5396,CHEMBL355371,C(CN1CCN(CC1)c2ccccn2)[C@@H]3CC[C@H](CC3)Nc4ncccn4,EC50,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,The in vitro intrinsic activity was measured at DA D2 receptor by measuring its ability to increase [3H]thymidine uptake in CHO-K1 cells transfected with the Dopamine receptor D2,B,14.0
5398,CHEMBL350567,O=C(CCCN1CC[C@H]2[C@@H](C1)c3cccc4SCCCN2c34)c5ccccc5,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,17.0
5399,CHEMBL352182,Nc1cc(Br)ccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5SCCCN3c45,Ki,=,4.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,4.7
5400,CHEMBL163895,CCNC(=O)Nc1cc(F)ccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5SCCCN3c45,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,26.0
5401,CHEMBL166252,C(CN1CCN(CC1)c2nccs2)[C@@H]3CC[C@H](CC3)Nc4ncccn4,Ki,=,46.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,46.0
5408,CHEMBL165897,Nc1cc(F)ccc1C(=O)CCCN2CC[C@@H]3[C@H](C2)c4cccc5CCCCN3c45,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,19.0
5409,CHEMBL163261,Nc1ccccc1C(=O)CCCN2CC[C@@H]3[C@H](C2)c4cccc5CCCCN3c45,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,20.0
5410,CHEMBL349683,Nc1cc(F)ccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5CCCCN3c45,Ki,=,3.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,3.5
5411,CHEMBL165140,C(C[C@@H]1CC[C@H](CC1)Nc2ncccn2)CN3CCN(CC3)c4ccccc4,Ki,=,7.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,7.4
5412,CHEMBL349034,Fc1ccc(cc1)N2CCN(CC[C@@H]3CC[C@H](CC3)Nc4ncccn4)CC2,Ki,=,8.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,8.5
5413,CHEMBL349034,Fc1ccc(cc1)N2CCN(CC[C@@H]3CC[C@H](CC3)Nc4ncccn4)CC2,IC50,=,79.0,nM,Dopamine D2 receptor,Homo sapiens,The in vitro intrinsic activity was measured at DA D2 receptor by measuring its ability to increase [3H]thymidine uptake in CHO-K1 cells transfected with the Dopamine receptor D2,B,39.5
5415,CHEMBL352194,Nc1ccccc1C(=O)CCCN2CC[C@H]3[C@@H](C2)c4cccc5CCCCN3c45,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,11.0
5416,CHEMBL349151,Nc1cc(F)ccc1C(=O)CCCN2CC[C@@H]3[C@H](C2)c4cccc5SCCCN3c45,Ki,=,4.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,B,4.7
5425,CHEMBL169222,CNc1cc(OC)c(cc1Cl)C(=O)NC[C@@H]2CCN(Cc3ccccc3)C2,Ki,=,58.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,B,58.0
5434,CHEMBL168611,CCC[C@H]1CN(Cc2ccccc2)C[C@H]1CNC(=O)c3cc(Cl)c(NC)cc3OC,Ki,=,45.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,B,45.0
5435,CHEMBL168611,CCC[C@H]1CN(Cc2ccccc2)C[C@H]1CNC(=O)c3cc(Cl)c(NC)cc3OC,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,B,28.0
5436,CHEMBL354180,CNc1cc(OC)c(cc1Cl)C(=O)NC[C@@H]2CN(Cc3ccccc3)C[C@H]2C,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,B,28.0
5437,CHEMBL354180,CNc1cc(OC)c(cc1Cl)C(=O)NC[C@@H]2CN(Cc3ccccc3)C[C@H]2C,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,B,10.0
5438,CHEMBL355566,CNc1cc(OC)c(cc1Cl)C(=O)NC[C@@H]2CN(Cc3ccccc3)C[C@@H]2C,Ki,=,51.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,B,51.0
5439,CHEMBL355566,CNc1cc(OC)c(cc1Cl)C(=O)NC[C@@H]2CN(Cc3ccccc3)C[C@@H]2C,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,B,21.0
5443,CHEMBL169193,CNc1cc(OC)c(cc1Cl)C(=O)NC[C@H]2CN(Cc3ccccc3)C[C@H]2C,Ki,=,79.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,B,79.0
5451,CHEMBL166587,CNc1cc(OC)c(cc1Cl)C(=O)NC[C@H]2CCN(Cc3ccccc3)C2,Ki,=,86.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,B,86.0
5454,CHEMBL168544,CCC[C@@H]1CN(Cc2ccccc2)C[C@H]1CNC(=O)c3cc(Cl)c(NC)cc3OC,Ki,=,54.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,B,54.0
5455,CHEMBL168544,CCC[C@@H]1CN(Cc2ccccc2)C[C@H]1CNC(=O)c3cc(Cl)c(NC)cc3OC,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,B,24.0
5485,CHEMBL367045,CN1CCN(CC1)C2=Cn3cccc3Sc4ccccc24,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards Dopamine receptor D2 in human using [3H]-spiperone as radioligand,B,13.0
5502,CHEMBL366900,Fc1ccc(cc1)C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,6.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,6.1
5503,CHEMBL366904,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3oc4ccccc4c3)CC2)c1Cl,Ki,=,76.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,76.5
5505,CHEMBL366904,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3oc4ccccc4c3)CC2)c1Cl,Ki,=,76.5,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,B,76.5
5508,CHEMBL175838,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3cccnc3)CC2)c1Cl,Ki,=,19.6,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,19.6
5509,CHEMBL179351,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccc(cc3)c4ncc[nH]4)CC2)c1Cl,Ki,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,8.0
5510,CHEMBL179003,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccccc3Cl)CC2)c1Cl,Ki,=,10.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,10.2
5511,CHEMBL176884,Clc1cccc(c1)C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,15.0
5512,CHEMBL367720,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccncc3)CC2)c1Cl,Ki,=,31.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,31.2
5513,CHEMBL175462,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3cnc4ccccc4n3)CC2)c1Cl,Ki,=,65.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,65.5
5514,CHEMBL180010,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccc(cc3)c4ccccn4)CC2)c1Cl,Ki,=,93.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,93.3
5516,CHEMBL180010,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccc(cc3)c4ccccn4)CC2)c1Cl,Ki,=,93.3,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,B,93.3
5519,CHEMBL180010,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccc(cc3)c4ccccn4)CC2)c1Cl,Ki,=,93.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,B,93.3
5521,CHEMBL180010,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccc(cc3)c4ccccn4)CC2)c1Cl,Ki,=,93.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,B,93.3
5522,CHEMBL180010,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccc(cc3)c4ccccn4)CC2)c1Cl,Ki,=,74.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells,B,74.0
5523,CHEMBL414838,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccc(cc3)c4cccnc4)CC2)c1Cl,Ki,=,54.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,54.5
5525,CHEMBL425143,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccc(cc3)c4ccncc4)CC2)c1Cl,Ki,=,43.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,43.7
5526,CHEMBL177398,Fc1ccccc1C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,10.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,10.1
5527,CHEMBL368961,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccc(cc3)c4ncccn4)CC2)c1Cl,Ki,=,45.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,45.7
5528,CHEMBL175677,Fc1cccc(c1)C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,8.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,8.8
5534,CHEMBL179025,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccccn3)CC2)c1Cl,Ki,=,16.9,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,16.9
5535,CHEMBL175466,Clc1ccc(cc1)C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,17.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,17.5
5536,CHEMBL176212,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccccc3I)CC2)c1Cl,Ki,=,10.6,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,10.6
5537,CHEMBL179053,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3cccc(I)c3)CC2)c1Cl,Ki,=,28.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,28.1
5538,CHEMBL180060,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccc(I)cc3)CC2)c1Cl,Ki,=,35.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,35.4
5539,CHEMBL180060,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccc(I)cc3)CC2)c1Cl,EC50,=,162.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of quinpirole stimulation of mitogenesis at human dopamine D2 receptors expressed in Chinese hamster ovary cells,F,81.0
5540,CHEMBL180060,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccc(I)cc3)CC2)c1Cl,Ki,=,35.4,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,B,35.4
5543,CHEMBL179960,Clc1cccc(N2CCN(CCCCNC(=O)c3ccc(cc3)c4cccnc4)CC2)c1Cl,Ki,=,18.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,18.2
5544,CHEMBL414839,COc1ccccc1C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,3.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,3.7
5545,CHEMBL175875,COc1cccc(c1)C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,39.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,39.1
5552,CHEMBL178803,CCN1CCN(CC1)c2cc(c3CCCCCCc3n2)c4ccc(F)cc4,Ki,=,0.14,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity against recombinant human dopamine receptor D2L in human liver microsomes,B,0.14
5553,CHEMBL362285,CCN1CCN(CC1)c2cc(c3CC[C@@H](O)CCCc3n2)c4ccc(F)cc4,Ki,=,21.2,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity against recombinant human dopamine receptor D2L in human liver microsomes,B,21.2
5554,CHEMBL181469,CCN1CCN(CC1)c2cc(c3CC[C@H](O)CCCc3n2)c4ccc(F)cc4,Ki,=,6.2,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity against recombinant human dopamine receptor D2L in human liver microsomes,B,6.2
5555,CHEMBL179649,CCN1CCN(CC1)c2cc(c3CCC[C@H](O)CCc3n2)c4ccc(F)cc4,Ki,=,11.9,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity against recombinant human dopamine receptor D2L in human liver microsomes,B,11.9
5556,CHEMBL360457,CCN1CCN(CC1)c2cc(c3CCC[C@@H](O)CCc3n2)c4ccc(F)cc4,Ki,=,3.6,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity against recombinant human dopamine receptor D2L in human liver microsomes,B,3.6
5567,CHEMBL182721,C(Cc1ccc2NCNc2c1)N3CCN(CC3)c4cccc5ccccc45,Ki,=,1.66,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2,B,1.66
5569,CHEMBL183776,COc1ccccc1N2CCN(CCc3ccc4[nH]nnc4c3)CC2,Ki,=,5.37,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2,B,5.37
5570,CHEMBL183776,COc1ccccc1N2CCN(CCc3ccc4[nH]nnc4c3)CC2,Ki,=,5.37,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,5.37
5571,CHEMBL181898,Oc1nc2cc(CCN3CCN(CC3)c4cccc(c4)C(F)(F)F)ccc2[nH]1,Ki,=,28.18,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2,B,28.18
5572,CHEMBL184770,Cc1cccc(N2CCN(CCc3ccc4[nH]nnc4c3)CC2)c1C,Ki,=,51.29,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2,B,51.29
5573,CHEMBL184770,Cc1cccc(N2CCN(CCc3ccc4[nH]nnc4c3)CC2)c1C,Ki,=,51.29,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,51.29
5574,CHEMBL363124,C(Cc1ccc2[nH]nnc2c1)N3CCN(CC3)c4cccc5ccccc45,Ki,=,23.99,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2,B,23.99
5575,CHEMBL363124,C(Cc1ccc2[nH]nnc2c1)N3CCN(CC3)c4cccc5ccccc45,Ki,=,23.99,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,23.99
5578,CHEMBL185436,C(Cc1ccc2[nH]c(nc2c1)c3ccccc3)N4CCN(CC4)c5ccccc5,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2,B,31.62
5579,CHEMBL185436,C(Cc1ccc2[nH]c(nc2c1)c3ccccc3)N4CCN(CC4)c5ccccc5,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,31.62
5582,CHEMBL184993,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4cc(I)ccc4s3)CC2,Ki,=,48.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,B,48.0
5583,CHEMBL184993,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4cc(I)ccc4s3)CC2,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells,B,1.0
5587,CHEMBL362101,Clc1cccc(N2CCN(CCCCNC(=O)c3ccc(I)s3)CC2)c1Cl,Ki,=,89.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,B,89.0
5588,CHEMBL362101,Clc1cccc(N2CCN(CCCCNC(=O)c3ccc(I)s3)CC2)c1Cl,Ki,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells,B,32.0
5590,CHEMBL182379,COc1ccccc1N2CCN(CCCCNC(=O)c3oc4ccc(I)cc4c3)CC2,Ki,=,59.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,B,59.0
5591,CHEMBL182379,COc1ccccc1N2CCN(CCCCNC(=O)c3oc4ccc(I)cc4c3)CC2,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells,B,27.0
5595,CHEMBL182652,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(I)s3)CC2,Ki,=,75.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,B,75.0
5596,CHEMBL182652,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(I)s3)CC2,Ki,=,35.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells,B,35.0
5608,CHEMBL187113,O=C(N[C@@H]1CCN(Cc2ccccc2)C1)c3cccc(c3)c4ccsc4,Ki,=,94.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,B,94.0
5611,CHEMBL426062,O=C(N[C@H]1CCN(Cc2ccccc2)C1)c3cccc(c3)c4ccsc4,Ki,=,70.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,B,70.0
5612,CHEMBL361035,O=C(N[C@H]1CCN(Cc2ccccc2)C1)c3cccc(c3)c4cccs4,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,B,60.0
5613,CHEMBL361035,O=C(N[C@H]1CCN(Cc2ccccc2)C1)c3cccc(c3)c4cccs4,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,B,60.0
5672,CHEMBL195057,Oc1ccc(cc1)C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,13.7,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,B,13.7
5673,CHEMBL195057,Oc1ccc(cc1)C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,65.8,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,B,65.8
5675,CHEMBL195057,Oc1ccc(cc1)C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,13.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,13.7
5677,CHEMBL194493,[O-][N+](=O)c1ccc(cc1)C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,19.7,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,B,19.7
5678,CHEMBL194493,[O-][N+](=O)c1ccc(cc1)C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,31.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,B,31.0
5680,CHEMBL194493,[O-][N+](=O)c1ccc(cc1)C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,19.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,19.7
5681,CHEMBL194493,[O-][N+](=O)c1ccc(cc1)C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,EC50,=,13.8,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of quinpirole stimulation of mitogenesis at human dopamine D2 receptors expressed in Chinese hamster ovary cells,F,6.9
5682,CHEMBL370713,COc1ccc(cc1)C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,30.4,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,B,30.4
5683,CHEMBL370713,COc1ccc(cc1)C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,96.5,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,B,96.5
5685,CHEMBL370713,COc1ccc(cc1)C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,30.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,30.4
5686,CHEMBL370713,COc1ccc(cc1)C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,EC50,=,61.8,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of quinpirole stimulation of mitogenesis at human dopamine D2 receptors expressed in Chinese hamster ovary cells,F,30.9
5687,CHEMBL372022,Oc1ccccc1C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,6.6,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,6.6
5688,CHEMBL364759,[O-][N+](=O)c1cccc(c1)C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,21.9,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,21.9
5689,CHEMBL426994,Nc1ccccc1C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,18.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,18.2
5690,CHEMBL191855,Nc1cccc(c1)C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,29.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,29.0
5691,CHEMBL191795,[O-][N+](=O)c1ccccc1C(=O)NC\C=C\CN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,7.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine D2 receptor,B,7.4
5692,CHEMBL194659,CN(C)C[C@H]1CC2[C@H](O1)c3cc(F)ccc3Oc4ccccc24,Ki,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,B,32.0
5693,CHEMBL364270,CN(C)C[C@@H]1CC2[C@H](O1)c3cc(Cl)ccc3Oc4ccccc24,Ki,=,68.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,B,68.0
5694,CHEMBL193435,CN(C)C[C@H]1CC2[C@H](O1)c3cc(Br)ccc3Oc4ccccc24,Ki,=,66.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,B,66.0
5695,CHEMBL363581,CN(C)C[C@@H]1CC2[C@H](O1)c3cc(F)ccc3Sc4ccccc24,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,B,12.0
5696,CHEMBL193639,CN(C)C[C@H]1CC2[C@H](O1)c3cc(F)ccc3Sc4ccccc24,Ki,=,2.3,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,B,2.3
5697,CHEMBL193639,CN(C)C[C@H]1CC2[C@H](O1)c3cc(F)ccc3Sc4ccccc24,Ki,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,B,1.7
5699,CHEMBL435301,CN(C)C[C@H]1CC2[C@H](O1)c3cc(Cl)ccc3Oc4ccccc24,Ki,=,5.9,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,B,5.9
5701,CHEMBL366164,CN(C)C[C@H]1C[C@H]2[C@H](O1)c3cc(F)ccc3Sc4ccccc24,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,B,12.0
5710,CHEMBL194727,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(F)cc3)CC2,Ki,=,98.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,B,98.0
5712,CHEMBL196744,Fc1ccc(cc1)C(=O)NCCCCN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,B,17.0
5713,CHEMBL196744,Fc1ccc(cc1)C(=O)NCCCCN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,B,18.0
5716,CHEMBL197162,Fc1ccc(cn1)C(=O)NCCCCN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,B,21.0
5717,CHEMBL197162,Fc1ccc(cn1)C(=O)NCCCCN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,29.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,B,29.0
5720,CHEMBL197195,Fc1cccc(n1)C(=O)NCCCCN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,44.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,B,44.0
5721,CHEMBL197195,Fc1cccc(n1)C(=O)NCCCCN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,57.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,B,57.0
5722,CHEMBL194755,COc1ccccc1N2CCN(CCCCNS(=O)(=O)c3ccc(F)cc3)CC2,Ki,=,72.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,B,72.0
5724,CHEMBL195247,Fc1ccc(cc1)S(=O)(=O)NCCCCN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,B,39.0
5725,CHEMBL195247,Fc1ccc(cc1)S(=O)(=O)NCCCCN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,49.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,B,49.0
5755,CHEMBL193337,CCCN(CCC)[C@H]1CCn2nccc2C1,Ki,=,4.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human dopamine D2long receptor expressed in CHO cells after 60 mins,B,4.6
5768,CHEMBL198224,C[C@@H]1Oc2c(NC1=O)cccc2N3CCN(CCCc4c[nH]c5ccccc45)CC3,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,1.0
5769,CHEMBL195015,C(N1CCN(CC1)c2cccc3OCCOc23)c4c[nH]c5ccccc45,Ki,=,62.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,62.0
5770,CHEMBL196514,C[C@H]1Oc2c(NC1=O)cccc2N3CCN(CCCc4c[nH]c5ccc(F)cc45)CC3,Ki,=,6.9,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,6.9
5771,CHEMBL196514,C[C@H]1Oc2c(NC1=O)cccc2N3CCN(CCCc4c[nH]c5ccc(F)cc45)CC3,Ki,=,0.7943,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,B,0.7943
5772,CHEMBL370457,C[C@@H]1Oc2c(NC1=O)cccc2N3CCN(CCCc4c[nH]c5ccc(F)cc45)CC3,Ki,=,4.7,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,4.7
5773,CHEMBL196505,C(Cc1c[nH]c2ccccc12)N3CCN(CC3)c4cccc5OCCOc45,Ki,=,45.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,45.0
5774,CHEMBL196171,C(CN1CCN(CC1)c2cccc3OCCOc23)Cc4c[nH]c5ccccc45,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,21.0
5775,CHEMBL196172,C[C@H]1Oc2c(NC1=O)cccc2N3CCN(CCCc4c[nH]c5c(F)cccc45)CC3,Ki,=,5.3,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,5.3
5776,CHEMBL198357,C[C@@H]1Oc2c(NC1=O)cccc2N3CCN(CCCc4c[nH]c5c(F)cccc45)CC3,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,1.0
5777,CHEMBL194844,C(CCc1c[nH]c2ccccc12)CN3CCN(CC3)c4cccc5OCCOc45,Ki,=,5.1,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,5.1
5778,CHEMBL263329,C(CCN1CCN(CC1)c2cccc3OCCOc23)CCc4c[nH]c5ccccc45,Ki,=,9.1,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,9.1
5779,CHEMBL193854,Fc1cccc2[nH]cc(CCCN3CCN(CC3)c4cccc5OCCOc45)c12,Ki,=,8.1,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,8.1
5780,CHEMBL193501,Fc1ccc2[nH]cc(CCCN3CCN(CC3)c4cccc5OCCOc45)c2c1,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,19.0
5781,CHEMBL369984,Fc1ccc2c(CCCN3CCN(CC3)c4cccc5OCCOc45)c[nH]c2c1,Ki,=,14.6,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,14.6
5782,CHEMBL196893,Fc1cccc2c(CCCN3CCN(CC3)c4cccc5OCCOc45)c[nH]c12,Ki,=,10.6,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,10.6
5783,CHEMBL196132,COc1ccc2[nH]cc(CCCN3CCN(CC3)c4cccc5OCCOc45)c2c1,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,15.0
5784,CHEMBL365605,Clc1cccc2[nH]cc(CCCN3CCN(CC3)c4cccc5OCCOc45)c12,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,24.0
5785,CHEMBL370359,Clc1ccc2[nH]cc(CCCN3CCN(CC3)c4cccc5OCCOc45)c2c1,Ki,=,31.6,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,31.6
5786,CHEMBL194240,Clc1ccc2c(CCCN3CCN(CC3)c4cccc5OCCOc45)c[nH]c2c1,Ki,=,2.1,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,2.1
5787,CHEMBL194510,Clc1cccc2c(CCCN3CCN(CC3)c4cccc5OCCOc45)c[nH]c12,Ki,=,15.5,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,15.5
5788,CHEMBL198107,Cc1ccc2[nH]cc(CCCN3CCN(CC3)c4cccc5OCCOc45)c2c1,Ki,=,10.7,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,10.7
5789,CHEMBL372735,Cc1cccc2c(CCCN3CCN(CC3)c4cccc5OCCOc45)c[nH]c12,Ki,=,15.9,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,15.9
5790,CHEMBL198812,C(CN1CCN(CC1)c2cccc3OCCCc23)Cc4c[nH]c5ccccc45,Ki,=,20.3,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,20.3
5791,CHEMBL198040,C(CN1CCN(CC1)c2cccc3NCCCc23)Cc4c[nH]c5ccccc45,Ki,=,11.3,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,11.3
5792,CHEMBL198041,CN1CCCc2c1cccc2N3CCN(CCCc4c[nH]c5ccccc45)CC3,Ki,=,90.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,90.0
5793,CHEMBL197839,CC1CNc2cccc(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c2C1,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,15.0
5794,CHEMBL383396,O=C1CCc2c(N1)cccc2N3CCN(CCCc4c[nH]c5ccccc45)CC3,Ki,=,11.4,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,11.4
5795,CHEMBL198069,O=C1COc2c(N1)cccc2N3CCN(CCCc4c[nH]c5ccccc45)CC3,Ki,=,4.3,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,4.3
5796,CHEMBL198070,CC1Oc2c(NC1=O)cccc2N3CCN(CCCc4c[nH]c5ccccc45)CC3,Ki,=,4.5,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,4.5
5797,CHEMBL199045,CC1(C)Oc2c(NC1=O)cccc2N3CCN(CCCc4c[nH]c5ccccc45)CC3,Ki,=,7.4,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,7.4
5798,CHEMBL197943,CC1Oc2c(cccc2N(C)C1=O)N3CCN(CCCc4c[nH]c5ccccc45)CC3,Ki,=,35.7,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,35.7
5799,CHEMBL197665,C(CN1CCN(CC1)c2cccc3NCCOc23)Cc4c[nH]c5ccccc45,Ki,=,17.9,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,17.9
5800,CHEMBL198216,C[C@H]1Oc2c(NC1=O)cccc2N3CCN(CCCc4c[nH]c5ccccc45)CC3,Ki,=,8.7,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,B,8.7
5808,CHEMBL197677,CC1CCN(C(=O)C2CCCCC2)c3c(CCN4CCN(CC4)c5nsc6ccccc56)cccc13,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,25.0
5809,CHEMBL372811,CC1CCN(C(=O)C)c2c(CCN3CCN(CC3)c4nsc5ccccc45)cc(F)cc12,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,18.0
5810,CHEMBL197663,CC1CCN(C(=O)C)c2c(CCN3CCN(CC3)c4noc5ccccc45)ccc(C)c12,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,17.0
5811,CHEMBL199182,CC1CCN(C(=O)C)c2c(CCN3CCN(CC3)c4nsc5ccccc45)cc(Cl)cc12,Ki,>,50.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,50.0
5812,CHEMBL370659,CC1CCN(C(=O)C)c2c(CCN3CCN(CC3)c4noc5ccccc45)cc(F)cc12,Ki,=,29.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,29.0
5813,CHEMBL439680,CC(=O)N1CCC(c2ccccc2)c3cccc(CCN4CCN(CC4)c5nsc6ccccc56)c13,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,12.0
5814,CHEMBL197990,CC1CCN(C(=O)C)c2c(CCN3CCN(CC3)c4nsc5ccccc45)ccc(C)c12,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,12.0
5816,CHEMBL371289,CC1CC(=O)Nc2c(CCN3CCN(CC3)c4nsc5ccccc45)cccc12,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,21.0
5817,CHEMBL197870,CC1CC(=O)Nc2c(CCN3CCN(CC3)c4nsc5ccccc45)cc(F)cc12,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,15.0
5818,CHEMBL197614,CC1Cc2cccc(CCN3CCN(CC3)c4nsc5ccccc45)c2NC1=O,Ki,=,73.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,73.0
5819,CHEMBL372541,CC1CC(=O)N(C)c2c(CCN3CCN(CC3)c4nsc5ccccc45)cccc12,Ki,=,81.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,81.0
5820,CHEMBL438980,O=C1CC(c2ccccc2)c3cccc(CCN4CCN(CC4)c5nsc6ccccc56)c3N1,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,15.0
5822,CHEMBL440389,CC1CC(=O)Nc2c(CCN3CCN(CC3)c4nsc5ccccc45)ccc(C)c12,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,11.0
5823,CHEMBL425208,CC1CC(=O)Nc2c(CCN3CCN(CC3)c4n[s+]([O-])c5ccccc45)cc(F)cc12,Ki,=,92.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,92.0
5824,CHEMBL198599,CC1CC(=O)Nc2c(CCN3CCN(CC3)c4noc5ccccc45)cc(C)cc12,Ki,=,35.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,35.0
5827,CHEMBL194312,CC1(C)CCNc2c(CCN3CCN(CC3)c4nsc5ccccc45)cccc12,Ki,=,59.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,59.0
5828,CHEMBL363829,CC1(C)CCNc2c(CCN3CCN(CC3)c4nsc5ccccc45)cc(F)cc12,Ki,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,55.0
5829,CHEMBL194953,CC1CCN(C(=O)c2ccccc2)c3c(CCN4CCN(CC4)c5nsc6ccccc56)cccc13,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,16.0
5830,CHEMBL369913,CC1CCN(C(=O)C)c2c(CCN3CCN(CC3)c4nsc5ccccc45)cccc12,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,17.0
5831,CHEMBL262469,COc1cccc(OC)c1CC(=O)N2CCC(C)c3cccc(CCN4CCN(CC4)c5nsc6ccccc56)c23,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,11.0
5832,CHEMBL199161,COc1cccc(CC(=O)N2CCC(C)c3cccc(CCN4CCN(CC4)c5nsc6ccccc56)c23)c1,Ki,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 expressed in CHO cells,B,4.0
5834,CHEMBL110365,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc4c(Cc5ccccc45)c3)CC2,Ki,=,55.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,B,55.4
5836,CHEMBL112065,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)c4ccccc4)CC2,Ki,=,48.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,B,48.0
5837,CHEMBL112065,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)c4ccccc4)CC2,Ki,=,42.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins,B,42.0
5839,CHEMBL112065,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)c4ccccc4)CC2,EC50,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human dopamine D2long receptor expressed in CHO cells assessed as induction of [3H]thymidine incorporation after 2 hrs,F,6.0
5854,CHEMBL381019,Cc1ccc(CN2CC[C@@H](C2)NC(=O)c3cccc(c3)c4cccs4)cc1,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,B,60.0
5857,CHEMBL198463,CN1CCc2c(C1)sc3N=CN(CCN4CCN(CC4)c5ccnc6ccccc56)C(=O)c23,Ki,=,1.46,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory activity against dopamine D2(long) receptor,B,1.46
5858,CHEMBL370110,CN1CCc2c(C1)sc3N=CN(CCN4CCN(CC4)c5cncc6ccccc56)C(=O)c23,Ki,=,1.2,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory activity against dopamine D2(long) receptor,B,1.2
5881,CHEMBL199824,[11CH3]Oc1ccc2cccc(N3CCN(CCCCN4N=CC(=O)N(C)C4=O)CC3)c2c1,Ki,=,22.01,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,22.01
5900,CHEMBL424667,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc4nonc4c3)CC2,Ki,=,31.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,B,31.0
5906,CHEMBL201551,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc4OCOc4c3)CC2,Ki,=,86.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,B,86.2
5907,CHEMBL202713,COc1cccc2cc(oc12)C(=O)NCCCCN3CCN(CC3)c4[nH]nc5ccccc45,Ki,=,56.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,B,56.6
5909,CHEMBL201270,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)n4ccnc4)CC2,Ki,=,27.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,B,27.2
5910,CHEMBL201270,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)n4ccnc4)CC2,Ki,=,51.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,B,51.7
5947,CHEMBL382850,CCN1CCc2ccccc2Cc3[nH]c4ccccc4c3CC1,Ki,=,82.6,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,82.6
5955,CHEMBL201093,CN1CCc2ccccc2Cc3ccsc3CC1,Ki,=,92.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,92.0
5984,CHEMBL201525,CN1CCc2ccccc2Cc3ccccc3CC1,Ki,=,8.47,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,8.47
5985,CHEMBL201525,CN1CCc2ccccc2Cc3ccccc3CC1,Ki,=,56.5,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by radioligand binding assay,B,56.5
5986,CHEMBL201525,CN1CCc2ccccc2Cc3ccccc3CC1,Ki,=,56.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,B,56.5
5988,CHEMBL201525,CN1CCc2ccccc2Cc3ccccc3CC1,Ki,=,58.88,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,B,58.88
5989,CHEMBL201525,CN1CCc2ccccc2Cc3ccccc3CC1,Ki,=,56.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned D2 dopamine receptor incubated for 90 mins by radioligand binding assay,B,56.5
5998,CHEMBL201170,CN1CCc2ccccc2Cc3ccc(O)cc3CC1,Ki,=,17.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2L dopamine receptor,B,17.5
5999,CHEMBL201170,CN1CCc2ccccc2Cc3ccc(O)cc3CC1,Ki,=,33.5,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,F,33.5
6000,CHEMBL201170,CN1CCc2ccccc2Cc3ccc(O)cc3CC1,Ki,=,17.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,B,17.5
6002,CHEMBL201170,CN1CCc2ccccc2Cc3ccc(O)cc3CC1,Ki,=,17.38,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,B,17.38
6003,CHEMBL201170,CN1CCc2ccccc2Cc3ccc(O)cc3CC1,Ki,=,17.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,B,17.5
6006,CHEMBL201170,CN1CCc2ccccc2Cc3ccc(O)cc3CC1,Ki,=,44.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned D2 dopamine receptor incubated for 90 mins by radioligand binding assay,B,44.5
6007,CHEMBL199453,CC(C)(C)c1nc(cc(n1)C(F)(F)F)N2CCN(CCCCN3C=CC(=NC3=O)N4CCC4)CC2,Ki,=,82.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,82.1
6008,CHEMBL201376,CC(C)(C)c1nc(cc(n1)C(F)(F)F)N2CCN(CCCCN3C=CC(=NC3=O)N4CCCCC4)CC2,Ki,=,89.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,89.4
6047,CHEMBL201481,CC(C)(C)c1nc(cc(n1)C(F)(F)F)N2CCN(CCCCN3CCC(=O)CCC3=O)CC2,Ki,=,65.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,65.0
6049,CHEMBL201318,CC(C)(C)c1nc(cc(n1)C(F)(F)F)N2CCN(CCCCN3C(=O)CCCc4c(O)cccc34)CC2,Ki,=,93.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,93.0
6054,CHEMBL370191,CC(C)(C)c1nc(cc(n1)C(F)(F)F)N2CCN(CCCCN3C(=O)CCSc4ccccc34)CC2,Ki,=,83.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,83.0
6069,CHEMBL203047,CN1CCc2ccccc2Cc3cc(O)c(Cl)cc3CC1,Ki,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2L dopamine receptor,B,2.0
6070,CHEMBL203047,CN1CCc2ccccc2Cc3cc(O)c(Cl)cc3CC1,Ki,=,4.8,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,F,4.8
6073,CHEMBL203689,CN1CCc2ccccc2Cc3c(O)cccc3CC1,Ki,=,84.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2L dopamine receptor,B,84.0
6074,CHEMBL203689,CN1CCc2ccccc2Cc3c(O)cccc3CC1,Ki,=,7.9,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,F,7.9
6076,CHEMBL379662,COc1cccc2CCN(C)CCc3ccccc3Cc12,Ki,=,39.9,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,F,39.9
6077,CHEMBL381936,CN1CCc2cc(O)ccc2Cc3ccc(O)cc3CC1,Ki,=,58.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2L dopamine receptor,B,58.7
6078,CHEMBL381936,CN1CCc2cc(O)ccc2Cc3ccc(O)cc3CC1,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,F,19.0
6079,CHEMBL204065,COc1ccc2Cc3ccc(OC)cc3CCN(C)CCc2c1,Ki,=,6.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2L dopamine receptor,B,6.5
6080,CHEMBL204065,COc1ccc2Cc3ccc(OC)cc3CCN(C)CCc2c1,Ki,=,0.62,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,F,0.62
6086,CHEMBL380330,COc1ccc2Cc3ccccc3CCN(C)CCc2c1,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2L dopamine receptor,B,13.0
6087,CHEMBL380330,COc1ccc2Cc3ccccc3CCN(C)CCc2c1,Ki,=,0.55,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,F,0.55
6088,CHEMBL380330,COc1ccc2Cc3ccccc3CCN(C)CCc2c1,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,B,13.0
6089,CHEMBL380330,COc1ccc2Cc3ccccc3CCN(C)CCc2c1,Ki,=,12.88,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,B,12.88
6090,CHEMBL380330,COc1ccc2Cc3ccccc3CCN(C)CCc2c1,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,B,13.0
6093,CHEMBL203637,CN1CCc2ccccc2Cc3ccc(O)c(Cl)c3CC1,Ki,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2L dopamine receptor,B,4.0
6094,CHEMBL203637,CN1CCc2ccccc2Cc3ccc(O)c(Cl)c3CC1,Ki,=,6.1,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,F,6.1
6095,CHEMBL203637,CN1CCc2ccccc2Cc3ccc(O)c(Cl)c3CC1,Ki,=,3.548,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,B,3.548
6099,CHEMBL204098,CN1CCc2ccccc2Cc3cc(N)c(O)cc3CC1,Ki,=,37.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2L dopamine receptor,B,37.3
6100,CHEMBL204098,CN1CCc2ccccc2Cc3cc(N)c(O)cc3CC1,Ki,=,26.1,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,F,26.1
6101,CHEMBL382010,CN1CCc2ccccc2Cc3cc(O)ccc3CC1,Ki,=,36.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2L dopamine receptor,B,36.9
6102,CHEMBL382010,CN1CCc2ccccc2Cc3cc(O)ccc3CC1,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,F,19.0
6103,CHEMBL381946,COc1ccc2CCN(C)CCc3ccccc3Cc2c1,Ki,=,62.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2L dopamine receptor,B,62.0
6104,CHEMBL381946,COc1ccc2CCN(C)CCc3ccccc3Cc2c1,Ki,=,21.1,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,F,21.1
6106,CHEMBL203734,COc1c(Cl)cc2CCN(C)CCc3ccccc3Cc2c1Cl,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,F,2.5
6107,CHEMBL380464,CN1CCc2ccccc2Cc3c(CC1)ccc(O)c3Cl,Ki,=,0.99,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2L dopamine receptor,B,0.99
6108,CHEMBL380464,CN1CCc2ccccc2Cc3c(CC1)ccc(O)c3Cl,Ki,=,0.13,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,F,0.13
6109,CHEMBL383451,CN1CCc2ccccc2Cc3cc(Cl)c(O)c(Cl)c3CC1,Ki,=,88.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2L dopamine receptor,B,88.0
6110,CHEMBL383451,CN1CCc2ccccc2Cc3cc(Cl)c(O)c(Cl)c3CC1,Ki,=,37.5,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,F,37.5
6126,CHEMBL202858,CCN(CC)C(=O)NCCCCN1CCN(CC1)c2cc(nc(n2)C(C)(C)C)C(F)(F)F,Ki,=,17.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to cloned human dopamine D2 receptor,B,17.3
6129,CHEMBL202670,CC(C)(C)c1nc(cc(n1)C(F)(F)F)N2CCN(CCCCN3C=CC(=CC3=O)O)CC2,Ki,=,25.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to cloned human dopamine D2 receptor,B,25.5
6132,CHEMBL205264,CC(C)(C)NC(=O)NCCCCN1CCN(CC1)c2cc(nc(n2)C(C)(C)C)C(F)(F)F,Ki,=,65.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to cloned human dopamine D2 receptor,B,65.8
6133,CHEMBL381514,CC(C)(C)CNC(=O)NCCCCN1CCN(CC1)c2cc(nc(n2)C(C)(C)C)C(F)(F)F,Ki,=,91.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to cloned human dopamine D2 receptor,B,91.3
6135,CHEMBL205497,CC(C)(C)c1nc(cc(n1)C(F)(F)F)N2CCN(CCCCNC(=O)Nc3ccccc3)CC2,Ki,=,59.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to cloned human dopamine D2 receptor,B,59.1
6137,CHEMBL382773,CC1=CC(=O)N(CCCCN2CCN(CC2)c3cc(nc(n3)C(C)(C)C)C(F)(F)F)C=C1,Ki,=,62.6,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to cloned human dopamine D2 receptor,B,62.6
6154,CHEMBL210578,OC1(CC2CCC(C1)N2CCCC(=O)c3ccc(F)cc3)c4ccc(Cl)cc4,Ki,=,0.31,nM,Dopamine D2 receptor,Homo sapiens,In vitro ability to inhibit the binding of [3H]spiperone to cloned human Dopamine receptor D2 using apomorphine induced climbing test in male Swiss mice,B,0.31
6155,CHEMBL210578,OC1(CC2CCC(C1)N2CCCC(=O)c3ccc(F)cc3)c4ccc(Cl)cc4,Ki,=,0.309,nM,Dopamine D2 receptor,Homo sapiens,Cataleptogenic effect against cloned human Dopamine receptor D2 in male Sprague-Dawley rats in a bar test,B,0.309
6156,CHEMBL210578,OC1(CC2CCC(C1)N2CCCC(=O)c3ccc(F)cc3)c4ccc(Cl)cc4,Ki,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor by radioligand binding assay,B,1.6
6157,CHEMBL210578,OC1(CC2CCC(C1)N2CCCC(=O)c3ccc(F)cc3)c4ccc(Cl)cc4,Ki,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,1.6
6158,CHEMBL210578,OC1(CC2CCC(C1)N2CCCC(=O)c3ccc(F)cc3)c4ccc(Cl)cc4,Ki,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,1.6
6159,CHEMBL210578,OC1(CC2CCC(C1)N2CCCC(=O)c3ccc(F)cc3)c4ccc(Cl)cc4,Ki,=,0.31,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,0.31
6166,CHEMBL210567,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4CCc5ccc(CCc3cc4)cc5)CC2,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,15.0
6167,CHEMBL210567,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4CCc5ccc(CCc3cc4)cc5)CC2,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,13.0
6168,CHEMBL210567,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4CCc5ccc(CCc3cc4)cc5)CC2,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,11.0
6169,CHEMBL210567,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4CCc5ccc(CCc3cc4)cc5)CC2,Ki,=,5.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,5.6
6170,CHEMBL210567,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4CCc5ccc(CCc3cc4)cc5)CC2,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,24.0
6171,CHEMBL210567,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4CCc5ccc(CCc3cc4)cc5)CC2,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,18.0
6172,CHEMBL379602,COc1ccccc1N2CCN(Cc3cnn(c3)c4ccccc4)CC2,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,B,11.0
6173,CHEMBL379602,COc1ccccc1N2CCN(Cc3cnn(c3)c4ccccc4)CC2,Ki,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,B,8.0
6175,CHEMBL379602,COc1ccccc1N2CCN(Cc3cnn(c3)c4ccccc4)CC2,EC50,=,0.28,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity against dopamine D2(long) receptor assessed as [3H]thymidine uptake in CHO cells by mitogenesis assay,F,0.14
6178,CHEMBL379602,COc1ccccc1N2CCN(Cc3cnn(c3)c4ccccc4)CC2,EC50,=,0.22,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity against dopamine D2(short) receptor assessed as [3H]thymidine uptake in CHO cells by mitogenesis assay,F,0.11
6180,CHEMBL208018,Cc1nn(cc1CN2CCN(CC2)c3ccccc3)c4ccccc4,Ki,=,71.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,B,71.0
6181,CHEMBL208018,Cc1nn(cc1CN2CCN(CC2)c3ccccc3)c4ccccc4,Ki,=,43.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,B,43.0
6182,CHEMBL208018,Cc1nn(cc1CN2CCN(CC2)c3ccccc3)c4ccccc4,Ki,=,70.79,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,70.79
6190,CHEMBL209876,COc1c(Cl)cccc1N2CCN(CCCCNC(=O)c3cc4CCc5ccc(CCc3cc4)cc5)CC2,Ki,=,42.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,42.0
6191,CHEMBL209876,COc1c(Cl)cccc1N2CCN(CCCCNC(=O)c3cc4CCc5ccc(CCc3cc4)cc5)CC2,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,28.0
6195,CHEMBL210232,COc1ccccc1N2CCN(Cc3cn(nn3)c4ccccc4)CC2,Ki,=,65.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,B,65.0
6196,CHEMBL210232,COc1ccccc1N2CCN(Cc3cn(nn3)c4ccccc4)CC2,Ki,=,65.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,65.0
6201,CHEMBL210717,Fc1ccccc1N2CCN(Cc3cnn(c3)c4ccccc4)CC2,Ki,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,B,63.0
6202,CHEMBL210717,Fc1ccccc1N2CCN(Cc3cnn(c3)c4ccccc4)CC2,Ki,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,B,37.0
6203,CHEMBL210717,Fc1ccccc1N2CCN(Cc3cnn(c3)c4ccccc4)CC2,Ki,=,63.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,63.1
6207,CHEMBL426863,Fc1cccc(N2CCN(CCCCNC(=O)c3cc4CCc5ccc(CCc3cc4)cc5)CC2)c1F,Ki,=,35.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,35.0
6208,CHEMBL378455,C(N1CCC(=CC1)c2ccccc2)c3cnn(c3)c4ccccc4,Ki,=,38.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,B,38.0
6209,CHEMBL378455,C(N1CCC(=CC1)c2ccccc2)c3cnn(c3)c4ccccc4,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,B,28.0
6211,CHEMBL378455,C(N1CCC(=CC1)c2ccccc2)c3cnn(c3)c4ccccc4,EC50,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity against dopamine D2(long) receptor assessed as [3H]thymidine uptake in CHO cells by mitogenesis assay,F,1.5
6212,CHEMBL378455,C(N1CCC(=CC1)c2ccccc2)c3cnn(c3)c4ccccc4,EC50,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity against dopamine D2(long) receptor expressed in CHO cells by GTPgammaS assay,F,12.5
6214,CHEMBL378455,C(N1CCC(=CC1)c2ccccc2)c3cnn(c3)c4ccccc4,EC50,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity against dopamine D2(short) receptor assessed as [3H]thymidine uptake in CHO cells by mitogenesis assay,F,0.85
6217,CHEMBL378455,C(N1CCC(=CC1)c2ccccc2)c3cnn(c3)c4ccccc4,EC50,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity against dopamine D2(short) receptor expressed in CHO cells by GTPgammaS assay,F,16.0
6223,CHEMBL208847,COc1ccccc1N2CCN(CCCCNC(=O)c3oc4c5CCc6ccc(CCc(cc5)c4c3)cc6)CC2,Ki,=,84.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,84.0
6227,CHEMBL210404,COc1ccccc1N2CCN(Cc3cnn(c3)c4ccccn4)CC2,Ki,=,40.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,B,40.0
6228,CHEMBL210404,COc1ccccc1N2CCN(Cc3cnn(c3)c4ccccn4)CC2,Ki,=,31.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,B,31.0
6229,CHEMBL210404,COc1ccccc1N2CCN(Cc3cnn(c3)c4ccccn4)CC2,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,39.81
6231,CHEMBL210405,C(N1CCN(CC1)c2ccccc2)c3cnn(c3)c4ccccc4,Ki,=,75.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,B,75.0
6233,CHEMBL210405,C(N1CCN(CC1)c2ccccc2)c3cnn(c3)c4ccccc4,Ki,=,75.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,B,75.0
6246,CHEMBL211590,COc1ccccc1N2CCN(Cc3cn4cc(C)cc(I)c4n3)CC2,Ki,=,97.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,B,97.0
6247,CHEMBL211590,COc1ccccc1N2CCN(Cc3cn4cc(C)cc(I)c4n3)CC2,Ki,=,88.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,88.0
6263,CHEMBL208274,COc1ccccc1N2CCN(Cc3cn4cc(C)cc(c5ccccc5)c4n3)CC2,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,B,28.0
6264,CHEMBL208274,COc1ccccc1N2CCN(Cc3cn4cc(C)cc(c5ccccc5)c4n3)CC2,Ki,=,49.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,49.0
6277,CHEMBL378515,COc1ccccc1N2CCN(Cc3cn4nc(Cl)ccc4n3)CC2,Ki,=,79.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,B,79.0
6278,CHEMBL378515,COc1ccccc1N2CCN(Cc3cn4nc(Cl)ccc4n3)CC2,Ki,=,96.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,96.0
6281,CHEMBL379125,COc1ccccc1N2CCN(Cc3cn4cc(I)ccc4n3)CC2,Ki,=,72.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,B,72.0
6282,CHEMBL379125,COc1ccccc1N2CCN(Cc3cn4cc(I)ccc4n3)CC2,Ki,=,73.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,73.0
6335,CHEMBL378324,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccc(Cl)c(Cl)c3,Ki,=,64.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,B,64.5
6343,CHEMBL210101,CO\N=C(/CCN1CCC(CC1)c2ccccn2)\c3ccc(Cl)cc3,Ki,=,25.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,B,25.3
6354,CHEMBL437532,CO\N=C(\CCN1CCC(CC1)c2ccccn2)/c3ccc(Cl)cc3,Ki,=,19.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,B,19.4
6361,CHEMBL212235,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccc(Cl)cc3,Ki,=,63.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,B,63.8
6391,CHEMBL215450,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3ccc(Cl)c(C)c3,Ki,=,60.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,B,60.9
6402,CHEMBL212292,CO\N=C(/CCN1CCN(CC1C)c2ccccn2)\c3ccc(Cl)cc3,Ki,=,76.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,B,76.5
6455,CHEMBL213164,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3cccc(F)c3,Ki,=,46.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,B,46.6
6458,CHEMBL212784,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3cccc(Cl)c3,Ki,=,98.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,B,98.7
6467,CHEMBL212861,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3cccc(C)c3,Ki,=,68.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,B,68.4
6474,CHEMBL212903,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3cccc(C)c3,Ki,=,68.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,B,68.0
6574,CHEMBL377452,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(c4ccccc24)S(=O)(=O)c5ccccc5C,Ki,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,63.0
6583,CHEMBL213577,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(Cc5ccc6OCCOc6c5)CC4,Ki,=,29.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,29.0
6590,CHEMBL212807,COc1cccc(OC)c1C(=O)NN2c3ccc(Cl)cc3N=C(N4CCN(C)CC4)c5cc(Cl)ccc25,Ki,=,97.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,97.0
6592,CHEMBL384634,FC1(F)Oc2cccc(CN3CCN(CC3)C4=Nc5cc(Cl)ccc5Nc6ccccc46)c2O1,Ki,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,8.0
6593,CHEMBL215669,FC(F)(F)Oc1cccc(CN2CCN(CC2)C3=Nc4cc(Cl)ccc4Nc5ccccc35)c1,Ki,=,3.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,3.4
6601,CHEMBL384916,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4sccc4c5ccccc5)c6ccccc26,Ki,=,78.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,78.0
6602,CHEMBL378341,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4cc(F)ccc4C(F)(F)F)c5ccc(Cl)cc25,Ki,=,69.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,69.0
6619,CHEMBL377756,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4c(N)cccc4C(F)(F)F)c5ccccc25,Ki,=,92.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,92.0
6620,CHEMBL212936,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4ccccc4I)c5ccc(Cl)cc25,Ki,=,36.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,36.0
6629,CHEMBL211915,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(Cc5cccc6OCOc56)CC4,Ki,=,80.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,80.0
6631,CHEMBL378301,Cc1ccc(CN2CCN(CC2)C3=Nc4cc(Cl)ccc4Nc5ccccc35)c(C)c1,Ki,=,65.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,65.0
6667,CHEMBL216439,CN1CCCc2c(Cc3ccccc3CC1)[nH]c4ccccc24,Ki,=,38.0,nM,Dopamine D2 receptor,Homo sapiens,Activity at human D2L dopamine receptor expressed in HEK293 cells by calcium fluorescence assay,B,38.0
6669,CHEMBL216258,CN1CCCc2ccccc2Cc3[nH]c4ccccc4c3CC1,Ki,=,14.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L dopamine receptor expressed in CHO cells,B,14.5
6670,CHEMBL216258,CN1CCCc2ccccc2Cc3[nH]c4ccccc4c3CC1,Ki,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,Activity at human D2L dopamine receptor expressed in HEK293 cells by calcium fluorescence assay,B,1.5
6671,CHEMBL216258,CN1CCCc2ccccc2Cc3[nH]c4ccccc4c3CC1,Ki,=,13.49,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,B,13.49
6679,CHEMBL1423,Fc1ccc(cc1)C(CCCN2CCC(CC2)N3C(=O)Nc4ccccc34)c5ccc(F)cc5,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2,B,12.0
6680,CHEMBL1423,Fc1ccc(cc1)C(CCCN2CCC(CC2)N3C(=O)Nc4ccccc34)c5ccc(F)cc5,Kd,=,29.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,29.0
6682,CHEMBL1423,Fc1ccc(cc1)C(CCCN2CCC(CC2)N3C(=O)Nc4ccccc34)c5ccc(F)cc5,Ki,=,11.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,B,11.7
6686,CHEMBL376092,COc1ccccc1C2CCN(CNC(=O)c3cccc(C)c3)CC2,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]7-OH-PIPAT from human D2L receptor expressed in HEK293 cell membrane,B,27.0
6709,CHEMBL219916,Clc1ccc2N(C3CCN(CCCN4C(=O)Nc5ccccc45)CC3)C(=O)Nc2c1,IC50,=,2.647,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,1.3235
6710,CHEMBL219916,Clc1ccc2N(C3CCN(CCCN4C(=O)Nc5ccccc45)CC3)C(=O)Nc2c1,Ki,=,0.882,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,0.882
6711,CHEMBL219916,Clc1ccc2N(C3CCN(CCCN4C(=O)Nc5ccccc45)CC3)C(=O)Nc2c1,Ki,=,1.3,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The pharmacological profile of metopimazine, metopimazine acid (MPZA), domperidone, and metoclopramide were assessed by radioligand binding and by a functional antagonist assay. For the radioligand binding assay, cell membranes of dopamine D2 receptor expressing cells were incubated with [3H]spiperone and competing drugs in buffer. The assay was terminated by rapid filtration, and the bound radioactive signal was determined by liquid scintillation counting.",B,1.3
6738,CHEMBL218318,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4cc(ccc4s3)C#N)CC2,Ki,=,67.61,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,67.61
6740,CHEMBL221681,COc1ccccc1N2CCN(CCCCNC(=O)c3oc4ccc(Br)cc4c3)CC2,Ki,=,95.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,95.5
6744,CHEMBL217981,COc1ccccc1N2CCN(CCCCCNC(=O)c3nnn(Cc4ccccc4Br)c3C)CC2,Ki,=,4.898,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,4.898
6745,CHEMBL217981,COc1ccccc1N2CCN(CCCCCNC(=O)c3nnn(Cc4ccccc4Br)c3C)CC2,Ki,=,0.58,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,0.58
6746,CHEMBL386986,CCCc1c(nnn1Cc2ccccc2Br)C(=O)NCCCCN3CCN(CC3)c4ccccc4OC,Ki,=,21.88,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,21.88
6747,CHEMBL386986,CCCc1c(nnn1Cc2ccccc2Br)C(=O)NCCCCN3CCN(CC3)c4ccccc4OC,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,3.0
6748,CHEMBL221600,C(N1CCC(CC1)c2ccccc2)c3cnn(c3)c4ccccc4,Ki,=,38.02,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,38.02
6750,CHEMBL373873,Cc1c(nnn1Cc2ccccc2)C(=O)NCCCCN3CCN(CC3)c4cccc(Cl)c4Cl,Ki,=,38.9,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,38.9
6751,CHEMBL373873,Cc1c(nnn1Cc2ccccc2)C(=O)NCCCCN3CCN(CC3)c4cccc(Cl)c4Cl,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,14.0
6752,CHEMBL221129,CCCc1c(nnn1Cc2ccccc2Br)C(=O)NCCCCCN3CCN(CC3)c4ccccc4OC,Ki,=,5.247999999999999,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,5.247999999999999
6753,CHEMBL221129,CCCc1c(nnn1Cc2ccccc2Br)C(=O)NCCCCCN3CCN(CC3)c4ccccc4OC,Ki,=,0.91,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,0.91
6755,CHEMBL221843,COc1ccccc1N2CCN(CCCCNC(=O)c3nnn(Cc4ccccc4)c3C)CC2,Ki,=,35.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,35.0
6756,CHEMBL221897,Cc1c(nnn1Cc2ccccc2)C(=O)NCCCCCN3CCN(CC3)c4cccc(Cl)c4Cl,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,10.0
6757,CHEMBL221587,COc1ccccc1N2CCN(CCCCCNC(=O)c3nnn(Cc4ccccc4)c3C)CC2,Ki,=,9.333,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,9.333
6758,CHEMBL221587,COc1ccccc1N2CCN(CCCCCNC(=O)c3nnn(Cc4ccccc4)c3C)CC2,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,2.5
6759,CHEMBL425285,CCCc1c(nnn1Cc2ccccc2)C(=O)NCCCCN3CCN(CC3)c4cccc(Cl)c4Cl,Ki,=,14.13,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,14.13
6760,CHEMBL425285,CCCc1c(nnn1Cc2ccccc2)C(=O)NCCCCN3CCN(CC3)c4cccc(Cl)c4Cl,Ki,=,6.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,6.4
6761,CHEMBL218607,CCCc1c(nnn1Cc2ccccc2)C(=O)NCCCCN3CCN(CC3)c4ccccc4OC,Ki,=,57.54,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,57.54
6762,CHEMBL218607,CCCc1c(nnn1Cc2ccccc2)C(=O)NCCCCN3CCN(CC3)c4ccccc4OC,Ki,=,6.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,6.4
6763,CHEMBL437525,COc1ccc(Cn2nnc(C(=O)NCCCCN3CCN(CC3)c4ccccc4OC)c2C)cc1,Ki,=,54.95,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,54.95
6764,CHEMBL437525,COc1ccc(Cn2nnc(C(=O)NCCCCN3CCN(CC3)c4ccccc4OC)c2C)cc1,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,13.0
6765,CHEMBL221866,COc1ccc(Cn2nnc(C(=O)NCCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)c2C)cc1,Ki,=,9.12,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,9.12
6766,CHEMBL221866,COc1ccc(Cn2nnc(C(=O)NCCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)c2C)cc1,Ki,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,1.5
6767,CHEMBL220754,COc1ccc(Cn2nnc(C(=O)NCCCCCN3CCN(CC3)c4ccccc4OC)c2C)cc1,Ki,=,16.98,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,16.98
6768,CHEMBL220754,COc1ccc(Cn2nnc(C(=O)NCCCCCN3CCN(CC3)c4ccccc4OC)c2C)cc1,Ki,=,2.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,2.7
6769,CHEMBL218351,CCCc1c(nnn1Cc2ccc(OC)cc2)C(=O)NCCCCN3CCN(CC3)c4ccccc4OC,Ki,=,42.66,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,42.66
6770,CHEMBL218351,CCCc1c(nnn1Cc2ccc(OC)cc2)C(=O)NCCCCN3CCN(CC3)c4ccccc4OC,Ki,=,7.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,7.1
6771,CHEMBL385289,COc1ccccc1N2CCN(CCCCNC(=O)c3nnn(Cc4ccccc4Br)c3C)CC2,Ki,=,61.66,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,61.66
6772,CHEMBL385289,COc1ccccc1N2CCN(CCCCNC(=O)c3nnn(Cc4ccccc4Br)c3C)CC2,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,17.0
6774,CHEMBL221652,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)c4cccc([18F])n4)CC2,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2(long) expressed in CHO cell membrane,B,27.0
6775,CHEMBL221652,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)c4cccc([18F])n4)CC2,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2(short) expressed in CHO cell membrane,B,16.0
6776,CHEMBL221640,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)c4ccc([18F])nc4)CC2,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2(long) expressed in CHO cell membrane,B,15.0
6777,CHEMBL221640,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)c4ccc([18F])nc4)CC2,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2(short) expressed in CHO cell membrane,B,12.0
6779,CHEMBL221692,Fc1ccc(cc1)c2cncc(CN3CCN(CC3)c4cccc5OCCOc45)c2,Ki,=,3.9810000000000003,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,B,3.9810000000000003
6780,CHEMBL220808,Fc1ccc(cc1)c2cncc(CNC[C@H]3CCc4ccccc4O3)c2,IC50,<,6.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopaminergic D2 receptor,B,3.0
6781,CHEMBL218166,O=C1Nc2cccc(N3CCN(Cc4cccc(c4)c5ccccc5)CC3)c2O1,Ki,=,2.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,B,2.2
6782,CHEMBL218166,O=C1Nc2cccc(N3CCN(Cc4cccc(c4)c5ccccc5)CC3)c2O1,Ki,=,2.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at dopamine D2 receptor,F,2.2
6783,CHEMBL218166,O=C1Nc2cccc(N3CCN(Cc4cccc(c4)c5ccccc5)CC3)c2O1,Ki,=,0.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,B,0.1
6784,CHEMBL218166,O=C1Nc2cccc(N3CCN(Cc4cccc(c4)c5ccccc5)CC3)c2O1,Ki,=,0.04,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,B,0.04
6789,CHEMBL218166,O=C1Nc2cccc(N3CCN(Cc4cccc(c4)c5ccccc5)CC3)c2O1,Ki,=,0.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,0.6
6790,CHEMBL218166,O=C1Nc2cccc(N3CCN(Cc4cccc(c4)c5ccccc5)CC3)c2O1,Ki,=,2.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]nemonapride from dopamine D2L receptor (unknown origin) expressed in African green monkey COS7 cells,B,2.3
6792,CHEMBL218166,O=C1Nc2cccc(N3CCN(Cc4cccc(c4)c5ccccc5)CC3)c2O1,Ki,=,2.291,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]nemonapride from dopamine D2L receptor (unknown origin) expressed in African green monkey COS7 cells,B,2.291
6818,CHEMBL224820,COc1ccccc1N2CCN(CCCCCC(=O)NC3CCCc4ccccc34)CC2,Ki,=,26.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,B,26.4
6819,CHEMBL389718,CC(=O)c1ccccc1N2CCN(CCCCCC(=O)NC3CCCc4ccccc34)CC2,Ki,=,68.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,B,68.0
6825,CHEMBL225230,CCCN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,50.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards Dopamine receptor D2,B,50.0
6826,CHEMBL225230,CCCN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Kd,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Equilibrium dissociation constant against recombinant Dopamine receptor D2A expressed in COS7 cells,B,20.0
6827,CHEMBL225230,CCCN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,EC50,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Activity at human dopamine D2 receptor in NIH/3T3 cells assessed as beta-galactosidase activity after 5 days by R-SAT assay,F,12.56
6830,CHEMBL225284,CSc1ccccc1N2CCN(CCCCCC(=O)NC3CCCc4ccccc34)CC2,Ki,=,7.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,B,7.3
6834,CHEMBL222477,Clc1ccccc1N2CCN(CCCCCC(=O)NC3CCCc4ccccc34)CC2,Ki,=,51.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,B,51.0
6877,CHEMBL390299,CN1C[C@@H](C=C2[C@H]1Cc3c[nH]c4cccc2c34)C(=O)N[C@@H](Cc5ccc(cc5)[N+](=O)[O-])C(=O)N[C@@H](Cc6ccc(F)cc6)C(=O)N7CCCC(C7)C(=O)N,Kd,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]YM 09151-2 from dopamine D2 receptor in lamb striatum membrane after 2 hrs,B,20.0
6902,CHEMBL231334,CCCCc1ccc(cc1)S(=O)(=O)Nc2ccc3CCN(C)CCc3c2,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,B,31.62
6904,CHEMBL231431,CN1CCc2ccc(NS(=O)(=O)c3ccc(cc3)c4ccc(F)c(Cl)c4)cc2CC1,Ki,=,50.12,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,B,50.12
6906,CHEMBL230069,CN1CCc2ccc(NS(=O)(=O)c3ccc(c(C)c3)c4ccc(Cl)cc4)cc2CC1,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,B,31.62
6910,CHEMBL395525,CN1CCc2cc(C)c(NS(=O)(=O)c3ccc(cc3)c4ccc(Cl)cc4)cc2CC1,Ki,=,15.85,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,B,15.85
6912,CHEMBL231546,CN1CCc2cc(Br)c(NS(=O)(=O)c3ccc(cc3)c4ccc(Cl)cc4)cc2CC1,Ki,=,63.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,B,63.1
6913,CHEMBL231648,CN1CCc2cc(Cl)c(NS(=O)(=O)c3ccc(cc3)c4ccc(Cl)cc4)cc2CC1,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,B,39.81
6914,CHEMBL231249,COc1cc2CCN(C)CCc2cc1NS(=O)(=O)c3ccc(cc3)c4ccc(Cl)cc4,Ki,=,3.9810000000000003,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,B,3.9810000000000003
6915,CHEMBL231349,CC(C)Oc1cc2CCN(C)CCc2cc1NS(=O)(=O)c3ccc(cc3)c4ccc(Cl)cc4,Ki,=,6.31,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,B,6.31
6916,CHEMBL231350,CC(C)Nc1cc2CCN(C)CCc2cc1NS(=O)(=O)c3ccc(cc3)c4ccc(Cl)cc4,Ki,=,50.12,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,B,50.12
6922,CHEMBL388361,COc1ccc(cc1OC)S(=O)(=O)N[C@@H]2CC[C@H](CC2)N3CCC(CC3)c4ccccc4OC(C)C,Ki,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor,B,55.0
6923,CHEMBL388361,COc1ccc(cc1OC)S(=O)(=O)N[C@@H]2CC[C@H](CC2)N3CCC(CC3)c4ccccc4OC(C)C,Ki,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,55.0
6924,CHEMBL390184,CC(C)Oc1ccccc1C2CCN(CC2)[C@@H]3CC[C@@H](CC3)NS(=O)(=O)c4ccc(F)c(F)c4,Ki,=,79.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor,B,79.0
6925,CHEMBL229084,CC(C)Oc1ccccc1C2CCN(CC2)[C@@H]3CC[C@H](CC3)NS(=O)(=O)c4ccc(F)c(F)c4,Ki,=,79.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor,B,79.0
6934,CHEMBL389104,O=S(=O)(N[C@@H]1CC[C@@H](CC1)N2CCC(CC2)c3ccccc3OC4CC4)c5ccc6OCOc6c5,Ki,=,66.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor,B,66.0
6935,CHEMBL228333,O=S(=O)(N[C@@H]1CC[C@H](CC1)N2CCC(CC2)c3ccccc3OC4CC4)c5ccc6OCOc6c5,Ki,=,71.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor,B,71.0
6938,CHEMBL228389,COc1ccc(cc1OC)S(=O)(=O)N[C@@H]2CC[C@H](CC2)N3CCC(CC3)c4ccccc4OCC(F)(F)F,Ki,=,83.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor,B,83.0
6939,CHEMBL228389,COc1ccc(cc1OC)S(=O)(=O)N[C@@H]2CC[C@H](CC2)N3CCC(CC3)c4ccccc4OCC(F)(F)F,Ki,=,83.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,83.0
6940,CHEMBL439197,FC(F)(F)COc1ccccc1C2CCN(CC2)[C@@H]3CC[C@@H](CC3)NS(=O)(=O)c4ccc5OCCOc5c4,Ki,=,57.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor,B,57.0
6941,CHEMBL228390,FC(F)(F)COc1ccccc1C2CCN(CC2)[C@@H]3CC[C@H](CC3)NS(=O)(=O)c4ccc5OCCOc5c4,Ki,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor,B,23.0
6942,CHEMBL442059,COc1ccc(Cl)cc1S(=O)(=O)N[C@@H]2CC[C@@H](CC2)N3CCC(CC3)c4ccccc4OCC(F)(F)F,Ki,=,69.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor,B,69.0
6943,CHEMBL390192,COc1ccc(Cl)cc1S(=O)(=O)N[C@@H]2CC[C@H](CC2)N3CCC(CC3)c4ccccc4OCC(F)(F)F,Ki,=,82.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor,B,82.0
6944,CHEMBL228445,Fc1ccc(Cl)cc1S(=O)(=O)N[C@@H]2CC[C@@H](CC2)N3CCC(CC3)c4ccccc4OCC(F)(F)F,Ki,=,78.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor,B,78.0
6945,CHEMBL228494,Fc1ccc(Cl)cc1S(=O)(=O)N[C@@H]2CC[C@H](CC2)N3CCC(CC3)c4ccccc4OCC(F)(F)F,Ki,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor,B,37.0
6946,CHEMBL228496,FC(F)Oc1cccc(c1)S(=O)(=O)N[C@@H]2CC[C@@H](CC2)N3CCC(CC3)c4ccccc4OCC(F)(F)F,Ki,=,85.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor,B,85.0
6956,CHEMBL228607,COc1ccc(cc1OC)S(=O)(=O)N[C@@H]2CC[C@H](CC2)N3CCC(CC3)c4ccccc4OCC(F)F,Ki,=,88.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor,B,88.0
6957,CHEMBL228607,COc1ccc(cc1OC)S(=O)(=O)N[C@@H]2CC[C@H](CC2)N3CCC(CC3)c4ccccc4OCC(F)F,Ki,=,88.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,88.0
6961,CHEMBL390473,COc1ccc(cc1OC)S(=O)(=O)N[C@@H]2CC[C@H](CC2)N3CCC(CC3)c4cc(F)ccc4OC(C)C,Ki,=,94.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor,B,94.0
6997,CHEMBL243743,CCCCc1ccccc1N2CCN(CCCCCC(=O)NC3CCCc4ccccc34)CC2,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,B,60.0
6998,CHEMBL243744,CC(C)c1ccccc1N2CCN(CCCCCC(=O)NC3CCCc4ccccc34)CC2,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,B,15.0
7002,CHEMBL243955,CN(C)c1ccccc1N2CCN(CCCCCC(=O)NC3CCCc4ccccc34)CC2,Ki,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,B,32.0
7030,CHEMBL241973,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)c4ccccn4)CC2,Ki,=,28.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,B,28.3
7032,CHEMBL241973,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)c4ccccn4)CC2,EC50,=,114.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,57.0
7034,CHEMBL244562,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccc(cc3)C4=CC=CC(=O)N4)CC2)c1Cl,Ki,=,23.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,B,23.6
7036,CHEMBL244562,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccc(cc3)C4=CC=CC(=O)N4)CC2)c1Cl,IC50,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",B,20.5
7040,CHEMBL244773,Cc1cccnc1c2ccc(cc2)C(=O)NC\C=C\CN3CCN(CC3)c4cccc(Cl)c4Cl,Ki,=,92.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,B,92.0
7043,CHEMBL244774,[O-][n+]1ccccc1c2ccc(cc2)C(=O)NC\C=C\CN3CCN(CC3)c4cccc(Cl)c4Cl,Ki,=,25.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,B,25.8
7047,CHEMBL244774,[O-][n+]1ccccc1c2ccc(cc2)C(=O)NC\C=C\CN3CCN(CC3)c4cccc(Cl)c4Cl,IC50,=,22.9,nM,Dopamine D2 receptor,Homo sapiens,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",B,11.45
7049,CHEMBL394541,COc1ccccc1N2CCN(C\C=C\CNC(=O)c3ccc(cc3)c4ccccn4)CC2,Ki,=,69.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,B,69.0
7051,CHEMBL394541,COc1ccccc1N2CCN(C\C=C\CNC(=O)c3ccc(cc3)c4ccccn4)CC2,IC50,=,175.0,nM,Dopamine D2 receptor,Homo sapiens,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",B,87.5
7052,CHEMBL244989,COc1ccccc1N2CCN(C\C=C\CNC(=O)c3ccc4c(Cc5ccccc45)c3)CC2,Ki,=,48.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,B,48.4
7054,CHEMBL244989,COc1ccccc1N2CCN(C\C=C\CNC(=O)c3ccc4c(Cc5ccccc45)c3)CC2,IC50,=,179.0,nM,Dopamine D2 receptor,Homo sapiens,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",B,89.5
7056,CHEMBL244990,OC(CCNC(=O)c1ccc(cc1)c2ccccn2)CN3CCN(CC3)c4cccc(Cl)c4Cl,EC50,=,15.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,7.9
7058,CHEMBL244990,OC(CCNC(=O)c1ccc(cc1)c2ccccn2)CN3CCN(CC3)c4cccc(Cl)c4Cl,IC50,=,15.8,nM,Dopamine D2 receptor,Homo sapiens,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",B,7.9
7067,CHEMBL390253,OC(CCN1CCN(CC1)c2cccc(Cl)c2Cl)CNC(=O)c3ccc(cc3)c4ccccn4,Ki,=,28.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,B,28.4
7069,CHEMBL390253,OC(CCN1CCN(CC1)c2cccc(Cl)c2Cl)CNC(=O)c3ccc(cc3)c4ccccn4,IC50,=,88.3,nM,Dopamine D2 receptor,Homo sapiens,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",B,44.15
7070,CHEMBL394862,OC(CCN1CCN(CC1)c2cccc(Cl)c2Cl)CNC(=O)c3ccc4c(Cc5ccccc45)c3,Ki,=,84.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,B,84.0
7071,CHEMBL231055,COc1ccccc1N2CCN(CCC(O)CNC(=O)c3ccc4c(Cc5ccccc45)c3)CC2,Ki,=,68.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,B,68.4
7072,CHEMBL231156,Clc1cccc(N2CCN(C[C@H]3C[C@@H]3CNC(=O)c4ccc(cc4)c5ccccn5)CC2)c1Cl,Ki,=,53.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,B,53.7
7074,CHEMBL231156,Clc1cccc(N2CCN(C[C@H]3C[C@@H]3CNC(=O)c4ccc(cc4)c5ccccn5)CC2)c1Cl,EC50,=,150.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,75.0
7077,CHEMBL230872,COc1ccccc1N2CCN(CCCOc3ccc(cc3)c4cn5ccccc5n4)CC2,Ki,=,49.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,B,49.0
7078,CHEMBL230971,Clc1cccc(N2CCN(CCCOc3ccc(cc3)c4cn5ccccc5n4)CC2)c1Cl,Ki,=,44.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,B,44.0
7079,CHEMBL230972,COc1ccccc1N2CCN(CCCOc3ccc(cc3)c4cn5cc(C)ccc5n4)CC2,Ki,=,78.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,B,78.0
7081,CHEMBL231078,COc1ccccc1N2CCN(CCCOc3ccc(cc3)c4cn5ccc(C)cc5n4)CC2,Ki,=,78.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,B,78.0
7082,CHEMBL231079,Cc1ccn2cc(nc2c1)c3ccc(OCCCN4CCN(CC4)c5cccc(Cl)c5Cl)cc3,Ki,=,83.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,B,83.0
7083,CHEMBL387569,COc1ccccc1N2CCN(CCCOc3ccc(cc3)c4cn5cccc(C)c5n4)CC2,Ki,=,49.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,B,49.0
7086,CHEMBL387784,Clc1cccc(N2CCN(CCCCOc3ccc(cc3)c4cn5ccccc5n4)CC2)c1Cl,Ki,=,68.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,B,68.0
7087,CHEMBL231182,COc1ccccc1N2CCN(CCCCOc3ccc(cc3)c4cn5cc(C)ccc5n4)CC2,Ki,=,47.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,B,47.0
7089,CHEMBL231158,COc1ccccc1N2CCN(CCCCOc3ccc(cc3)c4cn5ccc(C)cc5n4)CC2,Ki,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,B,52.0
7094,CHEMBL389357,COc1ccc2Cc3ccccc3CCN(C)CCCc2c1,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,25.0
7095,CHEMBL389357,COc1ccc2Cc3ccccc3CCN(C)CCCc2c1,Ki,=,24.55,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,B,24.55
7096,CHEMBL231070,CN1CCCc2ccccc2Cc3ccc(O)cc3CC1,Ki,=,74.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,74.0
7097,CHEMBL231070,CN1CCCc2ccccc2Cc3ccc(O)cc3CC1,Ki,=,41.69,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,B,41.69
7098,CHEMBL276778,COc1ccc2Cc3ccccc3CCCN(C)CCc2c1,Ki,=,87.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,87.0
7099,CHEMBL276778,COc1ccc2Cc3ccccc3CCCN(C)CCc2c1,Ki,=,86.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,B,86.7
7107,CHEMBL394779,CN1CCCc2ccccc2Cc3cc(O)ccc3CC1,Ki,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,63.0
7109,CHEMBL243712,CCN1CCCC1CNC(=O)c2cc(c(N)cc2OC)S(=O)(=O)CC,Ki,=,12.59,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,B,12.59
7111,CHEMBL243712,CCN1CCCC1CNC(=O)c2cc(c(N)cc2OC)S(=O)(=O)CC,IC50,=,3.04,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at D2 receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 assessed as inhibition of dopamine-induced calcium flux by fluo-4 dye based FLIPR assay,B,1.52
7142,CHEMBL390429,COc1ccccc1c2nnc(SCCCN3CCc4ccc(cc4CC3)c5cc(C)on5)n2C,Ki,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,F,79.43
7143,CHEMBL242599,COc1cccc(c1)c2nnc(SCCCN3CCc4ccc(cc4CC3)c5cc(C)on5)n2C,Ki,=,7.943,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,F,7.943
7160,CHEMBL243012,COc1ccc(cc1OC)C2=NO[C@H](CCCN3CCN(CC3)C(c4ccc(F)cc4)c5ccc(F)cc5)C2,Ki,=,80.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cells,B,80.0
7162,CHEMBL243224,CCOc1ccccc1N2CCN(CCC[C@@H]3CC(=NO3)c4ccc(OC)c(OC)c4)CC2,Ki,=,46.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cells,B,46.0
7163,CHEMBL243225,CCOc1ccccc1N2CCN(CCC[C@H]3CC(=NO3)c4ccc(OC)c(OC)c4)CC2,Ki,=,70.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cells,B,70.0
7211,CHEMBL234669,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@H](CC3)NS(=O)(=O)c4ccccc4,Ki,=,34.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,34.0
7212,CHEMBL234679,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@@H](CC3)NS(=O)(=O)c4ccccc4C#N,Ki,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,55.0
7213,CHEMBL234680,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@H](CC3)NS(=O)(=O)c4ccccc4C#N,Ki,=,2.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,2.4
7215,CHEMBL234681,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@H](CC3)NS(=O)(=O)c4ccccc4F,Ki,=,31.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,31.0
7216,CHEMBL232592,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@@H](CC3)NS(=O)(=O)c4ccccc4[N+](=O)[O-],Ki,=,51.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,51.0
7217,CHEMBL232593,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@H](CC3)NS(=O)(=O)c4ccccc4[N+](=O)[O-],Ki,=,86.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,86.0
7218,CHEMBL232779,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@@H](CC3)NS(=O)(=O)c4cccc(F)c4,Ki,=,74.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,74.0
7219,CHEMBL232780,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@H](CC3)NS(=O)(=O)c4cccc(F)c4,Ki,=,64.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,64.0
7221,CHEMBL233416,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@H](CC3)NS(=O)(=O)c4cccc(c4)C(F)(F)F,Ki,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,39.0
7222,CHEMBL234874,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@@H](CC3)NS(=O)(=O)c4ccc(F)cc4,Ki,=,69.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,69.0
7223,CHEMBL428197,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@H](CC3)NS(=O)(=O)c4ccc(F)cc4,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,27.0
7225,CHEMBL236618,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@H](CC3)NS(=O)(=O)c4ccc(cc4)S(=O)(=O)C,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,14.0
7227,CHEMBL392377,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@H](CC3)NS(=O)(=O)c4ccc(OC(F)(F)F)cc4,Ki,=,58.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,58.0
7228,CHEMBL391530,COc1ccc(cc1OC)S(=O)(=O)N[C@@H]2CC[C@@H](CC2)N3CCN(CC3)c4ccccc4OC(C)C,Ki,=,94.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,94.0
7231,CHEMBL236621,COc1ccc(cc1OC)S(=O)(=O)N[C@@H]2CC[C@H](CC2)N3CCN(CC3)c4ccccc4OC(C)C,Ki,=,62.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,62.0
7232,CHEMBL236621,COc1ccc(cc1OC)S(=O)(=O)N[C@@H]2CC[C@H](CC2)N3CCN(CC3)c4ccccc4OC(C)C,Ki,=,62.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,62.0
7233,CHEMBL236832,COc1ccc(OC)c(c1)S(=O)(=O)N[C@@H]2CC[C@@H](CC2)N3CCN(CC3)c4ccccc4OC(C)C,Ki,=,81.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,81.0
7234,CHEMBL234194,COc1ccc(OC)c(c1)S(=O)(=O)N[C@@H]2CC[C@H](CC2)N3CCN(CC3)c4ccccc4OC(C)C,Ki,=,62.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,62.0
7236,CHEMBL233623,COc1ccc(C)cc1S(=O)(=O)N[C@@H]2CC[C@H](CC2)N3CCN(CC3)c4ccccc4OC(C)C,Ki,=,50.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,50.0
7241,CHEMBL234607,COc1ccc(Cl)cc1S(=O)(=O)N[C@@H]2CC[C@H](CC2)N3CCN(CC3)c4ccccc4OC(C)C,Ki,=,78.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,78.0
7242,CHEMBL233849,COc1ccc(Br)cc1S(=O)(=O)N[C@@H]2CC[C@@H](CC2)N3CCN(CC3)c4ccccc4OC(C)C,Ki,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,37.0
7243,CHEMBL429076,COc1ccc(Br)cc1S(=O)(=O)N[C@@H]2CC[C@H](CC2)N3CCN(CC3)c4ccccc4OC(C)C,Ki,=,36.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,36.0
7245,CHEMBL234232,COc1ccc(cc1S(=O)(=O)N[C@@H]2CC[C@H](CC2)N3CCN(CC3)c4ccccc4OC(C)C)C(F)(F)F,Ki,=,1.9,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,1.9
7246,CHEMBL429623,COc1ccc(cc1S(=O)(=O)N[C@@H]2CC[C@@H](CC2)N3CCN(CC3)c4ccccc4OC(C)C)[N+](=O)[O-],Ki,=,45.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,45.0
7247,CHEMBL234422,COc1ccc(cc1S(=O)(=O)N[C@@H]2CC[C@H](CC2)N3CCN(CC3)c4ccccc4OC(C)C)[N+](=O)[O-],Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,18.0
7248,CHEMBL234423,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@@H](CC3)NS(=O)(=O)c4ccc(C)c(Cl)c4,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,60.0
7249,CHEMBL234609,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@H](CC3)NS(=O)(=O)c4ccc(C)c(Cl)c4,Ki,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,52.0
7250,CHEMBL391035,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@@H](CC3)NS(=O)(=O)c4ccc(Cl)cc4Cl,Ki,=,42.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,42.0
7251,CHEMBL393104,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@H](CC3)NS(=O)(=O)c4ccc(Cl)cc4Cl,Ki,=,76.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,76.0
7255,CHEMBL233582,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@H](CC3)NS(=O)(=O)c4ccc(Cl)cc4F,Ki,=,42.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,42.0
7260,CHEMBL234649,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@@H](CC3)NS(=O)(=O)Cc4ccccc4,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,24.0
7261,CHEMBL234650,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@H](CC3)NS(=O)(=O)Cc4ccccc4,Ki,=,71.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,71.0
7262,CHEMBL234854,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@@H](CC3)NS(=O)(=O)c4cccnc4,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,15.0
7263,CHEMBL391016,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@H](CC3)NS(=O)(=O)c4cccnc4,Ki,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,55.0
7264,CHEMBL232607,COc1ccncc1S(=O)(=O)N[C@@H]2CC[C@@H](CC2)N3CCN(CC3)c4ccccc4OC(C)C,Ki,=,92.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,92.0
7265,CHEMBL391017,COc1ccncc1S(=O)(=O)N[C@@H]2CC[C@H](CC2)N3CCN(CC3)c4ccccc4OC(C)C,Ki,=,43.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,43.0
7266,CHEMBL232609,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@@H](CC3)NS(=O)(=O)c4cnc(Cl)c(Br)c4,Ki,=,61.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,61.0
7267,CHEMBL233790,CC(C)Oc1ccccc1N2CCN(CC2)[C@@H]3CC[C@H](CC3)NS(=O)(=O)c4cnc(Cl)c(Br)c4,Ki,=,80.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,80.0
7310,CHEMBL238401,CCN([C@@H]1CC[C@H](CC1)N2CCN(CC2)c3ccccc3OC(C)C)S(=O)(=O)c4ccc(OC)c(OC)c4,Ki,=,2.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,2.7
7320,CHEMBL394110,O=C1N(CCCCN2CCN(CC2)c3ccccc3)S(=O)(=O)c4ccccc14,Ki,=,38.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,B,38.0
7322,CHEMBL394110,O=C1N(CCCCN2CCN(CC2)c3ccccc3)S(=O)(=O)c4ccccc14,Ki,=,4.1,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,F,4.1
7334,CHEMBL238917,COc1ccccc1N2CCN(CCCCN3C(=O)c4ccccc4S3(=O)=O)CC2,Ki,=,6.2,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,F,6.2
7336,CHEMBL238717,O=C1N(CCCCN2CCN(CC2)c3ccccc3)C=Nc4ccccc14,Ki,=,46.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,B,46.0
7344,CHEMBL398813,FC(F)(F)c1cccc(c1)N2CCN(CCCCN3C=Nc4ccccc4C3=O)CC2,Ki,=,73.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,B,73.0
7350,CHEMBL239700,COc1ccccc1N2CCN(CCCCN3C=Nc4ccccc4C3=O)CC2,Ki,=,1.2,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,F,1.2
7370,CHEMBL240774,O=C1N(CCCCN2CCN(CC2)c3ccccc3)Cc4ccccc14,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,F,60.0
7378,CHEMBL240996,FC(F)(F)c1cccc(c1)N2CCN(CCCCN3Cc4ccccc4C3=O)CC2,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,F,26.0
7382,CHEMBL393492,COc1ccccc1N2CCN(CCCCN3Cc4ccccc4C3=O)CC2,Ki,=,34.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,F,34.0
7385,CHEMBL241631,Clc1cccc(N2CCN(CCNC(=O)c3ccc(cc3)C#C)CC2)c1Cl,Ki,=,69.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,B,69.0
7386,CHEMBL241631,Clc1cccc(N2CCN(CCNC(=O)c3ccc(cc3)C#C)CC2)c1Cl,Ki,=,48.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,B,48.0
7394,CHEMBL394473,Clc1cccc(N2CCN(CCNC(=O)c3cccc(c3)C#C)CC2)c1Cl,Ki,=,83.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,B,83.0
7410,CHEMBL391256,COc1ccccc1N2CCN(CCCCNC(=O)c3cccc(c3)C#C)CC2,Ki,=,78.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,B,78.0
7417,CHEMBL394292,Clc1cccc(N2CCN(CCCCNC(=O)c3ccc(cc3)C#C)CC2)c1Cl,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,B,15.0
7418,CHEMBL394292,Clc1cccc(N2CCN(CCCCNC(=O)c3ccc(cc3)C#C)CC2)c1Cl,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,B,27.0
7425,CHEMBL392437,Clc1cccc(N2CCN(CCCCNC(=O)c3cccc(c3)C#C)CC2)c1Cl,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,B,15.0
7426,CHEMBL392437,Clc1cccc(N2CCN(CCCCNC(=O)c3cccc(c3)C#C)CC2)c1Cl,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,B,24.0
7439,CHEMBL240584,COc1ccccc1N2CCN(CCCCCNC(=O)c3cccc(c3)C#Cc4ccccc4)CC2,Ki,=,31.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,B,31.0
7440,CHEMBL240584,COc1ccccc1N2CCN(CCCCCNC(=O)c3cccc(c3)C#Cc4ccccc4)CC2,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,B,27.0
7443,CHEMBL393365,Clc1cccc(N2CCN(CCCCCNC(=O)c3ccc(cc3)C#C)CC2)c1Cl,Ki,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,B,23.0
7444,CHEMBL393365,Clc1cccc(N2CCN(CCCCCNC(=O)c3ccc(cc3)C#C)CC2)c1Cl,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,B,11.0
7449,CHEMBL239733,Clc1cccc(N2CCN(CCCCCNC(=O)c3cccc(c3)C#C)CC2)c1Cl,Ki,=,51.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,B,51.0
7450,CHEMBL239733,Clc1cccc(N2CCN(CCCCCNC(=O)c3cccc(c3)C#C)CC2)c1Cl,Ki,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,B,23.0
7503,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,64.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells; high binding affinity,B,64.0
7505,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells; high binding affinity,B,52.0
7507,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,2.2,nM,Dopamine D2 receptor,Homo sapiens,Effective concentration was determined as thymidine uptake in CHO-L6 cells transfected with the rat Dopamine receptor D2L by mitogenesis assay (intrinsic activity),B,1.1
7508,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,7.6,nM,Dopamine D2 receptor,Homo sapiens,In vitro inhibition of forskolin-stimulated cAMP accumulation in GH4C1 cells transfected with the human Dopamine D2 receptor,F,3.8
7511,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,3.7,nM,Dopamine D2 receptor,Homo sapiens,Effective dose was measured by the stimulation of mitogenesis at Dopamine receptor D4.2,B,1.85
7512,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,64.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,B,64.0
7513,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,B,52.0
7514,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,B,63.0
7516,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,35.0,nM,Dopamine D2 receptor,Homo sapiens,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,B,35.0
7518,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,35.0,nM,Dopamine D2 receptor,Homo sapiens,High binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,35.0
7521,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,7.4,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity against dopamine D2(long) receptor assessed as [3H]thymidine uptake in CHO cells by mitogenesis assay,F,3.7
7522,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity against dopamine D2(short) receptor assessed as [3H]thymidine uptake in CHO cells by mitogenesis assay,F,5.0
7533,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,140.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at DRD2 Long receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation by bioluminescence assay,F,70.0
7538,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as stimulation of mitogenesis incubated for 24 hrs by [3H]thymidine incorporation assay,F,9.5
7540,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,70.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,B,70.0
7542,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,B,18.0
7544,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,70.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,70.0
7551,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,70.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,B,70.0
7556,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,83.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ARMS2-PK2-tagged human dopamine D2S receptor expressed in HEK293 cells co-expressing (EA)-tagged beta arrestin fusion protein assessed as recruitment of beta-arrestin-2 after 5 hrs by chemiluminescence assay,B,41.5
7560,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,51.0,nM,Dopamine D2 receptor,Homo sapiens,Activity at pro-link-tagged D2S-ARMS2PK2 (unknown origin) expressed in HEK293 cells by beta-arrestin-2 recruitment assay,B,25.5
7561,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,5.56,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,5.56
7565,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,8.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,B,4.1
7568,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,70.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,70.0
7569,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2S receptor expressed in HEK293 cells cotransfected with Gqi5 protein assessed as [3H]IP3 accumulation after 120 mins by scintillation counting assay in presence of myo-[3H]-inositol,B,0.8
7571,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,86.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ARMS2-PK-tagged D2S receptor (unknown origin) transfected in HEK293 cells after 5 hrs by beta-arrestin assay,B,43.0
7574,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,B,1.5
7575,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,5.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,B,2.55
7576,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,5.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,B,2.95
7577,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,1.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,B,0.6
7578,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,1.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,B,0.6
7580,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,151.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,B,75.5
7581,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,64.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ARMS2-PK2 tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin-2 recruitment incubated for 5 hrs measured after 60 mins by PathHunter assay,B,32.0
7582,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,10.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as cAMP inhibition by BRET assay,B,5.45
7583,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,13.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,B,13.1
7584,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,147.6,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,B,73.8
7586,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,38.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,B,19.35
7587,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,B,26.0
7589,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 and GRK2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,B,8.0
7590,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,73.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,B,36.5
7599,CHEMBL392158,COc1cc(CCCF)cc(C(=O)NC[C@@H]2CCCN2CC=C)c1OC,Ki,=,2.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,B,2.1
7600,CHEMBL392158,COc1cc(CCCF)cc(C(=O)NC[C@@H]2CCCN2CC=C)c1OC,Ki,=,2.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,B,2.2
7602,CHEMBL392158,COc1cc(CCCF)cc(C(=O)NC[C@@H]2CCCN2CC=C)c1OC,Ki,=,0.09699999999999999,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,0.09699999999999999
7603,CHEMBL428561,COc1ccc(CCCF)cc1C(=O)NC[C@@H]2CCCN2CC=C,Ki,=,30.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,B,30.0
7604,CHEMBL428561,COc1ccc(CCCF)cc1C(=O)NC[C@@H]2CCCN2CC=C,Ki,=,30.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,B,30.0
7605,CHEMBL241169,COc1cc(I)cc(C(=O)NC[C@@H]2CCCN2CC=C)c1OC,Ki,=,0.68,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,B,0.68
7606,CHEMBL241169,COc1cc(I)cc(C(=O)NC[C@@H]2CCCN2CC=C)c1OC,Ki,=,0.74,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,B,0.74
7607,CHEMBL397103,COc1ccc(I)cc1C(=O)NC[C@@H]2CCCN2CC=C,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,B,14.0
7608,CHEMBL397103,COc1ccc(I)cc1C(=O)NC[C@@H]2CCCN2CC=C,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,B,15.0
7609,CHEMBL240106,COc1cc(Br)cc(C(=O)NC[C@@H]2CCCN2CC=C)c1OC,Ki,=,0.85,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,B,0.85
7610,CHEMBL240106,COc1cc(Br)cc(C(=O)NC[C@@H]2CCCN2CC=C)c1OC,Ki,=,0.88,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,B,0.88
7611,CHEMBL397592,COc1ccc(Br)cc1C(=O)NC[C@@H]2CCCN2CC=C,Ki,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,B,23.0
7612,CHEMBL397592,COc1ccc(Br)cc1C(=O)NC[C@@H]2CCCN2CC=C,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,B,27.0
7619,CHEMBL397770,OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4cccc(Cl)c4Cl,Ki,=,26.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,26.1
7620,CHEMBL397770,OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4cccc(Cl)c4Cl,EC50,=,34.3,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole stimulated mitogenesis,F,17.15
7622,CHEMBL396092,OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4cccc(Cl)c4,EC50,=,83.4,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole stimulated mitogenesis,F,41.7
7623,CHEMBL246637,OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)c(Cl)c4,Ki,=,6.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,6.9
7624,CHEMBL246637,OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)c(Cl)c4,EC50,=,15.3,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole stimulated mitogenesis,F,7.65
7625,CHEMBL246637,OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)c(Cl)c4,Ki,=,6.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,6.9
7627,CHEMBL246848,OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4cccc(c4)C(F)(F)F,EC50,=,69.1,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole stimulated mitogenesis,F,34.55
7636,CHEMBL245615,OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(cc4)c5ccccc5,Ki,=,98.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,98.4
7648,CHEMBL246021,CC(=O)NC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4,Ki,=,83.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,83.1
7649,CHEMBL246021,CC(=O)NC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4,EC50,=,24.8,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole stimulated mitogenesis,F,12.4
7654,CHEMBL246231,COC(=O)C1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,60.0
7655,CHEMBL246231,COC(=O)C1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4,EC50,=,76.7,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole stimulated mitogenesis,F,38.35
7656,CHEMBL399396,CCOC(=O)C1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4,Ki,=,58.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,58.8
7664,CHEMBL246438,COC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4,Ki,=,68.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,68.1
7665,CHEMBL246438,COC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4,EC50,=,34.7,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole stimulated mitogenesis,F,17.35
7668,CHEMBL246439,Cc1[nH]c2ccccc2c1CN3CCC(O)(CC3)c4ccc(Cl)cc4,Ki,=,15.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,15.4
7669,CHEMBL246439,Cc1[nH]c2ccccc2c1CN3CCC(O)(CC3)c4ccc(Cl)cc4,EC50,=,2.13,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole stimulated mitogenesis,F,1.065
7674,CHEMBL246643,OC1(CCN(Cc2coc3ccccc23)CC1)c4ccc(Cl)c(Cl)c4,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,21.0
7676,CHEMBL246644,OC1(CCN(Cc2coc3ccccc23)CC1)c4ccc(Cl)cc4,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,21.0
7678,CHEMBL246854,CSc1ccc(cc1)C2(O)CCN(Cc3coc4ccccc34)CC2,Ki,=,54.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,54.0
7680,CHEMBL400827,Cn1cc(CN2CCC(O)(CC2)c3ccc(Cl)cc3)c4ccccc14,Ki,=,29.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,29.6
7681,CHEMBL400827,Cn1cc(CN2CCC(O)(CC2)c3ccc(Cl)cc3)c4ccccc14,EC50,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole stimulated mitogenesis,F,10.0
7683,CHEMBL246855,CCCCCCn1cc(CN2CCC(O)(CC2)c3ccc(Cl)cc3)c4ccccc14,EC50,=,166.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole stimulated mitogenesis,F,83.0
7686,CHEMBL401031,CSc1ccc(cc1)C2(O)CCN(Cc3c[nH]c4ccccc34)CC2,Ki,=,23.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,23.9
7688,CHEMBL247058,COc1ccc2[nH]cc(CN3CCC(O)(CC3)c4ccc(SC)cc4)c2c1,Ki,=,5.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,5.5
7690,CHEMBL245621,Fc1ccc(cc1)C(=O)NCCN2CCC(CC2)N3C(=O)Nc4cc(Cl)ccc34,IC50,=,7.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine receptor D2 (unknown origin),B,3.5
7754,CHEMBL396560,COc1ccc2[nH]c3Cc4ccccc4CCN(C)CCc3c2c1,Ki,=,11.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,B,11.9
7755,CHEMBL245570,CN1CCc2ccccc2Cc3[nH]c4ccc(O)cc4c3CC1,Ki,=,38.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,B,38.4
7756,CHEMBL245570,CN1CCc2ccccc2Cc3[nH]c4ccc(O)cc4c3CC1,Ki,=,43.65,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,B,43.65
7757,CHEMBL396561,COc1ccc2Cc3[nH]c4ccccc4c3CCN(C)CCc2c1,Ki,=,22.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,B,22.8
7758,CHEMBL245571,CN1CCc2cc(O)ccc2Cc3[nH]c4ccccc4c3CC1,Ki,=,74.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,B,74.7
7759,CHEMBL245764,COc1ccc2c(c1)c3CCN(C)CCc4ccccc4Cc3n2C,Ki,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,B,1.7
7800,CHEMBL250552,CCCN(CCN1CCN(CC1)c2ccccc2)C3CCc4c(O)cccc4C3,Ki,=,58.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,B,58.6
7802,CHEMBL250552,CCCN(CCN1CCN(CC1)c2ccccc2)C3CCc4c(O)cccc4C3,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,B,26.0
7803,CHEMBL250552,CCCN(CCN1CCN(CC1)c2ccccc2)C3CCc4c(O)cccc4C3,EC50,=,2.22,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human cloned dopamine D2L receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding,F,1.11
7807,CHEMBL254199,Oc1ccc2CCC(Cc2c1)N(CCN3CCN(CC3)c4ccccc4)CCc5cccs5,Ki,=,24.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,B,24.6
7808,CHEMBL254202,CCCN(CCN1CCN(CC1)c2ccccc2)C3CCc4cc(O)c(O)cc4C3,Ki,=,70.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,B,70.3
7809,CHEMBL254203,CCCN(CCCCN1CCN(CC1)c2ccccc2)C3CCc4cc(O)c(O)cc4C3,Ki,=,21.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,B,21.7
7811,CHEMBL252343,CCCN(CCN1CCN(CC1)c2ccccc2)C3CCc4ccc5NC(=O)Cc5c4C3,Ki,=,90.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,B,90.6
7812,CHEMBL399164,CCCN(CCN1CCN(CC1)c2ccccc2OC)C3CCc4c(O)cccc4C3,Ki,=,88.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,B,88.7
7813,CHEMBL399164,CCCN(CCN1CCN(CC1)c2ccccc2OC)C3CCc4c(O)cccc4C3,Ki,=,35.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,B,35.8
7814,CHEMBL399164,CCCN(CCN1CCN(CC1)c2ccccc2OC)C3CCc4c(O)cccc4C3,Ki,=,9.56,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,B,9.56
7815,CHEMBL399164,CCCN(CCN1CCN(CC1)c2ccccc2OC)C3CCc4c(O)cccc4C3,EC50,=,1.56,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human cloned dopamine D2L receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding,F,0.78
7817,CHEMBL252539,CCCN(CCN1CCN(CC1)c2cccc(Cl)c2Cl)C3CCc4c(O)cccc4C3,Ki,=,14.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,B,14.6
7857,CHEMBL398615,CS(=O)(=O)c1ccc2Sc3ccccc3N(CCCN4CCC(CC4)C(=N)O)c2c1,Ki,=,0.07,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The pharmacological profile of metopimazine, metopimazine acid (MPZA), domperidone, and metoclopramide were assessed by radioligand binding and by a functional antagonist assay. For the radioligand binding assay, cell membranes of dopamine D2 receptor expressing cells were incubated with [3H]spiperone and competing drugs in buffer. The assay was terminated by rapid filtration, and the bound radioactive signal was determined by liquid scintillation counting.",B,0.07
7875,CHEMBL252816,FC(F)(F)C(=O)NC1CCc2ccc(CCN3CCN(CC3)c4nsc5ccccc45)cc12,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,10.0
7876,CHEMBL404000,NC1CCc2ccc(CCN3CCN(CC3)c4nsc5ccccc45)cc12,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,21.0
7877,CHEMBL252818,CC(=O)NC1CCc2ccc(CCN3CCN(CC3)c4nsc5ccccc45)cc12,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,22.0
7878,CHEMBL253022,CCC(=O)NC1CCc2ccc(CCN3CCN(CC3)c4nsc5ccccc45)cc12,Ki,=,34.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,34.0
7879,CHEMBL400235,CCCC(=O)NC1CCc2ccc(CCN3CCN(CC3)c4nsc5ccccc45)cc12,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,27.0
7880,CHEMBL253024,O=C(NC1CCc2ccc(CCN3CCN(CC3)c4nsc5ccccc45)cc12)C6CC6,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,21.0
7881,CHEMBL400236,CC(C)C(=O)NC1CCc2ccc(CCN3CCN(CC3)c4nsc5ccccc45)cc12,Ki,=,67.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,67.0
7882,CHEMBL253233,O=C(NC1CCc2ccc(CCN3CCN(CC3)c4nsc5ccccc45)cc12)c6ccccc6,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,22.0
7883,CHEMBL398618,Cc1ccc(cc1)C(=O)NC2CCc3ccc(CCN4CCN(CC4)c5nsc6ccccc56)cc23,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,15.0
7884,CHEMBL253439,Clc1ccc(cc1)C(=O)NC2CCc3ccc(CCN4CCN(CC4)c5nsc6ccccc56)cc23,Ki,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,5.0
7885,CHEMBL442290,Fc1ccc(cc1)C(=O)NC2CCc3ccc(CCN4CCN(CC4)c5nsc6ccccc56)cc23,Ki,=,6.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,6.0
7886,CHEMBL398619,O=C(NC1CCc2ccc(CCN3CCN(CC3)c4nsc5ccccc45)cc12)c6cccnc6,Ki,=,6.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,6.0
7887,CHEMBL253878,O=C(Cc1ccccc1)NC2CCc3ccc(CCN4CCN(CC4)c5nsc6ccccc56)cc23,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,26.0
7888,CHEMBL252201,O=C(CCc1ccccc1)NC2CCc3ccc(CCN4CCN(CC4)c5nsc6ccccc56)cc23,Ki,=,33.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,33.0
7889,CHEMBL398744,O=C(NC1CCc2ccc(CCN3CCN(CC3)c4nsc5ccccc45)cc12)c6occc6,Ki,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,5.0
7890,CHEMBL254500,CN1C[C@@H](C[C@H]2[C@H]1Cc3c(Br)[nH]c4cccc2c34)C(=O)N5CCN(CC5)C6=CC=CC(=O)N6C,Kd,=,56.23,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,56.23
7891,CHEMBL254500,CN1C[C@@H](C[C@H]2[C@H]1Cc3c(Br)[nH]c4cccc2c34)C(=O)N5CCN(CC5)C6=CC=CC(=O)N6C,Kd,=,56.23,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,56.23
7892,CHEMBL251834,O=C(NC1CCc2ccc(CCN3CCN(CC3)c4nsc5ccccc45)cc12)c6oncc6,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,3.0
7893,CHEMBL398711,FC(F)(F)C(=O)NC1CCc2cc(CCN3CCN(CC3)c4nsc5ccccc45)ccc12,Ki,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,8.0
7894,CHEMBL252030,CC(=O)NC1CCc2cc(CCN3CCN(CC3)c4nsc5ccccc45)ccc12,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,15.0
7899,CHEMBL252429,Fc1ccc(cc1)C(=O)NC2CCc3cc(CCN4CCN(CC4)c5nsc6ccccc56)ccc23,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,10.0
7900,CHEMBL252430,O=C(NC1CCc2cc(CCN3CCN(CC3)c4nsc5ccccc45)ccc12)c6cccnc6,Ki,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,5.0
7905,CHEMBL253319,CN1CCc2ccc3C(=O)Nc4cccc5C[C@@H]1c2c3c45,Ki,=,54.6,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,B,54.6
7927,CHEMBL405519,CCCN1CCC[C@@H]2Cc3c(O)c(O)ccc3C[C@@H]12,EC50,=,0.65,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production,F,0.325
7930,CHEMBL406221,CCOc1ccccc1N2CCN(CCCC(=O)NCC3=Nc4ccc(F)cc4C(=O)N3c5ccc(OC)cc5)CC2,IC50,=,140.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at dopamine D2 receptor,B,70.0
8002,CHEMBL437792,Cc1ncoc1c2nnc(SCCCN3CCc4ccc5oc(nc5c4CC3)C(C)(F)F)n2C,Ki,=,15.85,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,15.85
8065,CHEMBL270406,COc1cc(CN2CCN(CC2)c3ccccc3OC)c(OCCF)cc1OC,Ki,=,94.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 long receptor,B,94.0
8067,CHEMBL270408,COc1ccccc1N2CCN(Cc3cccc(OCCF)c3)CC2,Ki,=,57.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 long receptor,B,57.0
8090,CHEMBL256040,CC(C)Oc1ccccc1N2CCN(CC2)C3CCC(CC3)NC(=O)Nc4c(Cl)cc(Cl)cc4Cl,Ki,=,6.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,B,6.5
8093,CHEMBL256597,CC(C)Oc1ccccc1N2CCN(CC2)C3CCC(CC3)NC(=O)Nc4c(Cl)cccc4Cl,Ki,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,B,55.0
8094,CHEMBL256597,CC(C)Oc1ccccc1N2CCN(CC2)C3CCC(CC3)NC(=O)Nc4c(Cl)cccc4Cl,Ki,=,4.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,B,4.7
8096,CHEMBL256804,CC(C)Oc1ccccc1N2CCN(CC2)C3CCC(CC3)NC(=O)Nc4ccc(F)c(F)c4,Ki,=,54.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,B,54.0
8097,CHEMBL270589,CC(C)Oc1ccccc1N2CCN(CC2)C3CCC(CC3)NC(=O)Nc4c(F)cccc4F,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,B,22.0
8098,CHEMBL270589,CC(C)Oc1ccccc1N2CCN(CC2)C3CCC(CC3)NC(=O)Nc4c(F)cccc4F,Ki,=,2.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,B,2.4
8100,CHEMBL257097,CC(C)Oc1ccccc1N2CCN(CC2)C3CCC(CC3)NC(=O)Nc4cc(F)ccc4F,Ki,=,0.46,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,B,0.46
8101,CHEMBL403280,CC(C)Oc1ccccc1N2CCN(CC2)C3CCC(CC3)NC(=O)Nc4ccc(F)cc4F,Ki,=,35.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,B,35.5
8102,CHEMBL403280,CC(C)Oc1ccccc1N2CCN(CC2)C3CCC(CC3)NC(=O)Nc4ccc(F)cc4F,Ki,=,0.69,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,B,0.69
8103,CHEMBL271913,COc1ccc(Cl)cc1NC(=O)NC2CCC(CC2)N3CCN(CC3)c4ccccc4OC(C)C,Ki,=,99.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,B,99.0
8104,CHEMBL271913,COc1ccc(Cl)cc1NC(=O)NC2CCC(CC2)N3CCN(CC3)c4ccccc4OC(C)C,Ki,=,1.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,B,1.2
8108,CHEMBL257077,CC(C)Oc1ccccc1N2CCN(CC2)C3CCC(CC3)NC(=O)Nc4cccc(Cl)c4,Ki,=,84.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,B,84.0
8112,CHEMBL257098,CC(C)Oc1ccccc1N2CCN(CC2)C3CCC(CC3)NC(=O)Nc4ccccc4Cl,Ki,=,33.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,B,33.0
8117,CHEMBL273041,C(CN1CCN(Cc2ccccc2)CC1)Cc3ccccc3,IC50,>,100.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,50.0
8122,CHEMBL405260,FCCOc1ccccc1N2CCN(Cc3cc4ccccn4n3)CC2,Ki,=,46.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,B,46.0
8123,CHEMBL405260,FCCOc1ccccc1N2CCN(Cc3cc4ccccn4n3)CC2,Ki,=,79.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,B,79.0
8140,CHEMBL271989,COc1ccccc1N2CCN(CCCCNc3ccc4ccccc4n3)CC2,Ki,=,5.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,5.6
8148,CHEMBL487387,COc1cc2CCN3Cc4c(C[C@H]3c2cc1O)ccc(O)c4OC,IC50,=,105.41,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,B,52.705
8149,CHEMBL487387,COc1cc2CCN3Cc4c(C[C@H]3c2cc1O)ccc(O)c4OC,Ki,=,56.17,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,B,56.17
8150,CHEMBL487387,COc1cc2CCN3Cc4c(C[C@H]3c2cc1O)ccc(O)c4OC,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,B,11.0
8161,CHEMBL1557,Cl.NCCc1ccc(O)c(O)c1,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-iodosulpiride from cloned human dopamine D2S receptor expressed in CHO cells,B,22.0
8162,CHEMBL1557,Cl.NCCc1ccc(O)c(O)c1,Ki,=,56.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-iodosulpiride from recombinant high-affinity state of human dopamine D2L receptor,B,56.0
8163,CHEMBL1557,Cl.NCCc1ccc(O)c(O)c1,Ki,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from high-affinity state of human dopamine D2L receptor (443 amino acids) expressed in LTK deficient mouse fibroblasts after 60 mins by liquid scintillation counting analysis,B,2.0
8164,CHEMBL1557,Cl.NCCc1ccc(O)c(O)c1,EC50,=,0.631,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by LANCE assay,F,0.3155
8183,CHEMBL508399,CCN1CCc2ccccc2Cc3ccc(O)cc3CC1,Ki,=,77.62,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,B,77.62
8197,CHEMBL461353,CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C34)C2=C1,EC50,=,0.01,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at dopamine D2 receptor short isoform (unknown origin) expressed in mouse NIH/3T3 cells by R-SAT assay,B,0.005
8226,CHEMBL490533,COc1ccc2C[C@@H]3N(CCc4cc5OCOc5cc34)Cc2c1OC,Ki,=,80.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor after 1 hr,B,80.2
8234,CHEMBL465054,CN1CCc2cc(cc3c2[C@H]1Cc4ccc(O)c(O)c34)c5ccccc5,Ki,=,88.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human cloned dopamine D2 receptor expressed in CHO cell membrane,B,88.0
8235,CHEMBL517028,CN1CCc2cc(cc3c2[C@H]1Cc4ccc(O)c(O)c34)c5ccc(O)cc5,Ki,=,3.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human cloned dopamine D2 receptor expressed in CHO cell membrane,B,3.8
8257,CHEMBL504548,CN1C[C@H]2[C@H](C1)c3cc(Cl)ccc3Oc4ccccc24,Ki,=,8.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human cloned D2 dopamine receptor expressed in human fibroblasts incubated for 90 mins by scintillation counting based radioligand binding assay,B,8.9
8258,CHEMBL1621,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCC(O)C5=N1,IC50,=,8.28,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,4.14
8261,CHEMBL494661,CC(C)c1ccccc1N2CCN(CCCCCC(=O)NCc3ccc(OS(=O)(=O)C)cc3)CC2,Ki,=,7.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,B,7.8
8262,CHEMBL522194,COc1ccccc1N2CCN(CCCCCC(=O)NCc3ccc(OS(=O)(=O)C)cc3)CC2,Ki,=,91.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,B,91.0
8264,CHEMBL523381,CSc1ccccc1N2CCN(CCCCCC(=O)N3Cc4ccccc4C3)CC2,Ki,=,96.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,B,96.0
8265,CHEMBL494118,O=C(CCCCCN1CCN(CC1)c2ccccc2c3ccccc3)N4Cc5ccccc5C4,Ki,=,93.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,B,93.0
8266,CHEMBL494119,CC(C)c1ccccc1N2CCN(CCCCCC(=O)N3Cc4ccccc4C3)CC2,Ki,=,65.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,B,65.0
8268,CHEMBL493305,CSc1ccccc1N2CCN(CCCCCC(=O)N3CCc4ccccc4C3)CC2,Ki,=,40.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,B,40.0
8270,CHEMBL492282,CC(C)c1ccccc1N2CCN(CCCCCC(=O)N3CCc4ccccc4C3)CC2,Ki,=,1.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,B,1.3
8271,CHEMBL492690,COc1ccccc1N2CCN(CCCCCC(=O)N3CCc4ccccc4C3)CC2,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,B,22.0
8272,CHEMBL492691,CSc1ccccc1N2CCN(CCCCCC(=O)NCc3ccccc3)CC2,Ki,=,33.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,B,33.0
8273,CHEMBL1626,CN1CCC[C@@H]1CCO[C@](C)(c2ccccc2)c3ccc(Cl)cc3,IC50,=,136.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,68.0
8274,CHEMBL1626,CN1CCC[C@@H]1CCO[C@](C)(c2ccccc2)c3ccc(Cl)cc3,Ki,=,45.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,45.0
8276,CHEMBL492872,CC(C)c1ccccc1N2CCN(CCCCCC(=O)NCc3ccccc3)CC2,Ki,=,9.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,B,9.2
8278,CHEMBL495321,CSc1ccccc1N2CCN(CCCCCC(=O)NCc3ccncc3)CC2,Ki,=,64.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,B,64.0
8280,CHEMBL522343,CC(C)c1ccccc1N2CCN(CCCCCC(=O)NCc3ccncc3)CC2,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,B,21.0
8282,CHEMBL493909,CSc1ccccc1N2CCN(CCCCCC(=O)NCc3ccc(cc3)C#N)CC2,Ki,=,5.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,B,5.3
8285,CHEMBL494312,CC(C)c1ccccc1N2CCN(CCCCCC(=O)NCc3ccc(cc3)C#N)CC2,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,B,20.0
8287,CHEMBL521687,CSc1ccccc1N2CCN(CCCCCC(=O)NCc3ccc(OS(=O)(=O)C)cc3)CC2,Ki,=,30.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,B,30.0
8288,CHEMBL492689,Cl.Fc1ccc2c(noc2c1)C3CCN(C[C@@H]4CC(=O)c5ccoc5C4)CC3,Ki,=,41.69,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,41.69
8289,CHEMBL523680,Cl.Fc1ccc2c(noc2c1)C3CCN(C[C@H]4CC(=O)c5ccoc5C4)CC3,Ki,=,15.85,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,15.85
8293,CHEMBL461627,COC(=O)c1coc2CC(CN3CCC(CC3)c4noc5cc(F)ccc45)CC(=O)c12,Ki,=,85.11,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,85.11
8294,CHEMBL516809,Fc1ccc2c(noc2c1)C3CCN(CC4CC(=O)c5cc(oc5C4)c6ccccc6)CC3,Ki,=,12.02,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,12.02
8306,CHEMBL447809,CCCN1CCN(CC1)c2cccc(O)c2,Ki,=,69.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,B,69.0
8338,CHEMBL497963,Cc1ccc2c(OCCN3CCC(Cc4cccc(NS(=O)(=O)C)c4)CC3)cccc2n1,Ki,=,63.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of radioligand from human cloned dopamine D2 receptor,B,63.1
8345,CHEMBL468017,CCCN(CCN1CCN(CC1)c2cccc(Cl)c2Cl)C3CCc4nc(N)sc4C3,EC50,=,13.4,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding,F,6.7
8347,CHEMBL467540,CCCN(CCN1CCN(CC1)c2ccc(cc2)c3ccccc3)C4CCc5nc(N)sc5C4,EC50,=,19.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding,F,9.95
8357,CHEMBL476935,Fc1ccc(cc1)C(=O)CCCN2CCN(CC2)c3ccc(Cl)cc3,Ki,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,63.0
8358,CHEMBL476935,Fc1ccc(cc1)C(=O)CCCN2CCN(CC2)c3ccc(Cl)cc3,Ki,=,61.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,61.0
8360,CHEMBL478617,OC1(CC2CCC(C1)N2CCCC(=O)c3ccc(F)cc3)c4ccccc4,Ki,=,2.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,2.3
8361,CHEMBL476108,Fc1ccc(cc1)C(=O)CCCN2CCCN(CC2)c3ccc(Cl)cc3,Ki,=,43.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,43.3
8373,CHEMBL478671,CCCN1CCc2cccc3c2[C@H]1Cc4cccc(OC(=O)CCC)c34,Ki,=,55.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,B,55.5
8412,CHEMBL477646,Clc1cccc(N2CCN(CCCCN3CCc4ccccc4C3=O)CC2)c1Cl,Ki,=,11.48,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor,B,11.48
8413,CHEMBL514382,Clc1ccccc1N2CCN(CCCCN3CCc4ccccc4C3=O)CC2,Ki,=,35.48,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor,B,35.48
8415,CHEMBL477206,COc1ccccc1N2CCN(CCCCN3CCCc4ccccc4C3=O)CC2,Ki,=,3.6310000000000002,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor,B,3.6310000000000002
8416,CHEMBL477206,COc1ccccc1N2CCN(CCCCN3CCCc4ccccc4C3=O)CC2,Ki,=,3.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,3.9
8417,CHEMBL477206,COc1ccccc1N2CCN(CCCCN3CCCc4ccccc4C3=O)CC2,Ki,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,1.5
8421,CHEMBL476394,Clc1cccc(N2CCN(CCCCN3CCCc4ccccc4C3=O)CC2)c1Cl,Ki,=,36.31,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor,B,36.31
8422,CHEMBL476808,COc1ccccc1N2CCN(CCCCCN3CCc4ccccc4C3=O)CC2,Ki,=,20.42,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor,B,20.42
8439,CHEMBL477250,COc1ccccc1N2CCN(CCCCN3CCc4ccccc4C3=O)CC2,Ki,=,12.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor,B,12.3
8440,CHEMBL477250,COc1ccccc1N2CCN(CCCCN3CCc4ccccc4C3=O)CC2,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,21.0
8441,CHEMBL477250,COc1ccccc1N2CCN(CCCCN3CCc4ccccc4C3=O)CC2,Ki,=,7.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,7.0
8461,CHEMBL456825,CCCN(CCN1CCN(CC1)c2ccccc2)[C@@H]3CCc4ccc(O)cc4C3,Ki,=,40.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,40.6
8462,CHEMBL457024,CCCN(CCN1CCN(CC1)c2ccccc2)[C@H]3CCc4c(O)cccc4C3,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,B,26.0
8463,CHEMBL457025,CCCN(CCN1CCN(CC1)c2ccccc2)[C@@H]3CCc4c(O)cccc4C3,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,26.0
8465,CHEMBL514885,CCCN(CCN1CCN(CC1)c2ccc(cc2)c3ccccc3)[C@H]4CCc5nc(N)sc5C4,EC50,=,19.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cells assessed as stimulation of [35S]GTPgamma binding,F,9.95
8467,CHEMBL514885,CCCN(CCN1CCN(CC1)c2ccc(cc2)c3ccccc3)[C@H]4CCc5nc(N)sc5C4,EC50,=,33.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human cloned dopamine D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,16.55
8475,CHEMBL484358,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)C3CCC(=CC3)C#C,Ki,=,40.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,B,40.0
8476,CHEMBL484358,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)C3CCC(=CC3)C#C,Ki,=,43.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,43.0
8501,CHEMBL520821,Br.CN1CCc2c(cc(O)c(O)c2c3ccc4ccccc4c3)C(C1)c5cccc(C)c5,Ki,=,29.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in HEK293 cells,B,29.0
8503,CHEMBL456232,COc1ccccc1N2CCN(CCCNC(=O)c3ccc4nonc4c3)CC2,Ki,=,89.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,B,89.4
8508,CHEMBL456233,FCCOc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)n4ccnc4)CC2,Ki,=,5.92,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,B,5.92
8510,CHEMBL515535,FCCOc1ccccc1N2CCN(CCCCNC(=O)c3ccc4nonc4c3)CC2,Ki,=,17.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,B,17.8
8586,CHEMBL460854,OC1(CC2CCC(C1)N2CCc3c[nH]c4ccccc34)c5ccc(Cl)cc5,Ki,=,53.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,53.0
8595,CHEMBL514747,Clc1ccc(cc1)N2CC3CC2CN3Cc4c[nH]c5ncccc45,Ki,=,62.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,62.0
8600,CHEMBL459373,CN(CCCN1c2ccccc2Sc3ccc(Cl)cc13)Cc4ccc(OCCCN5CCCCC5)cc4,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,41.0
8601,CHEMBL517407,CN(CC\C=C\1/c2ccccc2Sc3ccc(Cl)cc13)Cc4ccc(OCCCN5CCCCC5)cc4,Ki,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,52.0
8603,CHEMBL455288,FC(F)(F)c1ccc2Sc3ccccc3N(CCCN4CCN(CCOC(=O)c5ccc(OCCCN6CCCCC6)cc5)CC4)c2c1,Ki,=,47.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,47.0
8675,CHEMBL554220,Cl.CCCN[C@@H]1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1,Ki,=,50.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards dopamine D2 receptor by using [3H]U-86170 as radioligand,B,50.0
8696,CHEMBL543344,Cl.Fc1ccc(cc1)C2COC3(CCN(Cc4ccccc4)CC3)C2=O,Ki,=,47.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,47.0
8697,CHEMBL543344,Cl.Fc1ccc(cc1)C2COC3(CCN(Cc4ccccc4)CC3)C2=O,Ki,=,47.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,B,47.0
8724,CHEMBL543398,Br.CN1CCc2c(Cl)c(O)c(O)cc2C(C1)c3ccccc3,Ki,=,77.0,nM,Dopamine D2 receptor,Homo sapiens,The compound was evaluated for the binding affinity towards dopamine receptor D2 at high affinity state.,B,77.0
8726,CHEMBL544114,Br.Oc1cc2C(CN(CC=C)CCc2c(Br)c1O)c3ccccc3,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,The compound was evaluated for the binding affinity towards dopamine receptor D2 at high affinity state.,B,19.0
8731,CHEMBL544115,Br.Oc1cc2C(CN(CC=C)CCc2c(Cl)c1O)c3ccccc3,Ki,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at high affinity state.,B,55.0
8739,CHEMBL545287,Cl.Fc1ccc(CN2CCC(CC2)C3CCc4ccccc4C3=O)cc1,Ki,=,61.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,61.0
8750,CHEMBL553311,Cl.Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)CCc4ccccc4C3=O,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,25.0
8755,CHEMBL553331,Cl.Cl.CN1C(=O)N(C)c2ncn(CCCN3CCN(CC3)C(c4ccc(F)cc4)c5ccc(F)cc5)c2C1=O,IC50,=,43.0,nM,Dopamine D2 receptor,Homo sapiens,Compound is evaluated for in vitro receptor binding affinity against Dopamine receptor D2,B,21.5
8760,CHEMBL542029,Cl.CCN1CCC(=CC1)C2=Cc3ccccc3Cc4ccccc24,Ki,=,44.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,B,44.0
8763,CHEMBL554670,Cl.CN1CCC(=CC1)C2=Cc3ccccc3Cc4ccccc24,Ki,=,89.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,B,89.0
8766,CHEMBL555362,Cl.C=CCN1CCC(=CC1)C2=Cc3ccccc3Cc4ccccc24,Ki,=,83.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,B,83.0
8767,CHEMBL556969,Cl.CCN1CCC(=CC1)C2=Cc3ccccc3Oc4ccccc24,Ki,=,61.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,B,61.0
8774,CHEMBL1713,Cl.CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,"Compound was evaluated for the binding affinity against [3H]U-86,170-labeled D2 sites in cloned CHO cells",B,3.0
8784,CHEMBL537975,Cl.CCOc1ccccc1N2CCN(CCCCc3onc(c3)c4cccc(c4)[N+](=O)[O-])CC2,Ki,=,95.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,B,95.0
8799,CHEMBL540799,Cl.Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)OC=C(C3=O)c4ccccc4,Ki,=,70.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,70.0
8808,CHEMBL541559,Br.Oc1cc2C(CNCCc2c(Br)c1O)c3ccccc3,Ki,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at high affinity state.,B,39.0
8811,CHEMBL541826,Br.C(CCNC1=Nc2ccccc2OC1)CCN3CCN(CC3)c4ccccc4,Ki,=,94.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at cloned human D2 dopamine receptor in CHO cells using [3H]-YM 09151 as radioligand,B,94.0
8821,CHEMBL538542,Cl.CCCN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,0.11,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to high-affinity state of D2L receptor (unknown origin) expressed in CHO cell membranes,B,0.11
8822,CHEMBL538542,Cl.CCCN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,0.38,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from high-affinity state of recombinant human dopamine D2L receptor expressed in CHO cells after 45 mins by scintillation counting analysis,B,0.38
8823,CHEMBL538542,Cl.CCCN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,10.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,10.6
8824,CHEMBL538542,Cl.CCCN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,1.73,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,1.73
8825,CHEMBL538542,Cl.CCCN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,0.075,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,0.075
8826,CHEMBL538542,Cl.CCCN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,4.898,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,4.898
8827,CHEMBL538542,Cl.CCCN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,1.6219999999999999,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,1.6219999999999999
8828,CHEMBL538542,Cl.CCCN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,0.07413,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,0.07413
8829,CHEMBL539057,Cl.CN1CCC(CC1)C2=Cc3ccccc3Oc4ccccc24,Ki,=,82.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,B,82.0
8835,CHEMBL540612,Cl.COc1ccccc1N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2,Ki,=,61.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,B,61.0
8836,CHEMBL553327,Cl.OC1(CC2CCC(C1)N2CCCC(=O)c3ccc(F)cc3)c4ccccc4,Ki,=,2.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor,B,2.3
8845,CHEMBL561054,CC1CCCCN1CCN2CCN(C2=O)c3cccc(Cl)c3,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,25.12
8853,CHEMBL563860,Clc1cccc(c1)N2CCN(CCN3C[C@H]4CC[C@@H]3C4)C2=O,Ki,=,3.9810000000000003,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,3.9810000000000003
8854,CHEMBL563860,Clc1cccc(c1)N2CCN(CCN3C[C@H]4CC[C@@H]3C4)C2=O,Ki,=,3.9810000000000003,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,B,3.9810000000000003
8855,CHEMBL562464,Clc1cccc(c1)N2CCN(CCN3C[C@@H]4CC[C@H]3Cc5ccccc5C4)C2=O,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,25.12
8856,CHEMBL562464,Clc1cccc(c1)N2CCN(CCN3C[C@@H]4CC[C@H]3Cc5ccccc5C4)C2=O,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,B,25.12
8857,CHEMBL559873,Clc1cccc(c1)N2CCN(CCN3CCCc4sccc4C3)C2=O,Ki,=,3.162,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,3.162
8858,CHEMBL559873,Clc1cccc(c1)N2CCN(CCN3CCCc4sccc4C3)C2=O,Ki,=,3.162,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,B,3.162
8868,CHEMBL561512,Clc1cc(Cl)cc(c1)N2CCN(CCN3Cc4ccccc4C3)C2=O,Ki,=,6.31,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,6.31
8869,CHEMBL565017,FC(F)(F)Oc1cccc(c1)N2CCN(CCN3Cc4ccccc4C3)C2=O,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,39.81
8892,CHEMBL563635,CCN(CC)CCN1CCN(C1=O)c2cccc(Cl)c2,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,25.12
8893,CHEMBL563635,CCN(CC)CCN1CCN(C1=O)c2cccc(Cl)c2,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,B,25.12
8899,CHEMBL561763,CSc1ccccc1N2CCN(CCCNC(=O)c3cnn4ccccc34)CC2,Ki,=,2.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from wild type human cloned dopamine D2L receptor expressed in HEK293 cells,B,2.2
8900,CHEMBL561763,CSc1ccccc1N2CCN(CCCNC(=O)c3cnn4ccccc34)CC2,Ki,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,B,1.4
8907,CHEMBL560574,FC(F)(F)C1CCN(CCN2CCN(C2=O)c3cccc(I)c3)CC1,Ki,=,12.59,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,12.59
8911,CHEMBL1732,CN1C[C@@H](C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](Cc8ccccc8)N6C5=O,IC50,=,8.88,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,4.44
8912,CHEMBL1732,CN1C[C@@H](C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](Cc8ccccc8)N6C5=O,Ki,=,2.96,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,2.96
8941,CHEMBL550222,CSc1ccccc1N2CCN(CCCCNC(=O)c3cc4ccccn4n3)CC2,Ki,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from wild type human cloned dopamine D2L receptor expressed in HEK293 cells,B,37.0
8942,CHEMBL550222,CSc1ccccc1N2CCN(CCCCNC(=O)c3cc4ccccn4n3)CC2,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,B,16.0
8959,CHEMBL565075,Clc1cccc(c1)N2CCN(CCN3C[C@@H]4CC[C@@H](CC4)C3)C2=O,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,25.12
8960,CHEMBL565075,Clc1cccc(c1)N2CCN(CCN3C[C@@H]4CC[C@@H](CC4)C3)C2=O,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,B,25.12
8969,CHEMBL551914,CC1CCN(CCN2CCN(C2=O)c3cccc(Cl)c3)CC1,Ki,=,15.85,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,15.85
8970,CHEMBL569846,Oc1cccc(c1)N2CCN(CCN3CCC(CC3)C(F)(F)F)C2=O,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,39.81
8973,CHEMBL559029,FC(F)(F)c1cccc(c1)N2CCN(CCN3Cc4ccccc4C3)C2=O,Ki,=,50.12,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,50.12
8985,CHEMBL551927,C[C@]12C[C@H](CC(C1)c3ccccc3)N(CCN4CCN(C4=O)c5cccc(Cl)c5)C2,Ki,=,15.85,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,15.85
8986,CHEMBL551927,C[C@]12C[C@H](CC(C1)c3ccccc3)N(CCN4CCN(C4=O)c5cccc(Cl)c5)C2,Ki,=,15.85,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,B,15.85
8989,CHEMBL554738,CN(CCN1CCN(C1=O)c2cccc(Cl)c2)Cc3cc4ccccc4s3,Ki,=,50.12,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,50.12
8990,CHEMBL554738,CN(CCN1CCN(C1=O)c2cccc(Cl)c2)Cc3cc4ccccc4s3,Ki,=,50.12,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,B,50.12
8997,CHEMBL552371,CC1CCCN(CCN2CCN(C2=O)c3cccc(Cl)c3)C1,Ki,=,19.95,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,19.95
9016,CHEMBL564930,C[C@@]12CC[C@@H](CN(CCN3CCN(C3=O)c4cccc(Cl)c4)C1)C2(C)C,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,31.62
9017,CHEMBL564930,C[C@@]12CC[C@@H](CN(CCN3CCN(C3=O)c4cccc(Cl)c4)C1)C2(C)C,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,B,31.62
9020,CHEMBL558058,CN(CCN1CCN(C1=O)c2cccc(c2)C(F)(F)F)C[C@@]34CC[C@@H](CC3)C4(C)C,Ki,=,19.95,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,19.95
9021,CHEMBL558058,CN(CCN1CCN(C1=O)c2cccc(c2)C(F)(F)F)C[C@@]34CC[C@@H](CC3)C4(C)C,Ki,=,19.95,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,B,19.95
9025,CHEMBL556269,CCCN(CCN1CCN(CC1)C(=O)c2ccc3[nH]ccc3c2)[C@H]4CCc5c(O)cccc5C4,EC50,=,41.2,nM,Dopamine D2 receptor,Homo sapiens,Activity at human dopamine D2L receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding,F,20.6
9027,CHEMBL556272,Fc1cc(Cl)cc(c1)N2CCN(CCN3Cc4ccccc4C3)C2=O,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,31.62
9033,CHEMBL540241,CC(C)c1cccc(c1)N2CCN(CCN3Cc4ccccc4C3)C2=O,Ki,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,79.43
9039,CHEMBL555744,COC[C@@H]1CCCN1N2CCN(C2=O)c3cccc(Cl)c3,Ki,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,79.43
9040,CHEMBL555744,COC[C@@H]1CCCN1N2CCN(C2=O)c3cccc(Cl)c3,Ki,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,B,79.43
9041,CHEMBL563580,Clc1cccc(c1)N2CCN(CCN3[C@@H]4CCC[C@H]3CC4)C2=O,Ki,=,5.012,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,5.012
9042,CHEMBL563580,Clc1cccc(c1)N2CCN(CCN3[C@@H]4CCC[C@H]3CC4)C2=O,Ki,=,5.012,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,B,5.012
9043,CHEMBL556496,COc1cccc(c1)C2CCCN(CCN3CCN(C3=O)c4cccc(Cl)c4)C2,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,25.12
9044,CHEMBL556496,COc1cccc(c1)C2CCCN(CCN3CCN(C3=O)c4cccc(Cl)c4)C2,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,B,25.12
9045,CHEMBL557110,Clc1cccc(c1)N2CCN(CCN3CCCC(C3)OCc4ccccc4)C2=O,Ki,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,79.43
9046,CHEMBL557110,Clc1cccc(c1)N2CCN(CCN3CCCC(C3)OCc4ccccc4)C2=O,Ki,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,B,79.43
9047,CHEMBL563926,COc1cccc(CCN(C)CCN2CCN(C2=O)c3cccc(Cl)c3)c1,Ki,=,50.12,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,50.12
9048,CHEMBL563926,COc1cccc(CCN(C)CCN2CCN(C2=O)c3cccc(Cl)c3)c1,Ki,=,50.12,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,B,50.12
9055,CHEMBL574595,COc1ccccc1N2CCN(CCCn3cc(CCCN4CCc5cc(O)c(O)cc5C(C4)c6ccccc6C)nn3)CC2,Ki,=,39.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,39.1
9061,CHEMBL582945,COc1ccccc1N2CCN(CCCn3cc(CCCCN4CCc5cc(O)c(O)cc5C(C4)c6cccc(C)c6)nn3)CC2,Ki,=,80.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,80.0
9066,CHEMBL574700,COc1ccccc1N2CCN(CCCc3cn(CCCN4CCc5cc(O)c(O)cc5C(C4)c6ccccc6C)nn3)CC2,Ki,=,19.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,19.1
9073,CHEMBL573791,COc1ccccc1N2CCN(CCNC(=O)c3cn(nn3)c4ccc(cc4)[N+](=O)[O-])CC2,Ki,=,6.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2-long expressed in CHO cells,B,6.5
9078,CHEMBL573792,[O-][N+](=O)c1ccc(cc1)n2cc(nn2)C(=O)NCCCCN3CCN(CC3)c4cccc(Cl)c4Cl,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2-short expressed in CHO cells,B,17.0
9079,CHEMBL574030,COc1ccc(cc1)n2cc(nn2)C(=O)NCCCCN3CCN(CC3)c4cccc(Cl)c4Cl,Ki,=,49.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2-long expressed in CHO cells,B,49.0
9083,CHEMBL572379,[O-][N+](=O)c1ccc(cc1)n2cc(CCCC(=O)NCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)nn2,Ki,=,53.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2-long expressed in CHO cells,B,53.0
9084,CHEMBL572379,[O-][N+](=O)c1ccc(cc1)n2cc(CCCC(=O)NCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)nn2,Ki,=,44.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2-short expressed in CHO cells,B,44.0
9086,CHEMBL572867,COc1ccc(cc1)n2cc(CCCC(=O)NCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)nn2,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2-long expressed in CHO cells,B,1.0
9087,CHEMBL572867,COc1ccc(cc1)n2cc(CCCC(=O)NCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)nn2,Ki,=,68.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2-short expressed in CHO cells,B,68.0
9093,CHEMBL575788,Fc1ccc2c(noc2c1)C3CCN(CC4CC(=O)c5cnc(nc5C4)c6ccccc6)CC3,Ki,=,33.88,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,33.88
9097,CHEMBL566508,CSc1ncc2C(=O)CC(CN3CCC(CC3)c4noc5cc(F)ccc45)Cc2n1,Ki,=,32.36,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,32.36
9099,CHEMBL576756,CNc1ncc2C(=O)CC(CN3CCC(CC3)c4noc5cc(F)ccc45)Cc2n1,Ki,=,48.98,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,48.98
9107,CHEMBL566133,Oc1cccc2[C@H]3CCN(CC=C)[C@H]3CCc12,Ki,=,59.0,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,59.0
9124,CHEMBL577073,CCCN(CCN1CCN(CC1)c2ccnc3ccccc23)[C@H]4CCc5nc(N)sc5C4,EC50,=,77.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cells assessed as stimulation of [35S]GTPgamma binding,F,38.6
9126,CHEMBL569107,CCCN(CCN1CCN(CC1)c2cccc3ncccc23)[C@H]4CCc5nc(N)sc5C4,EC50,=,13.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cells assessed as stimulation of [35S]GTPgamma binding,F,6.75
9127,CHEMBL569107,CCCN(CCN1CCN(CC1)c2cccc3ncccc23)[C@H]4CCc5nc(N)sc5C4,Ki,=,57.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,57.7
9129,CHEMBL569003,CCCN(CCN1CCN(CC1)c2ccc3ccccc3c2)C4CCc5ccc(O)cc5C4,Ki,=,8.85,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,8.85
9130,CHEMBL571992,CCCN(CCN1CCN(CC1)c2nccc3ccccc23)[C@H]4CCc5nc(N)sc5C4,EC50,=,116.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cells assessed as stimulation of [35S]GTPgamma binding,F,58.0
9133,CHEMBL571992,CCCN(CCN1CCN(CC1)c2nccc3ccccc23)[C@H]4CCc5nc(N)sc5C4,EC50,=,116.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human cloned dopamine D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,58.0
9136,CHEMBL571992,CCCN(CCN1CCN(CC1)c2nccc3ccccc23)[C@H]4CCc5nc(N)sc5C4,EC50,=,116.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting analysis,F,58.0
9137,CHEMBL570187,CCCN(CCN1CCN(CC1)c2ccnc3ccccc23)C4CCc5ccc(O)cc5C4,Ki,=,7.08,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,7.08
9139,CHEMBL568822,CCCN(CCN1CCN(CC1)c2cccc3ncccc23)C4CCc5ccc(O)cc5C4,Ki,=,5.22,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,5.22
9140,CHEMBL569322,CCCN(CCN1CCN(CC1)c2nccc3ccccc23)C4CCc5ccc(O)cc5C4,Ki,=,21.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,21.7
9141,CHEMBL568801,CCCN(CCN1CCN(CC1)c2ccnc3ccccc23)C4CCc5c(C4)cccc5OC,Ki,=,4.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,4.89
9142,CHEMBL569746,CCCN(CCN1CCN(CC1)C(=O)c2cc3ccccc3[nH]2)[C@H]4CCc5c(O)cccc5C4,Ki,=,47.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,47.5
9143,CHEMBL569747,CCCN(CCN1CCN(CC1)c2cccc3ccccc23)C4CCc5ccc(O)cc5C4,Ki,=,13.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,13.5
9144,CHEMBL569977,CCCN(CCN1CCN(CC1)c2ccnc3ccccc23)[C@H]4CCc5c(C4)cccc5OC,Ki,=,3.74,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,3.74
9146,CHEMBL568103,Fc1ccc2[nH]c3CC(CCCN4CCN(CC4)c5cccc6NC(=O)Oc56)CCc3c2c1,Ki,=,50.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2 receptor,B,50.0
9147,CHEMBL566356,Fc1ccc2[nH]c3CCC(CN4C[C@H]5C[C@@H]4CN5c6cccc7NC(=O)Oc67)Cc3c2c1,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2 receptor,B,14.0
9149,CHEMBL569251,Fc1ccc2[nH]c3CCC(CNC[C@H]4COc5c6CC(=O)Nc6ccc5O4)Cc3c2c1,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2 receptor,B,3.0
9151,CHEMBL569251,Fc1ccc2[nH]c3CCC(CNC[C@H]4COc5c6CC(=O)Nc6ccc5O4)Cc3c2c1,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2 receptor,B,3.0
9154,CHEMBL569513,Fc1ccc2[nH]c3CCC(CN4CCN(CC4)c5cccc6NC(=O)Oc56)Cc3c2c1,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2 receptor,B,60.0
9155,CHEMBL569513,Fc1ccc2[nH]c3CCC(CN4CCN(CC4)c5cccc6NC(=O)Oc56)Cc3c2c1,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2 receptor,B,17.0
9157,CHEMBL568538,Fc1ccc2[nH]c3CCC(CCNC[C@H]4COc5c6CC(=O)Nc6ccc5O4)Cc3c2c1,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2 receptor,B,24.0
9159,CHEMBL571464,Fc1ccc2[nH]c3CCC(CN4CCN(CC4)c5cccc6NC(=O)Cc56)Cc3c2c1,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2 receptor,B,15.0
9161,CHEMBL566155,Fc1ccc2[nH]c3CC(CCNC[C@H]4COc5c6CC(=O)Nc6ccc5O4)CCc3c2c1,Ki,=,36.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2 receptor,B,36.0
9162,CHEMBL566379,Fc1ccc2[nH]c3CC(CCCNC[C@H]4COc5c6CC(=O)Nc6ccc5O4)CCc3c2c1,Ki,=,50.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2 receptor,B,50.0
9164,CHEMBL566379,Fc1ccc2[nH]c3CC(CCCNC[C@H]4COc5c6CC(=O)Nc6ccc5O4)CCc3c2c1,Ki,=,45.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2 receptor,B,45.0
9169,CHEMBL566396,Fc1ccc2[nH]c3CCC(CN4CCC(COc5cccc6NC(=O)Oc56)CC4)Cc3c2c1,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2 receptor,B,28.0
9183,CHEMBL567286,FC(F)(F)C1CCN(CCN2CCN(C2=O)c3cccc(c3)[11C]#N)CC1,Ki,=,42.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,B,42.0
9195,CHEMBL605405,CN1CCc2c(C1)c3cc(C)ccc3n2\C=C/c4ccccc4,Ki,=,34.67,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human recombinant dopamine D2S receptor expressed in CHO cells,B,34.67
9196,CHEMBL592752,CN1CCc2c(C1)c3cc(C)ccc3n2CCc4ccccc4,Ki,=,85.11,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human recombinant dopamine D2S receptor expressed in CHO cells,B,85.11
9214,CHEMBL593196,Cn1c(CN2CCC(CC2)c3ccccc3)nc4ccccc14,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,F,25.12
9215,CHEMBL607689,Cn1c(CN2CCC(CC2)c3ccccc3F)nc4ccccc14,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,F,39.81
9216,CHEMBL593744,Cn1c(CN2CCC(CC2)c3ccc(Cl)cc3)nc4ccccc14,Ki,=,15.85,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,F,15.85
9220,CHEMBL608103,Cn1c(CN2CCC(CC2)c3cccc(Cl)c3)nc4ccccc14,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,F,39.81
9222,CHEMBL596527,Cn1c(CN2CCC(CC2)c3nsc4ccccc34)nc5ccccc15,Ki,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,F,79.43
9272,CHEMBL592377,Oc1cccc(c1)C2CCN(Cc3ccccc3)CC2,Ki,=,35.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,B,35.0
9346,CHEMBL601635,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4ccc(CN5CCN(CC5)c6ccccn6)cc34,Ki,=,1.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,1.3
9347,CHEMBL600998,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4ccc(CN5CCCCC5)cc34,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,26.0
9355,CHEMBL599135,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4c(\C=N\OCc5ccccc5)cccc34,Ki,=,69.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,B,69.0
9357,CHEMBL599528,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4c3cccc4c5ccccc5,Ki,=,79.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,B,79.0
9364,CHEMBL597310,CN(C)c1ccc(cc1)c2cccc3[C@H]4[C@H](CCc23)N(C)CCc5cc(Cl)c(O)cc45,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,B,12.0
9366,CHEMBL604176,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4c3cccc4c5ccc(CO)cc5,Ki,=,89.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,B,89.0
9367,CHEMBL597900,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4c3cccc4c5cccs5,Ki,=,93.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,B,93.0
9369,CHEMBL597503,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4c3cccc4c5ccc6[nH]ccc6c5,Ki,=,51.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,B,51.0
9371,CHEMBL602065,CCCN(CCN1CCN(CC1)c2ccnc3ccccc23)[C@H]4CCc5c(O)cccc5C4,Ki,=,3.74,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,B,3.74
9372,CHEMBL602264,CCCN(CCN1CCN(CC1)c2ccc(O)c3ncccc23)C4CCc5ccc(O)cc5C4,Ki,=,86.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,B,86.0
9373,CHEMBL599636,CCCN(CCN1CCN(CC1)c2ccnc3c(O)cccc23)C4CCc5c(O)cccc5C4,Ki,=,20.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,B,20.7
9374,CHEMBL599636,CCCN(CCN1CCN(CC1)c2ccnc3c(O)cccc23)C4CCc5c(O)cccc5C4,Ki,=,3.75,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,B,3.75
9375,CHEMBL599636,CCCN(CCN1CCN(CC1)c2ccnc3c(O)cccc23)C4CCc5c(O)cccc5C4,EC50,=,4.51,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,2.255
9377,CHEMBL599636,CCCN(CCN1CCN(CC1)c2ccnc3c(O)cccc23)C4CCc5c(O)cccc5C4,Ki,=,13.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,B,13.8
9380,CHEMBL599635,CCCN(CCN1CCN(CC1)c2ccnc3c(O)cccc23)C4CCc5ccc(O)cc5C4,Ki,=,15.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,B,15.9
9381,CHEMBL599635,CCCN(CCN1CCN(CC1)c2ccnc3c(O)cccc23)C4CCc5ccc(O)cc5C4,Ki,=,4.55,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,B,4.55
9382,CHEMBL599635,CCCN(CCN1CCN(CC1)c2ccnc3c(O)cccc23)C4CCc5ccc(O)cc5C4,EC50,=,1.69,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,0.845
9384,CHEMBL599841,CCCN(CCN1CCN(CC1)c2ccc(O)c3ncccc23)C4CCc5c(O)cccc5C4,Ki,=,41.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,B,41.4
9399,CHEMBL611207,CN1CCCC[C@@H]1CCN2c3ccccc3Sc4ccc(cc24)[S+](C)[O-],IC50,=,77.0,nM,Dopamine D2 receptor,Homo sapiens,Concentration required to inhibit [3H]YM-09151-2 binding to human D2 dopamine receptor,B,38.5
9401,CHEMBL611207,CN1CCCC[C@@H]1CCN2c3ccccc3Sc4ccc(cc24)[S+](C)[O-],Ki,=,2.2,nM,Dopamine D2 receptor,Homo sapiens,High binding affinity towards human D2 dopamine receptor was determined by using [3H]YM-09151-2 as radioligand,B,2.2
9405,CHEMBL611207,CN1CCCC[C@@H]1CCN2c3ccccc3Sc4ccc(cc24)[S+](C)[O-],IC50,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Concentration required to inhibit [3H]YM-09151-2 binding to human D2 dopamine receptor,B,31.5
9407,CHEMBL611207,CN1CCCC[C@@H]1CCN2c3ccccc3Sc4ccc(cc24)[S+](C)[O-],Ki,=,1.2,nM,Dopamine D2 receptor,Homo sapiens,High binding affinity towards human D2 dopamine receptor was determined by using [3H]YM-09151-2 as radioligand,B,1.2
9412,CHEMBL612083,CCCN(CCc1ccccc1)[C@H]2CCc3c(O)cccc3C2,Ki,=,2.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,B,2.1
9413,CHEMBL612083,CCCN(CCc1ccccc1)[C@H]2CCc3c(O)cccc3C2,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards Dopamine receptor D2,B,20.0
9414,CHEMBL609151,CN1C[C@@H](C=C2[C@H]1Cc3c(Br)[nH]c4cccc2c34)C(=O)N,Ki,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards Dopamine receptor D2,B,2.0
9416,CHEMBL606939,CCCN(CCc1ccccc1)[C@@H]2CCc3c(O)cccc3C2,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,B,60.0
9423,CHEMBL1081868,Cc1ncoc1c2nnc(SCCCN3CC4CC4(C3)c5cc(F)cc(c5)C(F)(F)F)n2C,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,31.62
9424,CHEMBL1081868,Cc1ncoc1c2nnc(SCCCN3CC4CC4(C3)c5cc(F)cc(c5)C(F)(F)F)n2C,Ki,=,12.59,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,12.59
9449,CHEMBL1079822,Cc1ncoc1c2nnc(SCCCN3CC4CC4(C3)c5ccc(cc5)C(C)(C)C)n2C,Ki,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,79.43
9451,CHEMBL1079824,Cc1ncoc1c2nnc(SCCCN3C[C@@H]4C[C@@]4(C3)c5ccc(cc5)C(C)(C)C)n2C,Ki,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,79.43
9454,CHEMBL1081934,Cc1ncoc1c2nnc(SCCCN3CC4CC4(C3)c5cccc(OC(F)(F)F)c5)n2C,Ki,=,19.95,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,19.95
9468,CHEMBL1079461,Cc1ncoc1c2nnc(SCCCN3CC4CC4(C3)c5cccc(Cl)c5)n2C,Ki,=,50.12,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,50.12
9476,CHEMBL1081957,Cc1ncoc1c2nnc(SCCCN3CC4CC4(C3)c5cccc(c5)C(F)(F)F)n2C,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,31.62
9477,CHEMBL1081957,Cc1ncoc1c2nnc(SCCCN3CC4CC4(C3)c5cccc(c5)C(F)(F)F)n2C,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,31.62
9479,CHEMBL1081957,Cc1ncoc1c2nnc(SCCCN3CC4CC4(C3)c5cccc(c5)C(F)(F)F)n2C,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor assessed as inhibition of dopamine-induced [35S]GTPgammaS binding by FLIPR assay,F,31.62
9487,CHEMBL1080846,Cc1ncoc1c2nnc(SCCCN3CC4CC4(C3)c5ccc(Cl)c(Cl)c5)n2C,Ki,=,12.59,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,12.59
9488,CHEMBL1080846,Cc1ncoc1c2nnc(SCCCN3CC4CC4(C3)c5ccc(Cl)c(Cl)c5)n2C,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,31.62
9501,CHEMBL1081587,Cc1ncoc1c2nnc(SCCCN3CC4CC4(C3)c5ccc(F)c(c5)C(F)(F)F)n2C,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,31.62
9515,CHEMBL1079938,Cc1ncoc1c2nnc(SCCCN3CC4CC4(C3)c5cccc(c5F)C(F)(F)F)n2C,Ki,=,63.1,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,63.1
9517,CHEMBL1080126,Cc1ncoc1c2nnc(SCCCN3CC4CC4(C3)c5ccc(c(F)c5)C(F)(F)F)n2C,Ki,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,79.43
9544,CHEMBL1083813,Fc1ccc(cc1Cl)N2CCN(CCN3CCCCCC3)C2=O,EC50,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,5.0
9545,CHEMBL1083813,Fc1ccc(cc1Cl)N2CCN(CCN3CCCCCC3)C2=O,Ki,=,15.85,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,15.85
9547,CHEMBL1083814,O=C1N(CCN2CCCCCC2)CCN1c3cccnc3,EC50,=,7.943,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,3.9715
9552,CHEMBL1083816,Clc1cccc(c1)N2C=CN(CCN3CCCCCC3)C2=O,EC50,=,125.89,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,62.945
9555,CHEMBL1084121,Clc1cccc(c1)N2CCN(CCN3CCCCCC3)S2(=O)=O,EC50,=,125.89,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,62.945
9562,CHEMBL1087300,CN1CCc2ccccc2Cc3c[nH]c4cccc(CC1)c34,Ki,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in HEK293 cells by microplate scintillation counting,B,4.0
9564,CHEMBL1087301,CN1CCc2ccccc2Cc3c(CC1)[nH]c4ccccc34,Ki,=,55.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in HEK293 cells by microplate scintillation counting,B,55.1
9565,CHEMBL1085672,Clc1cccc(c1)N2CCN(CC3CCCCN3)C2=O,EC50,=,0.631,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,0.3155
9566,CHEMBL1085672,Clc1cccc(c1)N2CCN(CC3CCCCN3)C2=O,Ki,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,79.43
9573,CHEMBL1085903,FC(F)(F)c1cccc(c1)N2CCN(CC3CCCCN3)C2=O,Ki,=,19.95,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,19.95
9585,CHEMBL1077344,Clc1cccc(c1)N2CCN(CCN3CCCCCC3)C2=O,EC50,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,0.5
9586,CHEMBL1077344,Clc1cccc(c1)N2CCN(CCN3CCCCCC3)C2=O,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,10.0
9588,CHEMBL1079190,CN1CCCCC1CN2CCN(C2=O)c3cccc(Cl)c3,EC50,=,2.512,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,1.256
9589,CHEMBL1079190,CN1CCCCC1CN2CCN(C2=O)c3cccc(Cl)c3,Ki,=,15.85,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,15.85
9591,CHEMBL1079191,Clc1ccc(cc1)N2CCN(CCN3CCCCCC3)C2=O,EC50,=,50.12,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,25.06
9595,CHEMBL1081309,Clc1cc(Cl)cc(c1)N2CCN(CCN3CCCCCC3)C2=O,Ki,=,0.631,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,0.631
9598,CHEMBL1081311,Cc1cccc(c1)N2CCN(CCN3CCCCCC3)C2=O,EC50,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,5.0
9599,CHEMBL1081311,Cc1cccc(c1)N2CCN(CCN3CCCCCC3)C2=O,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,25.12
9602,CHEMBL1077348,Cc1ccc(cc1)N2CCN(CCN3CCCCCC3)C2=O,Ki,=,50.12,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,50.12
9604,CHEMBL1081487,COc1cccc(c1)N2CCN(CCN3CCCCCC3)C2=O,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,39.81
9606,CHEMBL1081488,FC(F)(F)c1cccc(c1)N2CCN(CCN3CCCCCC3)C2=O,Ki,=,1.585,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,1.585
9607,CHEMBL1081489,O=C1N(CCN2CCCCCC2)CCN1c3ccccc3,EC50,=,0.631,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,0.3155
9608,CHEMBL1081489,O=C1N(CCN2CCCCCC2)CCN1c3ccccc3,Ki,=,7.943,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,7.943
9610,CHEMBL1081490,Fc1cccc(c1)N2CCN(CCN3CCCCCC3)C2=O,EC50,=,0.7943,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,0.39715
9611,CHEMBL1081490,Fc1cccc(c1)N2CCN(CCN3CCCCCC3)C2=O,Ki,=,2.512,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,2.512
9613,CHEMBL1081491,Fc1ccc(cc1)N2CCN(CCN3CCCCCC3)C2=O,EC50,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,5.0
9614,CHEMBL1081491,Fc1ccc(cc1)N2CCN(CCN3CCCCCC3)C2=O,Ki,=,63.1,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,63.1
9640,CHEMBL1087452,O=C1CCc2ccc(OCCN3CCN(CC3)c4cccc5NC(=O)Oc45)cc2N1,Ki,=,8.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,B,8.6
9641,CHEMBL1087453,O=C1CCc2ccc(OCCCN3CCN(CC3)c4cccc5NC(=O)Oc45)cc2N1,Ki,=,8.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,B,8.6
9642,CHEMBL1087454,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4cccc5NC(=O)Oc45)cc2N1,Ki,=,8.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,B,8.3
9644,CHEMBL1087455,O=C1CCc2ccc(CC3CCN(C[C@@H]4COc5c6CC(=O)Nc6ccc5O4)CC3)cc2N1,Ki,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,B,8.0
9646,CHEMBL1088560,CS(=O)(=O)Nc1cccc(OCCN2CCC(Cc3ccc4CCC(=O)Nc4c3)CC2)c1,Ki,=,9.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,B,9.0
9648,CHEMBL1087743,CS(=O)(=O)Nc1cc(OCCN2CCC(Cc3ccc4CCC(=O)Nc4c3)CC2)ccc1F,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,B,19.0
9650,CHEMBL1087744,O=C1CCc2ccc(OC3CCN(C[C@@H]4COc5c6CC(=O)Nc6ccc5O4)CC3)cc2N1,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,B,2.5
9652,CHEMBL1087745,CS(=O)(=O)Nc1cccc(OCCN2CCC(CC2)Oc3ccc4CCC(=O)Nc4c3)c1,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,B,18.0
9654,CHEMBL1087872,CS(=O)(=O)Nc1cc(OCCN2CCC(CC2)Oc3ccc4CCC(=O)Nc4c3)ccc1F,Ki,=,9.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,B,9.0
9656,CHEMBL1088000,O=C1CCc2ccc(CC3CC4CCC(C3)N4C[C@@H]5COc6c7CC(=O)Nc7ccc6O5)cc2N1,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,B,16.0
9657,CHEMBL1087817,O=C1CCc2ccc(CC3C4CCC3CN(C[C@@H]5COc6c7CC(=O)Nc7ccc6O5)C4)cc2N1,Ki,=,6.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,B,6.3
9659,CHEMBL1087818,CS(=O)(=O)Nc1cccc(OCCN2CC3CCC(C2)C3Cc4ccc5CCC(=O)Nc5c4)c1,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,B,11.0
9661,CHEMBL1087585,CS(=O)(=O)Nc1cc(OCCN2CC3CCC(C2)C3Cc4ccc5CCC(=O)Nc5c4)ccc1F,Ki,=,7.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,B,7.0
9671,CHEMBL1172208,OC(=O)C(=O)O.OC1(CCN(Cc2c[nH]c3ncccc23)CC1)c4ccc(I)cc4,Ki,=,61.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,61.0
9673,CHEMBL1172210,OC(=O)C(=O)O.OC1(CCN(Cc2oc3ccccc3c2)CC1)c4ccc(Br)cc4,Ki,=,17.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,17.3
9674,CHEMBL1170456,OC(=O)C(=O)O.OC1(CCN(Cc2oc3ccccc3c2)CC1)c4ccc(I)cc4,Ki,=,14.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,14.3
9675,CHEMBL1172212,OC(=O)C(=O)O.OC1(CCN(Cc2cc3ccccc3s2)CC1)c4ccccc4,Ki,=,46.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,46.8
9676,CHEMBL1172213,OC(=O)C(=O)O.OC1(CCN(Cc2coc3ccccc23)CC1)c4ccc(Br)cc4,Ki,=,6.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,6.6
9677,CHEMBL1171249,OC(=O)C(=O)O.OC1(CCN(Cc2coc3ccccc23)CC1)c4ccc(I)cc4,Ki,=,2.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,2.4
9678,CHEMBL1172214,OC(=O)C(=O)O.O=C1Nc2ccccc2N1C3CCN(Cc4coc5ccccc45)CC3,Ki,=,13.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,13.6
9679,CHEMBL1169895,OC(=O)C(=O)O.O=C1Nc2ccccc2N1C3CCN(Cc4csc5ccccc45)CC3,Ki,=,37.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,37.8
9680,CHEMBL1169896,CN1CN(c2ccccc2)C3(CCN(Cc4coc5ccccc45)CC3)C1=O.OC(=O)C(=O)O,Ki,=,7.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,7.1
9681,CHEMBL1170085,OC(=O)C(=O)O.FCCN1CN(c2ccccc2)C3(CCN(Cc4coc5ccccc45)CC3)C1=O,Ki,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,8.0
9682,CHEMBL1169728,CN1CN(c2ccccc2)C3(CCN(Cc4csc5ccccc45)CC3)C1=O.OC(=O)C(=O)O,Ki,=,71.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,71.4
9683,CHEMBL1171630,OC(=O)C(=O)O.FCCn1cc(CN2CN(c3ccccc3)C4(CCN(Cc5coc6ccccc56)CC4)C2=O)nn1,Ki,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,2.0
9684,CHEMBL1169904,COc1cccc2[nH]cc(CN3CCC(O)(CC3)c4ccc(Cl)cc4)c12,Ki,=,4.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,4.2
9685,CHEMBL1170094,COc1ccc2[nH]cc(CN3CCC(O)(CC3)c4ccc(Cl)cc4)c2c1,Ki,=,4.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,4.2
9686,CHEMBL1170095,COc1cccc2[nH]cc(CN3CCC(O)(CC3)c4ccc(Br)cc4)c12,Ki,=,2.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,2.3
9687,CHEMBL1170096,COc1ccc2[nH]cc(CN3CCC(O)(CC3)c4ccc(Br)cc4)c2c1,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,2.5
9688,CHEMBL1170683,OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Br)cc4,Ki,=,4.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,4.8
9689,CHEMBL1173285,OC(=O)C(=O)O.OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(I)cc4,Ki,=,3.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,3.8
9690,CHEMBL1173287,COc1cccc2[nH]cc(CN3CCC(O)(CC3)c4ccc(I)cc4)c12.OC(=O)C(=O)O,Ki,=,0.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,0.9
9693,CHEMBL1173288,COc1ccc2[nH]cc(CN3CCC(O)(CC3)c4ccc(I)cc4)c2c1.OC(=O)C(=O)O,Ki,=,0.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,0.9
9697,CHEMBL1173366,OC(=O)C(=O)O.OC1(CCN(Cc2c[nH]c3ccc(OCCF)cc23)CC1)c4ccc(Br)cc4,Ki,=,13.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,13.8
9698,CHEMBL1173436,COc1cccc2[nH]cc(CN3CCC(CC3)N4C(=O)Nc5ccccc45)c12.OC(=O)C(=O)O,Ki,=,23.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,23.3
9699,CHEMBL1173711,OC(=O)C(=O)O.OC1(CCN(Cc2c[nH]c3cccc(OCCF)c23)CC1)c4ccc(Br)cc4,Ki,=,27.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,27.7
9700,CHEMBL1173778,COc1ccc2[nH]cc(CN3CCC(CC3)N4C(=O)Nc5ccccc45)c2c1.OC(=O)C(=O)O,Ki,=,12.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,12.5
9702,CHEMBL1180430,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccccc3)CC2,Ki,=,13.54,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,B,13.54
9703,CHEMBL1180455,COc1ccccc1N2CCN(CCCCNC(=O)\C=C\c3ccc(Cl)cc3)CC2,Ki,=,22.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,B,22.6
9706,CHEMBL1188090,CCCN(CCc1ccccc1)CCc2cccc(O)c2,EC50,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as stimulation of mitogenesis incubated for 24 hrs by [3H]thymidine incorporation assay,F,19.5
9707,CHEMBL1188090,CCCN(CCc1ccccc1)CCc2cccc(O)c2,Ki,=,64.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,B,64.4
9714,CHEMBL1200270,COc1cccc2[nH]cc(CN3CCC(O)(CC3)c4ccc(I)cc4)c12,Ki,=,0.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,B,0.9
9755,CHEMBL1200986,CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,1.8
9756,CHEMBL1200986,CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.46,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,0.46
9775,CHEMBL1201192,NC(=O)C[S@@+]([O-])C(c1ccccc1)c2ccccc2,IC50,=,2.1,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at DRD2 (unknown origin) expressed in HEK293T cells transfected with Galphai1-RLuc8 and gamma2-GFP10 assessed as inhibition of quinpirole-induced Gi1 activation pre-incubated with quinpirole for 10 mins before compound incubation for 10 mins by BRET assay,B,1.05
9796,CHEMBL1202202,Br.Oc1ccc(cc1)[C@H]2C[C@@H]2CN3CCN(CC3)c4ccc(Cl)cc4Cl,IC50,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,6.0
9799,CHEMBL1202205,Br.COc1ccc(Cl)cc1N2CCN(C[C@H]3C[C@@H]3c4ccccc4)CC2,IC50,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,2.5
9800,CHEMBL1202206,Br.COc1ccc(cc1)[C@H]2C[C@@H]2CN3CCN(CC3)c4ccc(Cl)cc4Cl,IC50,=,7.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,3.5
9802,CHEMBL1202208,Br.Cc1ccc(N2CCN(C[C@@H]3C[C@H]3c4ccccc4)CC2)c(C)c1,IC50,=,73.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,36.5
9803,CHEMBL1202208,Br.Cc1ccc(N2CCN(C[C@@H]3C[C@H]3c4ccccc4)CC2)c(C)c1,Ki,=,61.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonism of dopamine-stimulated [35S]GTP-gamma-S binding against human Dopamine receptor D2 in CHO cells,F,61.0
9804,CHEMBL1202209,Br.Cc1cc(F)ccc1N2CCN(C[C@H]3C[C@@H]3c4ccccc4)CC2,IC50,=,68.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,34.0
9805,CHEMBL1202210,Br.Cc1cc(Cl)ccc1N2CCN(C[C@H]3C[C@@H]3c4ccccc4)CC2,IC50,=,128.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,64.0
9806,CHEMBL1202211,Br.COc1cc(Cl)ccc1N2CCN(C[C@H]3C[C@@H]3c4ccccc4)CC2,IC50,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,8.5
9808,CHEMBL1202213,Br.Clc1cccc(N2CCN(C[C@H]3C[C@@H]3c4ccccc4)CC2)c1Cl,IC50,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,1.0
9809,CHEMBL1202214,Br.Br.COc1cc(F)ccc1N2CCN(C[C@H]3C[C@@H]3c4ccccc4)CC2,IC50,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,5.0
9810,CHEMBL1202215,Br.Clc1ccccc1N2CCN(C[C@H]3C[C@@H]3c4ccccc4)CC2,IC50,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,2.5
9811,CHEMBL1202216,Br.COc1ccccc1N2CCN(C[C@H]3C[C@@H]3c4ccccc4)CC2,IC50,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,2.5
9812,CHEMBL1202217,Br.COc1cccc(c1)N2CCN(C[C@H]3C[C@@H]3c4ccccc4)CC2,IC50,=,171.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,85.5
9813,CHEMBL1202219,Br.Fc1ccc(cc1)[C@H]2C[C@@H]2CN3CCN(CC3)c4ccccc4Cl,IC50,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,6.5
9815,CHEMBL1202221,Br.Clc1cccc(c1)N2CCN(C[C@H]3C[C@@H]3c4ccccc4)CC2,IC50,=,146.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,73.0
9817,CHEMBL1202223,Br.Fc1ccc(cc1)[C@H]2C[C@@H]2CN3CCN(CC3)c4cccc(Cl)c4,IC50,=,56.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,28.0
9819,CHEMBL1202225,Br.Clc1cc(Cl)cc(c1)N2CCN(C[C@H]3C[C@@H]3c4ccccc4)CC2,IC50,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,16.0
9820,CHEMBL1202298,Br.CN1CCc2ccccc2Cc3cc(O)c(O)cc3CC1,Ki,=,65.7,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,65.7
9826,CHEMBL1204116,Br.Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c4ccccc4)CC2)c(Cl)c1,IC50,=,93.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,46.5
9828,CHEMBL1204116,Br.Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c4ccccc4)CC2)c(Cl)c1,IC50,=,65.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,32.5
9829,CHEMBL1204119,Br.Cc1ccc(N2CCN(C[C@H]3C[C@@H]3c4ccccc4)CC2)c(C)c1,IC50,=,45.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,22.5
9830,CHEMBL1204122,Br.CN1CCc2ccccc2Cc3ccc(O)cc3CC1,Ki,=,33.5,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,33.5
9831,CHEMBL1204122,Br.CN1CCc2ccccc2Cc3ccc(O)cc3CC1,Ki,=,17.5,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by radioligand binding assay,B,17.5
9832,CHEMBL1204203,Cl.CCS(=O)(=O)Nc1cccc(c1)N2CCN(CCCCN3C(=O)C4CCCN4C3=O)CC2,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards D2 receptor was determined,B,22.0
9843,CHEMBL1210614,Cc1ncoc1c2nnc(SCCCN3CC4CC4(C3)c5cccc(c5)S(F)(F)(F)(F)F)n2C,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor assessed as inhibition of dopamine-induced [35S]GTPgammaS binding by FLIPR assay,F,31.62
9867,CHEMBL1221512,CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(=O)(=O)C)C(=O)OC(C)C)NC[C@@H](N)CS,IC50,=,157.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,78.5
9868,CHEMBL1221512,CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(=O)(=O)C)C(=O)OC(C)C)NC[C@@H](N)CS,Ki,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,52.0
9870,CHEMBL1221545,COc1ccccc1N2CCN(CCCCNS(=O)(=O)c3ccc4ccccc4c3)CC2,Ki,=,46.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor after 60 mins,B,46.5
9874,CHEMBL1221594,COc1ccccc1N2CCN(CCCCCCNS(=O)(=O)c3ccc4ccccc4c3)CC2,Ki,=,99.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor after 60 mins,B,99.0
9886,CHEMBL1223602,CCC(C)(C)c1ccc(cc1)S(=O)(=O)Nc2ccc(cc2)[C@]34CNC[C@H]3C4,Ki,=,50.12,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,50.12
9887,CHEMBL1223615,COc1ccccc1N2CCN(CCCCNc3ccccn3)CC2,Ki,=,0.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,0.8
9888,CHEMBL1223616,Clc1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1Cl,Ki,=,0.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,0.4
9889,CHEMBL1223617,FC(F)(F)c1cccc(c1)N2CCN(CCCCNc3ccccn3)CC2,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,17.0
9892,CHEMBL1223680,Fc1ccccc1N2CCN(CCCCNc3ccccn3)CC2,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,11.0
9893,CHEMBL1223681,Cc1ccccc1N2CCN(CCCCNc3ccccn3)CC2,Ki,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,32.0
9894,CHEMBL1223682,Cc1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1C,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,12.0
9895,CHEMBL1223683,Clc1cccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)c1Cl,Ki,=,0.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,0.6
9896,CHEMBL1223747,FC(F)(F)c1cccc(c1)N2CCN(CCCCNc3ccc4ccccc4n3)CC2,Ki,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,1.6
9897,CHEMBL1223748,COc1ccccc1N2CCN(CCCCNc3nccc4ccccc34)CC2,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,1.0
9898,CHEMBL1223749,Clc1cccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)c1Cl,Ki,=,3.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,3.1
9899,CHEMBL1223750,FC(F)(F)c1cccc(c1)N2CCN(CCCCNc3nccc4ccccc34)CC2,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,1.0
9900,CHEMBL1223799,Fc1ccccc1N2CCN(CCCCNc3ccc(cn3)c4ccccc4)CC2,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,2.5
9901,CHEMBL1223800,Clc1cccc(N2CCN(CCCCNc3ccc(cn3)c4ccccc4)CC2)c1Cl,Ki,=,0.59,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,0.59
9902,CHEMBL1223801,FC(F)(F)c1cccc(c1)N2CCN(CCCCNc3ccc(cn3)c4ccccc4)CC2,Ki,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,1.1
9903,CHEMBL1223802,Fc1ccccc1N2CCN(CCCCNc3cc(ccn3)c4ccccc4)CC2,Ki,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,1.5
9904,CHEMBL1223856,Clc1cccc(N2CCN(CCCCNc3cc(ccn3)c4ccccc4)CC2)c1Cl,Ki,=,0.55,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,0.55
9905,CHEMBL1223857,FC(F)(F)c1cccc(c1)N2CCN(CCCCNc3cc(ccn3)c4ccccc4)CC2,Ki,=,0.76,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,0.76
9906,CHEMBL1223858,FC(F)(F)c1cccc(c1)N2CCN(CCCCNc3oc(cn3)c4ccccc4)CC2,Ki,=,9.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,9.6
9907,CHEMBL1223859,FC(F)(F)c1cccc(c1)N2CCN(CCCCNc3nc(cs3)c4ccccc4)CC2,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,B,13.0
9912,CHEMBL1224639,CC(C)c1ccc(cc1)S(=O)(=O)Nc2ccc(cc2)[C@@]34C[C@@H]3CN(C)C4,Ki,=,63.1,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,63.1
9914,CHEMBL1224698,CC(C)c1ccc(cc1)S(=O)(=O)Nc2ccc(cc2)[C@@]34C[C@@H]3CN(CC=C)C4,Ki,=,63.1,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,63.1
9915,CHEMBL1224699,COc1cc(ccc1NS(=O)(=O)c2ccc(cc2)C(C)C)[C@]34CNC[C@H]3C4,Ki,=,50.12,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,50.12
9934,CHEMBL1237149,Br.Fc1ccc2[nH]c3CCC(CN4C[C@H]5C[C@@H]4CN5c6cccc7NC(=O)Oc67)Cc3c2c1,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2 receptor,B,12.0
9935,CHEMBL1237165,Cl.Fc1ccc2[nH]c3CCC(CCNC[C@H]4COc5c6CC(=O)Nc6ccc5O4)Cc3c2c1,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2 receptor,B,24.0
9947,CHEMBL1242950,CCCCC1CCN(CCCC(=O)c2ccccc2C)CC1,Ki,=,77.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2S receptor by radioligand displacement assay,B,77.0
9949,CHEMBL1253770,CCCN(CCN1CCN(CC1)c2ccc(cc2)c3ccccc3)C4CCc5ccc(O)cc5C4,EC50,=,108.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding,F,54.0
9951,CHEMBL1254947,CCCN(CCN1CCN(CC1)c2ccc(cc2)c3ccccc3)C4CCc5c(O)cccc5C4,EC50,=,52.6,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding,F,26.3
9955,CHEMBL1255837,CC(C)[C@@]1(NC(=O)[C@@H]2C[C@H]3[C@@H](Cc4c[nH]c5cccc3c45)N(C)C2)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](Cc8ccccc8)N6C1=O.CS(=O)(=O)O,IC50,=,1.474,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,0.737
9956,CHEMBL1255837,CC(C)[C@@]1(NC(=O)[C@@H]2C[C@H]3[C@@H](Cc4c[nH]c5cccc3c45)N(C)C2)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](Cc8ccccc8)N6C1=O.CS(=O)(=O)O,Ki,=,0.491,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,0.491
9964,CHEMBL1256170,O=C(CCCN1CCC(CC1)c2cc3CCc4ccc(CCc2cc3)cc4)c5cc6CCc7ccc(CCc5cc6)cc7,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,17.0
9965,CHEMBL1256170,O=C(CCCN1CCC(CC1)c2cc3CCc4ccc(CCc2cc3)cc4)c5cc6CCc7ccc(CCc5cc6)cc7,Ki,=,30.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,30.0
9966,CHEMBL1256171,O=C(NCCCCN1CCN(CC1)c2cc3CCc4ccc(CCc2cc3)cc4)c5cc6CCc7ccc(CCc5cc6)cc7,Ki,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,32.0
9967,CHEMBL1256171,O=C(NCCCCN1CCN(CC1)c2cc3CCc4ccc(CCc2cc3)cc4)c5cc6CCc7ccc(CCc5cc6)cc7,Ki,=,48.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,48.0
9969,CHEMBL1255588,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc5cccc([C@H]2C1)c35,Ki,=,0.6,nM,Dopamine D2 receptor,Homo sapiens,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,B,0.6
9971,CHEMBL1255588,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc5cccc([C@H]2C1)c35,IC50,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 receptor,B,7.5
9972,CHEMBL1255588,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc5cccc([C@H]2C1)c35,Ki,=,2.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of radiolabeled (+)butaclamol from human dopamine D2S receptor,B,2.9
9973,CHEMBL1255588,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc5cccc([C@H]2C1)c35,IC50,=,8.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of radiolabeled (+)butaclamol from human dopamine D2S receptor,B,4.35
9974,CHEMBL1255588,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc5cccc([C@H]2C1)c35,IC50,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 receptor,B,6.0
9975,CHEMBL1255588,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc5cccc([C@H]2C1)c35,Ki,=,0.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methyl-spiperone from human dopamine D2s receptor,B,0.5
9976,CHEMBL1255588,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc5cccc([C@H]2C1)c35,IC50,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2S receptor by radioligand displacement assay,B,0.7
9977,CHEMBL1255588,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc5cccc([C@H]2C1)c35,Ki,=,0.74,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2S receptor by radioligand displacement assay,B,0.74
9978,CHEMBL1255588,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc5cccc([C@H]2C1)c35,IC50,=,2.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2S receptor by radioligand displacement assay,B,1.1
9979,CHEMBL1255588,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc5cccc([C@H]2C1)c35,Ki,=,2.58,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,B,2.58
9980,CHEMBL1255588,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc5cccc([C@H]2C1)c35,Ki,=,0.37,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,0.37
9981,CHEMBL1257144,Fc1ccc2c(cccc2c1)N3CCN(CCCCOc4ccc5CNC(=O)c5c4)CC3,Ki,=,58.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,58.0
9984,CHEMBL1257145,Fc1cc2cccc(N3CCN(CCCOc4ccc5CNC(=O)c5c4)CC3)c2cc1F,Ki,=,10.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,10.2
9987,CHEMBL1257146,Fc1cccc2cccc(N3CCN(CCCOc4ccc5CNC(=O)c5c4Cl)CC3)c12,Ki,=,9.01,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,9.01
9989,CHEMBL1257147,Fc1cccc2cccc(N3CCN(CCCCOc4ccc5CNC(=O)c5c4Cl)CC3)c12,Ki,=,9.86,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,9.86
9993,CHEMBL1257261,Fc1cc2cccc(N3CCN(CCCCOc4ccc5CNC(=O)c5c4)CC3)c2cc1F,Ki,=,8.23,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,8.23
9996,CHEMBL1257262,O=C1NCc2ccc(OCCCN3CCN(CC3)c4cccc5CCCc45)cc12,Ki,=,0.302,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,0.302
9999,CHEMBL1257263,Clc1cc2CNC(=O)c2cc1OCCCN3CCN(CC3)c4cccc5ccccc45,Ki,=,51.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,51.6
10001,CHEMBL1257264,Clc1cc2CNC(=O)c2cc1OCCCCN3CCN(CC3)c4cccc5ccccc45,Ki,=,9.31,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,9.31
10006,CHEMBL1257382,O=C1NCc2ccc(OCCCCN3CCN(CC3)c4cccc5CCCc45)cc12,Ki,=,0.0575,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,0.0575
10009,CHEMBL1257382,O=C1NCc2ccc(OCCCCN3CCN(CC3)c4cccc5CCCc45)cc12,Ki,=,0.05754,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin),B,0.05754
10010,CHEMBL1257383,O=C1NCc2ccc(OCCCN3CCN(CC3)c4cccc5OCCc45)cc12,Ki,=,12.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,12.1
10013,CHEMBL1257384,Fc1cccc2cccc(N3CCN(CCCOc4cc5C(=O)NCc5cc4Cl)CC3)c12,Ki,=,24.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,24.5
10015,CHEMBL1257385,Fc1cccc2cccc(N3CCN(CCCCOc4cc5C(=O)NCc5cc4Cl)CC3)c12,Ki,=,5.91,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,5.91
10019,CHEMBL1257492,O=C1NCc2ccc(OCCCCN3CCN(CC3)c4cccc5OCCc45)cc12,Ki,=,2.08,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,2.08
10022,CHEMBL1257492,O=C1NCc2ccc(OCCCCN3CCN(CC3)c4cccc5OCCc45)cc12,Ki,=,2.089,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin),B,2.089
10023,CHEMBL1257493,O=C1NCc2ccc(OCCCCN3CCN(CC3)c4cccc5COCc45)cc12,Ki,=,0.575,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,0.575
10026,CHEMBL1257493,O=C1NCc2ccc(OCCCCN3CCN(CC3)c4cccc5COCc45)cc12,Ki,=,0.5754,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin),B,0.5754
10027,CHEMBL1257494,Cc1c(OCCCN2CCN(CC2)c3cccc4ccccc34)ccc5CNC(=O)c15,Ki,=,6.81,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,6.81
10029,CHEMBL1257495,Cc1c(OCCCCN2CCN(CC2)c3cccc4ccccc34)ccc5CNC(=O)c15,Ki,=,13.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,13.1
10033,CHEMBL1257613,O=C1NCc2ccc(OCCCN3CCN(CC3)c4cccc5CCCCc45)cc12,Ki,=,2.63,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,2.63
10036,CHEMBL1257614,O=C1NCc2ccc(OCCCCN3CCN(CC3)c4cccc5CCCCc45)cc12,Ki,=,1.54,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,1.54
10039,CHEMBL1257614,O=C1NCc2ccc(OCCCCN3CCN(CC3)c4cccc5CCCCc45)cc12,Ki,=,1.5490000000000002,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin),B,1.5490000000000002
10040,CHEMBL1257615,Cc1c(OCCCN2CCN(CC2)c3cccc4cccc(F)c34)ccc5CNC(=O)c15,Ki,=,13.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,13.6
10042,CHEMBL1257616,Cc1c(OCCCCN2CCN(CC2)c3cccc4cccc(F)c34)ccc5CNC(=O)c15,Ki,=,3.03,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,3.03
10046,CHEMBL1257688,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3cc4CCc5ccc(CCc3cc4)cc5,Ki,=,4.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,4.8
10047,CHEMBL1257688,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3cc4CCc5ccc(CCc3cc4)cc5,Ki,=,3.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,3.6
10048,CHEMBL1257689,Cc1ccc(C)c(c1)C2(O)CCN(CCCC(=O)c3ccc(F)cc3)CC2,Ki,=,3.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,3.4
10049,CHEMBL1257689,Cc1ccc(C)c(c1)C2(O)CCN(CCCC(=O)c3ccc(F)cc3)CC2,Ki,=,6.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,6.5
10050,CHEMBL1257734,O=C1NCc2ccc(OCCCN3CCN(CC3)c4cccc5CCCOc45)cc12,Ki,=,4.47,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,4.47
10053,CHEMBL1257735,O=C1NCc2ccc(OCCCCN3CCN(CC3)c4cccc5CCCOc45)cc12,Ki,=,0.5760000000000001,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,0.5760000000000001
10056,CHEMBL1257735,O=C1NCc2ccc(OCCCCN3CCN(CC3)c4cccc5CCCOc45)cc12,Ki,=,0.5754,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin),B,0.5754
10057,CHEMBL1257736,Cc1c(OCCCN2CCN(CC2)c3cccc4cc(F)ccc34)ccc5CNC(=O)c15,Ki,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,1.7
10059,CHEMBL1257737,Cc1c(OCCCCN2CCN(CC2)c3cccc4cc(F)ccc34)ccc5CNC(=O)c15,Ki,=,9.44,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,9.44
10063,CHEMBL1257810,OC1(CCN(CCCC(=O)c2cc3CCc4ccc(CCc2cc3)cc4)CC1)c5ccc(Cl)cc5,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,21.0
10064,CHEMBL1257810,OC1(CCN(CCCC(=O)c2cc3CCc4ccc(CCc2cc3)cc4)CC1)c5ccc(Cl)cc5,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,13.0
10065,CHEMBL1257811,Cc1ccc(C)c(c1)C(=O)CCCN2CCC(O)(CC2)c3ccc(Cl)cc3,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,15.0
10066,CHEMBL1257811,Cc1ccc(C)c(c1)C(=O)CCCN2CCC(O)(CC2)c3ccc(Cl)cc3,Ki,=,43.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,43.0
10070,CHEMBL1257857,O=C1NCc2ccc(OCCCCN3CCN(CC3)c4cccc5CCOCc45)cc12,Ki,=,22.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,22.3
10073,CHEMBL1257857,O=C1NCc2ccc(OCCCCN3CCN(CC3)c4cccc5CCOCc45)cc12,Ki,=,22.39,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin),B,22.39
10074,CHEMBL1257858,Cc1cc2CNC(=O)c2cc1OCCCN3CCN(CC3)c4cccc5ccccc45,Ki,=,21.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,21.8
10076,CHEMBL1257859,Cc1cc2CNC(=O)c2cc1OCCCCN3CCN(CC3)c4cccc5ccccc45,Ki,=,2.46,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,2.46
10080,CHEMBL1257927,Cc1ccc(C)c(c1)C(=O)CCCN2CCC(O)(CC2)c3cc(C)ccc3C,Ki,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,55.0
10081,CHEMBL1257927,Cc1ccc(C)c(c1)C(=O)CCCN2CCC(O)(CC2)c3cc(C)ccc3C,Ki,=,46.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,46.0
10082,CHEMBL1257968,O=C1NCc2ccc(OCCCCN3CCN(CC3)c4cccc5COCCc45)cc12,Ki,=,11.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,11.5
10085,CHEMBL1257968,O=C1NCc2ccc(OCCCCN3CCN(CC3)c4cccc5COCCc45)cc12,Ki,=,11.48,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin),B,11.48
10086,CHEMBL1257969,Fc1c(OCCCN2CCN(CC2)c3cccc4ccccc34)ccc5CNC(=O)c15,Ki,=,13.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,13.8
10088,CHEMBL1257970,Cc1cc2CNC(=O)c2cc1OCCCN3CCN(CC3)c4cccc5cccc(F)c45,Ki,=,16.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,16.6
10090,CHEMBL1257971,Cc1cc2CNC(=O)c2cc1OCCCCN3CCN(CC3)c4cccc5cccc(F)c45,Ki,=,2.34,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,2.34
10095,CHEMBL1258036,Fc1ccc(cc1)C(=O)CCCN2CCN(CC2)c3cc4CCc5ccc(CCc3cc4)cc5,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,19.0
10096,CHEMBL1258036,Fc1ccc(cc1)C(=O)CCCN2CCN(CC2)c3cc4CCc5ccc(CCc3cc4)cc5,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,22.0
10097,CHEMBL1258037,Cc1ccc(C)c(c1)N2CCN(CCCC(=O)c3ccc(F)cc3)CC2,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,13.0
10098,CHEMBL1258037,Cc1ccc(C)c(c1)N2CCN(CCCC(=O)c3ccc(F)cc3)CC2,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,16.0
10099,CHEMBL1258084,Fc1c(OCCCCN2CCN(CC2)c3cccc4ccccc34)ccc5CNC(=O)c15,Ki,=,22.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,22.3
10101,CHEMBL1258084,Fc1c(OCCCCN2CCN(CC2)c3cccc4ccccc34)ccc5CNC(=O)c15,Ki,=,22.39,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin),B,22.39
10102,CHEMBL1258085,Fc1cccc2cccc(N3CCN(CCCOc4ccc5CNC(=O)c5c4F)CC3)c12,Ki,=,5.49,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,5.49
10104,CHEMBL1258086,Cc1cc2CNC(=O)c2cc1OCCCN3CCN(CC3)c4cccc5cc(F)ccc45,Ki,=,3.81,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,3.81
10106,CHEMBL1258087,Cc1cc2CNC(=O)c2cc1OCCCCN3CCN(CC3)c4cccc5cc(F)ccc45,Ki,=,0.812,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,0.812
10113,CHEMBL1258199,Fc1cccc2cccc(N3CCN(CCCCOc4ccc5CNC(=O)c5c4F)CC3)c12,Ki,=,35.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,35.2
10115,CHEMBL1258199,Fc1cccc2cccc(N3CCN(CCCCOc4ccc5CNC(=O)c5c4F)CC3)c12,Ki,=,35.48,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin),B,35.48
10116,CHEMBL1258200,Fc1ccc2cccc(N3CCN(CCCOc4ccc5CNC(=O)c5c4F)CC3)c2c1,Ki,=,10.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,10.3
10123,CHEMBL1258312,C(COc1ccc2CNCc2c1)CN3CCN(CC3)c4cccc5ccccc45,Ki,=,34.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,34.0
10125,CHEMBL1258313,Fc1ccc2cccc(N3CCN(CCCCOc4ccc5CNC(=O)c5c4F)CC3)c2c1,Ki,=,5.75,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,5.75
10127,CHEMBL1258313,Fc1ccc2cccc(N3CCN(CCCCOc4ccc5CNC(=O)c5c4F)CC3)c2c1,Ki,=,5.754,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin),B,5.754
10128,CHEMBL1258314,Fc1ccc2c(cccc2c1)N3CCN(CCCOc4ccc5CNC(=O)c5c4F)CC3,Ki,=,8.59,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,8.59
10132,CHEMBL1258382,O=C(NCCCCN1CCN(CC1)c2cc3CCc4ccc(CCc2cc3)cc4)c5cc6ccccc6s5,Ki,=,83.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,83.0
10134,CHEMBL1258383,Cc1ccc(C)c(c1)N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2,Ki,=,84.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,84.0
10135,CHEMBL1258383,Cc1ccc(C)c(c1)N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2,Ki,=,65.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,65.0
10137,CHEMBL1258425,C(CCN1CCN(CC1)c2cccc3ccccc23)COc4ccc5CNCc5c4,Ki,=,40.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,40.7
10139,CHEMBL1258426,Fc1ccc2cccc(N3CCN(CCCOc4ccc5CNCc5c4)CC3)c2c1,Ki,=,24.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,24.7
10142,CHEMBL1258427,Fc1ccc2c(cccc2c1)N3CCN(CCCCOc4ccc5CNC(=O)c5c4F)CC3,Ki,=,15.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,15.8
10144,CHEMBL1258427,Fc1ccc2c(cccc2c1)N3CCN(CCCCOc4ccc5CNC(=O)c5c4F)CC3,Ki,=,15.85,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin),B,15.85
10145,CHEMBL1258428,Fc1cc2CNC(=O)c2cc1OCCCN3CCN(CC3)c4cccc5ccccc45,Ki,=,8.92,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,8.92
10149,CHEMBL1258494,COc1ccccc1N2CCN(CCCCNC(=O)c3cc(C)ccc3C)CC2,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,22.0
10150,CHEMBL1258494,COc1ccccc1N2CCN(CCCCNC(=O)c3cc(C)ccc3C)CC2,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,17.0
10151,CHEMBL1258495,Cc1ccc(C)c(c1)N2CCN(CCCCNC(=O)c3cc(C)ccc3C)CC2,Ki,=,99.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,99.0
10152,CHEMBL1258495,Cc1ccc(C)c(c1)N2CCN(CCCCNC(=O)c3cc(C)ccc3C)CC2,Ki,=,86.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,86.0
10154,CHEMBL1258532,Fc1ccc2cccc(N3CCN(CCCCOc4ccc5CNCc5c4)CC3)c2c1,Ki,=,80.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,80.7
10156,CHEMBL1258533,O=C1NCc2ccc(OCCCN3CCN(CC3)c4cccc5ccccc45)cc12,Ki,=,16.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,16.3
10159,CHEMBL1258534,Fc1cc2CNC(=O)c2cc1OCCCCN3CCN(CC3)c4cccc5ccccc45,Ki,=,0.877,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,0.877
10161,CHEMBL1258535,Fc1cc2CNC(=O)c2cc1OCCCN3CCN(CC3)c4cccc5cccc(F)c45,Ki,=,9.54,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,9.54
10166,CHEMBL1258647,O=C1NCc2ccc(OCCCCN3CCN(CC3)c4cccc5ccccc45)cc12,Ki,=,7.39,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,7.39
10169,CHEMBL1258647,O=C1NCc2ccc(OCCCCN3CCN(CC3)c4cccc5ccccc45)cc12,Ki,=,7.412999999999999,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin),B,7.412999999999999
10170,CHEMBL1258648,Fc1ccc2cccc(N3CCN(CCCOc4ccc5CNC(=O)c5c4)CC3)c2c1,Ki,=,27.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,27.8
10172,CHEMBL1258649,Fc1cccc2cccc(N3CCN(CCCCOc4cc5C(=O)NCc5cc4F)CC3)c12,Ki,=,1.41,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,1.41
10174,CHEMBL1258650,Fc1ccc2cccc(N3CCN(CCCOc4cc5C(=O)NCc5cc4F)CC3)c2c1,Ki,=,5.81,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,5.81
10181,CHEMBL1258760,Fc1ccc2cccc(N3CCN(CCCCOc4ccc5CNC(=O)c5c4)CC3)c2c1,Ki,=,33.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,33.8
10183,CHEMBL1258761,Fc1cccc2cccc(N3CCN(CCCOc4ccc5CNC(=O)c5c4)CC3)c12,Ki,=,13.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,13.6
10186,CHEMBL1258762,Fc1ccc2cccc(N3CCN(CCCCOc4cc5C(=O)NCc5cc4F)CC3)c2c1,Ki,=,11.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,11.2
10188,CHEMBL1258763,Fc1ccc2c(cccc2c1)N3CCN(CCCOc4cc5C(=O)NCc5cc4F)CC3,Ki,=,1.86,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,1.86
10190,CHEMBL1258833,Cc1ncoc1c2nnc(SCCCN3CCC4(CCc5ccc(Br)cc45)C3)n2C,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,F,39.81
10193,CHEMBL1258879,Fc1cccc2cccc(N3CCN(CCCCOc4ccc5CNC(=O)c5c4)CC3)c12,Ki,=,3.18,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,3.18
10198,CHEMBL1258880,Fc1ccc2c(cccc2c1)N3CCN(CCCOc4ccc5CNC(=O)c5c4)CC3,Ki,=,44.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,44.5
10199,CHEMBL1258881,Fc1ccc2c(cccc2c1)N3CCN(CCCCOc4cc5C(=O)NCc5cc4F)CC3,Ki,=,0.8909999999999999,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,0.8909999999999999
10201,CHEMBL1258882,Clc1c(OCCCN2CCN(CC2)c3cccc4ccccc34)ccc5CNC(=O)c15,Ki,=,10.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,B,10.6
10205,CHEMBL1258987,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(cc24)c5cnn(C)c5,Ki,=,2.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,2.3
10206,CHEMBL1258988,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(cc24)c5ncn(C)n5,Ki,=,5.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,5.9
10209,CHEMBL1259005,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(cc24)c5ccc(C)s5,Ki,=,2.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,2.9
10210,CHEMBL1259006,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(cc24)c5ccccn5,Ki,=,1.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,1.9
10211,CHEMBL1259023,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(cc24)c5cccnc5,Ki,=,0.62,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,0.62
10212,CHEMBL1259024,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(cc24)c5ccncc5,Ki,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,1.1
10213,CHEMBL1259042,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(cc24)c5cncnc5,Ki,=,0.73,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,0.73
10214,CHEMBL1259043,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(cc24)c5ccccc5,Ki,=,1.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,1.8
10215,CHEMBL1259062,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(cc24)c5ccccc5C,Ki,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,1.6
10216,CHEMBL1259063,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(cc24)c5cccc(C)c5,Ki,=,3.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,3.4
10219,CHEMBL1259079,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(cc24)c5ccc(C)cc5,Ki,=,6.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,6.3
10220,CHEMBL1259080,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(cc24)c5cccc(C)c5C,Ki,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,2.0
10221,CHEMBL1259097,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(cc24)c5c(C)cccc5C,Ki,=,4.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,4.6
10222,CHEMBL1259098,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(cc24)c5c(C)cc(C)cc5C,Ki,=,4.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,4.9
10223,CHEMBL1259112,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(cc24)C#N,Ki,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,1.4
10224,CHEMBL1259113,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(CN)cc24,Ki,=,35.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,35.0
10225,CHEMBL1259128,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(Cc5nnn(C)n5)cc24,Ki,=,0.35,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor expressed in HEK293 cells,B,0.35
10226,CHEMBL1259129,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(Cc5nnnn5C)cc24,Ki,=,1.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor expressed in HEK293 cells,B,1.9
10227,CHEMBL1259144,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(CNC(=O)C)cc24,Ki,=,7.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,7.1
10228,CHEMBL1259145,CC(C)C(=O)NCc1ccc2Sc3ccccc3CC(N4CCN(C)CC4)c2c1,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,12.0
10229,CHEMBL1259158,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(CNC(=O)C(C)(C)C)cc24,Ki,=,6.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,6.1
10230,CHEMBL1259172,NCc1ccc2c(c1)c(cn2c3ccc(F)cc3)C4CCN(CCN5CCNC5=O)CC4,Ki,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,37.0
10231,CHEMBL1259173,CN1CCN(CC1)[C@@H]2Cc3ccccc3Sc4ccc(CNC(=O)C)cc24,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,27.0
10232,CHEMBL1259174,CN1CCN(CC1)[C@H]2Cc3ccccc3Sc4ccc(CNC(=O)C)cc24,Ki,=,3.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,3.3
10233,CHEMBL1259187,CC(=O)NCc1ccc2c(c1)c(cn2c3ccc(F)cc3)C4CCN(CCN5CCNC5=O)CC4,Ki,=,3.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,3.1
10234,CHEMBL1259188,Cn1nnc(Cc2ccc3c(c2)c(cn3c4ccc(F)cc4)C5CCN(CCN6CCNC6=O)CC5)n1,Ki,=,2.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,2.7
10235,CHEMBL1259189,CC(C)C(=O)NCc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1,Ki,=,31.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,31.0
10236,CHEMBL1259190,CC(C)C(=O)NCc1ccc2Sc3ccccc3C[C@H](N4CCN(C)CC4)c2c1,Ki,=,4.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,4.5
10241,CHEMBL1259216,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(cc24)c5nnn(C)n5,Ki,=,2.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,2.3
10242,CHEMBL1259216,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(cc24)c5nnn(C)n5,Ki,=,0.44,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor expressed in HEK293 cells,B,0.44
10244,CHEMBL1259231,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(cc24)c5ccnn5C,Ki,=,0.86,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,0.86
10245,CHEMBL1259232,CN1CCN(CC1)C2Cc3ccccc3Sc4ccc(cc24)c5ccn(C)n5,Ki,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,B,1.6
10312,CHEMBL1278088,NN1C(=NC2=C(CCCC2)C1=O)CCCCN3CCN(CC3)c4ccc5ccccc5n4,IC50,>,100.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 receptor,B,50.0
10314,CHEMBL1288585,CC[11CH2]N1CCO[C@H]2[C@H]1CCc3ccc(O)cc23,Ki,=,8.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor expressed in CHO cells,B,8.5
10333,CHEMBL1385840,CC(C)[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,IC50,=,5.032,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,2.516
10334,CHEMBL1385840,CC(C)[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,Ki,=,1.6769999999999998,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,1.6769999999999998
10339,CHEMBL1403281,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,IC50,=,1.95,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,0.975
10340,CHEMBL1403281,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,Ki,=,0.65,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,0.65
10355,CHEMBL1457510,COc1c(O)ccc2C[C@@H]3N(CCc4cc5OCOc5cc34)Cc12,Ki,=,49.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor after 1 hr,B,49.2
10391,CHEMBL1627305,OC(CCNC(=O)c1cc2ccccc2[nH]1)CN3CCN(CC3)c4cccc(Cl)c4Cl,EC50,=,170.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as stimulation of quinpirole-stimulated mitogenesis,B,85.0
10404,CHEMBL1628275,Cl.O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCN4CCN(CC4)c5ncccn5,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for DA2 receptor,B,28.0
10423,CHEMBL1632223,Cc1ccc2c(cccc2n1)N3CCN(CCc4cccc(NC(=O)Nc5ccccc5)c4)CC3,Ki,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,B,79.43
10426,CHEMBL1642118,CC1CC(=O)c2ccc(cc2N1S(=O)(=O)c3ccc4ccccc4c3)N5CCN(C)CC5,IC50,=,136.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in cells,B,68.0
10471,CHEMBL1684128,CCCN1CCc2cccc3c2C1Cc4cccc(OCCCCN5CCN(CC5)c6ccccc6OC)c34,Ki,=,88.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,B,88.0
10479,CHEMBL1688990,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)N(C)C)CC2,Ki,=,34.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,34.4
10482,CHEMBL1688990,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)N(C)C)CC2,Ki,=,34.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,B,34.4
10484,CHEMBL1688991,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(CCF)cc3)CC2,Ki,=,54.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,54.5
10487,CHEMBL1688991,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(CCF)cc3)CC2,Ki,=,54.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,B,54.5
10489,CHEMBL1688992,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(OCCF)cc3)CC2.OC(=O)C(=O)O,Ki,=,27.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,27.1
10491,CHEMBL1688993,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(OCCOCCF)cc3)CC2.OC(=O)C(=O)O,Ki,=,20.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,20.9
10492,CHEMBL1688994,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(OCCOCCOCCF)cc3)CC2.OC(=O)C(=O)O,Ki,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,52.0
10495,CHEMBL1688996,COc1ccccc1N2CCN(C\C=C\CNC(=O)c3ccc(OCCF)cc3)CC2.OC(=O)C(=O)O,Ki,=,55.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,55.3
10496,CHEMBL1688997,COc1ccccc1N2CCN(C\C=C\CNC(=O)c3ccc(OCCOCCF)cc3)CC2.OC(=O)C(=O)O,Ki,=,59.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,59.2
10497,CHEMBL1688998,COc1ccccc1N2CCN(C\C=C\CNC(=O)c3cc(C)ccc3OCCF)CC2.OC(=O)C(=O)O,Ki,=,17.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,17.8
10498,CHEMBL1688999,COc1ccccc1N2CCN(C\C=C\CNC(=O)c3cc(Br)ccc3OCCF)CC2.OC(=O)C(=O)O,Ki,=,13.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,13.4
10499,CHEMBL1689000,COc1ccccc1N2CCN(C\C=C\CNC(=O)c3cc(I)ccc3OCCF)CC2.OC(=O)C(=O)O,Ki,=,13.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,13.2
10500,CHEMBL1689001,COc1cc(Br)cc(C(=O)NC\C=C\CN2CCN(CC2)c3ccccc3OC)c1OCCF.OC(=O)C(=O)O,Ki,=,57.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,57.6
10501,CHEMBL1689002,CN(C)c1ccc(cc1)C(=O)NCCCCN2CCN(CC2)c3ccccc3OCCF.OC(=O)C(=O)O,Ki,=,15.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,15.1
10503,CHEMBL1689003,OC(=O)C(=O)O.FCCOc1ccccc1N2CCN(CCCCNC(=O)c3ccc(CCF)cc3)CC2,Ki,=,21.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,21.4
10504,CHEMBL1689004,OC(=O)C(=O)O.FCCOc1ccc(cc1)C(=O)NCCCCN2CCN(CC2)c3ccccc3OCCF,Ki,=,15.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,15.1
10506,CHEMBL1689005,OC(=O)C(=O)O.FCCOCCOc1ccc(cc1)C(=O)NCCCCN2CCN(CC2)c3ccccc3OCCF,Ki,=,14.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,14.2
10507,CHEMBL1689006,OC(=O)C(=O)O.FCCOc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)c4ccsc4)CC2,Ki,=,27.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,27.7
10509,CHEMBL1689007,OC(=O)C(=O)O.FCCOCCOCCOc1ccc(cc1)C(=O)NCCCCN2CCN(CC2)c3ccccc3OCCF,Ki,=,31.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,31.7
10510,CHEMBL1689008,CN(C)c1ccc(cc1)C(=O)NC\C=C\CN2CCN(CC2)c3ccccc3OCCF.OC(=O)C(=O)O,Ki,=,35.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,35.2
10511,CHEMBL1689009,OC(=O)C(=O)O.FCCOc1ccccc1N2CCN(C\C=C\CNC(=O)c3ccc(CCF)cc3)CC2,Ki,=,17.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,17.7
10513,CHEMBL1689010,OC(=O)C(=O)O.FCCOc1ccc(cc1)C(=O)NC\C=C\CN2CCN(CC2)c3ccccc3OCCF,Ki,=,37.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,37.9
10514,CHEMBL1689011,OC(=O)C(=O)O.FCCOCCOc1ccc(cc1)C(=O)NC\C=C\CN2CCN(CC2)c3ccccc3OCCF,Ki,=,64.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,64.8
10515,CHEMBL1689012,OC(=O)C(=O)O.FCCOc1ccccc1N2CCN(C\C=C\CNC(=O)c3ccc(cc3)c4ccsc4)CC2,Ki,=,70.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,B,70.5
10529,CHEMBL1744037,CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)[C@@H]2CCc3ccc4[nH]c(cc4c3C2)C(=O)N,Ki,=,38.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,B,38.0
10532,CHEMBL1744044,COc1ccccc1N2CCN(CC3CN=C4N3C(=Nc5ccccc45)SC)CC2,Ki,>,50.0,nM,Dopamine D2 receptor,Homo sapiens,Compound is evaluated for binding affinity towards recombinant human Dopamine receptor D2 using [3H]spiperone in CHO cells at 10 uM,B,50.0
10534,CHEMBL1744088,CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)[C@@H]2CCc3ccc4[nH]c(cc4c3C2)C#N,Ki,=,44.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,B,44.0
10539,CHEMBL1765629,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)C3CCn4nccc4C3,Ki,=,77.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins,B,77.0
10542,CHEMBL1765630,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)C3CCn4ncc(Cl)c4C3,Ki,=,43.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins,B,43.0
10547,CHEMBL1765633,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@H]3CCn4nccc4C3,EC50,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2long receptor expressed in HEK293 cells co-expressing Galphao1 assessed as incorporation of [35S]GTPgammaS into Galphao1 after 30 mins by scintillation counting,F,13.0
10549,CHEMBL1765633,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@H]3CCn4nccc4C3,EC50,=,110.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2long receptor expressed in CHO cells assessed as increase of forskolin-induced cAMP accumulation by bioluminescence assay,F,55.0
10550,CHEMBL1765633,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@H]3CCn4nccc4C3,EC50,=,0.51,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2long receptor expressed in CHO cells assessed as induction of [3H]thymidine incorporation after 2 hrs,F,0.255
10552,CHEMBL1765633,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@H]3CCn4nccc4C3,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human dopamine D2long receptor expressed in CHO cells after 60 mins,B,1.0
10553,CHEMBL1765633,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@H]3CCn4nccc4C3,Ki,=,5.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,B,5.3
10557,CHEMBL1765634,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@@H]3CCn4nccc4C3,Ki,=,49.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human dopamine D2long receptor expressed in CHO cells after 60 mins,B,49.0
10561,CHEMBL1771105,COc1ccc2C(=O)N(CCCCN3CCN(CC3)c4ccccc4OC)CCCc2c1,Ki,=,3.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,3.2
10562,CHEMBL1771105,COc1ccc2C(=O)N(CCCCN3CCN(CC3)c4ccccc4OC)CCCc2c1,Ki,=,0.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,0.93
10563,CHEMBL1771106,COc1ccccc1N2CCN(CCCCN3CCc4cc(F)ccc4C3=O)CC2,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,26.0
10564,CHEMBL1771106,COc1ccccc1N2CCN(CCCCN3CCc4cc(F)ccc4C3=O)CC2,Ki,=,9.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,9.2
10565,CHEMBL1771107,COc1ccccc1N2CCN(CCCCN3CCc4cc(ccc4C3=O)c5ccccc5)CC2,Ki,=,38.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,38.0
10566,CHEMBL1771107,COc1ccccc1N2CCN(CCCCN3CCc4cc(ccc4C3=O)c5ccccc5)CC2,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,15.0
10567,CHEMBL1771108,COc1ccccc1N2CCN(CCCCN3CCc4c(cccc4c5ccccc5)C3=O)CC2,Ki,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,52.0
10568,CHEMBL1771108,COc1ccccc1N2CCN(CCCCN3CCc4c(cccc4c5ccccc5)C3=O)CC2,Ki,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,63.0
10569,CHEMBL1771109,COc1ccccc1N2CCN(CCCCN3CCc4cc(ccc4C3=O)c5occc5)CC2,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,16.0
10570,CHEMBL1771109,COc1ccccc1N2CCN(CCCCN3CCc4cc(ccc4C3=O)c5occc5)CC2,Ki,=,4.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,4.8
10571,CHEMBL1771110,COc1ccccc1N2CCN(CCCCN3CCc4cc(ccc4C3=O)c5cccs5)CC2,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,11.0
10572,CHEMBL1771110,COc1ccccc1N2CCN(CCCCN3CCc4cc(ccc4C3=O)c5cccs5)CC2,Ki,=,6.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,6.9
10573,CHEMBL1771111,COc1ccccc1N2CCN(CCCCN3CCCc4cc(ccc4C3=O)c5cccs5)CC2,Ki,=,5.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,5.1
10574,CHEMBL1771111,COc1ccccc1N2CCN(CCCCN3CCCc4cc(ccc4C3=O)c5cccs5)CC2,Ki,=,2.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,2.1
10575,CHEMBL1771112,COc1ccccc1N2CCN(CCCCN3CCc4cc(ccc4C3=O)c5ccncc5)CC2,Ki,=,7.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,7.1
10576,CHEMBL1771112,COc1ccccc1N2CCN(CCCCN3CCc4cc(ccc4C3=O)c5ccncc5)CC2,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,13.0
10577,CHEMBL1771113,COc1ccccc1N2CCN(CCCCN3CCc4cc(ccc4C3=O)C#N)CC2,Ki,=,38.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,38.0
10578,CHEMBL1771113,COc1ccccc1N2CCN(CCCCN3CCc4cc(ccc4C3=O)C#N)CC2,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,22.0
10579,CHEMBL1771114,COc1ccccc1N2CCN(CCCCN3CCc4cc(ccc4C3=O)C#C)CC2,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,B,24.0
10580,CHEMBL1771114,COc1ccccc1N2CCN(CCCCN3CCc4cc(ccc4C3=O)C#C)CC2,Ki,=,8.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,B,8.8
10582,CHEMBL1774062,Clc1cccc(N2CCN(CCCCCc3ccc4CCC(=O)Nc4n3)CC2)c1Cl,Ki,=,2.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,2.6
10584,CHEMBL1774063,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2)c1Cl,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,1.0
10587,CHEMBL1774063,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2)c1Cl,EC50,=,3.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,1.6
10589,CHEMBL1774063,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2)c1Cl,Ki,=,3.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,3.4
10591,CHEMBL1774064,Clc1cccc(N2CCN(CCCCOc3ccc4C=CC(=O)Nc4n3)CC2)c1Cl,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,1.0
10593,CHEMBL1774065,Clc1cccc(N2CCN(CCCCOc3cc4NC(=O)C=Cc4cn3)CC2)c1Cl,Ki,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,2.0
10595,CHEMBL1774066,Clc1cccc(N2CCN(CCCCOc3ncc4C=CC(=O)Nc4n3)CC2)c1Cl,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,1.0
10597,CHEMBL1774067,Clc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2,Ki,=,5.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,5.7
10599,CHEMBL1774068,Fc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2)c1Cl,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,2.5
10601,CHEMBL1774069,Cc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2)c1Cl,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,1.0
10603,CHEMBL1774070,Cc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2,Ki,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,5.0
10605,CHEMBL1774071,Cc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2)c1C,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,2.5
10607,CHEMBL1774072,Cc1c(Cl)cccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,3.0
10609,CHEMBL1774073,Fc1c(Cl)cccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,1.0
10611,CHEMBL1774074,FC(F)(F)c1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2)c1Cl,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,1.0
10613,CHEMBL1774075,FC(F)(F)c1c(Cl)cccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,3.0
10615,CHEMBL1774076,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4cccc5CCCc45)nc2N1,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,1.0
10617,CHEMBL1774077,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4cccc5CCCCc45)nc2N1,Ki,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,1.4
10619,CHEMBL1774078,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4cccc5OCCCc45)nc2N1,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,1.0
10621,CHEMBL1774079,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4cccc5CCCOc45)nc2N1,Ki,=,0.71,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,0.71
10623,CHEMBL1774080,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4cccc5ccccc45)nc2N1,Ki,=,0.81,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,0.81
10625,CHEMBL1774081,Fc1ccc2ccccc2c1N3CCN(CCCCOc4ccc5CCC(=O)Nc5n4)CC3,Ki,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,1.6
10627,CHEMBL1774082,Fc1cc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2)c5ccccc5c1,Ki,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,1.1
10629,CHEMBL1774083,Fc1ccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2)c5ccccc15,Ki,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,2.0
10631,CHEMBL1774084,Fc1cccc2c(cccc12)N3CCN(CCCCOc4ccc5CCC(=O)Nc5n4)CC3,Ki,=,6.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,6.0
10633,CHEMBL1774085,Fc1ccc2c(cccc2c1)N3CCN(CCCCOc4ccc5CCC(=O)Nc5n4)CC3,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,1.0
10635,CHEMBL1774086,Fc1ccc2cccc(N3CCN(CCCCOc4ccc5CCC(=O)Nc5n4)CC3)c2c1,Ki,=,1.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,1.2
10637,CHEMBL1774087,Fc1cccc2cccc(N3CCN(CCCCOc4ccc5CCC(=O)Nc5n4)CC3)c12,Ki,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,1.7
10645,CHEMBL1774386,FC(CCNC(=O)c1oc2ccccc2c1)CN3CCN(CC3)c4cccc(Cl)c4Cl,Kd,=,0.03,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to wild type human dopamine D2 receptor expressed in HEK293 cells,B,0.03
10672,CHEMBL1774543,CCCN(CCCCN1CCN(CC1)c2ccccc2OC)Cc3csc4ccccc34,Ki,=,69.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,B,69.9
10683,CHEMBL1774552,Clc1cccc(N2CCN(CCCCNC(=O)c3csc4ccccc34)CC2)c1Cl,Ki,=,64.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,B,64.7
10701,CHEMBL1788258,CCS(=O)(=O)c1ccc(OC)c(c1)c2ccc(CN3CCCCC[C@@H]3c4ccccc4)[nH]2,Ki,=,25.12,nM,Dopamine D2 receptor,Homo sapiens,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",B,25.12
10707,CHEMBL1802360,Fc1ccc(OCCCN2CCC(CC2)N3C(=O)Nc4ccccc34)cc1,Ki,=,0.5012,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,0.5012
10708,CHEMBL1803023,COc1ccccc1N2CCN(Cc3ccc(OCc4cn(CCCCCCCCn5cc(COc6ccc(CN7CCN(CC7)c8ccccc8OC)cc6OC)nn5)nn4)c(OC)c3)CC2,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,B,16.0
10709,CHEMBL1803023,COc1ccccc1N2CCN(Cc3ccc(OCc4cn(CCCCCCCCn5cc(COc6ccc(CN7CCN(CC7)c8ccccc8OC)cc6OC)nn5)nn4)c(OC)c3)CC2,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,25.0
10710,CHEMBL1803024,COc1ccccc1N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCn5cc(CCCOc6ccc(CN7CCN(CC7)c8ccccc8OC)cc6OC)nn5)nn4)c(OC)c3)CC2,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,B,22.0
10711,CHEMBL1803024,COc1ccccc1N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCn5cc(CCCOc6ccc(CN7CCN(CC7)c8ccccc8OC)cc6OC)nn5)nn4)c(OC)c3)CC2,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,41.0
10712,CHEMBL1803024,COc1ccccc1N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCn5cc(CCCOc6ccc(CN7CCN(CC7)c8ccccc8OC)cc6OC)nn5)nn4)c(OC)c3)CC2,Ki,=,35.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells in presence of 100 mM sodium chloride,B,35.0
10717,CHEMBL1803024,COc1ccccc1N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCn5cc(CCCOc6ccc(CN7CCN(CC7)c8ccccc8OC)cc6OC)nn5)nn4)c(OC)c3)CC2,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,B,41.0
10718,CHEMBL1803024,COc1ccccc1N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCn5cc(CCCOc6ccc(CN7CCN(CC7)c8ccccc8OC)cc6OC)nn5)nn4)c(OC)c3)CC2,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,B,22.0
10719,CHEMBL1803025,COc1ccccc1N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCCCn5cc(CCCOc6ccc(CN7CCN(CC7)c8ccccc8OC)cc6OC)nn5)nn4)c(OC)c3)CC2,Ki,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,B,23.0
10720,CHEMBL1803025,COc1ccccc1N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCCCn5cc(CCCOc6ccc(CN7CCN(CC7)c8ccccc8OC)cc6OC)nn5)nn4)c(OC)c3)CC2,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,17.0
10721,CHEMBL1803026,COc1ccccc1N2CCN(Cc3ccc(OCCCCc4cn(CCCCCCCCCCn5cc(CCCCOc6ccc(CN7CCN(CC7)c8ccccc8OC)cc6OC)nn5)nn4)c(OC)c3)CC2,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,B,17.0
10722,CHEMBL1803026,COc1ccccc1N2CCN(Cc3ccc(OCCCCc4cn(CCCCCCCCCCn5cc(CCCCOc6ccc(CN7CCN(CC7)c8ccccc8OC)cc6OC)nn5)nn4)c(OC)c3)CC2,Ki,=,8.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,8.2
10723,CHEMBL1803027,COc1ccccc1N2CCN(Cc3ccc(OCc4cn(CCOCCOCCn5cc(COc6ccc(CN7CCN(CC7)c8ccccc8OC)cc6OC)nn5)nn4)c(OC)c3)CC2,Ki,=,3.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,B,3.3
10724,CHEMBL1803027,COc1ccccc1N2CCN(Cc3ccc(OCc4cn(CCOCCOCCn5cc(COc6ccc(CN7CCN(CC7)c8ccccc8OC)cc6OC)nn5)nn4)c(OC)c3)CC2,Ki,=,3.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,3.4
10725,CHEMBL1803028,COc1ccccc1N2CCN(Cc3ccc(OCCCc4cn(CCOCCOCCn5cc(CCCOc6ccc(CN7CCN(CC7)c8ccccc8OC)cc6OC)nn5)nn4)c(OC)c3)CC2,Ki,=,2.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,B,2.8
10726,CHEMBL1803028,COc1ccccc1N2CCN(Cc3ccc(OCCCc4cn(CCOCCOCCn5cc(CCCOc6ccc(CN7CCN(CC7)c8ccccc8OC)cc6OC)nn5)nn4)c(OC)c3)CC2,Ki,=,3.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,3.7
10727,CHEMBL1803029,COc1ccccc1N2CCN(Cc3ccc(OCCCc4cn(CCOCCOCCOCCn5cc(CCCOc6ccc(CN7CCN(CC7)c8ccccc8OC)cc6OC)nn5)nn4)c(OC)c3)CC2,Ki,=,4.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,B,4.8
10728,CHEMBL1803029,COc1ccccc1N2CCN(Cc3ccc(OCCCc4cn(CCOCCOCCOCCn5cc(CCCOc6ccc(CN7CCN(CC7)c8ccccc8OC)cc6OC)nn5)nn4)c(OC)c3)CC2,Ki,=,6.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,6.2
10729,CHEMBL1803030,CCCCn1cc(COc2ccc(CN3CCN(CC3)c4ccccc4OC)cc2OC)nn1,Ki,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,B,63.0
10730,CHEMBL1803030,CCCCn1cc(COc2ccc(CN3CCN(CC3)c4ccccc4OC)cc2OC)nn1,Ki,=,70.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,70.0
10731,CHEMBL1803049,CCCCn1cc(CCCOc2ccc(CN3CCN(CC3)c4ccccc4OC)cc2OC)nn1,Ki,=,67.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,B,67.0
10732,CHEMBL1803049,CCCCn1cc(CCCOc2ccc(CN3CCN(CC3)c4ccccc4OC)cc2OC)nn1,Ki,=,53.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,53.0
10733,CHEMBL1803049,CCCCn1cc(CCCOc2ccc(CN3CCN(CC3)c4ccccc4OC)cc2OC)nn1,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells in presence of 100 mM sodium chloride,B,12.0
10738,CHEMBL1803049,CCCCn1cc(CCCOc2ccc(CN3CCN(CC3)c4ccccc4OC)cc2OC)nn1,Ki,=,53.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,B,53.0
10739,CHEMBL1803049,CCCCn1cc(CCCOc2ccc(CN3CCN(CC3)c4ccccc4OC)cc2OC)nn1,Ki,=,67.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,B,67.0
10740,CHEMBL1803050,CCCCn1cc(CCCCOc2ccc(CN3CCN(CC3)c4ccccc4OC)cc2OC)nn1,Ki,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,B,52.0
10741,CHEMBL1803050,CCCCn1cc(CCCCOc2ccc(CN3CCN(CC3)c4ccccc4OC)cc2OC)nn1,Ki,=,67.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,67.0
10742,CHEMBL1803051,CCOCCn1cc(COc2ccc(CN3CCN(CC3)c4ccccc4OC)cc2OC)nn1,Ki,=,68.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,B,68.0
10744,CHEMBL1803052,CCOCCn1cc(CCCOc2ccc(CN3CCN(CC3)c4ccccc4OC)cc2OC)nn1,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,B,18.0
10745,CHEMBL1803052,CCOCCn1cc(CCCOc2ccc(CN3CCN(CC3)c4ccccc4OC)cc2OC)nn1,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,16.0
10746,CHEMBL1803053,CCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(CC4)c5ccccc5OC)cc3OC)nn2)nn1,Ki,=,36.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,B,36.0
10747,CHEMBL1803053,CCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(CC4)c5ccccc5OC)cc3OC)nn2)nn1,Ki,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,32.0
10748,CHEMBL1803054,COc1ccccc1N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCn5cc(CCCOc6ccc(CN7CCN(C)CC7)cc6OC)nn5)nn4)c(OC)c3)CC2,Ki,=,9.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,B,9.8
10749,CHEMBL1803054,COc1ccccc1N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCn5cc(CCCOc6ccc(CN7CCN(C)CC7)cc6OC)nn5)nn4)c(OC)c3)CC2,Ki,=,7.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,7.3
10750,CHEMBL1803055,COc1cc(CN2CCN(CC2)C3CCCCC3)ccc1OCCCc4cn(CCCCCCCCn5cc(CCCOc6ccc(CN7CCN(CC7)c8ccccc8OC)cc6OC)nn5)nn4,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,B,19.0
10751,CHEMBL1803055,COc1cc(CN2CCN(CC2)C3CCCCC3)ccc1OCCCc4cn(CCCCCCCCn5cc(CCCOc6ccc(CN7CCN(CC7)c8ccccc8OC)cc6OC)nn5)nn4,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,17.0
10780,CHEMBL1807820,O[C@@H](CNCCCSCCOCCc1cccc2ccccc12)c3ccc(O)c4NC(=O)Sc34,IC50,=,199.53,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine 2 receptor,B,99.765
10811,CHEMBL1813590,COc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2.OC(=O)C(=O)O,Ki,=,0.22,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,B,0.22
10814,CHEMBL1813591,OC(=O)C(=O)O.FCCOc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,Ki,=,0.26,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,B,0.26
10817,CHEMBL1813592,COc1ccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c(OC)c1.OC(=O)C(=O)O,Ki,=,25.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,B,25.3
10818,CHEMBL1813593,COc1cc(C)ccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2.OC(=O)C(=O)O,Ki,=,4.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,B,4.6
10819,CHEMBL1813594,COc1ccccc1N2CCN(CCCCOc3ccc4C=CC(=O)Nc4c3)CC2.OC(=O)C(=O)O,Ki,=,0.14,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,B,0.14
10820,CHEMBL1813595,OC(=O)C(=O)O.FCCOc1ccccc1N2CCN(CCCCOc3ccc4C=CC(=O)Nc4c3)CC2,Ki,=,0.07,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,B,0.07
10821,CHEMBL1813596,COc1ccccc1N2CCN(CCCOc3ccc4CCC(=O)Nc4c3)CC2.OC(=O)C(=O)O,Ki,=,4.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,B,4.8
10822,CHEMBL1813597,COc1ccccc1N2CCN(CCCOc3ccc4C=CC(=O)Nc4c3)CC2.OC(=O)C(=O)O,Ki,=,2.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,B,2.6
10823,CHEMBL1813598,COc1ccccc1N2CCN(CCCCCOc3ccc4CCC(=O)Nc4c3)CC2.OC(=O)C(=O)O,Ki,=,7.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,B,7.3
10824,CHEMBL1813599,COc1ccccc1N2CCN(CCCCCOc3ccc4C=CC(=O)Nc4c3)CC2.OC(=O)C(=O)O,Ki,=,7.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,B,7.4
10846,CHEMBL1834258,C(CCc1ccccc1)CN2CCN(Cc3oc4ccccc4c3)CC2,Ki,=,89.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,B,89.0
10876,CHEMBL1909072,NC(=O)C1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1,IC50,=,4.05,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,2.025
10877,CHEMBL1909072,NC(=O)C1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1,Ki,=,1.35,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,1.35
10888,CHEMBL1916548,CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(CN5CCN(CC5)c6ccccc6OC)cc4OC)nn3)nn2)c(OC)c1)C7Cc8ccccc8C7,Ki,=,8.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,B,8.8
10889,CHEMBL1916548,CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(CN5CCN(CC5)c6ccccc6OC)cc4OC)nn3)nn2)c(OC)c1)C7Cc8ccccc8C7,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,B,14.0
10895,CHEMBL1916549,CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(cc4OC)C(=O)NCCCCN(CCC)C5Cc6ccccc6C5)nn3)nn2)c(OC)c1)C7Cc8ccccc8C7,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,B,16.0
10896,CHEMBL1916549,CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(cc4OC)C(=O)NCCCCN(CCC)C5Cc6ccccc6C5)nn3)nn2)c(OC)c1)C7Cc8ccccc8C7,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,B,16.0
10902,CHEMBL1916551,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)C3Cc4ccccc4C3)nn1,EC50,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at DRD2 Long receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation by bioluminescence assay,F,6.5
10904,CHEMBL1916551,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)C3Cc4ccccc4C3)nn1,Ki,=,4.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,B,4.1
10905,CHEMBL1916551,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)C3Cc4ccccc4C3)nn1,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,B,12.0
10908,CHEMBL1916552,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN3CCN(CC3)c4ccccc4OC)nn1,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,B,12.0
10909,CHEMBL1916552,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN3CCN(CC3)c4ccccc4OC)nn1,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,B,17.0
10911,CHEMBL1916720,CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(cc4OC)C(=O)NCCCCN5CCN(CC5)c6ccccc6OC)nn3)nn2)c(OC)c1)C7Cc8ccccc8C7,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,B,17.0
10912,CHEMBL1916720,CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(cc4OC)C(=O)NCCCCN5CCN(CC5)c6ccccc6OC)nn3)nn2)c(OC)c1)C7Cc8ccccc8C7,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,B,25.0
10925,CHEMBL1928120,CCOCCOc1cccc(c1)C(=O)NCCCCN2CCN(CC2)c3ccccc3OC,Ki,=,95.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,95.0
10926,CHEMBL1928120,CCOCCOc1cccc(c1)C(=O)NCCCCN2CCN(CC2)c3ccccc3OC,Ki,=,44.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,44.0
10927,CHEMBL1928121,COc1ccccc1N2CCN(CCCNC(=O)c3cccc(OCCOCCOCCOCCOc4cccc(c4)C(=O)NCCCN5CCN(CC5)c6ccccc6OC)c3)CC2,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,16.0
10928,CHEMBL1928121,COc1ccccc1N2CCN(CCCNC(=O)c3cccc(OCCOCCOCCOCCOc4cccc(c4)C(=O)NCCCN5CCN(CC5)c6ccccc6OC)c3)CC2,Ki,=,6.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,6.4
10929,CHEMBL1928122,COc1ccccc1N2CCN(CCCCNC(=O)c3cccc(OCCOCCOCCOCCOc4cccc(c4)C(=O)NCCCCN5CCN(CC5)c6ccccc6OC)c3)CC2,Ki,=,6.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,6.6
10930,CHEMBL1928122,COc1ccccc1N2CCN(CCCCNC(=O)c3cccc(OCCOCCOCCOCCOc4cccc(c4)C(=O)NCCCCN5CCN(CC5)c6ccccc6OC)c3)CC2,Ki,=,1.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,1.8
10934,CHEMBL1928124,CCOCCOCc1ccc(cc1)C(=O)NCCCCN2CCN(CC2)c3ccccc3OC,Ki,=,83.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,83.0
10935,CHEMBL1928125,COc1ccccc1N2CCN(CCCNC(=O)c3ccc(COCCOCCOCCOCCOCc4ccc(cc4)C(=O)NCCCN5CCN(CC5)c6ccccc6OC)cc3)CC2,Ki,=,42.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,42.0
10936,CHEMBL1928125,COc1ccccc1N2CCN(CCCNC(=O)c3ccc(COCCOCCOCCOCCOCc4ccc(cc4)C(=O)NCCCN5CCN(CC5)c6ccccc6OC)cc3)CC2,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,19.0
10937,CHEMBL1928126,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(COCCOCCOCCOCCOCc4ccc(cc4)C(=O)NCCCCN5CCN(CC5)c6ccccc6OC)cc3)CC2,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,25.0
10938,CHEMBL1928126,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(COCCOCCOCCOCCOCc4ccc(cc4)C(=O)NCCCCN5CCN(CC5)c6ccccc6OC)cc3)CC2,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,11.0
10939,CHEMBL1928127,COc1ccccc1N2CCN(CCCNC(=O)c3ccc(COCCOCCOCCOCCOCCOCc4ccc(cc4)C(=O)NCCCN5CCN(CC5)c6ccccc6OC)cc3)CC2,Ki,=,47.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,47.0
10940,CHEMBL1928127,COc1ccccc1N2CCN(CCCNC(=O)c3ccc(COCCOCCOCCOCCOCCOCc4ccc(cc4)C(=O)NCCCN5CCN(CC5)c6ccccc6OC)cc3)CC2,Ki,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,32.0
10941,CHEMBL1928128,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(COCCOCCOCCOCCOCCOCc4ccc(cc4)C(=O)NCCCCN5CCN(CC5)c6ccccc6OC)cc3)CC2,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,20.0
10942,CHEMBL1928128,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(COCCOCCOCCOCCOCCOCc4ccc(cc4)C(=O)NCCCCN5CCN(CC5)c6ccccc6OC)cc3)CC2,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,14.0
10943,CHEMBL1928129,COc1ccccc1N2CCN(CCCNC(=O)c3ccc(COCCOCCOCCOCCOCCOCCOCc4ccc(cc4)C(=O)NCCCN5CCN(CC5)c6ccccc6OC)cc3)CC2,Ki,=,51.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,51.0
10944,CHEMBL1928129,COc1ccccc1N2CCN(CCCNC(=O)c3ccc(COCCOCCOCCOCCOCCOCCOCc4ccc(cc4)C(=O)NCCCN5CCN(CC5)c6ccccc6OC)cc3)CC2,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,20.0
10945,CHEMBL1928130,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(COCCOCCOCCOCCOCCOCCOCc4ccc(cc4)C(=O)NCCCCN5CCN(CC5)c6ccccc6OC)cc3)CC2,Ki,=,40.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,40.0
10946,CHEMBL1928130,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(COCCOCCOCCOCCOCCOCCOCc4ccc(cc4)C(=O)NCCCCN5CCN(CC5)c6ccccc6OC)cc3)CC2,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,25.0
10948,CHEMBL1928131,COc1ccccc1N2CCN(CCCNC(=O)c3ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc4ccc(cc4)C(=O)NCCCN5CCN(CC5)c6ccccc6OC)cc3)CC2,Ki,=,66.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,66.0
10949,CHEMBL1928132,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc4ccc(cc4)C(=O)NCCCCN5CCN(CC5)c6ccccc6OC)cc3)CC2,Ki,=,38.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,38.0
10950,CHEMBL1928132,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc4ccc(cc4)C(=O)NCCCCN5CCN(CC5)c6ccccc6OC)cc3)CC2,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,16.0
10951,CHEMBL1928133,CCOCCOc1ccn2ncc(C(=O)NCCCN3CCN(CC3)c4ccccc4OC)c2c1,Ki,=,29.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,29.0
10952,CHEMBL1928133,CCOCCOc1ccn2ncc(C(=O)NCCCN3CCN(CC3)c4ccccc4OC)c2c1,Ki,=,6.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,6.4
10953,CHEMBL1928134,CCOCCOc1ccn2ncc(C(=O)NCCCCN3CCN(CC3)c4ccccc4OC)c2c1,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,18.0
10954,CHEMBL1928134,CCOCCOc1ccn2ncc(C(=O)NCCCCN3CCN(CC3)c4ccccc4OC)c2c1,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,3.0
10955,CHEMBL1928135,CCOCCOCc1ccn2ncc(C(=O)NCCCN3CCN(CC3)c4ccccc4OC)c2c1,Ki,=,67.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,67.0
10956,CHEMBL1928135,CCOCCOCc1ccn2ncc(C(=O)NCCCN3CCN(CC3)c4ccccc4OC)c2c1,Ki,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,32.0
10957,CHEMBL1928136,CCOCCOCc1ccn2ncc(C(=O)NCCCCN3CCN(CC3)c4ccccc4OC)c2c1,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,25.0
10958,CHEMBL1928136,CCOCCOCc1ccn2ncc(C(=O)NCCCCN3CCN(CC3)c4ccccc4OC)c2c1,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,12.0
10959,CHEMBL1926700,COc1ccccc1N2CCN(CCCNC(=O)c3cnn4ccc(OCCOCCOCCOCCOc5ccn6ncc(C(=O)NCCCN7CCN(CC7)c8ccccc8OC)c6c5)cc34)CC2,Ki,=,8.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,8.4
10960,CHEMBL1926700,COc1ccccc1N2CCN(CCCNC(=O)c3cnn4ccc(OCCOCCOCCOCCOc5ccn6ncc(C(=O)NCCCN7CCN(CC7)c8ccccc8OC)c6c5)cc34)CC2,Ki,=,2.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,2.7
10961,CHEMBL1928137,COc1ccccc1N2CCN(CCCCNC(=O)c3cnn4ccc(OCCOCCOCCOCCOc5ccn6ncc(C(=O)NCCCCN7CCN(CC7)c8ccccc8OC)c6c5)cc34)CC2,Ki,=,1.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,1.8
10962,CHEMBL1928137,COc1ccccc1N2CCN(CCCCNC(=O)c3cnn4ccc(OCCOCCOCCOCCOc5ccn6ncc(C(=O)NCCCCN7CCN(CC7)c8ccccc8OC)c6c5)cc34)CC2,Ki,=,0.59,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,0.59
10963,CHEMBL1928138,COc1ccccc1N2CCN(CCCNC(=O)c3cnn4ccc(COCCOCCOCCOCCOCc5ccn6ncc(C(=O)NCCCN7CCN(CC7)c8ccccc8OC)c6c5)cc34)CC2,Ki,=,4.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,4.7
10964,CHEMBL1928138,COc1ccccc1N2CCN(CCCNC(=O)c3cnn4ccc(COCCOCCOCCOCCOCc5ccn6ncc(C(=O)NCCCN7CCN(CC7)c8ccccc8OC)c6c5)cc34)CC2,Ki,=,3.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,3.9
10965,CHEMBL1928139,COc1ccccc1N2CCN(CCCCNC(=O)c3cnn4ccc(COCCOCCOCCOCCOCc5ccn6ncc(C(=O)NCCCCN7CCN(CC7)c8ccccc8OC)c6c5)cc34)CC2,Ki,=,8.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,8.3
10966,CHEMBL1928139,COc1ccccc1N2CCN(CCCCNC(=O)c3cnn4ccc(COCCOCCOCCOCCOCc5ccn6ncc(C(=O)NCCCCN7CCN(CC7)c8ccccc8OC)c6c5)cc34)CC2,Ki,=,4.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,4.6
10974,CHEMBL1940402,OC1(CCN(CCCCc2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,24.0
10975,CHEMBL1940402,OC1(CCN(CCCCc2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,24.0
10976,CHEMBL1940403,OC1(CCN(CCCSc2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,8.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,8.8
10977,CHEMBL1940403,OC1(CCN(CCCSc2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,5.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,5.3
10978,CHEMBL1940404,OC1(CCN(CCCOc2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,5.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,5.3
10979,CHEMBL1940404,OC1(CCN(CCCOc2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,8.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,8.8
10981,CHEMBL1940406,Fc1ccc(OCCCN2CCC(CC2)c3ccc(Cl)cc3)cc1,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,41.0
10982,CHEMBL1940406,Fc1ccc(OCCCN2CCC(CC2)c3ccc(Cl)cc3)cc1,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,41.0
10991,CHEMBL1940412,Fc1ccc(OCCCN2CCN(CC2)c3ccccc3)cc1,Ki,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,37.0
11038,CHEMBL1945296,O[C@@H](CNCCCc1cccc(CNCCc2c(Cl)cccc2Cl)c1)c3ccc(O)c4NC(=O)Sc34,IC50,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,39.715
11039,CHEMBL1945297,CC(Cc1cccc(CNCCc2c(Cl)cccc2Cl)c1)NC[C@H](O)c3ccc(O)c4NC(=O)Sc34,IC50,=,125.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,62.945
11045,CHEMBL1946122,OC1(C[C@H]2CC[C@@H](C1)N2CCCOc3ccc(F)cc3)c4ccc(Cl)cc4,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,B,22.0
11046,CHEMBL1946123,OC1(C[C@H]2CC[C@@H](C1)N2CCCCc3ccc(F)cc3)c4ccc(Cl)cc4,Ki,=,33.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,B,33.0
11061,CHEMBL1946745,OC1(C[C@H]2CC[C@@H](C1)N2CCCCc3nc4ccccc4s3)c5ccc(Cl)cc5,Ki,=,44.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,B,44.0
11063,CHEMBL1949725,C[C@H]1Cc2c(Cc3ccccc3CCN1C)[nH]c4ccccc24,Ki,=,85.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in human HEK293 cells,B,85.3
11117,CHEMBL2016625,CCCCCCCCCC(=O)NCCCN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,8.913,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,B,8.913
11120,CHEMBL2016625,CCCCCCCCCC(=O)NCCCN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Ki,=,9.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,B,9.1
11121,CHEMBL2016626,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(CCCNC(=O)CCCCC(=O)NCCCN5CCN(CC5)C6=Nc7cc(Cl)ccc7Nc8ccccc68)CC4,Ki,=,3.162,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,B,3.162
11122,CHEMBL2016626,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(CCCNC(=O)CCCCC(=O)NCCCN5CCN(CC5)C6=Nc7cc(Cl)ccc7Nc8ccccc68)CC4,IC50,=,87.1,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,43.55
11123,CHEMBL2016626,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(CCCNC(=O)CCCCC(=O)NCCCN5CCN(CC5)C6=Nc7cc(Cl)ccc7Nc8ccccc68)CC4,IC50,=,87.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,43.5
11124,CHEMBL2016626,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(CCCNC(=O)CCCCC(=O)NCCCN5CCN(CC5)C6=Nc7cc(Cl)ccc7Nc8ccccc68)CC4,Ki,=,3.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,B,3.6
11126,CHEMBL2016627,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(CCCNC(=O)CCCCCCC(=O)NCCCN5CCN(CC5)C6=Nc7cc(Cl)ccc7Nc8ccccc68)CC4,Ki,=,1.349,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,B,1.349
11127,CHEMBL2016627,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(CCCNC(=O)CCCCCCC(=O)NCCCN5CCN(CC5)C6=Nc7cc(Cl)ccc7Nc8ccccc68)CC4,IC50,=,23.44,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,11.72
11128,CHEMBL2016627,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(CCCNC(=O)CCCCCCC(=O)NCCCN5CCN(CC5)C6=Nc7cc(Cl)ccc7Nc8ccccc68)CC4,IC50,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,11.5
11129,CHEMBL2016627,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(CCCNC(=O)CCCCCCC(=O)NCCCN5CCN(CC5)C6=Nc7cc(Cl)ccc7Nc8ccccc68)CC4,Ki,=,1.41,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,B,1.41
11131,CHEMBL2016628,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(CCCNC(=O)CCCCCCCCC(=O)NCCCN5CCN(CC5)C6=Nc7cc(Cl)ccc7Nc8ccccc68)CC4,Ki,=,1.23,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,B,1.23
11132,CHEMBL2016628,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(CCCNC(=O)CCCCCCCCC(=O)NCCCN5CCN(CC5)C6=Nc7cc(Cl)ccc7Nc8ccccc68)CC4,IC50,=,44.67,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,22.335
11133,CHEMBL2016628,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(CCCNC(=O)CCCCCCCCC(=O)NCCCN5CCN(CC5)C6=Nc7cc(Cl)ccc7Nc8ccccc68)CC4,IC50,=,44.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,22.0
11134,CHEMBL2016628,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(CCCNC(=O)CCCCCCCCC(=O)NCCCN5CCN(CC5)C6=Nc7cc(Cl)ccc7Nc8ccccc68)CC4,Ki,=,1.35,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,B,1.35
11149,CHEMBL2021538,Cl.CCCN[C@H]1CCc2c(CS(=O)(=O)C(F)(F)F)cccc2C1,Ki,=,8.7,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards Dopamine receptor D2 by using [3H]U-86170 as radioligand,B,8.7
11151,CHEMBL2021539,Cl.CCCN[C@@H]1CCc2cccc(CS(=O)(=O)C(F)(F)F)c2C1,Ki,=,69.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards Dopamine receptor D2 by using [3H]U-86170 as radioligand,B,69.0
11155,CHEMBL2024517,Cl.CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,Ki,=,5.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor,B,5.7
11156,CHEMBL2024517,Cl.CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,Ki,=,0.81,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2S receptor,B,0.81
11159,CHEMBL2028019,CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,Ki,=,17.78,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,B,17.78
11160,CHEMBL2028019,CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,Ki,=,0.47,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,0.47
11161,CHEMBL2028019,CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,Ki,=,0.41,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,0.41
11163,CHEMBL2028019,CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,EC50,=,112.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells co-expressing Galphai2 after 30 mins by [35S]GTPgammaS binding assay,F,56.1
11164,CHEMBL2028019,CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,EC50,=,110.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells co-expressing Galphai2 after 30 mins by [35S]GTPgammaS binding assay,F,55.0
11166,CHEMBL2028019,CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,IC50,=,1.66,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,0.83
11167,CHEMBL2028019,CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,IC50,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,0.85
11169,CHEMBL2028019,CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,EC50,=,3.467,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,1.7335
11171,CHEMBL2028019,CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,Ki,=,1.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,1.3
11172,CHEMBL2028019,CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,Ki,=,0.49,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,B,0.49
11173,CHEMBL2028019,CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,Ki,=,0.69,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human D2S receptor expressed in CHO cells,B,0.69
11181,CHEMBL2028019,CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,Ki,=,0.47,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2-long receptor expressed in CHO cell membranes,B,0.47
11182,CHEMBL2028019,CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,Ki,=,0.41,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2-short receptor expressed in CHO cell membranes,B,0.41
11184,CHEMBL2029916,O=C(Cc1ccccn1)Nc2ccc(CCN3CCN(CC3)c4ccccc4)cc2,Ki,=,70.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,B,70.7
11185,CHEMBL2029917,O=C(Cc1cccnc1)Nc2ccc(CCN3CCN(CC3)c4ccccc4)cc2,Ki,=,69.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,B,69.6
11186,CHEMBL2029918,O=C(Cc1ccncc1)Nc2ccc(CCN3CCN(CC3)c4ccccc4)cc2,Ki,=,48.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,B,48.6
11188,CHEMBL2029920,O=C(Nc1ccc(CCN2CCN(CC2)c3ccccc3)cc1)Nc4ccccn4,Ki,=,14.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,B,14.2
11189,CHEMBL2029921,O=C(Nc1ccc(CCN2CCN(CC2)c3ccccc3)cc1)Nc4cccnc4,Ki,=,8.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,B,8.2
11190,CHEMBL2029922,O=C(Nc1ccncc1)Nc2ccc(CCN3CCN(CC3)c4ccccc4)cc2,Ki,=,3.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,B,3.6
11193,CHEMBL2029925,O=C(Cc1cccnc1)Nc2cccc(CCN3CCN(CC3)c4ccccc4)c2,Ki,=,82.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,B,82.4
11197,CHEMBL2029929,O=C(Nc1cccnc1)Nc2cccc(CCN3CCN(CC3)c4ccccc4)c2,Ki,=,29.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,B,29.7
11198,CHEMBL2029930,O=C(Nc1ccncc1)Nc2cccc(CCN3CCN(CC3)c4ccccc4)c2,Ki,=,48.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,B,48.7
11236,CHEMBL2037521,C(CCc1nc2ccccc2s1)CN3CCN(CC3)c4ncccn4,Ki,=,26.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,26.5
11237,CHEMBL2037521,C(CCc1nc2ccccc2s1)CN3CCN(CC3)c4ncccn4,Ki,=,26.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,26.5
11238,CHEMBL2037522,C(CCc1nc2ccccc2s1)CN3CCc4ccccc4C3,Ki,=,30.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,30.8
11242,CHEMBL2037526,O=C(CCCCN1CCC2(CC1)N(CNC2=O)c3ccccc3)c4nc5ccccc5s4,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,25.0
11243,CHEMBL2037526,O=C(CCCCN1CCC2(CC1)N(CNC2=O)c3ccccc3)c4nc5ccccc5s4,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,B,25.0
11244,CHEMBL2037526,O=C(CCCCN1CCC2(CC1)N(CNC2=O)c3ccccc3)c4nc5ccccc5s4,Ki,=,25.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,B,25.7
11308,CHEMBL2059304,O=C1Nc2ccccc2N1C3CCN(CCOc4ccccc4)CC3,Ki,=,5.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,5.5
11309,CHEMBL2059305,O=C1CCc2ccccc2N1CCCN3CCC(CC3)c4ccc5[nH]ccc5c4,Ki,=,42.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,42.0
11310,CHEMBL2059306,O=C1CCc2ccccc2N1CCCN3CCC(CC3)N4C(=O)Nc5ccccc45,Ki,=,9.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,9.5
11315,CHEMBL2059311,O=C1COc2ccccc2N1CCCN3CCC(CC3)N4C(=O)Nc5ccccc45,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,16.0
11316,CHEMBL2059312,O=C1CCc2ccccc2N1OCCN3CCC(CC3)N4C(=O)Nc5ccccc45,Ki,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,55.0
11321,CHEMBL2059317,Fc1cccc2N(CCCN3CCC(CC3)N4C(=O)Nc5ccccc45)C(=O)CCc12,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,60.0
11322,CHEMBL2059318,Fc1ccc2N(CCCN3CCC(CC3)N4C(=O)Nc5ccccc45)C(=O)CCc2c1,Ki,=,6.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,6.5
11323,CHEMBL2059319,Fc1ccc2CCC(=O)N(CCCN3CCC(CC3)N4C(=O)Nc5ccccc45)c2c1,Ki,=,90.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,90.0
11324,CHEMBL2059320,Fc1cccc2CCC(=O)N(CCCN3CCC(CC3)N4C(=O)Nc5ccccc45)c12,Ki,=,95.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,95.0
11325,CHEMBL2059321,Fc1cccc2NC(=O)N(C3CCN(CCCN4C(=O)COc5ccccc45)CC3)c12,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,41.0
11326,CHEMBL2059322,Fc1ccc2NC(=O)N(C3CCN(CCCN4C(=O)COc5ccccc45)CC3)c2c1,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,14.0
11327,CHEMBL2059323,Fc1ccc2N(C3CCN(CCCN4C(=O)COc5ccccc45)CC3)C(=O)Nc2c1,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,2.5
11328,CHEMBL2059324,Fc1cccc2N(C3CCN(CCCN4C(=O)COc5ccccc45)CC3)C(=O)Nc12,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,15.0
11347,CHEMBL2092940,CCCN(CCc1ccc(C)cc1)[C@H]2CCc3c(O)cccc3C2,Ki,=,6.7,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,B,6.7
11348,CHEMBL2092961,Br.Cc1ccc(N2CCN(CC3CC3c4ccccc4)CC2)c(C)c1,IC50,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,30.0
11351,CHEMBL2094011,Fc1ccc2[nH]c3CCC(CCN4CCN(CC4)c5cccc6NC(=O)Cc56)Cc3c2c1,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from D2 receptor,B,15.0
11362,CHEMBL2106804,Cl.CCCN1CCO[C@H]2[C@H]1CCc3ccc(O)cc23,Ki,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to high-affinity state of D2L receptor (unknown origin),B,1.5
11363,CHEMBL2106804,Cl.CCCN1CCO[C@H]2[C@H]1CCc3ccc(O)cc23,Ki,=,18.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,18.7
11364,CHEMBL2106804,Cl.CCCN1CCO[C@H]2[C@H]1CCc3ccc(O)cc23,Ki,=,21.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,21.4
11365,CHEMBL2106804,Cl.CCCN1CCO[C@H]2[C@H]1CCc3ccc(O)cc23,Ki,=,0.45,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,0.45
11366,CHEMBL2106804,Cl.CCCN1CCO[C@H]2[C@H]1CCc3ccc(O)cc23,Ki,=,16.98,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,16.98
11367,CHEMBL2106804,Cl.CCCN1CCO[C@H]2[C@H]1CCc3ccc(O)cc23,Ki,=,20.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,20.89
11368,CHEMBL2106804,Cl.CCCN1CCO[C@H]2[C@H]1CCc3ccc(O)cc23,Ki,=,0.3388,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,0.3388
11384,CHEMBL2111528,COc1ccc(Br)cc1c2nc(CNCC3CCN(Cc4ccccc4)C3)cs2,Ki,=,92.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,B,92.0
11391,CHEMBL2112210,Nc1ccc(cc1)c2ccc(cc2)C(=O)NCCCCN3C[C@@H]4COc5ccc(cc5[C@H]4C3)C#N,Ki,=,19.95,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,B,19.95
11400,CHEMBL2112882,CC(C)C[C@@H]1N2C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@@H]4Cc5c[nH]c6cccc(C4=C3)c56)O[C@@]2(O)[C@H](Cc7ccccc7)NC1=O,Ki,=,3.162,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2 in CHO cells using [125I]iodosulpiride,B,3.162
11405,CHEMBL2112912,C(Cc1c[nH]c2ncccc12)N3CCC(=CC3)c4ccccc4,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,B,21.0
11419,CHEMBL2113356,Cl.COc1ccc(\C=C\C(=O)N[C@@H]2CC[C@@H](CCN3CCc4ccc(OS(=O)(=O)C)cc4CC3)CC2)cc1,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,B,31.62
11423,CHEMBL2113364,Cl.CS(=O)(=O)Oc1ccc2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)\C=C\c4ccc(F)cc4)CCc2c1,Ki,=,63.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,B,63.1
11428,CHEMBL2114337,CCCN1CCC2Cc3c(O)cccc3CC12,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",F,11.0
11433,CHEMBL2152633,CCCN(CCN1CCN(CC1)c2ccc3[nH]ccc3c2)[C@H]4CCc5nc(N)sc5C4,EC50,=,2.96,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human cloned dopamine D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,1.48
11436,CHEMBL2152746,CCCN(CCN1CCN(CC1)C(=O)c2cc3ccccc3[nH]2)C4CCc5nc(N)sc5C4,EC50,=,114.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting analysis,F,57.0
11437,CHEMBL2152747,CCCN(CCN1CCN(CC1)C(=O)c2cc3ccccc3[nH]2)[C@H]4CCc5nc(N)sc5C4,EC50,=,114.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human cloned dopamine D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,57.0
11439,CHEMBL2152752,CCCN(CCN1CCN(CC1)C(=O)c2c[nH]c3ccccc23)[C@H]4CCc5nc(N)sc5C4,EC50,=,86.4,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human cloned dopamine D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,43.2
11441,CHEMBL2152755,CCCN(CCN1CCN(CC1)C(=O)c2ccc3[nH]ccc3c2)[C@H]4CCc5nc(N)sc5C4,EC50,=,70.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human cloned dopamine D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,35.35
11446,CHEMBL2159455,Clc1ccc(s1)S(=O)(=O)NCC2CCN(CCOc3ccccc3c4ccccc4)CC2,Ki,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,32.0
11448,CHEMBL2159457,CC(C)c1ccccc1OCCN2CCC(CNS(=O)(=O)c3ccc(F)cc3)CC2,Ki,=,50.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,50.0
11449,CHEMBL2159458,Fc1ccc(cc1)S(=O)(=O)NCC2CCN(CCOc3ccccc3c4ccccc4)CC2,Ki,=,46.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,46.0
11451,CHEMBL2159460,CC(C)c1ccccc1OCCN2CCC(CNS(=O)(=O)c3cccc(Cl)c3)CC2,Ki,=,66.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,66.0
11452,CHEMBL2159461,CSc1ccccc1OCCN2CCC(CNS(=O)(=O)c3cccc(Cl)c3)CC2,Ki,=,50.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,50.0
11454,CHEMBL2159463,CCOc1ccccc1C(=O)NC2CCN(CCOc3cccc(F)c3)CC2,Ki,=,76.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,76.0
11455,CHEMBL2159464,O=S(=O)(NC1CCN(CCOc2ccccc2)CC1)c3cccs3,Ki,=,84.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,84.0
11456,CHEMBL2159465,CC(C)c1ccccc1OCCN2CCC(CC2)NS(=O)(=O)c3ccc(F)cc3,Ki,=,51.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,51.0
11457,CHEMBL2159466,Fc1ccc(cc1F)S(=O)(=O)NC2CCN(CCOc3ccccc3c4ccccc4)CC2,Ki,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,63.0
11458,CHEMBL2159466,Fc1ccc(cc1F)S(=O)(=O)NC2CCN(CCOc3ccccc3c4ccccc4)CC2,Ki,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr by microplate reader based assay,B,63.0
11459,CHEMBL2159467,Fc1cccc(C(=O)NC2CCN(CCOc3ccccc3c4ccccc4)C2)c1F,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,15.0
11460,CHEMBL2159468,CC(C)c1ccccc1OCCN2CCC(C2)NC(=O)c3ccc4ccccc4n3,Ki,=,79.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,79.0
11461,CHEMBL2159469,O=C(NC1CCN(CCOc2ccccc2c3ccccc3)C1)c4ccc5ccccc5n4,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,24.0
11462,CHEMBL2159470,CC(C)c1ccccc1OCCN2CCC(C2)NS(=O)(=O)c3cccs3,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,16.0
11463,CHEMBL2159471,O=S(=O)(NC1CCN(CCOc2ccccc2c3ccccc3)C1)c4cccs4,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,16.0
11464,CHEMBL2159472,O=S(=O)(NC1CCN(CCOc2cccc3CCCCc23)C1)c4cccs4,Ki,=,72.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,72.0
11466,CHEMBL2159474,Clc1ccc(s1)S(=O)(=O)NC2CCN(CCOc3cccc(Cl)c3Cl)C2,Ki,=,67.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,67.0
11467,CHEMBL2159475,Clc1ccc(Cl)c(OCCN2CCC(C2)NS(=O)(=O)c3ccc(Cl)s3)c1,Ki,=,78.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,78.0
11469,CHEMBL2159477,CC(C)c1ccccc1OCCN2CCC(C2)NS(=O)(=O)c3cccc4cccnc34,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,10.0
11470,CHEMBL2159478,CSc1ccccc1OCCN2CCC(C2)NS(=O)(=O)c3ccc(F)cc3,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,41.0
11471,CHEMBL2159479,Fc1ccc(cc1)S(=O)(=O)NC2CCN(CCOc3ccccc3)C2,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,11.0
11472,CHEMBL2159480,Fc1ccc(cc1)S(=O)(=O)NC2CCN(CCOc3cccc4CCCCc34)C2,Ki,=,72.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,72.0
11473,CHEMBL2159481,Fc1ccc(cc1F)S(=O)(=O)NC2CCN(CCOc3ccccc3c4ccccc4)C2,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,24.0
11475,CHEMBL2159483,Fc1ccc(F)c(c1)S(=O)(=O)NC2CCN(CCOc3ccccc3c4ccccc4)C2,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,18.0
11476,CHEMBL2159484,Fc1ccc(F)c(c1)S(=O)(=O)NC2CCN(CCOc3cccc4CCCCc34)C2,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,60.0
11477,CHEMBL2159485,CC(C)c1ccccc1OCCN2CCC(C2)NS(=O)(=O)c3cccc(Cl)c3,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,25.0
11478,CHEMBL2159486,CSc1ccccc1OCCN2CCC(C2)NS(=O)(=O)c3cccc(Cl)c3,Ki,=,36.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,36.0
11479,CHEMBL2159487,CC(C)c1ccccc1OCCN2CC[C@H](C2)NS(=O)(=O)c3ccc(Cl)s3,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,20.0
11480,CHEMBL2159488,Clc1ccc(s1)S(=O)(=O)N[C@@H]2CCN(CCOc3ccccc3c4ccccc4)C2,Ki,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,39.0
11481,CHEMBL2159489,Fc1ccc(cc1)S(=O)(=O)N[C@@H]2CCN(CCOc3ccccc3c4ccccc4)C2,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,16.0
11482,CHEMBL2159490,CC(C)c1ccccc1OCCN2CC[C@@H](C2)NS(=O)(=O)c3ccc(Cl)s3,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,25.0
11483,CHEMBL2159491,Clc1ccc(s1)S(=O)(=O)N[C@H]2CCN(CCOc3ccccc3c4ccccc4)C2,Ki,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,8.0
11484,CHEMBL2159492,Fc1ccc(cc1)S(=O)(=O)N[C@H]2CCN(CCOc3ccccc3c4ccccc4)C2,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,10.0
11493,CHEMBL2165114,Clc1cccc(N2CCCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,EC50,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,12.5
11495,CHEMBL2165114,Clc1cccc(N2CCCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,18.0
11496,CHEMBL2165114,Clc1cccc(N2CCCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,18.0
11497,CHEMBL2165114,Clc1cccc(N2CCCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,EC50,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,11.5
11500,CHEMBL2165115,Clc1cccc(C2CCN(CCCCOc3ccc4NC(=O)Nc4c3)CC2)c1Cl,EC50,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,10.0
11502,CHEMBL2165115,Clc1cccc(C2CCN(CCCCOc3ccc4NC(=O)Nc4c3)CC2)c1Cl,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,11.0
11503,CHEMBL2165115,Clc1cccc(C2CCN(CCCCOc3ccc4NC(=O)Nc4c3)CC2)c1Cl,Ki,=,10.9,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,10.9
11504,CHEMBL2165115,Clc1cccc(C2CCN(CCCCOc3ccc4NC(=O)Nc4c3)CC2)c1Cl,EC50,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,12.5
11511,CHEMBL2165116,Clc1cccc(N2CCN(CCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,EC50,=,9.7,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,4.85
11512,CHEMBL2165116,Clc1cccc(N2CCN(CCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,EC50,=,59.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,29.5
11515,CHEMBL2165117,Clc1cccc(N2CCN(CCCOc3ccc4CCNC(=O)c4c3)CC2)c1Cl,EC50,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,10.0
11517,CHEMBL2165117,Clc1cccc(N2CCN(CCCOc3ccc4CCNC(=O)c4c3)CC2)c1Cl,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,18.0
11518,CHEMBL2165117,Clc1cccc(N2CCN(CCCOc3ccc4CCNC(=O)c4c3)CC2)c1Cl,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,18.0
11519,CHEMBL2165117,Clc1cccc(N2CCN(CCCOc3ccc4CCNC(=O)c4c3)CC2)c1Cl,EC50,=,30.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,15.0
11522,CHEMBL2165118,Clc1cccc(N2CCCN(CCCOc3ccc4CCNC(=O)c4c3)CC2)c1Cl,EC50,=,6.3,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,3.15
11524,CHEMBL2165118,Clc1cccc(N2CCCN(CCCOc3ccc4CCNC(=O)c4c3)CC2)c1Cl,Ki,=,5.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,5.7
11525,CHEMBL2165118,Clc1cccc(N2CCCN(CCCOc3ccc4CCNC(=O)c4c3)CC2)c1Cl,Ki,=,5.7,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,5.7
11526,CHEMBL2165118,Clc1cccc(N2CCCN(CCCOc3ccc4CCNC(=O)c4c3)CC2)c1Cl,EC50,=,5.6,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,2.8
11527,CHEMBL2165118,Clc1cccc(N2CCCN(CCCOc3ccc4CCNC(=O)c4c3)CC2)c1Cl,EC50,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,4.0
11530,CHEMBL2165119,Clc1cccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2)c1Cl,EC50,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,0.8
11532,CHEMBL2165119,Clc1cccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2)c1Cl,Ki,=,1.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,1.2
11533,CHEMBL2165119,Clc1cccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2)c1Cl,Ki,=,1.2,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,1.2
11534,CHEMBL2165119,Clc1cccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2)c1Cl,EC50,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,6.5
11535,CHEMBL2165119,Clc1cccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2)c1Cl,EC50,=,3.3,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,1.65
11536,CHEMBL2165119,Clc1cccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2)c1Cl,Ki,=,2.6,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,2.6
11539,CHEMBL2165120,Clc1cccc(N2CCCN(CCCCOc3ccc4C=CC(=O)Nc4c3)CC2)c1Cl,EC50,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,1.25
11541,CHEMBL2165120,Clc1cccc(N2CCCN(CCCCOc3ccc4C=CC(=O)Nc4c3)CC2)c1Cl,Ki,=,3.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,3.4
11542,CHEMBL2165120,Clc1cccc(N2CCCN(CCCCOc3ccc4C=CC(=O)Nc4c3)CC2)c1Cl,Ki,=,3.4,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,3.4
11543,CHEMBL2165120,Clc1cccc(N2CCCN(CCCCOc3ccc4C=CC(=O)Nc4c3)CC2)c1Cl,EC50,=,2.8,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,1.4
11544,CHEMBL2165120,Clc1cccc(N2CCCN(CCCCOc3ccc4C=CC(=O)Nc4c3)CC2)c1Cl,EC50,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,"pERK High-Content Assay: Cell Culture: Chinese Hamster Ovary (CHO) cells stably expressing the hD2L dopamine receptor (Urban et al., Neuropsychopharmacology 32:67 (2007)) were maintained in Ham's F12 medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, 100 ug/mL streptomycin, and 0.5 ug/ml G418. On day 1 of the assay, cells were seeded onto black clear-bottom tissue culture-treated 96-well plates (Greiner, BioOne). On day 2 of the assay, cells were washed with serum-free medium (Ham's F-12, penicillin and streptomycin) and incubated in 100 uL serum-free medium overnight.Immunofluorescence: Automatic multichannel pipetters were used for liquid handling and multichannel vacuum manifolds for aspirations. Each tested concentration was typically measured in triplicate or quadruplicate. For concentration curves, half-log-dilutions were used. Drug dilutions were prepared in stimulation medium (serum-free medium, 100 mg/L ascorbic acid).",B,0.5
11546,CHEMBL2165121,CC(C)Oc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,1.0
11548,CHEMBL2165121,CC(C)Oc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2L receptor expressed in HEK293T cells coexpressing Gi subunit assessed as inhibition of isoproterenol-stimulated cAMP production by luminescence assay,F,12.5
11549,CHEMBL2165121,CC(C)Oc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,Ki,=,3.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,3.1
11551,CHEMBL2165122,FC(F)(F)c1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,1.25
11553,CHEMBL2165122,FC(F)(F)c1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2L receptor expressed in HEK293T cells coexpressing Gi subunit assessed as inhibition of isoproterenol-stimulated cAMP production by luminescence assay,F,12.5
11554,CHEMBL2165122,FC(F)(F)c1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,Ki,=,4.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,4.2
11556,CHEMBL2165123,CCOc1cccc(c1)N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,5.0
11558,CHEMBL2165123,CCOc1cccc(c1)N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,158.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2L receptor expressed in HEK293T cells coexpressing Gi subunit assessed as inhibition of isoproterenol-stimulated cAMP production by luminescence assay,F,79.0
11559,CHEMBL2165123,CCOc1cccc(c1)N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,21.0
11561,CHEMBL2165124,CCOc1ccc(cc1)N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,50.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,25.0
11564,CHEMBL2165124,CCOc1ccc(cc1)N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,Ki,=,53.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,53.0
11566,CHEMBL2165125,Clc1cccc(C2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,1.0
11569,CHEMBL2165125,Clc1cccc(C2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,11.0
11571,CHEMBL2165126,Clc1cccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,1.0
11573,CHEMBL2165126,Clc1cccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,3.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,3.6
11575,CHEMBL2165126,Clc1cccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,3.6,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,3.6
11576,CHEMBL2165126,Clc1cccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,126.0,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,63.0
11577,CHEMBL2165126,Clc1cccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,3.3,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,1.65
11578,CHEMBL2165126,Clc1cccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,5.0
11579,CHEMBL2165126,Clc1cccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,0.53,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,B,0.53
11580,CHEMBL2165126,Clc1cccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,0.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,B,0.2
11588,CHEMBL2165127,Clc1cccc(N2CCN(CCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,79.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,39.5
11591,CHEMBL2165127,Clc1cccc(N2CCN(CCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,21.0
11599,CHEMBL2165129,Clc1cccc(N2CCN(CC#CCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,199.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,99.5
11616,CHEMBL2165131,Clc1cccc(N2CCN(Cc3cccc(Oc4ccc5CCC(=O)Nc5c4)c3)CC2)c1Cl,EC50,=,58.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,29.0
11623,CHEMBL2165132,Clc1cccc(N2CCN(Cc3ccc(Oc4ccc5CCC(=O)Nc5c4)cc3)CC2)c1Cl,EC50,=,5.7,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,2.85
11627,CHEMBL2165133,Clc1cccc(N2CCN(CCCCOc3ccc4CCNC(=O)c4c3)CC2)c1Cl,EC50,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,2.0
11629,CHEMBL2165133,Clc1cccc(N2CCN(CCCCOc3ccc4CCNC(=O)c4c3)CC2)c1Cl,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,18.0
11630,CHEMBL2165133,Clc1cccc(N2CCN(CCCCOc3ccc4CCNC(=O)c4c3)CC2)c1Cl,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,18.0
11632,CHEMBL2165133,Clc1cccc(N2CCN(CCCCOc3ccc4CCNC(=O)c4c3)CC2)c1Cl,EC50,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,9.0
11635,CHEMBL2165134,Clc1cccc(N2CCN(CCCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,EC50,=,100.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,50.0
11637,CHEMBL2165134,Clc1cccc(N2CCN(CCCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,Ki,=,66.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,66.0
11638,CHEMBL2165134,Clc1cccc(N2CCN(CCCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,Ki,=,66.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,66.0
11639,CHEMBL2165134,Clc1cccc(N2CCN(CCCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,EC50,=,5.7,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,2.85
11640,CHEMBL2165134,Clc1cccc(N2CCN(CCCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,EC50,=,92.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,46.0
11643,CHEMBL2165135,Clc1cccc(N2CCN(CCCCOc3ccc4NC(=O)Nc4c3)CC2)c1Cl,EC50,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,8.0
11645,CHEMBL2165135,Clc1cccc(N2CCN(CCCCOc3ccc4NC(=O)Nc4c3)CC2)c1Cl,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,15.0
11646,CHEMBL2165135,Clc1cccc(N2CCN(CCCCOc3ccc4NC(=O)Nc4c3)CC2)c1Cl,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,15.0
11647,CHEMBL2165135,Clc1cccc(N2CCN(CCCCOc3ccc4NC(=O)Nc4c3)CC2)c1Cl,EC50,=,65.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,32.5
11650,CHEMBL2165136,Clc1cccc(N2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,EC50,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,31.5
11652,CHEMBL2165136,Clc1cccc(N2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,17.0
11653,CHEMBL2165136,Clc1cccc(N2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,17.0
11654,CHEMBL2165136,Clc1cccc(N2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,EC50,=,64.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,32.0
11657,CHEMBL2165137,Clc1cccc(C2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,EC50,=,79.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,39.5
11659,CHEMBL2165137,Clc1cccc(C2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,Ki,=,42.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,42.0
11660,CHEMBL2165137,Clc1cccc(C2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,Ki,=,42.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,42.0
11661,CHEMBL2165137,Clc1cccc(C2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,EC50,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,10.5
11662,CHEMBL2165137,Clc1cccc(C2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,EC50,=,82.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,41.0
11665,CHEMBL2165138,Clc1cccc(C2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,EC50,=,50.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,25.0
11667,CHEMBL2165138,Clc1cccc(C2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,Ki,=,75.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,75.0
11668,CHEMBL2165138,Clc1cccc(C2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,Ki,=,75.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,75.0
11669,CHEMBL2165138,Clc1cccc(C2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,EC50,=,100.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,50.0
11670,CHEMBL2165138,Clc1cccc(C2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,EC50,=,50.0,nM,Dopamine D2 receptor,Homo sapiens,"pERK High-Content Assay: Cell Culture: Chinese Hamster Ovary (CHO) cells stably expressing the hD2L dopamine receptor (Urban et al., Neuropsychopharmacology 32:67 (2007)) were maintained in Ham's F12 medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, 100 ug/mL streptomycin, and 0.5 ug/ml G418. On day 1 of the assay, cells were seeded onto black clear-bottom tissue culture-treated 96-well plates (Greiner, BioOne). On day 2 of the assay, cells were washed with serum-free medium (Ham's F-12, penicillin and streptomycin) and incubated in 100 uL serum-free medium overnight.Immunofluorescence: Automatic multichannel pipetters were used for liquid handling and multichannel vacuum manifolds for aspirations. Each tested concentration was typically measured in triplicate or quadruplicate. For concentration curves, half-log-dilutions were used. Drug dilutions were prepared in stimulation medium (serum-free medium, 100 mg/L ascorbic acid).",B,25.0
11673,CHEMBL2165139,Clc1cccc(N2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,EC50,=,126.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,63.0
11675,CHEMBL2165139,Clc1cccc(N2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,Ki,=,30.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,30.0
11676,CHEMBL2165139,Clc1cccc(N2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,Ki,=,30.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,30.0
11677,CHEMBL2165139,Clc1cccc(N2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,EC50,=,9.8,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,4.9
11678,CHEMBL2165139,Clc1cccc(N2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,EC50,=,107.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,53.5
11681,CHEMBL2165140,Clc1cccc(N2CCCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,EC50,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,F,31.5
11683,CHEMBL2165140,Clc1cccc(N2CCCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,20.0
11684,CHEMBL2165140,Clc1cccc(N2CCCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,20.0
11686,CHEMBL2165140,Clc1cccc(N2CCCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,EC50,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,31.5
11696,CHEMBL2165673,CN1CCN(CC1)c2cccc(Cl)c2Cl,Ki,=,45.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,B,45.9
11698,CHEMBL2165675,OCCN1CCN(CC1)c2cccc(Cl)c2Cl,Ki,=,63.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,B,63.7
11699,CHEMBL2165676,CCCN1CCN(CC1)c2cccc(Cl)c2Cl,Ki,=,5.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,B,5.2
11700,CHEMBL2165677,CCCCN1CCN(CC1)c2cccc(Cl)c2Cl,Ki,=,3.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,B,3.4
11701,CHEMBL2165677,CCCCN1CCN(CC1)c2cccc(Cl)c2Cl,Ki,=,3.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,B,3.4
11702,CHEMBL2165678,CCC(=O)NCCCCN1CCN(CC1)c2cccc(Cl)c2Cl,Ki,=,15.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,B,15.6
11703,CHEMBL2165679,CCC(=O)NCCCCN1CCN(CC1)c2ccccc2OC,Ki,=,84.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,B,84.0
11713,CHEMBL2180638,Oc1cccc(CCN(CCc2ccccc2)CC3CC3)c1,EC50,=,181.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as stimulation of mitogenesis incubated for 24 hrs by [3H]thymidine incorporation assay,F,90.5
11725,CHEMBL2204343,O[Si]1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,0.55,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 receptor,B,0.55
11762,CHEMBL2206264,CCCN(CCCCCCCCCN(CCC)[C@H]1CCc2c(O)cccc2C1)[C@H]3CCc4c(O)cccc4C3,EC50,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human cloned dopamine D2 receptor expressed in CHO cells by [35S]GTP gammaS binding assay,F,0.85
11765,CHEMBL2206265,CCCN(CCCCCCCCCCN(CCC)[C@H]1CCc2c(O)cccc2C1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.44,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human cloned dopamine D2 receptor expressed in CHO cells by [35S]GTP gammaS binding assay,F,0.22
11771,CHEMBL2207484,CCCN1CCC(CC1)c2c[nH]c3cc(F)ccc23,Ki,=,43.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,B,43.0
11772,CHEMBL2207484,CCCN1CCC(CC1)c2c[nH]c3cc(F)ccc23,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,B,27.0
11775,CHEMBL2207486,CCCN1CCC(CC1)c2cn(C)c3ccc(F)cc23,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,B,19.0
11776,CHEMBL2207486,CCCN1CCC(CC1)c2cn(C)c3ccc(F)cc23,Ki,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,B,32.0
11777,CHEMBL2207487,CCCN1CCC(CC1)c2csc3ccccc23,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,B,26.0
11781,CHEMBL2207489,CCCN1CCC(CC1)c2noc3cc(F)ccc23,Ki,=,34.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,B,34.0
11795,CHEMBL2207496,CCCN1CCC(CC1)c2cccc3ccccc23,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,B,41.0
11801,CHEMBL2207632,COc1ccccc1N2CCN(Cc3cc(C#C)c4cccccc34)CC2,Ki,=,76.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,B,76.0
11802,CHEMBL2207632,COc1ccccc1N2CCN(Cc3cc(C#C)c4cccccc34)CC2,Ki,=,95.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,B,95.0
11803,CHEMBL2207633,COc1ccccc1N2CCN(Cc3cc(C#Cc4ccccc4)c5cccccc35)CC2,Ki,=,67.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,B,67.0
11804,CHEMBL2207633,COc1ccccc1N2CCN(Cc3cc(C#Cc4ccccc4)c5cccccc35)CC2,Ki,=,65.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,B,65.0
11805,CHEMBL2207634,CCCC#Cc1cc(CN2CCN(CC2)c3ccccc3OC)c4cccccc14,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,B,60.0
11806,CHEMBL2207634,CCCC#Cc1cc(CN2CCN(CC2)c3ccccc3OC)c4cccccc14,Ki,=,76.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,B,76.0
11807,CHEMBL2207635,COc1ccccc1N2CCN(Cc3cc(CO)c4cccccc34)CC2,Ki,=,68.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,B,68.0
11809,CHEMBL2207636,COc1ccccc1N2CCN(Cc3cc(C#N)c4cccccc34)CC2,Ki,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,B,39.0
11810,CHEMBL2207636,COc1ccccc1N2CCN(Cc3cc(C#N)c4cccccc34)CC2,Ki,=,8.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,B,8.3
11813,CHEMBL2207638,COc1ccccc1N2CCN(Cc3cc(CN4CCCCC4)c5cccccc35)CC2,Ki,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,B,37.0
11814,CHEMBL2207638,COc1ccccc1N2CCN(Cc3cc(CN4CCCCC4)c5cccccc35)CC2,Ki,=,51.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,B,51.0
11815,CHEMBL2207639,COc1ccccc1N2CCN(Cc3cc(CN4CCOCC4)c5cccccc35)CC2,Ki,=,92.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,B,92.0
11817,CHEMBL2207640,COc1ccccc1N2CCN(Cc3cc(CN4CCN(C)CC4)c5cccccc35)CC2,Ki,=,57.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,B,57.0
11818,CHEMBL2207640,COc1ccccc1N2CCN(Cc3cc(CN4CCN(C)CC4)c5cccccc35)CC2,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,B,60.0
11819,CHEMBL2207641,COc1ccccc1N2CCN(Cc3cc(CN4CCN(CC4)c5ccccc5OC)c6cccccc36)CC2,Ki,=,34.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,B,34.0
11820,CHEMBL2207641,COc1ccccc1N2CCN(Cc3cc(CN4CCN(CC4)c5ccccc5OC)c6cccccc36)CC2,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,B,17.0
11822,CHEMBL2207642,COc1ccccc1N2CCN(Cc3cc(CN4CCN(CC4)c5ccc(Cl)cc5)c6cccccc36)CC2,Ki,=,95.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,B,95.0
11823,CHEMBL2207643,COc1ccccc1N2CCN(Cc3ccc4cccccc34)CC2,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,B,24.0
11824,CHEMBL2207643,COc1ccccc1N2CCN(Cc3ccc4cccccc34)CC2,Ki,=,33.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,B,33.0
11839,CHEMBL2298799,[O-][N+](=O)c1ccc(CCN2CCN(CC2)c3ccccc3)cc1[N+](=O)[O-],Ki,=,51.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,51.3
11841,CHEMBL2298801,Clc1cccc(c1)N2CCN(CCOc3ccc4NC(=O)Nc4c3)CC2,Ki,=,45.5,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,45.5
11845,CHEMBL2298805,COc1ccccc1N2CCN(CCOc3ccc4nn[nH]c4c3)CC2,Ki,=,1.51,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,1.51
11846,CHEMBL2298806,C(Cc1ccc2[nH]cnc2c1)N3CCN(CC3)c4cccc5ccccc45,Ki,=,1.66,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,1.66
11847,CHEMBL2298807,FC(F)(F)c1cccc(c1)N2CCN(CCc3ccc4NC(=O)C(=O)Nc4c3)CC2,Ki,=,28.18,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,28.18
11852,CHEMBL2298817,COc1ccccc1N2CCN(CCCc3ccc4nc[nH]c4c3)CC2,Ki,=,97.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,97.0
11853,CHEMBL2298818,S=C1Nc2ccc(CCCN3CCN(CC3)c4ccccc4)cc2N1,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,3.0
11854,CHEMBL2298819,FC(F)(F)c1cccc(c1)N2CCN(CCCc3ccc4NC(=S)Nc4c3)CC2,Ki,=,5.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,5.8
11855,CHEMBL2298820,Clc1ccc(cc1)N2CCN(CCCc3ccc4NC(=S)Nc4c3)CC2,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,20.0
11856,CHEMBL2298821,COc1ccc(cc1)N2CCN(CCCc3ccc4NC(=S)Nc4c3)CC2,Ki,=,33.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,33.0
11857,CHEMBL2298822,COc1ccccc1N2CCN(CCCc3ccc4NC(=S)Nc4c3)CC2,Ki,=,0.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,0.4
11859,CHEMBL2298824,COc1ccccc1N2CCN(CCOc3ccc4nc[nH]c4c3)CC2,Ki,=,12.6,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,12.6
11862,CHEMBL2298827,S=C1Nc2ccc(OCCN3CCN(CC3)c4ccccc4)cc2N1,Ki,=,0.67,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,0.67
11863,CHEMBL2298828,FC(F)(F)c1cccc(c1)N2CCN(CCOc3ccc4NC(=S)Nc4c3)CC2,Ki,=,5.94,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,5.94
11864,CHEMBL2298829,COc1ccccc1N2CCN(CCOc3ccc4NC(=S)Nc4c3)CC2,Ki,=,0.19,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,0.19
11865,CHEMBL2298830,COc1cccc(c1)N2CCN(CCOc3ccc4NC(=S)Nc4c3)CC2,Ki,=,13.2,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,13.2
11867,CHEMBL2298832,Clc1ccccc1N2CCN(CCOc3ccc4NC(=S)Nc4c3)CC2,Ki,=,2.75,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,2.75
11868,CHEMBL2298833,Clc1cccc(c1)N2CCN(CCOc3ccc4NC(=S)Nc4c3)CC2,Ki,=,7.06,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,7.06
11870,CHEMBL2299000,O=C1Nc2ccc(OCCN3CCN(CC3)c4ccccc4)cc2N1,Ki,=,7.53,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,7.53
11871,CHEMBL2299001,FC(F)(F)c1cccc(c1)N2CCN(CCOc3ccc4NC(=O)Nc4c3)CC2,Ki,=,26.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,26.1
11872,CHEMBL2299002,COc1ccccc1N2CCN(CCOc3ccc4NC(=O)Nc4c3)CC2,Ki,=,1.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,1.3
11873,CHEMBL2299003,COc1cccc(c1)N2CCN(CCOc3ccc4NC(=O)Nc4c3)CC2,Ki,=,44.8,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,44.8
11877,CHEMBL2308105,Fc1ccc(cc1)C(O[C@H]2C[C@H]3CC[C@@H](C2)N3CCCCc4ccccc4)c5ccc(F)cc5,Ki,=,81.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human dopamine receptor D2,B,81.3
11878,CHEMBL2312227,COc1ccccc1OCCNCC2COCC(O2)(c3ccccc3)c4ccccc4,Ki,=,12.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from recombinant human D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting method,A,12.3
11879,CHEMBL2312637,Clc1cccc(N2CCN(CCCCNS(=O)(=O)c3ccc4cccnc4c3)CC2)c1Cl,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 after 1 hr,B,11.0
11880,CHEMBL2312639,Clc1cccc(N2CCN(CCCCNS(=O)(=O)c3cc4ccccc4cn3)CC2)c1Cl,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 after 1 hr,B,17.0
11881,CHEMBL2312640,Clc1cccc(N2CCN(CCCCNS(=O)(=O)c3cncc4ccccc34)CC2)c1Cl,Ki,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 after 1 hr,B,8.0
11882,CHEMBL2312934,Clc1cccc(N2CCN(CCCNS(=O)(=O)c3ccc4cccnc4c3)CC2)c1Cl,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 after 1 hr,B,16.0
11883,CHEMBL2312935,Clc1cccc(N2CCN(CCCCNS(=O)(=O)c3cnc4ccccc4c3)CC2)c1Cl,Ki,=,9.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 after 1 hr,B,9.0
11889,CHEMBL2323579,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3cn(C)c4cccc2c34)N(C)C1,EC50,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2 receptor transfected in HTLA cells measured after overnight incubation by luminescence counter analysis,B,0.7
11892,CHEMBL2325926,CN1CCC(CC1)c2cn(c3ccc(F)cc3)c4ccc(cc24)c5ccnn5C,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,B,15.0
11898,CHEMBL2325930,CN1CCC(CC1)c2cn(c3ccc(F)cc3)c4ccc(cc24)c5ccncc5,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,B,27.0
11901,CHEMBL2325932,CN1CCC(CC1)c2cn(c3ccc(F)cc3)c4ccc(cc24)c5cccnc5,Ki,=,76.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,B,76.0
11905,CHEMBL2325935,CN1CCC(CC1)c2cn(c3ccc(F)cc3)c4ccc(cc24)c5nnn(C)n5,Ki,=,69.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,B,69.0
11925,CHEMBL2326472,Cn1cc(CN2CCc3cc4nc(N)sc4cc3CC2)cn1,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,15.0
11937,CHEMBL2326476,Nc1nc2cc3CCN(Cc4ccccc4)CCc3cc2s1,Ki,=,80.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,80.0
11940,CHEMBL2326477,Nc1nc2cc3CCN(Cc4ccc(F)cc4)CCc3cc2s1,Ki,=,75.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,75.0
11943,CHEMBL2326478,Nc1nc2cc3CCN(Cc4cccc(F)c4)CCc3cc2s1,Ki,=,42.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,42.0
11946,CHEMBL2326479,COc1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)cc1,Ki,=,92.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,92.0
11949,CHEMBL2326480,COc1cccc(CN2CCc3cc4nc(N)sc4cc3CC2)c1,Ki,=,34.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,34.0
11952,CHEMBL2326481,CN(C)C(=O)c1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)cc1,Ki,=,42.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,42.0
11955,CHEMBL2326482,CN(C)C(=O)c1cccc(CN2CCc3cc4nc(N)sc4cc3CC2)c1,Ki,=,42.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,42.0
11964,CHEMBL2326485,Nc1nc2cc3CCN(Cc4ccncc4)CCc3cc2s1,Ki,=,38.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,38.0
12000,CHEMBL2334885,COc1cc2[C@@H]3Cc4ccc(OC)c(OC)c4CN3CCc2cc1O,Ki,=,42.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor after 1 hr,B,42.4
12011,CHEMBL2334891,COc1cc2CCN3Cc4c(C[C@H]3c2cc1O)ccc(OC)c4OC,Ki,=,91.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,B,91.0
12013,CHEMBL2334891,COc1cc2CCN3Cc4c(C[C@H]3c2cc1O)ccc(OC)c4OC,Ki,=,41.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human FLAG-tagged dopamine D2 receptor expressed in HEK293 cells after 1 hr,B,41.8
12016,CHEMBL2334893,COc1cc2CCN3Cc4cc5OCOc5cc4C[C@H]3c2cc1O,Ki,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,B,32.0
12018,CHEMBL2334893,COc1cc2CCN3Cc4cc5OCOc5cc4C[C@H]3c2cc1O,Ki,=,32.16,nM,Dopamine D2 receptor,Homo sapiens,"Reception Binding Assay: Different concentrations (10^¿5 M-10^¿11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 ¿L liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",B,32.16
12019,CHEMBL2334893,COc1cc2CCN3Cc4cc5OCOc5cc4C[C@H]3c2cc1O,IC50,=,91.11,nM,Dopamine D2 receptor,Homo sapiens,"Reception Binding Assay: Different concentrations (10^¿5 M-10^¿11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 ¿L liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",B,45.555
12024,CHEMBL2335736,COc1cc2CCN3CC[C@@](O)(C[C@@H]3c2cc1O)c4ccc(OC(F)(F)F)cc4,Ki,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,B,4.0
12026,CHEMBL2335737,Cc1cc2CCN3CC[C@@](O)(C[C@@H]3c2cc1O)c4ccc(Cl)cc4,Ki,=,12.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,B,12.3
12034,CHEMBL2335740,COc1cc2CCN3CC[C@@](O)(C[C@@H]3c2cc1O)c4ccc(Cl)cc4,Ki,=,14.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,B,14.8
12040,CHEMBL2336280,CCCN1CCC(CC1)c2ccccc2OC,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,B,12.0
12041,CHEMBL2336280,CCCN1CCC(CC1)c2ccccc2OC,Ki,=,12.59,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,B,12.59
12061,CHEMBL2336892,C(N1CCN(CC1)c2ccccc2)c3cnn(c3)c4cc5CCc6ccc(CCc4cc5)cc6,Ki,=,33.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,B,33.0
12062,CHEMBL2336892,C(N1CCN(CC1)c2ccccc2)c3cnn(c3)c4cc5CCc6ccc(CCc4cc5)cc6,Ki,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,B,55.0
12065,CHEMBL2336893,C(N1CCN(CC1)c2cc3CCc4ccc(CCc2cc3)cc4)c5cnn(c5)c6ccccc6,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,B,28.0
12066,CHEMBL2336893,C(N1CCN(CC1)c2cc3CCc4ccc(CCc2cc3)cc4)c5cnn(c5)c6ccccc6,Ki,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,B,39.0
12073,CHEMBL2368618,Cl.COc1cccc(\C=C\C(=O)N[C@@H]2CC[C@@H](CCN3CCc4ccc(OS(=O)(=O)C)cc4CC3)CC2)c1,Ki,=,63.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,B,63.1
12076,CHEMBL2368622,Cl.CS(=O)(=O)Oc1ccc2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)\C=C\c4cccc(F)c4)CCc2c1,Ki,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,B,79.43
12079,CHEMBL2368625,Cl.CS(=O)(=O)Oc1ccc2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)\C=C\c4ccccc4F)CCc2c1,Ki,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,B,79.43
12082,CHEMBL2368629,Cl.CS(=O)(=O)c1ccc2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)\C=C\c4ccc(F)cc4)CCc2c1,Ki,=,79.43,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,B,79.43
12095,CHEMBL2377445,Fc1ccc2[nH]cc(C3CCN(CCN4C(=O)CC(C4=O)c5c[nH]c6ccccc56)CC3)c2c1,Ki,=,80.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,80.0
12096,CHEMBL2377590,Fc1ccc2[nH]cc(C3CCN(CCCCN4C(=O)CC(C4=O)c5c[nH]c6ccccc56)CC3)c2c1,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,14.0
12099,CHEMBL2386603,Clc1cccc(N2CCN(CCCCNC(=O)c3ccc4c(c3)C(=O)c5ccccc45)CC2)c1Cl,Ki,=,89.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,B,89.0
12119,CHEMBL2386611,COc1ccccc1N2CCCN(CCCCNC(=O)c3ccc(F)cc3)CC2,Ki,=,95.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,B,95.2
12121,CHEMBL2386612,COc1ccccc1N2CCCN(CCCCNC(=O)c3ccc(C)s3)CC2,Ki,=,56.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,B,56.5
12135,CHEMBL2386618,COc1ccccc1N2CCCN(CCCCNC(=O)c3ccc(Br)s3)CC2,Ki,=,43.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,B,43.7
12149,CHEMBL2387229,CC1=CC(=O)Oc2c(Cl)c(OCCCCN3CCC(CC3)c4noc5cc(F)ccc45)ccc12,IC50,=,26.3,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 assessed as inhibition of agonist-induced response incubated for 60 mins in incubator followed by 15 mins at room temperature by FLIPR assay,B,13.15
12155,CHEMBL2387709,CCCN(CCN1CCN(CC1)c2ccccc2)[C@@H]3CCc4ccc(N)cc4C3,EC50,=,179.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting analysis,F,89.5
12159,CHEMBL2392349,COc1ccccc1N2CCN(CCCCCN3Cc4ccc5ccccc5c4C3=O)CC2,IC50,=,3.5,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human recombinant dopamine D2S receptor expressed in HEK293 cells,B,1.75
12162,CHEMBL2392351,COc1ccccc1N2CCN(CCCCCN3Cc4c(Cl)nc5ccccc5c4C3=O)CC2,IC50,>,100.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human recombinant dopamine D2S receptor expressed in HEK293 cells,B,50.0
12165,CHEMBL2393243,Cl.C(c1ccccc1)c2nc3CCNCCc3c(Nc4ccccc4)n2,IC50,=,146.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from dopamine D2L receptor (unknown origin) after 60 mins,B,73.35
12166,CHEMBL2393244,Cl.Fc1cccc(Nc2nc(Cc3ccccc3)nc4CCNCCc24)c1,IC50,=,63.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from dopamine D2L receptor (unknown origin) after 60 mins,B,31.65
12167,CHEMBL2393245,Cl.Clc1cccc(Nc2nc(Cc3ccccc3)nc4CCNCCc24)c1,IC50,=,85.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from dopamine D2L receptor (unknown origin) after 60 mins,B,42.9
12168,CHEMBL2393246,Cl.COc1cccc(Nc2nc(Cc3ccccc3)nc4CCNCCc24)c1,IC50,=,162.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from dopamine D2L receptor (unknown origin) after 60 mins,B,81.4
12171,CHEMBL2397380,Cl.CN1CCc2ccc(C)c3c2[C@H]1Cc4ccc(O)c(O)c34,EC50,=,5.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in HEK293 cells assessed as forskolin-stimulated cAMP accumulation after 15 mins,F,2.55
12172,CHEMBL2397380,Cl.CN1CCc2ccc(C)c3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,54.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,B,54.0
12174,CHEMBL2397381,Cl.CN1CCc2ccc(Cc3ccccc3)c4c2[C@H]1Cc5ccc(O)c(O)c45,EC50,=,49.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in HEK293 cells assessed as forskolin-stimulated cAMP accumulation after 15 mins,F,24.5
12175,CHEMBL2397381,Cl.CN1CCc2ccc(Cc3ccccc3)c4c2[C@H]1Cc5ccc(O)c(O)c45,Ki,=,77.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,B,77.0
12177,CHEMBL2397382,Cl.CN1CCc2ccc(CO)c3c2[C@H]1Cc4ccc(O)c(O)c34,EC50,=,3.4,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in HEK293 cells assessed as forskolin-stimulated cAMP accumulation after 15 mins,F,1.7
12178,CHEMBL2397382,Cl.CN1CCc2ccc(CO)c3c2[C@H]1Cc4ccc(O)c(O)c34,Ki,=,43.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,B,43.0
12180,CHEMBL2397383,Cl.CN1CCc2ccc(Cc3ccc(O)cc3)c4c2[C@H]1Cc5ccc(O)c(O)c45,EC50,=,2.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in HEK293 cells assessed as forskolin-stimulated cAMP accumulation after 15 mins,F,1.35
12181,CHEMBL2397383,Cl.CN1CCc2ccc(Cc3ccc(O)cc3)c4c2[C@H]1Cc5ccc(O)c(O)c45,Ki,=,47.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,B,47.0
12183,CHEMBL2397385,Cl.CN1CCc2ccc(Cc3ccc(O)c4ccccc34)c5c2[C@H]1Cc6ccc(O)c(O)c56,EC50,=,76.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in HEK293 cells assessed as forskolin-stimulated cAMP accumulation after 15 mins,F,38.0
12192,CHEMBL2397389,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@@H]3CCC(=CC3)C#C,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,B,18.0
12193,CHEMBL2397389,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@@H]3CCC(=CC3)C#C,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,B,11.0
12194,CHEMBL2397389,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@@H]3CCC(=CC3)C#C,Ki,=,0.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,B,0.6
12195,CHEMBL2397389,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@@H]3CCC(=CC3)C#C,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,B,14.0
12196,CHEMBL2397389,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@@H]3CCC(=CC3)C#C,Ki,=,8.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,B,8.8
12201,CHEMBL2397389,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@@H]3CCC(=CC3)C#C,EC50,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity at human dopamine D2L receptor expressed in HEK293 cells co-transfected with Galpha0i assessed as [35S]GTPgammaS binding after 30 mins by [35S]GTPgammaS incorporation assay,B,27.5
12203,CHEMBL2397389,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@@H]3CCC(=CC3)C#C,EC50,=,66.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity at human dopamine D2L receptor expressed in HEK293 cells co-transfected with Galphai2 assessed as [35S]GTPgammaS binding after 30 mins by [35S]GTPgammaS incorporation assay,B,33.0
12205,CHEMBL2397389,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@@H]3CCC(=CC3)C#C,EC50,=,140.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ARMS2-PK2-tagged human dopamine D2S receptor expressed in HEK293 cells co-expressing (EA)-tagged beta arrestin fusion protein assessed as recruitment of beta-arrestin-2 after 5 hrs by chemiluminescence assay,B,70.0
12214,CHEMBL2396663,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@H]3CCC(=CC3)C#C,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,B,21.0
12215,CHEMBL2396663,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@H]3CCC(=CC3)C#C,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,B,14.0
12216,CHEMBL2396663,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@H]3CCC(=CC3)C#C,Ki,=,1.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,B,1.2
12217,CHEMBL2396663,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@H]3CCC(=CC3)C#C,Ki,=,9.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,B,9.4
12218,CHEMBL2396663,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@H]3CCC(=CC3)C#C,Ki,=,3.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,B,3.9
12219,CHEMBL2396663,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@H]3CCC(=CC3)C#C,EC50,=,130.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity at human dopamine D2S receptor expressed in HEK293 cells co-transfected with Galpha0i assessed as [35S]GTPgammaS binding after 30 mins by [35S]GTPgammaS incorporation assay,B,65.0
12223,CHEMBL2396663,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@H]3CCC(=CC3)C#C,EC50,=,92.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity at human dopamine D2L receptor expressed in HEK293 cells co-transfected with Galpha0i assessed as [35S]GTPgammaS binding after 30 mins by [35S]GTPgammaS incorporation assay,B,46.0
12227,CHEMBL2396663,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@H]3CCC(=CC3)C#C,EC50,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ARMS2-PK2-tagged human dopamine D2S receptor expressed in HEK293 cells co-expressing (EA)-tagged beta arrestin fusion protein assessed as recruitment of beta-arrestin-2 after 5 hrs by chemiluminescence assay,B,8.0
12237,CHEMBL2397390,CCCN(CCCCNC(=O)c1cc2ccccn2n1)[C@@H]3CCC(=CC3)C#C,Ki,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,B,63.0
12238,CHEMBL2397390,CCCN(CCCCNC(=O)c1cc2ccccn2n1)[C@@H]3CCC(=CC3)C#C,Ki,=,5.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,B,5.5
12247,CHEMBL2397391,CCCN(CCCCNC(=O)c1cc2ccccn2n1)[C@H]3CCC(=CC3)C#C,Ki,=,66.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,B,66.0
12248,CHEMBL2397391,CCCN(CCCCNC(=O)c1cc2ccccn2n1)[C@H]3CCC(=CC3)C#C,Ki,=,3.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,B,3.9
12256,CHEMBL2397392,CCCN(CCCCNC(=O)c1cnn2ccccc12)[C@@H]3CCC(=CC3)C#C,Ki,=,9.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,B,9.3
12257,CHEMBL2397392,CCCN(CCCCNC(=O)c1cnn2ccccc12)[C@@H]3CCC(=CC3)C#C,Ki,=,7.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,B,7.1
12258,CHEMBL2397392,CCCN(CCCCNC(=O)c1cnn2ccccc12)[C@@H]3CCC(=CC3)C#C,Ki,=,0.55,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,B,0.55
12266,CHEMBL2397476,CCCN(CCCCNC(=O)c1cnn2ccccc12)[C@H]3CCC(=CC3)C#C,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,B,14.0
12267,CHEMBL2397476,CCCN(CCCCNC(=O)c1cnn2ccccc12)[C@H]3CCC(=CC3)C#C,Ki,=,7.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,B,7.8
12268,CHEMBL2397476,CCCN(CCCCNC(=O)c1cnn2ccccc12)[C@H]3CCC(=CC3)C#C,Ki,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,B,1.1
12276,CHEMBL2397477,CCCCn1ncc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@@H]3CCC(=CC3)C#C)n1,Ki,=,8.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,B,8.8
12277,CHEMBL2397477,CCCCn1ncc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@@H]3CCC(=CC3)C#C)n1,Ki,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,B,8.0
12278,CHEMBL2397477,CCCCn1ncc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@@H]3CCC(=CC3)C#C)n1,Ki,=,4.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,B,4.2
12286,CHEMBL2397478,CCCCn1ncc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@H]3CCC(=CC3)C#C)n1,Ki,=,3.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,B,3.9
12287,CHEMBL2397478,CCCCn1ncc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@H]3CCC(=CC3)C#C)n1,Ki,=,6.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,B,6.0
12288,CHEMBL2397478,CCCCn1ncc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@H]3CCC(=CC3)C#C)n1,Ki,=,0.53,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,B,0.53
12296,CHEMBL2397479,CCCN(CCCCNC(=O)c1cc2ccccc2s1)[C@@H]3CCC(=CC3)C#C,Ki,=,33.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,B,33.0
12297,CHEMBL2397479,CCCN(CCCCNC(=O)c1cc2ccccc2s1)[C@@H]3CCC(=CC3)C#C,Ki,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,B,32.0
12298,CHEMBL2397479,CCCN(CCCCNC(=O)c1cc2ccccc2s1)[C@@H]3CCC(=CC3)C#C,Ki,=,3.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,B,3.1
12306,CHEMBL2397480,CCCN(CCCCNC(=O)c1cc2ccccc2s1)[C@H]3CCC(=CC3)C#C,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,B,16.0
12307,CHEMBL2397480,CCCN(CCCCNC(=O)c1cc2ccccc2s1)[C@H]3CCC(=CC3)C#C,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,B,22.0
12308,CHEMBL2397480,CCCN(CCCCNC(=O)c1cc2ccccc2s1)[C@H]3CCC(=CC3)C#C,Ki,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,B,2.0
12309,CHEMBL2413153,CN1C(=O)C=NN(CCCCN2CCN(CC2)c3ccccc3OCCF)C1=O,Ki,=,37.1,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine 2 receptor (unknown origin),B,37.1
12414,CHEMBL3084502,O[C@@]1(C[C@H]2CC[C@@H](C1)N2Cc3c[nH]c4ccccc34)c5ccc(Cl)cc5,Ki,=,33.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,33.4
12417,CHEMBL3084503,O[C@]1(C[C@H]2CC[C@@H](C1)N2Cc3c[nH]c4ccccc34)c5ccc(Cl)c(Cl)c5,Ki,=,35.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,35.3
12420,CHEMBL3084505,O[C@]1(C[C@H]2CC[C@@H](C1)N2Cc3c[nH]c4ccccc34)c5ccc(F)cc5,Ki,=,41.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,41.4
12425,CHEMBL3084510,COc1ccc2[nH]cc(CN3[C@@H]4CC[C@H]3C[C@@](O)(C4)c5ccc(Cl)cc5)c2c1,Ki,=,39.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,39.4
12427,CHEMBL3084512,O[C@]1(C[C@H]2CC[C@@H](C1)N2Cc3csc4ccccc34)c5ccc(Cl)cc5,Ki,=,12.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,12.9
12429,CHEMBL3084513,O[C@]1(C[C@H]2CC[C@@H](C1)N2Cc3csc4ccccc34)c5ccc(Cl)c(Cl)c5,Ki,=,29.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,29.8
12431,CHEMBL3084515,O[C@]1(C[C@H]2CC[C@@H](C1)N2Cc3coc4ccccc34)c5ccc(Cl)cc5,Ki,=,1.06,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,1.06
12433,CHEMBL3084516,O[C@@]1(C[C@H]2CC[C@@H](C1)N2Cc3coc4ccccc34)c5ccc(Cl)c(Cl)c5,Ki,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,1.7
12434,CHEMBL3084517,O[C@]1(C[C@H]2CC[C@@H](C1)N2Cc3coc4ccccc34)c5cccc(Cl)c5Cl,Ki,=,40.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,40.1
12435,CHEMBL3084518,O[C@]1(C[C@H]2CC[C@@H](C1)N2Cc3coc4ccccc34)c5ccc(F)cc5,Ki,=,4.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,4.9
12436,CHEMBL3084519,O[C@]1(C[C@H]2CC[C@@H](C1)N2Cc3coc4ccccc34)c5ccc(Br)cc5,Ki,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,1.5
12437,CHEMBL3084520,COc1ccc2occ(CN3[C@@H]4CC[C@H]3C[C@@](O)(C4)c5ccc(Cl)cc5)c2c1,Ki,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,1.5
12438,CHEMBL3084521,O[C@]1(C[C@H]2CC[C@@H](C1)N2Cc3coc4ccc(F)cc34)c5ccc(Cl)cc5,Ki,=,1.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,1.2
12439,CHEMBL3084522,O[C@]1(C[C@H]2CC[C@@H](C1)N2Cc3coc4ccc5ccccc5c34)c6ccc(Cl)cc6,Ki,=,11.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,11.7
12440,CHEMBL3084523,O[C@]1(C[C@H]2CC[C@@H](C1)N2Cc3coc4c3ccc5ccccc45)c6ccc(Cl)cc6,Ki,=,5.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,5.6
12441,CHEMBL3084524,O[C@]1(C[C@H]2CC[C@@H](C1)N2Cc3coc4ccc(F)cc34)c5ccc(Cl)c(Cl)c5,Ki,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,1.4
12460,CHEMBL3084971,C(CN1CCN(CC1)c2ccccc2)[C@@H]3CC[C@@H](CC3)Nc4ncccn4,Ki,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,28.0
12489,CHEMBL3085819,CC(=O)N[C@@H]1CC[C@@H](CCN2CCc3ccc(cc3C2)C#N)CC1,Ki,=,23.44,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,B,23.44
12492,CHEMBL3085820,CC(C)(C)OC(=O)N[C@@H]1CC[C@@H](CCN2CCCN(CC2)c3cccc(Cl)c3Cl)CC1,Ki,=,10.47,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,B,10.47
12495,CHEMBL3085821,CC(C)(C)OC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,B,39.81
12504,CHEMBL3085824,CC(C)(C)OC(=O)N[C@@H]1CC[C@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,Ki,=,33.11,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,B,33.11
12507,CHEMBL3085825,CN(C)C(=O)NC[C@@H]1CC[C@@H](CN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,Ki,=,42.66,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,B,42.66
12548,CHEMBL3099222,Cl.CCCN1C[C@H](CSC)O[C@@H]2Cc3c(O)cccc3C[C@@H]12,EC50,=,0.6,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase of forskolin-induced cAMP production after 20 mins,F,0.3
12550,CHEMBL3099223,Br.CN1CCC[C@@H]2Cc3c(O)cccc3C[C@@H]12,EC50,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase of forskolin-induced cAMP production after 20 mins,F,12.5
12552,CHEMBL3098131,CCCN1CCC[C@@H]2Cc3c(O)cccc3C[C@@H]12.OC(=O)C(F)(F)F,EC50,=,0.17,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase of forskolin-induced cAMP production after 20 mins,F,0.085
12555,CHEMBL3099224,Cl.CN1CCO[C@@H]2Cc3c(O)cccc3C[C@@H]12,EC50,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase of forskolin-induced cAMP production after 20 mins,F,2.0
12557,CHEMBL3099225,Cl.CCN1CCO[C@@H]2Cc3c(O)cccc3C[C@@H]12,EC50,=,0.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase of forskolin-induced cAMP production after 20 mins,F,0.4
12559,CHEMBL3099226,Cl.CCCN1CCO[C@@H]2Cc3c(O)cccc3C[C@@H]12,EC50,=,0.14,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase of forskolin-induced cAMP production after 20 mins,F,0.07
12561,CHEMBL3099227,Cl.Oc1cccc2C[C@@H]3[C@@H](Cc12)OCCN3CC=C,EC50,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase of forskolin-induced cAMP production after 20 mins,F,0.55
12563,CHEMBL3099228,Cl.Oc1cccc2C[C@@H]3[C@@H](Cc12)OCCN3CC4CC4,EC50,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase of forskolin-induced cAMP production after 20 mins,F,9.0
12567,CHEMBL3099230,CCCN1C[C@H](Cn2cccn2)O[C@@H]3Cc4c(O)cccc4C[C@@H]13,EC50,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase of forskolin-induced cAMP production after 20 mins,F,0.75
12569,CHEMBL3099231,CCCN1C[C@@H](Cn2cccn2)O[C@@H]3Cc4c(O)cccc4C[C@@H]13,EC50,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase of forskolin-induced cAMP production after 20 mins,F,0.5
12571,CHEMBL3099232,CCCN1C[C@H](Cn2ccc(n2)c3ccccc3)O[C@@H]4Cc5c(O)cccc5C[C@@H]14,EC50,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase of forskolin-induced cAMP production after 20 mins,F,6.5
12573,CHEMBL3099233,CCCN1C[C@@H](Cn2ccc(n2)c3ccccc3)O[C@@H]4Cc5c(O)cccc5C[C@@H]14,EC50,=,33.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase of forskolin-induced cAMP production after 20 mins,F,16.5
12575,CHEMBL3099234,CCCN1C[C@H](Cn2cncn2)O[C@@H]3Cc4c(O)cccc4C[C@@H]13,EC50,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase of forskolin-induced cAMP production after 20 mins,F,0.85
12577,CHEMBL3099235,CCCN1C[C@@H](Cn2cncn2)O[C@@H]3Cc4c(O)cccc4C[C@@H]13,EC50,=,0.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase of forskolin-induced cAMP production after 20 mins,F,0.25
12579,CHEMBL3099236,Cl.CCCN1C[C@H](Cn2cc(Cl)cn2)O[C@@H]3Cc4c(O)cccc4C[C@@H]13,EC50,=,2.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase of forskolin-induced cAMP production after 20 mins,F,1.05
12581,CHEMBL3099239,CCCN1C[C@@H](Cn2cc(Cl)cn2)O[C@@H]3Cc4c(O)cccc4C[C@@H]13,EC50,=,3.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase of forskolin-induced cAMP production after 20 mins,F,1.75
12589,CHEMBL3104516,CC(=O)c1ccc2C(=O)CC(CN3CCC(CC3)c4noc5cc(F)ccc45)Cc2c1,Ki,=,50.12,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor,B,50.12
12591,CHEMBL3104517,Fc1ccc2c(noc2c1)C3CCN(CC4CC(=O)c5ccc(cc5C4)c6ccccc6)CC3,Ki,=,17.38,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor,B,17.38
12592,CHEMBL3102875,CC(=O)c1ccc2C(=O)CC(CN3CCC(CC3)C(=O)c4ccc(F)cc4)Cc2c1,Ki,=,32.36,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor,B,32.36
12595,CHEMBL3104520,COc1ccccc1N2CCN(CCC3CCc4ccc(cc4C3O)[N+](=O)[O-])CC2,Ki,=,19.05,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor,B,19.05
12597,CHEMBL3104522,Nc1ccc2CCC(CCN3CCC(CC3)c4noc5cc(F)ccc45)C(O)c2c1,Ki,=,87.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor,B,87.1
12600,CHEMBL3104524,[O-][N+](=O)c1ccc2CCC(CCN3CCC(CC3)c4noc5cc(F)ccc45)C(=O)c2c1,Ki,=,37.15,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor,B,37.15
12601,CHEMBL3104646,COc1ccccc1N2CCN(CCC3CCc4ccc(cc4C3=O)[N+](=O)[O-])CC2,Ki,=,41.69,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor,B,41.69
12603,CHEMBL3104647,Nc1ccc2CCC(CCN3CCC(CC3)c4noc5cc(F)ccc45)C(=O)c2c1,Ki,=,46.77,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor,B,46.77
12604,CHEMBL3104648,COc1ccccc1N2CCN(CCC3CCc4ccc(N)cc4C3=O)CC2,Ki,=,50.12,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor,B,50.12
12613,CHEMBL3115574,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccc(I)cc3)Oc2c1,EC50,=,0.631,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by LANCE assay,F,0.3155
12615,CHEMBL3115574,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccc(I)cc3)Oc2c1,Ki,=,51.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,51.8
12616,CHEMBL3115574,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccc(I)cc3)Oc2c1,Ki,=,3.79,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,3.79
12617,CHEMBL3115574,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccc(I)cc3)Oc2c1,Ki,=,81.28,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,81.28
12618,CHEMBL3115574,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccc(I)cc3)Oc2c1,Ki,=,35.48,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,35.48
12619,CHEMBL3115574,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccc(I)cc3)Oc2c1,Ki,=,2.042,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,2.042
12621,CHEMBL3115575,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3cccc(I)c3)Oc2c1,EC50,=,0.03162,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by LANCE assay,F,0.01581
12622,CHEMBL3115575,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3cccc(I)c3)Oc2c1,Ki,=,30.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,30.8
12623,CHEMBL3115575,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3cccc(I)c3)Oc2c1,Ki,=,72.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,72.9
12624,CHEMBL3115575,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3cccc(I)c3)Oc2c1,Ki,=,2.06,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,2.06
12625,CHEMBL3115575,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3cccc(I)c3)Oc2c1,Ki,=,28.84,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,28.84
12626,CHEMBL3115575,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3cccc(I)c3)Oc2c1,Ki,=,33.88,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,33.88
12627,CHEMBL3115575,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3cccc(I)c3)Oc2c1,Ki,=,1.023,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,1.023
12629,CHEMBL3115576,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccccc3I)Oc2c1,Ki,=,51.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,51.2
12630,CHEMBL3115576,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccccc3I)Oc2c1,Ki,=,0.68,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,0.68
12631,CHEMBL3115576,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccccc3I)Oc2c1,Ki,=,83.18,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,83.18
12632,CHEMBL3115576,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccccc3I)Oc2c1,Ki,=,29.51,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,29.51
12633,CHEMBL3115576,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccccc3I)Oc2c1,Ki,=,0.1622,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,0.1622
12638,CHEMBL3115578,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCCN3CCN(CC3)c4ccc(I)cc4)Oc2c1,EC50,=,1.585,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by LANCE assay,F,0.7925
12640,CHEMBL3115578,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCCN3CCN(CC3)c4ccc(I)cc4)Oc2c1,Ki,=,80.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,80.5
12641,CHEMBL3115578,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCCN3CCN(CC3)c4ccc(I)cc4)Oc2c1,Ki,=,95.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,95.5
12642,CHEMBL3115578,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCCN3CCN(CC3)c4ccc(I)cc4)Oc2c1,Ki,=,66.07,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,66.07
12644,CHEMBL3115579,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccc(OCCCCF)cc3)Oc2c1,EC50,=,0.3981,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by LANCE assay,F,0.19905
12645,CHEMBL3115579,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccc(OCCCCF)cc3)Oc2c1,Ki,=,92.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,92.7
12646,CHEMBL3115579,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccc(OCCCCF)cc3)Oc2c1,Ki,=,80.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,80.5
12647,CHEMBL3115579,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccc(OCCCCF)cc3)Oc2c1,Ki,=,5.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,5.6
12648,CHEMBL3115579,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccc(OCCCCF)cc3)Oc2c1,Ki,=,91.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,91.2
12649,CHEMBL3115579,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccc(OCCCCF)cc3)Oc2c1,Ki,=,61.66,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,61.66
12650,CHEMBL3115579,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCc3ccc(OCCCCF)cc3)Oc2c1,Ki,=,5.495,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,5.495
12659,CHEMBL3115582,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCCN3CCN(CC3)c4ccc(OCCF)cc4)Oc2c1,EC50,=,0.1585,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by LANCE assay,F,0.07925
12662,CHEMBL3115582,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCCN3CCN(CC3)c4ccc(OCCF)cc4)Oc2c1,Ki,=,6.67,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,6.67
12665,CHEMBL3115582,OC(=O)C(=O)O.Oc1ccc2CC[C@H](CNCCN3CCN(CC3)c4ccc(OCCF)cc4)Oc2c1,Ki,=,5.012,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,5.012
12667,CHEMBL3115585,CCCCCCNC[C@H]1CCc2ccc(O)cc2O1.OC(=O)C(=O)O,EC50,=,0.05012,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by LANCE assay,F,0.02506
12670,CHEMBL3115585,CCCCCCNC[C@H]1CCc2ccc(O)cc2O1.OC(=O)C(=O)O,Ki,=,8.19,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,8.19
12673,CHEMBL3115585,CCCCCCNC[C@H]1CCc2ccc(O)cc2O1.OC(=O)C(=O)O,Ki,=,6.31,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,6.31
12675,CHEMBL3125987,CCCN(CCN1CCN(CC1)c2ccc(cc2)c3cccc(OC)c3)[C@H]4CCc5nc(N)sc5C4,EC50,=,36.8,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding,F,18.4
12677,CHEMBL3125990,CCCN(CCN1CCN(CC1)c2ccc(cc2)c3cccc(O)c3)[C@H]4CCc5nc(N)sc5C4,EC50,=,15.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding,F,7.95
12683,CHEMBL3133779,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4cc(OCCF)ccc4[nH]3)CC2.OC(=O)C(=O)O,Ki,=,23.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,B,23.9
12684,CHEMBL3133780,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4cc(OCCOCCF)ccc4[nH]3)CC2.OC(=O)C(=O)O,Ki,=,21.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,B,21.8
12686,CHEMBL3133862,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4cc(OCCOCCOCCF)ccc4[nH]3)CC2.OC(=O)C(=O)O,Ki,=,42.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,B,42.4
12687,CHEMBL3133863,OC(=O)C(=O)O.FCCOc1ccccc1N2CCN(C\C=C\CNC(=O)c3cc4ccccc4[nH]3)CC2,Ki,=,40.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,B,40.4
12688,CHEMBL3133864,OC(=O)C(=O)O.Oc1ccc2[nH]c(cc2c1)C(=O)NC\C=C\CN3CCN(CC3)c4ccccc4OCCF,Ki,=,33.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,B,33.6
12689,CHEMBL3133865,COc1ccc2[nH]c(cc2c1)C(=O)NC\C=C\CN3CCN(CC3)c4ccccc4OCCF.OC(=O)C(=O)O,Ki,=,66.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,B,66.3
12692,CHEMBL3133867,COc1ccccc1N2CCN(C\C=C\CNC(=O)c3cc4cc(OCCF)ccc4[nH]3)CC2.OC(=O)C(=O)O,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,B,60.0
12696,CHEMBL3133870,OC(=O)C(=O)O.FCCOc1ccccc1N2CCN(CCCCNC(=O)c3c[nH]c4ccccc34)CC2,Ki,=,5.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,B,5.1
12697,CHEMBL3133871,COc1ccc2[nH]cc(C(=O)NCCCCN3CCN(CC3)c4ccccc4OCCF)c2c1.OC(=O)C(=O)O,Ki,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,B,2.0
12698,CHEMBL3133872,COc1ccc2[nH]cc(C(=O)NC\C=C\CN3CCN(CC3)c4ccccc4OC)c2c1.OC(=O)C(=O)O,Ki,=,11.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,B,11.7
12699,CHEMBL3133873,COc1ccc2[nH]cc(C(=O)NC\C=C\CN3CCN(CC3)c4ccccc4OCCF)c2c1.OC(=O)C(=O)O,Ki,=,7.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,B,7.5
12700,CHEMBL3133874,COc1ccc2c(c[nH]c2c1)C(=O)NC\C=C\CN3CCN(CC3)c4ccccc4OCCF.OC(=O)C(=O)O,Ki,=,5.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,B,5.9
12702,CHEMBL3133875,COc1ccccc1N2CCN(CCCCNC(=O)c3cc4cc(O)ccc4[nH]3)CC2.OC(=O)C(=O)O,Ki,=,15.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,B,15.7
12703,CHEMBL3134061,CN1CCc2cccc3c2[C@H]1Cc4ccc(OCCCN)c(O)c34,EC50,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2L receptor expressed in CHOFlpIn cells assessed as ERK1/2 phosphorylation by alphascreen assay,B,5.0
12705,CHEMBL3134062,CN1CCc2cccc3c2[C@H]1Cc4ccc(OCCCNC(=O)C)c(O)c34,EC50,=,132.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2L receptor expressed in CHOFlpIn cells assessed as ERK1/2 phosphorylation by alphascreen assay,B,66.0
12717,CHEMBL3134065,CN1CCc2cccc3c2[C@H]1Cc4ccc(OCCCNC(=O)CCCCC(=O)NCCCOc5ccc6C[C@H]7N(C)CCc8cccc(c78)c6c5O)c(O)c34,EC50,=,149.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2L receptor expressed in CHOFlpIn cells assessed as ERK1/2 phosphorylation by alphascreen assay,B,74.5
12725,CHEMBL3134067,CN1CCc2cccc3c2[C@H]1Cc4ccc(OCCCNC(=O)CCCCCCCCC(=O)NCCCOc5ccc6C[C@H]7N(C)CCc8cccc(c78)c6c5O)c(O)c34,EC50,=,79.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2L receptor expressed in CHOFlpIn cells assessed as ERK1/2 phosphorylation by alphascreen assay,B,39.5
12728,CHEMBL3134068,CN1CCc2cccc3c2[C@H]1Cc4ccc(OCCCNC(=O)CCCCCCCCCCC(=O)NCCCOc5ccc6C[C@H]7N(C)CCc8cccc(c78)c6c5O)c(O)c34,IC50,=,183.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,B,91.5
12729,CHEMBL3134068,CN1CCc2cccc3c2[C@H]1Cc4ccc(OCCCNC(=O)CCCCCCCCCCC(=O)NCCCOc5ccc6C[C@H]7N(C)CCc8cccc(c78)c6c5O)c(O)c34,EC50,=,110.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2L receptor expressed in CHOFlpIn cells assessed as ERK1/2 phosphorylation by alphascreen assay,B,55.0
12751,CHEMBL3216146,Cl.Cl.CN(C)c1ccc(Cc2ccc3CCN(C)[C@@H]4Cc5ccc(O)c(O)c5c2c34)cc1,EC50,=,174.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in HEK293 cells assessed as forskolin-stimulated cAMP accumulation after 15 mins,F,87.0
12752,CHEMBL3216146,Cl.Cl.CN(C)c1ccc(Cc2ccc3CCN(C)[C@@H]4Cc5ccc(O)c(O)c5c2c34)cc1,Ki,=,79.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,B,79.0
12758,CHEMBL3220212,Cc1noc2CC(CN3CCC(CC3)c4c[nH]c5cc(F)ccc45)CC(=O)c12,Ki,=,63.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,B,63.1
12760,CHEMBL3220214,Cc1oc2CC(CN3CCC(CC3)c4noc5cc(F)ccc45)CC(=O)c2n1,Ki,=,32.36,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,B,32.36
12766,CHEMBL3220220,Fc1ccc2c(c[nH]c2c1)C3=CCN(CC4CC(=O)c5sc(nc5C4)N6CCCC6)CC3,Ki,=,54.95,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,B,54.95
12767,CHEMBL3221299,CCN1CCCC1CNc2nncc3ccc(OC)c(OC)c23,Ki,=,3.9,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin),B,3.9
12816,CHEMBL3234536,CCN1C(=O)c2ccccc2[S@+]([O-])c3ccc(cc13)C(=O)NCc4ccc(F)cc4,Ki,=,90.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,B,90.0
12819,CHEMBL3234537,CCN1C(=O)c2ccccc2[S@+]([O-])c3ccc(cc13)C(=O)NCc4ccc(cc4)C#N,Ki,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,B,23.0
12844,CHEMBL3265038,COc1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N3CCC[C@H]3C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCC(=O)N)C(=O)O)C2=O)cc(C(=O)NC[C@@H]5CCCN5CC=C)c1OC,Ki,=,21.47,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,21.47
12845,CHEMBL3265039,COc1cc(CCCSC2CC(=O)N(CCCCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C2=O)cc(C(=O)NC[C@@H]3CCCN3CC=C)c1OC,Ki,=,9.69,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,9.69
12846,CHEMBL3265040,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCCCCN2C(=O)CC(SCCCc3cc(OC)c(OC)c(c3)C(=O)NC[C@@H]4CCCN4CC=C)C2=O)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)N6CCC[C@H]6C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc7cnc[nH]7)C(=O)O,Ki,=,10.32,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,10.32
12847,CHEMBL3265041,COc1cc(CCCSC2CC(=O)N(CCCCCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N4CCC[C@H]4C(=O)N5CCC[C@H]5C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc6c[nH]c7ccccc67)C(=O)N[C@@H](CO)C(=O)N8CCC[C@H]8C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc9c[nH]c%10ccccc9%10)C(=O)N%11CCC[C@H]%11C(=O)O)C2=O)cc(C(=O)NC[C@@H]%12CCCN%12CC=C)c1OC,Ki,=,27.32,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,27.32
12848,CHEMBL3265042,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CNC(=O)CCCCCN4C(=O)CC(SCCCc5cc(OC)c(OC)c(c5)C(=O)NC[C@@H]6CCCN6CC=C)C4=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O,Ki,=,12.27,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,12.27
12849,CHEMBL3265043,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCN1C(=O)CC(SCCCc2cc(OC)c(OC)c(c2)C(=O)NC[C@@H]3CCCN3CC=C)C1=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)N[C@@H](Cc6ccccc6)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc7c[nH]c8ccccc78)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Ki,=,8.14,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,8.14
12850,CHEMBL3265044,COc1cc(CCCSC2CC(=O)N(CCCCCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N3CCC[C@H]3C(=O)O)C2=O)cc(C(=O)NC[C@@H]4CCCN4CC=C)c1OC,Ki,=,12.96,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,12.96
12851,CHEMBL3265045,COc1cc(CCCSC2CC(=O)N(CCCCCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)CN6CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC6)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc7ccccc7)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc8ccc(O)cc8)C(=O)O)C2=O)cc(C(=O)NC[C@@H]9CCCN9CC=C)c1OC,Ki,=,8.01,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,8.01
12852,CHEMBL3265046,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCCNC(=O)CCCCCN2C(=O)CC(SCCCc3cc(OC)c(OC)c(c3)C(=O)NC[C@@H]4CCCN4CC=C)C2=O)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)N6CCC[C@H]6C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc7cnc[nH]7)C(=O)O,Ki,=,28.43,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,28.43
12853,CHEMBL3265047,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)COCCOCCNC(=O)CCCCCN2C(=O)CC(SCCCc3cc(OC)c(OC)c(c3)C(=O)NC[C@@H]4CCCN4CC=C)C2=O)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)N6CCC[C@H]6C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc7cnc[nH]7)C(=O)O,Ki,=,30.33,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,30.33
12854,CHEMBL3265048,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCOCCOCCOCCCNC(=O)CCCCCN2C(=O)CC(SCCCc3cc(OC)c(OC)c(c3)C(=O)NC[C@@H]4CCCN4CC=C)C2=O)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)N6CCC[C@H]6C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc7cnc[nH]7)C(=O)O,Ki,=,23.78,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,23.78
12855,CHEMBL3265049,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCOCCOCCOCCOCCNC(=O)CCCCCN2C(=O)CC(SCCCc3cc(OC)c(OC)c(c3)C(=O)NC[C@@H]4CCCN4CC=C)C2=O)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)N6CCC[C@H]6C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc7cnc[nH]7)C(=O)O,Ki,=,1.47,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,1.47
12861,CHEMBL3265314,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCOCCOCCOCCOCCOCCOCCNC(=O)CCCCCN2C(=O)CC(SCCCc3cc(OC)c(OC)c(c3)C(=O)NC[C@@H]4CCCN4CC=C)C2=O)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)N6CCC[C@H]6C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc7cnc[nH]7)C(=O)O,Ki,=,27.39,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,27.39
12862,CHEMBL3265315,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CCCCCN2C(=O)CC(SCCCc3cc(OC)c(OC)c(c3)C(=O)NC[C@@H]4CCCN4CC=C)C2=O)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)N6CCC[C@H]6C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc7cnc[nH]7)C(=O)O,Ki,=,53.92,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,53.92
12863,CHEMBL3265316,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CCCCCN2C(=O)CC(SCCCc3cc(OC)c(OC)c(c3)C(=O)NC[C@@H]4CCCN4CC=C)C2=O)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)N6CCC[C@H]6C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc7cnc[nH]7)C(=O)O,Ki,=,25.27,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,25.27
12864,CHEMBL3265317,COc1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)CN6CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC6)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc7ccccc7)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc8ccc(O)cc8)C(=O)O)C2=O)cc(C(=O)NC[C@@H]9CCCN9CC=C)c1OC,Ki,=,26.13,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,26.13
12865,CHEMBL3265318,COc1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCOCCOCCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)CN6CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC6)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc7ccccc7)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc8ccc(O)cc8)C(=O)O)C2=O)cc(C(=O)NC[C@@H]9CCCN9CC=C)c1OC,Ki,=,35.77,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,35.77
12866,CHEMBL3265319,COc1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)CN6CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC6)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc7ccccc7)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc8ccc(O)cc8)C(=O)O)C2=O)cc(C(=O)NC[C@@H]9CCCN9CC=C)c1OC,Ki,=,42.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,42.8
12867,CHEMBL3265320,COc1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)CN6CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC6)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc7ccccc7)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc8ccc(O)cc8)C(=O)O)C2=O)cc(C(=O)NC[C@@H]9CCCN9CC=C)c1OC,Ki,=,44.67,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,44.67
12868,CHEMBL3265321,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCCNC(=O)O\N=C\c2ccc(cc2)[Si](F)(C(C)(C)C)C(C)(C)C)NC(=O)CCOCCOCCOCCOCCNC(=O)CCCCCN3C(=O)CC(SCCCc4cc(OC)c(OC)c(c4)C(=O)NC[C@@H]5CCCN5CC=C)C3=O)C(=O)N[C@@H](Cc6ccc(O)cc6)C(=O)N7CCC[C@H]7C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc8cnc[nH]8)C(=O)O,Ki,=,5.98,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,5.98
12869,CHEMBL3265322,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCCNC(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)NC(=O)CCOCCOCCOCCOCCNC(=O)CCCCCN3C(=O)CC(SCCCc4cc(OC)c(OC)c(c4)C(=O)NC[C@@H]5CCCN5CC=C)C3=O)C(=O)N[C@@H](Cc6ccc(O)cc6)C(=O)N7CCC[C@H]7C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc8cnc[nH]8)C(=O)O,Ki,=,52.03,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,52.03
12870,CHEMBL3265323,COc1cc(CCCSC2CC(=O)N(CCCCCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)CN6CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC6)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc7ccccc7)C(=O)N[C@@H](CCCC[n+]8c(C)cc(\C=C\C=C\c9ccc(cc9)N(C)C)cc8C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc%10ccc(O)cc%10)C(=O)O)C2=O)cc(C(=O)NC[C@@H]%11CCCN%11CC=C)c1OC,Ki,=,64.16,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,64.16
12871,CHEMBL3265324,COc1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCC(=O)N)C2=O)cc(C(=O)NC[C@@H]3CCCN3CC=C)c1OC,Ki,=,7.31,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,7.31
12876,CHEMBL3265329,FCCCc1cccc(c1)C(=O)NC[C@@H]2CCCN2CC=C,Ki,=,0.63,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,B,0.63
12895,CHEMBL3286573,CCCCCN1CCN2C(C1)Cc3c[nH]c4cccc2c34,Ki,=,98.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,B,98.0
12896,CHEMBL3286573,CCCCCN1CCN2C(C1)Cc3c[nH]c4cccc2c34,Ki,=,97.72,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,B,97.72
12898,CHEMBL3286574,CC(C)CCN1CCN2C(C1)Cc3c[nH]c4cccc2c34,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,B,24.0
12900,CHEMBL3286574,CC(C)CCN1CCN2C(C1)Cc3c[nH]c4cccc2c34,Ki,=,23.99,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,B,23.99
12901,CHEMBL3286575,C(C1CCCCC1)N2CCN3C(C2)Cc4c[nH]c5cccc3c45,Ki,=,54.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,B,54.0
12903,CHEMBL3286575,C(C1CCCCC1)N2CCN3C(C2)Cc4c[nH]c5cccc3c45,Ki,=,53.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,B,53.7
12910,CHEMBL3286578,C(N1CCN2C(C1)Cc3c[nH]c4cccc2c34)c5cccc(c5)c6ccccc6,Ki,=,0.65,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,B,0.65
12912,CHEMBL3286578,C(N1CCN2C(C1)Cc3c[nH]c4cccc2c34)c5cccc(c5)c6ccccc6,Ki,=,0.2291,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,B,0.2291
12920,CHEMBL3287390,Clc1cccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c1Cl,Ki,=,34.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,34.0
12921,CHEMBL3287390,Clc1cccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c1Cl,Ki,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,39.0
12923,CHEMBL3287390,Clc1cccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c1Cl,EC50,=,177.83,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells co-expressing Galphai2 after 30 mins by [35S]GTPgammaS binding assay,F,88.915
12924,CHEMBL3287390,Clc1cccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c1Cl,EC50,=,180.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells co-expressing Galphai2 after 30 mins by [35S]GTPgammaS binding assay,F,90.0
12926,CHEMBL3287391,Clc1cccc(N2CCN(CCCCOc3cccn4nccc34)CC2)c1Cl,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,25.0
12927,CHEMBL3287391,Clc1cccc(N2CCN(CCCCOc3cccn4nccc34)CC2)c1Cl,Ki,=,30.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,30.0
12928,CHEMBL3287392,Clc1cccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)c1Cl,Ki,=,4.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,4.2
12929,CHEMBL3287392,Clc1cccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)c1Cl,Ki,=,2.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,2.1
12935,CHEMBL3287393,Clc1cccc(N2CCN(CCCCOc3cccc4ccnn34)CC2)c1Cl,Ki,=,64.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,64.0
12936,CHEMBL3287393,Clc1cccc(N2CCN(CCCCOc3cccc4ccnn34)CC2)c1Cl,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,16.0
12937,CHEMBL3287394,Clc1cccc(N2CCN(CCCCOc3cc4ccccn4n3)CC2)c1Cl,Ki,=,9.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,9.4
12938,CHEMBL3287394,Clc1cccc(N2CCN(CCCCOc3cc4ccccn4n3)CC2)c1Cl,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,10.0
12939,CHEMBL3287395,CCOC(=O)c1cc2cc(OCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)ccn2n1,Ki,=,7.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,7.4
12940,CHEMBL3287395,CCOC(=O)c1cc2cc(OCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)ccn2n1,Ki,=,6.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,6.7
12946,CHEMBL3287396,OCc1cc2cc(OCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)ccn2n1,Ki,=,3.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,3.1
12947,CHEMBL3287396,OCc1cc2cc(OCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)ccn2n1,Ki,=,2.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,2.3
12953,CHEMBL3287397,Clc1cccc(N2CCN(CCCCOc3ccn4ncc(C=O)c4c3)CC2)c1Cl,Ki,=,4.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,4.6
12954,CHEMBL3287397,Clc1cccc(N2CCN(CCCCOc3ccn4ncc(C=O)c4c3)CC2)c1Cl,Ki,=,3.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,3.2
12963,CHEMBL3287398,Clc1cccc(N2CCN(CCCCOc3cccn4ncc(C=O)c34)CC2)c1Cl,Ki,=,29.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,29.0
12964,CHEMBL3287398,Clc1cccc(N2CCN(CCCCOc3cccn4ncc(C=O)c34)CC2)c1Cl,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,24.0
12965,CHEMBL3287399,Clc1cccc(N2CCN(CCCCOc3ccc4c(C=O)cnn4c3)CC2)c1Cl,Ki,=,6.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,6.2
12966,CHEMBL3287399,Clc1cccc(N2CCN(CCCCOc3ccc4c(C=O)cnn4c3)CC2)c1Cl,Ki,=,8.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,8.1
12972,CHEMBL3287400,Clc1cccc(N2CCN(CCCCOc3cccc4c(C=O)cnn34)CC2)c1Cl,Ki,=,51.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,51.0
12973,CHEMBL3287400,Clc1cccc(N2CCN(CCCCOc3cccc4c(C=O)cnn34)CC2)c1Cl,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,15.0
12974,CHEMBL3287401,Clc1cccc(N2CCN(CCCCOc3nn4ccccc4c3C=O)CC2)c1Cl,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,10.0
12975,CHEMBL3287401,Clc1cccc(N2CCN(CCCCOc3nn4ccccc4c3C=O)CC2)c1Cl,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,14.0
12976,CHEMBL3287402,Clc1cccc(N2CCN(CCCCOc3ccn4nc(C=O)cc4c3)CC2)c1Cl,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,14.0
12977,CHEMBL3287402,Clc1cccc(N2CCN(CCCCOc3ccn4nc(C=O)cc4c3)CC2)c1Cl,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,14.0
12982,CHEMBL3287402,Clc1cccc(N2CCN(CCCCOc3ccn4nc(C=O)cc4c3)CC2)c1Cl,IC50,=,28.84,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,14.42
12983,CHEMBL3287402,Clc1cccc(N2CCN(CCCCOc3ccn4nc(C=O)cc4c3)CC2)c1Cl,IC50,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,11.0
12986,CHEMBL3287403,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)cc12,Ki,=,1.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,1.8
12987,CHEMBL3287403,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)cc12,Ki,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,1.7
12993,CHEMBL3287403,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)cc12,Ki,=,0.17,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,0.17
12994,CHEMBL3287403,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)cc12,Ki,=,0.25,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,0.25
12999,CHEMBL3287403,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)cc12,IC50,=,3.802,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,1.901
13000,CHEMBL3287403,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)cc12,IC50,=,3.8,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,1.9
13003,CHEMBL3287404,O\N=C\c1cc2cc(OCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)ccn2n1,Ki,=,3.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,3.3
13004,CHEMBL3287404,O\N=C\c1cc2cc(OCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)ccn2n1,Ki,=,2.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,2.3
13010,CHEMBL3287405,Clc1cccc(N2CCN(CCCCOc3ccn4ncc(C#N)c4c3)CC2)c1Cl,Ki,=,0.58,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,0.58
13011,CHEMBL3287405,Clc1cccc(N2CCN(CCCCOc3ccn4ncc(C#N)c4c3)CC2)c1Cl,Ki,=,0.32,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,0.32
13013,CHEMBL3287405,Clc1cccc(N2CCN(CCCCOc3ccn4ncc(C#N)c4c3)CC2)c1Cl,EC50,=,109.65,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells co-expressing Galphai2 after 30 mins by [35S]GTPgammaS binding assay,F,54.825
13014,CHEMBL3287405,Clc1cccc(N2CCN(CCCCOc3ccn4ncc(C#N)c4c3)CC2)c1Cl,EC50,=,110.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells co-expressing Galphai2 after 30 mins by [35S]GTPgammaS binding assay,F,55.0
13017,CHEMBL3287406,Clc1cccc(N2CCN(CCCCOc3ccn4nc(cc4c3)C#N)CC2)c1Cl,Ki,=,8.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,B,8.9
13018,CHEMBL3287406,Clc1cccc(N2CCN(CCCCOc3ccn4nc(cc4c3)C#N)CC2)c1Cl,Ki,=,6.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,B,6.7
13020,CHEMBL3287406,Clc1cccc(N2CCN(CCCCOc3ccn4nc(cc4c3)C#N)CC2)c1Cl,EC50,=,97.72,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells co-expressing Galphai2 after 30 mins by [35S]GTPgammaS binding assay,F,48.86
13021,CHEMBL3287406,Clc1cccc(N2CCN(CCCCOc3ccn4nc(cc4c3)C#N)CC2)c1Cl,EC50,=,98.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells co-expressing Galphai2 after 30 mins by [35S]GTPgammaS binding assay,F,49.0
13050,CHEMBL3289708,Cc1cccc(c1)S(=O)(=O)NCCN2CCN(CC2)c3nsc4ccccc34,Ki,=,43.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,43.0
13051,CHEMBL3289709,Cc1cccc(c1)S(=O)(=O)NCCCN2CCN(CC2)c3nsc4ccccc34,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,13.0
13052,CHEMBL3289944,Cc1cccc(c1)S(=O)(=O)NCCCCN2CCN(CC2)c3nsc4ccccc34,Ki,=,8.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,8.7
13053,CHEMBL3289945,Clc1ccc(cc1Cl)S(=O)(=O)NCCCN2CCN(CC2)c3nsc4ccccc34,Ki,=,7.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,7.8
13054,CHEMBL3289946,Clc1ccc(cc1Cl)S(=O)(=O)NCCCCN2CCN(CC2)c3nsc4ccccc34,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,27.0
13055,CHEMBL3289947,Fc1ccc(cc1Cl)S(=O)(=O)NCCCN2CCN(CC2)c3nsc4ccccc34,Ki,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,37.0
13056,CHEMBL3286432,Fc1ccc(cc1Cl)S(=O)(=O)NCCCCN2CCN(CC2)c3nsc4ccccc34,Ki,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,39.0
13057,CHEMBL3289948,FC(F)(F)Oc1ccc(cc1)S(=O)(=O)NCCCN2CCN(CC2)c3nsc4ccccc34,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,27.0
13058,CHEMBL3289949,FC(F)(F)Oc1ccc(cc1)S(=O)(=O)NCCCCN2CCN(CC2)c3nsc4ccccc34,Ki,=,48.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,48.0
13059,CHEMBL3289950,O=S(=O)(NCCCN1CCN(CC1)c2nsc3ccccc23)c4cccs4,Ki,=,56.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,56.0
13060,CHEMBL3289951,O=S(=O)(NCCCCN1CCN(CC1)c2nsc3ccccc23)c4cccs4,Ki,=,3.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,3.2
13061,CHEMBL3289952,O=S(=O)(NCCN1CCN(CC1)c2nsc3ccccc23)c4ccc5ccccc5c4,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,18.0
13062,CHEMBL3289953,O=S(=O)(NCCCN1CCN(CC1)c2nsc3ccccc23)c4ccc5ccccc5c4,Ki,=,2.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,2.2
13063,CHEMBL3289954,O=S(=O)(NCCCCN1CCN(CC1)c2nsc3ccccc23)c4ccc5ccccc5c4,Kb,=,5.5,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human recombinant D2 receptor expressed in CHO-K1 cells assessed as inhibition of apomorphine-induced response treated 15 to 30 mins before agonist challenge by luminescence analysis,B,5.5
13065,CHEMBL3289954,O=S(=O)(NCCCCN1CCN(CC1)c2nsc3ccccc23)c4ccc5ccccc5c4,Ki,=,0.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,0.9
13066,CHEMBL3289955,Clc1ccc2cc(ccc2c1)S(=O)(=O)NCCCN3CCN(CC3)c4nsc5ccccc45,Ki,=,6.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,6.0
13067,CHEMBL3289956,Clc1ccc2cc(ccc2c1)S(=O)(=O)NCCCCN3CCN(CC3)c4nsc5ccccc45,Ki,=,49.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,49.0
13068,CHEMBL3289957,O=S(=O)(NCCCN1CCN(CC1)c2nsc3ccccc23)c4cc5ccccc5s4,Ki,=,48.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,48.0
13069,CHEMBL3289958,O=S(=O)(NCCCCN1CCN(CC1)c2nsc3ccccc23)c4cc5ccccc5s4,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,15.0
13071,CHEMBL3289960,Clc1ccc2cc(sc2c1)S(=O)(=O)NCCCCN3CCN(CC3)c4nsc5ccccc45,Ki,=,45.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,45.0
13072,CHEMBL3289961,Cc1c(sc2ccc(F)cc12)S(=O)(=O)NCCCN3CCN(CC3)c4nsc5ccccc45,Ki,=,8.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,8.3
13073,CHEMBL3289962,Cc1c(sc2ccc(F)cc12)S(=O)(=O)NCCCCN3CCN(CC3)c4nsc5ccccc45,Ki,=,44.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,44.0
13074,CHEMBL3289963,O=S(=O)(NCCCN1CCN(CC1)c2nsc3ccccc23)c4cnc5ccccn45,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,26.0
13075,CHEMBL3289964,O=S(=O)(NCCCCN1CCN(CC1)c2nsc3ccccc23)c4cnc5ccccn45,Ki,=,46.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,46.0
13076,CHEMBL3289965,O=S(=O)(NCCCN1CCN(CC1)c2nsc3ccccc23)c4cccc5scnc45,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,27.0
13077,CHEMBL3289966,O=S(=O)(NCCCCN1CCN(CC1)c2nsc3ccccc23)c4cccc5scnc45,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,16.0
13079,CHEMBL3289968,Cc1cccc(c1)S(=O)(=O)NCCCCN2CCN(CC2)c3noc4ccccc34,Ki,=,44.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,44.0
13081,CHEMBL3289970,Clc1ccc(cc1Cl)S(=O)(=O)NCCCCN2CCN(CC2)c3noc4ccccc34,Ki,=,57.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,57.0
13083,CHEMBL3289972,Fc1ccc(cc1Cl)S(=O)(=O)NCCCCN2CCN(CC2)c3noc4ccccc34,Ki,=,77.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,77.0
13084,CHEMBL3289973,FC(F)(F)Oc1ccc(cc1)S(=O)(=O)NCCCN2CCN(CC2)c3noc4ccccc34,Ki,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,63.0
13086,CHEMBL3289975,O=S(=O)(NCCCN1CCN(CC1)c2noc3ccccc23)c4cccs4,Ki,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,55.0
13087,CHEMBL3289976,O=S(=O)(NCCCCN1CCN(CC1)c2noc3ccccc23)c4cccs4,Ki,=,5.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,5.3
13089,CHEMBL3289978,O=S(=O)(NCCCCN1CCN(CC1)c2noc3ccccc23)c4ccc5ccccc5c4,Kb,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human recombinant D2 receptor expressed in CHO-K1 cells assessed as inhibition of apomorphine-induced response treated 15 to 30 mins before agonist challenge by luminescence analysis,B,11.0
13091,CHEMBL3289978,O=S(=O)(NCCCCN1CCN(CC1)c2noc3ccccc23)c4ccc5ccccc5c4,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,15.0
13093,CHEMBL3289980,Clc1ccc2cc(ccc2c1)S(=O)(=O)NCCCCN3CCN(CC3)c4noc5ccccc45,Ki,=,51.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,51.0
13094,CHEMBL3289981,O=S(=O)(NCCCN1CCN(CC1)c2noc3ccccc23)c4cc5ccccc5s4,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,15.0
13096,CHEMBL3289983,Clc1ccc2cc(sc2c1)S(=O)(=O)NCCCN3CCN(CC3)c4noc5ccccc45,Ki,=,30.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,30.0
13097,CHEMBL3289984,Clc1ccc2cc(sc2c1)S(=O)(=O)NCCCCN3CCN(CC3)c4noc5ccccc45,Ki,=,54.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,54.0
13099,CHEMBL3289986,Cc1c(sc2ccc(F)cc12)S(=O)(=O)NCCCCN3CCN(CC3)c4noc5ccccc45,Ki,=,46.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,46.0
13103,CHEMBL3289990,Cc1cccc(c1)S(=O)(=O)NCCN2CCC(CC2)c3noc4cc(F)ccc34,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,20.0
13104,CHEMBL3289991,Cc1cccc(c1)S(=O)(=O)NCCCN2CCC(CC2)c3noc4cc(F)ccc34,Kb,=,1.8,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human recombinant D2 receptor expressed in CHO-K1 cells assessed as inhibition of apomorphine-induced response treated 15 to 30 mins before agonist challenge by luminescence analysis,B,1.8
13106,CHEMBL3289991,Cc1cccc(c1)S(=O)(=O)NCCCN2CCC(CC2)c3noc4cc(F)ccc34,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,16.0
13107,CHEMBL3289992,Cc1cccc(c1)S(=O)(=O)NCCCCN2CCC(CC2)c3noc4cc(F)ccc34,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,17.0
13108,CHEMBL3289993,Fc1ccc2c(noc2c1)C3CCN(CCCNS(=O)(=O)c4ccc(Cl)c(Cl)c4)CC3,Kb,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human recombinant D2 receptor expressed in CHO-K1 cells assessed as inhibition of apomorphine-induced response treated 15 to 30 mins before agonist challenge by luminescence analysis,B,14.0
13110,CHEMBL3289993,Fc1ccc2c(noc2c1)C3CCN(CCCNS(=O)(=O)c4ccc(Cl)c(Cl)c4)CC3,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,14.0
13111,CHEMBL3289994,Fc1ccc2c(noc2c1)C3CCN(CCCCNS(=O)(=O)c4ccc(Cl)c(Cl)c4)CC3,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,15.0
13112,CHEMBL3289995,Fc1ccc2c(noc2c1)C3CCN(CCCNS(=O)(=O)c4ccc(F)c(Cl)c4)CC3,Kb,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human recombinant D2 receptor expressed in CHO-K1 cells assessed as inhibition of apomorphine-induced response treated 15 to 30 mins before agonist challenge by luminescence analysis,B,1.1
13114,CHEMBL3289995,Fc1ccc2c(noc2c1)C3CCN(CCCNS(=O)(=O)c4ccc(F)c(Cl)c4)CC3,Ki,=,3.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,3.7
13115,CHEMBL3289996,Fc1ccc2c(noc2c1)C3CCN(CCCCNS(=O)(=O)c4ccc(F)c(Cl)c4)CC3,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,26.0
13116,CHEMBL3289997,Fc1ccc2c(noc2c1)C3CCN(CCCNS(=O)(=O)c4ccc(OC(F)(F)F)cc4)CC3,Ki,=,33.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,33.0
13117,CHEMBL3289998,Fc1ccc2c(noc2c1)C3CCN(CCCCNS(=O)(=O)c4ccc(OC(F)(F)F)cc4)CC3,Ki,=,64.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,64.0
13118,CHEMBL3289999,Fc1ccc2c(noc2c1)C3CCN(CCCNS(=O)(=O)c4cccs4)CC3,Ki,=,8.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,8.7
13120,CHEMBL3290001,Fc1ccc2c(noc2c1)C3CCN(CCNS(=O)(=O)c4cccc5ccccc45)CC3,Ki,=,9.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,9.1
13121,CHEMBL3290002,Fc1ccc2c(noc2c1)C3CCN(CCCNS(=O)(=O)c4cccc5ccccc45)CC3,Ki,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,4.0
13122,CHEMBL3290003,Fc1ccc2c(noc2c1)C3CCN(CCCCNS(=O)(=O)c4cccc5ccccc45)CC3,Kb,=,8.4,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human recombinant D2 receptor expressed in CHO-K1 cells assessed as inhibition of apomorphine-induced response treated 15 to 30 mins before agonist challenge by luminescence analysis,B,8.4
13124,CHEMBL3290003,Fc1ccc2c(noc2c1)C3CCN(CCCCNS(=O)(=O)c4cccc5ccccc45)CC3,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,3.0
13125,CHEMBL3290004,Fc1ccc2c(noc2c1)C3CCN(CCNS(=O)(=O)c4ccc5ccccc5c4)CC3,Ki,=,5.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,5.2
13126,CHEMBL3290005,Fc1ccc2c(noc2c1)C3CCN(CCCNS(=O)(=O)c4ccc5ccccc5c4)CC3,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,1.0
13127,CHEMBL3290006,Fc1ccc2c(noc2c1)C3CCN(CCCCNS(=O)(=O)c4ccc5ccccc5c4)CC3,Kb,=,2.4,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human recombinant D2 receptor expressed in CHO-K1 cells assessed as inhibition of apomorphine-induced response treated 15 to 30 mins before agonist challenge by luminescence analysis,B,2.4
13129,CHEMBL3290006,Fc1ccc2c(noc2c1)C3CCN(CCCCNS(=O)(=O)c4ccc5ccccc5c4)CC3,Ki,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,1.1
13130,CHEMBL3290007,Fc1ccc2c(noc2c1)C3CCN(CCCNS(=O)(=O)c4ccc5cc(Cl)ccc5c4)CC3,Ki,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,23.0
13131,CHEMBL3290008,Fc1ccc2c(noc2c1)C3CCN(CCCCNS(=O)(=O)c4ccc5cc(Cl)ccc5c4)CC3,Kb,=,7.3,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human recombinant D2 receptor expressed in CHO-K1 cells assessed as inhibition of apomorphine-induced response treated 15 to 30 mins before agonist challenge by luminescence analysis,B,7.3
13133,CHEMBL3290008,Fc1ccc2c(noc2c1)C3CCN(CCCCNS(=O)(=O)c4ccc5cc(Cl)ccc5c4)CC3,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,1.0
13134,CHEMBL3290009,Fc1ccc2c(noc2c1)C3CCN(CCCNS(=O)(=O)c4csc5ccccc45)CC3,Ki,=,36.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,36.0
13135,CHEMBL3290010,Fc1ccc2c(noc2c1)C3CCN(CCCCNS(=O)(=O)c4csc5ccccc45)CC3,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,22.0
13136,CHEMBL3290011,Fc1ccc2c(noc2c1)C3CCN(CCCNS(=O)(=O)c4cc5ccccc5s4)CC3,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,11.0
13137,CHEMBL3290012,Fc1ccc2c(noc2c1)C3CCN(CCCCNS(=O)(=O)c4cc5ccccc5s4)CC3,Kb,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human recombinant D2 receptor expressed in CHO-K1 cells assessed as inhibition of apomorphine-induced response treated 15 to 30 mins before agonist challenge by luminescence analysis,B,17.0
13139,CHEMBL3290012,Fc1ccc2c(noc2c1)C3CCN(CCCCNS(=O)(=O)c4cc5ccccc5s4)CC3,Ki,=,1.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human recombinant D2S receptor expressed in HEK293 cells,B,1.8
13140,CHEMBL3290012,Fc1ccc2c(noc2c1)C3CCN(CCCCNS(=O)(=O)c4cc5ccccc5s4)CC3,Kb,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human recombinant at D2S receptor assessed as inhibition of dopamine-induced cAMP accumulation,F,13.0
13141,CHEMBL3290012,Fc1ccc2c(noc2c1)C3CCN(CCCCNS(=O)(=O)c4cc5ccccc5s4)CC3,Ki,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,2.0
13142,CHEMBL3290013,Fc1ccc2c(noc2c1)C3CCN(CCCNS(=O)(=O)c4cc5ccc(Cl)cc5s4)CC3,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,27.0
13143,CHEMBL3290014,Fc1ccc2c(noc2c1)C3CCN(CCCCNS(=O)(=O)c4cc5ccc(Cl)cc5s4)CC3,Kb,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human recombinant D2 receptor expressed in CHO-K1 cells assessed as inhibition of apomorphine-induced response treated 15 to 30 mins before agonist challenge by luminescence analysis,B,15.0
13145,CHEMBL3290014,Fc1ccc2c(noc2c1)C3CCN(CCCCNS(=O)(=O)c4cc5ccc(Cl)cc5s4)CC3,Ki,=,1.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,1.2
13146,CHEMBL3290015,Cc1c(sc2ccc(F)cc12)S(=O)(=O)NCCCN3CCC(CC3)c4noc5cc(F)ccc45,Ki,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,8.0
13147,CHEMBL3290016,Cc1c(sc2ccc(F)cc12)S(=O)(=O)NCCCCN3CCC(CC3)c4noc5cc(F)ccc45,Kb,=,3.4,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human recombinant D2 receptor expressed in CHO-K1 cells assessed as inhibition of apomorphine-induced response treated 15 to 30 mins before agonist challenge by luminescence analysis,B,3.4
13149,CHEMBL3290016,Cc1c(sc2ccc(F)cc12)S(=O)(=O)NCCCCN3CCC(CC3)c4noc5cc(F)ccc45,Ki,=,1.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,1.9
13150,CHEMBL3290017,Cc1c(sc2ccc(Cl)cc12)S(=O)(=O)NCCCCN3CCC(CC3)c4noc5cc(F)ccc45,Kb,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human recombinant D2 receptor expressed in CHO-K1 cells assessed as inhibition of apomorphine-induced response treated 15 to 30 mins before agonist challenge by luminescence analysis,B,11.0
13152,CHEMBL3290017,Cc1c(sc2ccc(Cl)cc12)S(=O)(=O)NCCCCN3CCC(CC3)c4noc5cc(F)ccc45,Ki,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,1.5
13153,CHEMBL3290018,Fc1ccc2c(noc2c1)C3CCN(CCCNS(=O)(=O)c4cnc5ccccn45)CC3,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,15.0
13156,CHEMBL3290021,Fc1ccc2c(noc2c1)C3CCN(CCCCNS(=O)(=O)c4cccc5scnc45)CC3,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,25.0
13173,CHEMBL3298758,COc1ccccc1N2CCN(CCNC(=O)c3sc4nc(OC)c(Cl)c(C)c4c3N)CC2,Ki,=,48.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,48.3
13174,CHEMBL3298758,COc1ccccc1N2CCN(CCNC(=O)c3sc4nc(OC)c(Cl)c(C)c4c3N)CC2,Ki,=,47.86,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,47.86
13177,CHEMBL3298759,COc1ccccc1N2CCN(CCCNC(=O)c3sc4nc(OC)c(Cl)c(C)c4c3N)CC2,Ki,=,19.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,19.5
13178,CHEMBL3298759,COc1ccccc1N2CCN(CCCNC(=O)c3sc4nc(OC)c(Cl)c(C)c4c3N)CC2,Ki,=,19.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,19.5
13184,CHEMBL3298826,COc1ccccc1N2CCN(CCCCNC(=O)c3sc4nc(OC)c(Cl)c(C)c4c3N)CC2,Ki,=,6.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,6.3
13185,CHEMBL3298826,COc1ccccc1N2CCN(CCCCNC(=O)c3sc4nc(OC)c(Cl)c(C)c4c3N)CC2,Ki,=,6.31,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,6.31
13188,CHEMBL3298827,COc1ccccc1N2CCN(CCCCCNC(=O)c3sc4nc(OC)c(Cl)c(C)c4c3N)CC2,Ki,=,3.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,3.5
13189,CHEMBL3298827,COc1ccccc1N2CCN(CCCCCNC(=O)c3sc4nc(OC)c(Cl)c(C)c4c3N)CC2,Ki,=,3.548,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,3.548
13190,CHEMBL3298827,COc1ccccc1N2CCN(CCCCCNC(=O)c3sc4nc(OC)c(Cl)c(C)c4c3N)CC2,EC50,=,2.69,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,B,1.345
13191,CHEMBL3298827,COc1ccccc1N2CCN(CCCCCNC(=O)c3sc4nc(OC)c(Cl)c(C)c4c3N)CC2,EC50,=,2.6919999999999997,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,B,1.3459999999999999
13200,CHEMBL3298828,COc1nc2sc(C(=O)NCCCCCCN3CCC(CC3)c4ccc(Cl)cc4)c(N)c2c(C)c1Cl,Ki,=,0.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,0.6
13201,CHEMBL3298828,COc1nc2sc(C(=O)NCCCCCCN3CCC(CC3)c4ccc(Cl)cc4)c(N)c2c(C)c1Cl,Ki,=,0.6166,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,0.6166
13202,CHEMBL3298828,COc1nc2sc(C(=O)NCCCCCCN3CCC(CC3)c4ccc(Cl)cc4)c(N)c2c(C)c1Cl,EC50,=,5.49,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,B,2.745
13203,CHEMBL3298828,COc1nc2sc(C(=O)NCCCCCCN3CCC(CC3)c4ccc(Cl)cc4)c(N)c2c(C)c1Cl,EC50,=,5.495,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,B,2.7475
13205,CHEMBL3298829,CC(C)(C)OC(=O)NCCCCCN1CCN(CC1)c2cccc(Cl)c2Cl,Ki,=,42.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,42.6
13213,CHEMBL3298829,CC(C)(C)OC(=O)NCCCCCN1CCN(CC1)c2cccc(Cl)c2Cl,Ki,=,42.66,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,42.66
13214,CHEMBL3298830,COc1nc2sc(C(=O)NCCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)c(N)c2c(C)c1Cl,Ki,=,15.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,15.5
13224,CHEMBL3298830,COc1nc2sc(C(=O)NCCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)c(N)c2c(C)c1Cl,Ki,=,15.49,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,15.49
13226,CHEMBL3298830,COc1nc2sc(C(=O)NCCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)c(N)c2c(C)c1Cl,EC50,=,87.6,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,B,43.8
13227,CHEMBL3298895,Cc1cc(C)c2c(N)c(sc2n1)C(=O)NCCCCCN3CCN(CC3)c4cccc(Cl)c4Cl,Ki,=,11.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,11.2
13236,CHEMBL3298895,Cc1cc(C)c2c(N)c(sc2n1)C(=O)NCCCCCN3CCN(CC3)c4cccc(Cl)c4Cl,Ki,=,11.22,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,11.22
13237,CHEMBL3298895,Cc1cc(C)c2c(N)c(sc2n1)C(=O)NCCCCCN3CCN(CC3)c4cccc(Cl)c4Cl,EC50,=,0.3,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of forskolin-stimulated cAMP production treated for 30 mins by AlphaScreen assay,F,0.15
13239,CHEMBL3298895,Cc1cc(C)c2c(N)c(sc2n1)C(=O)NCCCCCN3CCN(CC3)c4cccc(Cl)c4Cl,EC50,=,13.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,B,6.6
13240,CHEMBL3298896,COc1ccccc1N2CCN(CCCCCNC(=O)c3sc4nc(C)cc(C)c4c3N)CC2,Ki,=,9.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,9.1
13248,CHEMBL3298896,COc1ccccc1N2CCN(CCCCCNC(=O)c3sc4nc(C)cc(C)c4c3N)CC2,Ki,=,9.12,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,9.12
13258,CHEMBL3299093,COc1ccccc1N2CCN(CCNC(=O)OC(C)(C)C)CC2,IC50,=,93.3,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of dopamine-induced ERK1/2 phosphorylation treated for 30 mins prior to dopamine stimulation for 5 mins by AlphaScreen assay,B,46.65
13259,CHEMBL3299093,COc1ccccc1N2CCN(CCNC(=O)OC(C)(C)C)CC2,IC50,=,93.33,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of dopamine-induced ERK1/2 phosphorylation treated for 30 mins prior to dopamine stimulation for 5 mins by AlphaScreen assay,B,46.665
13260,CHEMBL3299094,COc1ccccc1N2CCN(CCCNC(=O)OC(C)(C)C)CC2,Ki,=,16.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,16.1
13261,CHEMBL3299094,COc1ccccc1N2CCN(CCCNC(=O)OC(C)(C)C)CC2,Ki,=,15.85,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,15.85
13263,CHEMBL3299094,COc1ccccc1N2CCN(CCCNC(=O)OC(C)(C)C)CC2,EC50,=,0.39,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,B,0.195
13264,CHEMBL3299094,COc1ccccc1N2CCN(CCCNC(=O)OC(C)(C)C)CC2,EC50,=,0.389,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,B,0.1945
13266,CHEMBL3299095,COc1ccccc1N2CCN(CCCCNC(=O)OC(C)(C)C)CC2,Ki,=,18.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,18.9
13267,CHEMBL3299095,COc1ccccc1N2CCN(CCCCNC(=O)OC(C)(C)C)CC2,Ki,=,19.05,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,19.05
13269,CHEMBL3299095,COc1ccccc1N2CCN(CCCCNC(=O)OC(C)(C)C)CC2,EC50,=,0.6,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,B,0.3
13270,CHEMBL3299095,COc1ccccc1N2CCN(CCCCNC(=O)OC(C)(C)C)CC2,EC50,=,0.6026,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,B,0.3013
13272,CHEMBL3299096,COc1ccccc1N2CCN(CCCCCNC(=O)OC(C)(C)C)CC2,Ki,=,12.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,12.1
13273,CHEMBL3299096,COc1ccccc1N2CCN(CCCCCNC(=O)OC(C)(C)C)CC2,Ki,=,12.02,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,12.02
13275,CHEMBL3299096,COc1ccccc1N2CCN(CCCCCNC(=O)OC(C)(C)C)CC2,EC50,=,1.43,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,B,0.715
13276,CHEMBL3299096,COc1ccccc1N2CCN(CCCCCNC(=O)OC(C)(C)C)CC2,EC50,=,1.445,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,B,0.7225
13285,CHEMBL3299097,COc1ccccc1N2CCN(CCCCCCNC(=O)OC(C)(C)C)CC2,Ki,=,74.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,74.8
13286,CHEMBL3299097,COc1ccccc1N2CCN(CCCCCCNC(=O)OC(C)(C)C)CC2,Ki,=,74.13,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,74.13
13288,CHEMBL3299097,COc1ccccc1N2CCN(CCCCCCNC(=O)OC(C)(C)C)CC2,IC50,=,3.98,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of dopamine-induced ERK1/2 phosphorylation treated for 30 mins prior to dopamine stimulation for 5 mins by AlphaScreen assay,B,1.99
13289,CHEMBL3299097,COc1ccccc1N2CCN(CCCCCCNC(=O)OC(C)(C)C)CC2,IC50,=,3.9810000000000003,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of dopamine-induced ERK1/2 phosphorylation treated for 30 mins prior to dopamine stimulation for 5 mins by AlphaScreen assay,B,1.9905
13300,CHEMBL3318824,CCC(=O)OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,3.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,3.9
13301,CHEMBL3318824,CCC(=O)OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,1.6
13302,CHEMBL3318831,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCC(=O)OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)c5ccc(Cl)cc5)c6ccc(Cl)cc6,Ki,=,6.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,6.7
13303,CHEMBL3318831,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCC(=O)OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)c5ccc(Cl)cc5)c6ccc(Cl)cc6,Ki,=,5.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,5.4
13304,CHEMBL3318832,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCCC(=O)OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)c5ccc(Cl)cc5)c6ccc(Cl)cc6,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,12.0
13305,CHEMBL3318832,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCCC(=O)OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)c5ccc(Cl)cc5)c6ccc(Cl)cc6,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,12.0
13306,CHEMBL3318833,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCCCC(=O)OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)c5ccc(Cl)cc5)c6ccc(Cl)cc6,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,3.0
13307,CHEMBL3318833,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCCCC(=O)OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)c5ccc(Cl)cc5)c6ccc(Cl)cc6,Ki,=,2.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,2.3
13308,CHEMBL3318834,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCCCCC(=O)OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)c5ccc(Cl)cc5)c6ccc(Cl)cc6,Ki,=,3.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,3.3
13309,CHEMBL3318834,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCCCCC(=O)OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)c5ccc(Cl)cc5)c6ccc(Cl)cc6,Ki,=,2.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,2.6
13310,CHEMBL3318835,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCCCCCC(=O)OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)c5ccc(Cl)cc5)c6ccc(Cl)cc6,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,2.5
13311,CHEMBL3318835,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCCCCCC(=O)OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)c5ccc(Cl)cc5)c6ccc(Cl)cc6,Ki,=,2.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,2.9
13312,CHEMBL3318836,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCCCCCCC(=O)OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)c5ccc(Cl)cc5)c6ccc(Cl)cc6,Ki,=,5.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,5.6
13313,CHEMBL3318836,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCCCCCCC(=O)OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)c5ccc(Cl)cc5)c6ccc(Cl)cc6,Ki,=,6.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,6.5
13314,CHEMBL3318837,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCCCCCCCC(=O)OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)c5ccc(Cl)cc5)c6ccc(Cl)cc6,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,15.0
13315,CHEMBL3318837,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCCCCCCCC(=O)OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)c5ccc(Cl)cc5)c6ccc(Cl)cc6,Ki,=,31.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,31.0
13316,CHEMBL3318838,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCCCCCCCCCC(=O)OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)c5ccc(Cl)cc5)c6ccc(Cl)cc6,Ki,=,66.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,66.0
13317,CHEMBL3318838,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCCCCCCCCCC(=O)OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)c5ccc(Cl)cc5)c6ccc(Cl)cc6,Ki,=,46.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,46.0
13319,CHEMBL3318839,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCCCCCCCCCCCC(=O)OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)c5ccc(Cl)cc5)c6ccc(Cl)cc6,Ki,=,62.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,62.0
13324,CHEMBL3318842,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCCCCCCCCCCCCCCCCCC(=O)OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)c5ccc(Cl)cc5)c6ccc(Cl)cc6,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,25.0
13325,CHEMBL3318842,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCCCCCCCCCCCCCCCCCC(=O)OC3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)c5ccc(Cl)cc5)c6ccc(Cl)cc6,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,27.0
13328,CHEMBL3318844,Cc1ccc(cc1)C(=O)OC2(CCN(CCCC(=O)c3ccc(F)cc3)CC2)c4ccc(Cl)cc4,Ki,=,56.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,56.0
13329,CHEMBL3318844,Cc1ccc(cc1)C(=O)OC2(CCN(CCCC(=O)c3ccc(F)cc3)CC2)c4ccc(Cl)cc4,Ki,=,47.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,47.0
13330,CHEMBL3318845,CC(=O)OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,4.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,4.5
13331,CHEMBL3318845,CC(=O)OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,4.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,4.5
13332,CHEMBL3318846,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCN3CCN(CCC(=O)OC4(CCN(CCCC(=O)c5ccc(F)cc5)CC4)c6ccc(Cl)cc6)CC3)c7ccc(Cl)cc7,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,2.5
13333,CHEMBL3318846,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCN3CCN(CCC(=O)OC4(CCN(CCCC(=O)c5ccc(F)cc5)CC4)c6ccc(Cl)cc6)CC3)c7ccc(Cl)cc7,Ki,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,1.1
13334,CHEMBL3318847,CN(CCN(C)CCC(=O)OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3)CCC(=O)OC4(CCN(CCCC(=O)c5ccc(F)cc5)CC4)c6ccc(Cl)cc6,Ki,=,3.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,3.2
13335,CHEMBL3318847,CN(CCN(C)CCC(=O)OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3)CCC(=O)OC4(CCN(CCCC(=O)c5ccc(F)cc5)CC4)c6ccc(Cl)cc6,Ki,=,2.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,2.2
13336,CHEMBL3318848,CN(C)CCC(=O)OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,1.9
13337,CHEMBL3318848,CN(C)CCC(=O)OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,1.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,1.8
13338,CHEMBL3318849,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCc3cn(CCCCCCCCn4cc(CCC(=O)OC5(CCN(CCCC(=O)c6ccc(F)cc6)CC5)c7ccc(Cl)cc7)nn4)nn3)c8ccc(Cl)cc8,Ki,=,1.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,1.3
13339,CHEMBL3318849,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCc3cn(CCCCCCCCn4cc(CCC(=O)OC5(CCN(CCCC(=O)c6ccc(F)cc6)CC5)c7ccc(Cl)cc7)nn4)nn3)c8ccc(Cl)cc8,Ki,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,1.6
13340,CHEMBL3318850,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCc3cn(CCCCCCCCCCn4cc(CCC(=O)OC5(CCN(CCCC(=O)c6ccc(F)cc6)CC5)c7ccc(Cl)cc7)nn4)nn3)c8ccc(Cl)cc8,Ki,=,4.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,4.9
13341,CHEMBL3318850,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCc3cn(CCCCCCCCCCn4cc(CCC(=O)OC5(CCN(CCCC(=O)c6ccc(F)cc6)CC5)c7ccc(Cl)cc7)nn4)nn3)c8ccc(Cl)cc8,Ki,=,5.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,5.4
13342,CHEMBL3317465,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCc3cn(CCOCCOCCOCCn4cc(CCC(=O)OC5(CCN(CCCC(=O)c6ccc(F)cc6)CC5)c7ccc(Cl)cc7)nn4)nn3)c8ccc(Cl)cc8,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,1.0
13343,CHEMBL3317465,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCc3cn(CCOCCOCCOCCn4cc(CCC(=O)OC5(CCN(CCCC(=O)c6ccc(F)cc6)CC5)c7ccc(Cl)cc7)nn4)nn3)c8ccc(Cl)cc8,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,3.0
13344,CHEMBL3318851,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCc3cn(CCOCCOCCOCCOCCn4cc(CCC(=O)OC5(CCN(CCCC(=O)c6ccc(F)cc6)CC5)c7ccc(Cl)cc7)nn4)nn3)c8ccc(Cl)cc8,Ki,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,B,1.6
13345,CHEMBL3318851,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(OC(=O)CCc3cn(CCOCCOCCOCCOCCn4cc(CCC(=O)OC5(CCN(CCCC(=O)c6ccc(F)cc6)CC5)c7ccc(Cl)cc7)nn4)nn3)c8ccc(Cl)cc8,Ki,=,3.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,B,3.8
13348,CHEMBL3321788,OC1(CC2CCC(C1)N2CCCCc3ccc(F)cc3)c4ccc(Cl)cc4,Ki,=,33.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,33.0
13349,CHEMBL3321789,OC1(CC2CCC(C1)N2CCCOc3ccc(F)cc3)c4ccc(Cl)cc4,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,22.0
13350,CHEMBL3321790,OC1(CC2CCC(C1)N2CCCSc3ccc(F)cc3)c4ccc(Cl)cc4,Ki,=,2.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,2.9
13351,CHEMBL3321791,OC1(CC2CCC(C1)N2CCCSc3cccc(F)c3)c4ccc(Cl)cc4,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,27.0
13352,CHEMBL3321792,OC1(CC2CCC(C1)N2CCCSc3ccccc3F)c4ccc(Cl)cc4,Ki,=,4.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,4.8
13354,CHEMBL3322993,COc1ccccc1N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,B,19.0
13356,CHEMBL3322993,COc1ccccc1N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2,IC50,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,B,13.0
13360,CHEMBL3322993,COc1ccccc1N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2,IC50,=,6.6,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,3.3
13361,CHEMBL3322994,Clc1cccc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)c1Cl,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,B,12.0
13363,CHEMBL3322994,Clc1cccc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)c1Cl,IC50,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,B,27.5
13367,CHEMBL3322994,Clc1cccc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)c1Cl,IC50,=,91.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,45.5
13374,CHEMBL3322995,FC(F)(F)c1cccc(c1)N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2,IC50,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,30.0
13383,CHEMBL3322998,O=C(NCCCCN1CCN(CC1)c2ccnc3ccccc23)c4cn5ccccc5n4,IC50,=,161.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,80.5
13431,CHEMBL3323015,CC(C)(C)c1nc(cc(n1)C(F)(F)F)N2CCN(CCCCNC(=O)c3cn4cccnc4n3)CC2,IC50,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,18.5
13438,CHEMBL3323016,CC(C)(C)c1nc(cc(n1)C(F)(F)F)N2CCN(CCCCNC(=O)c3cn4ccncc4n3)CC2,IC50,=,49.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,24.5
13447,CHEMBL3323017,CC(C)(C)c1nc(cc(n1)C(F)(F)F)N2CCN(CCCCNC(=O)c3cn4nc(Cl)ccc4n3)CC2,IC50,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,11.0
13453,CHEMBL3323112,CN(C)Cc1c(nc2ccccn12)C(=O)NCCCCN3CCN(CC3)c4cc(nc(n4)C(C)(C)C)C(F)(F)F,Ki,=,72.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from chimeric human D2 receptor possessing extracellular loop II of D3 receptor expressed in HEK293 cell membranes by gamma counting method,B,72.0
13502,CHEMBL3335470,NC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cc(cc(c3)C(F)(F)F)C#N)CC1,Ki,=,30.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from human D2long receptor expressed in HEK293Galpha15 cells after 120 mins by scintillation counting analysis,B,30.0
13503,CHEMBL3335471,NCC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cc(cc(c3)C(F)(F)F)C#N)CC1,Ki,=,5.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from human D2long receptor expressed in HEK293Galpha15 cells after 120 mins by scintillation counting analysis,B,5.4
13504,CHEMBL3335472,NS(=O)(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cc(cc(c3)C(F)(F)F)C#N)CC1,Ki,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from human D2long receptor expressed in HEK293Galpha15 cells after 120 mins by scintillation counting analysis,B,37.0
13528,CHEMBL3344356,COc1cc2CCN3Cc4ccsc4C[C@H]3c2cc1O,Ki,=,88.02,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,B,88.02
13530,CHEMBL3344456,CCc1cc2CN3CCc4cc(OC)c(O)cc4[C@@H]3Cc2s1,Ki,=,40.83,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,B,40.83
13532,CHEMBL3344457,CCCc1cc2CN3CCc4cc(OC)c(O)cc4[C@@H]3Cc2s1,Ki,=,38.63,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,B,38.63
13534,CHEMBL3344458,CCCCc1cc2CN3CCc4cc(OC)c(O)cc4[C@@H]3Cc2s1,Ki,=,17.61,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,B,17.61
13537,CHEMBL3344459,COc1cc2CCN3Cc4cc(CC(C)C)sc4C[C@H]3c2cc1O,Ki,=,7.54,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,B,7.54
13540,CHEMBL3344460,CCCCCc1cc2CN3CCc4cc(OC)c(O)cc4[C@@H]3Cc2s1,Ki,=,46.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,B,46.7
13542,CHEMBL3344461,COc1cc2CCN3Cc4cc(CCC(C)C)sc4C[C@H]3c2cc1O,Ki,=,79.54,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,B,79.54
13544,CHEMBL3344462,CCC(C)Cc1cc2CN3CCc4cc(OC)c(O)cc4[C@@H]3Cc2s1,Ki,=,29.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,B,29.1
13549,CHEMBL3344465,COc1cc2CCN3Cc4cc(CC5CCC5)sc4C[C@H]3c2cc1O,Ki,=,34.23,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,B,34.23
13551,CHEMBL3344466,COc1cc2CCN3Cc4cc(CC5CC5)sc4C[C@H]3c2cc1O,Ki,=,11.51,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,B,11.51
13553,CHEMBL3344467,COc1cc2CCN3Cc4cc(CCCl)sc4C[C@H]3c2cc1O,Ki,=,34.36,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,B,34.36
13555,CHEMBL3344468,COc1cc2CCN3Cc4cc(CCCCl)sc4C[C@H]3c2cc1O,Ki,=,18.38,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,B,18.38
13557,CHEMBL3344469,COc1cc2CCN3Cc4cc(CC(C)Cl)sc4C[C@H]3c2cc1O,Ki,=,16.49,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,B,16.49
13559,CHEMBL3344470,COc1cc2CCN3Cc4cc(CCCCCl)sc4C[C@H]3c2cc1O,Ki,=,12.02,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,B,12.02
13562,CHEMBL3353894,COc1ccccc1N2CCN(CCCc3cn(nn3)c4ccccc4)CC2,Ki,=,64.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,B,64.0
13563,CHEMBL3353895,COc1ccccc1N2CCN(CCCCc3cn(nn3)c4ccccc4)CC2,Ki,=,30.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,B,30.9
13564,CHEMBL3353895,COc1ccccc1N2CCN(CCCCc3cn(nn3)c4ccccc4)CC2,Ki,=,53.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,53.6
13565,CHEMBL3353896,COc1ccccc1N2CCN(CCCCCc3cn(nn3)c4ccccc4)CC2,Ki,=,19.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,B,19.4
13566,CHEMBL3353897,COc1ccccc1N2CCN(CCCc3cn(nn3)c4cccc5cnccc45)CC2,Ki,=,79.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,B,79.3
13567,CHEMBL3353898,COc1ccccc1N2CCN(CCCCc3cn(nn3)c4cccc5cnccc45)CC2,Ki,=,42.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,B,42.3
13569,CHEMBL3353899,COc1ccccc1N2CCN(CCCCCc3cn(nn3)c4cccc5cnccc45)CC2,Ki,=,17.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,B,17.7
13573,CHEMBL3353901,COc1ccccc1N2CCN(CCCCc3cn(nn3)c4ccc(cc4)c5ccsc5)CC2,Ki,=,94.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,B,94.3
13577,CHEMBL3353903,COc1ccccc1N2CCN(CCCc3cn(nn3)c4ccc(F)cc4)CC2,Ki,=,73.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,B,73.5
13578,CHEMBL3353904,COc1ccccc1N2CCN(CCCCc3cn(nn3)c4ccc(F)cc4)CC2,Ki,=,46.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,B,46.7
13579,CHEMBL3353905,COc1ccccc1N2CCN(CCCCCc3cn(nn3)c4ccc(F)cc4)CC2,Ki,=,23.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,B,23.7
13582,CHEMBL3353908,COc1ccccc1N2CCN(CCCCCc3cn(nn3)c4ccccc4OC)CC2,Ki,=,62.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,B,62.7
13586,CHEMBL3353911,COc1ccccc1N2CCN(CCCCCc3cn(nn3)c4ccc(cc4)N(C)C)CC2,Ki,=,62.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,B,62.6
13587,CHEMBL3353912,COc1ccccc1N2CCN(CCCc3cn(nn3)c4ccc(SC)cc4)CC2,Ki,=,44.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,B,44.1
13588,CHEMBL3353913,COc1ccccc1N2CCN(CCCCc3cn(nn3)c4ccc(SC)cc4)CC2,Ki,=,37.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,B,37.7
13590,CHEMBL3353914,COc1ccccc1N2CCN(CCCCCc3cn(nn3)c4ccc(SC)cc4)CC2,Ki,=,26.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,B,26.6
13592,CHEMBL3353915,COc1ccccc1N2CCN(CCCc3cn(nn3)c4ccccc4O)CC2,Ki,=,12.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,B,12.8
13593,CHEMBL3353916,COc1ccccc1N2CCN(CCCCc3cn(nn3)c4ccccc4O)CC2,Ki,=,9.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,B,9.4
13606,CHEMBL3358104,FC(F)(F)c1cccc(c1)N2CCN(CCCCNC(=O)c3cc4ccccc4[nH]3)CC2,Ki,=,53.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,53.0
13607,CHEMBL3358105,Fc1ccccc1N2CCN(CCCCNC(=O)c3oc4ccccc4c3)CC2,Ki,=,76.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,76.0
13611,CHEMBL3358493,Cc1cccc(N2CCN(CCCCNC(=O)c3oc4ccccc4c3)CC2)c1C,Ki,=,85.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,85.0
13630,CHEMBL3358512,O=C(NCCCCN1CCN(CC1)c2cccc3ccccc23)c4ccccc4,Ki,=,58.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,58.0
13631,CHEMBL3358513,O=C(NCCCCN1CCN(CC1)c2cnc3ccccc3c2)c4ccccc4,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,1.0
13642,CHEMBL3394254,CCCN(CCCNC(=O)CCCCCCCCCCCNC(=O)OC(C)(C)C)CCc1cccc2NC(=O)Cc12,EC50,=,114.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,57.0
13643,CHEMBL3394254,CCCN(CCCNC(=O)CCCCCCCCCCCNC(=O)OC(C)(C)C)CCc1cccc2NC(=O)Cc12,EC50,=,112.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,56.1
13645,CHEMBL3394255,CCCN(CCCNC(=O)COc1ccc(CCNc2nc(N)n3nc(nc3n2)c4occc4)cc1)CCc5cccc6NC(=O)Cc56,EC50,=,148.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,74.0
13646,CHEMBL3394255,CCCN(CCCNC(=O)COc1ccc(CCNc2nc(N)n3nc(nc3n2)c4occc4)cc1)CCc5cccc6NC(=O)Cc56,EC50,=,147.91,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,73.955
13675,CHEMBL3394265,CCCN(CCCNc1nc(N)n2nc(nc2n1)c3occc3)CCc4cccc5NC(=O)Cc45,EC50,=,88.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,44.0
13676,CHEMBL3394265,CCCN(CCCNc1nc(N)n2nc(nc2n1)c3occc3)CCc4cccc5NC(=O)Cc45,EC50,=,87.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,43.55
13678,CHEMBL3394266,CCCN(CCCCCCNc1nc(N)n2nc(nc2n1)c3occc3)CCc4cccc5NC(=O)Cc45,EC50,=,38.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,19.0
13679,CHEMBL3394266,CCCN(CCCCCCNc1nc(N)n2nc(nc2n1)c3occc3)CCc4cccc5NC(=O)Cc45,EC50,=,37.15,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,18.575
13713,CHEMBL3409232,O=C1CCc2ccc(OCCCCN3CCC(=CC3)c4cn(Cc5ccccc5)c6ccccc46)cc2N1,Ki,=,73.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,73.0
13714,CHEMBL3409233,O=C1CCc2ccc(OCCCCN3CCC(=CC3)c4cn(c5ccccc45)S(=O)(=O)c6ccccc6)cc2N1,Ki,=,40.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,40.0
13715,CHEMBL3409234,O=C1CCc2ccc(OCCCCN3CCC(CC3)c4cn(Cc5ccccc5)c6ccccc46)cc2N1,Ki,=,4.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,4.8
13716,CHEMBL3407518,O=C1CCc2ccc(OCCCCN3CCC(CC3)c4cn(c5ccccc45)S(=O)(=O)c6ccccc6)cc2N1,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,14.0
13717,CHEMBL3409235,O=C1CCc2ccc(OCCCCNCCc3cn(Cc4ccccc4)c5ccccc35)cc2N1,Ki,=,70.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,70.0
13719,CHEMBL3409237,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4cccc5c4ccn5Cc6ccccc6)cc2N1,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,20.0
13723,CHEMBL3409238,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4cccc5c4ccn5S(=O)(=O)c6ccccc6)cc2N1,Ki,=,1.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,1.3
13727,CHEMBL3409239,Fc1ccccc1Cn2ccc3c(cccc23)N4CCN(CCCCOc5ccc6CCC(=O)Nc6c5)CC4,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,11.0
13728,CHEMBL3409240,Fc1cccc(Cn2ccc3c(cccc23)N4CCN(CCCCOc5ccc6CCC(=O)Nc6c5)CC4)c1,Ki,=,6.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,6.1
13732,CHEMBL3409241,Fc1ccc(Cn2ccc3c(cccc23)N4CCN(CCCCOc5ccc6CCC(=O)Nc6c5)CC4)cc1,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,12.0
13733,CHEMBL3409242,Clc1cccc(Cn2ccc3c(cccc23)N4CCN(CCCCOc5ccc6CCC(=O)Nc6c5)CC4)c1,Ki,=,1.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,1.3
13737,CHEMBL3409243,NC(=O)c1ccccc1OCCCN2CCC(=CC2)c3cn(Cc4ccccc4)c5ccccc35,Ki,=,31.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,31.0
13739,CHEMBL3409245,NC(=O)c1ccccc1OCCCN2CCC(CC2)c3cn(Cc4ccccc4)c5ccccc35,Ki,=,29.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,29.0
13740,CHEMBL3409246,NC(=O)c1ccccc1OCCCN2CCC(CC2)c3cn(c4ccccc34)S(=O)(=O)c5ccccc5,Ki,=,62.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,62.0
13743,CHEMBL3409249,NC(=O)c1ccccc1OCCCN2CCN(CC2)c3cccc4c3ccn4Cc5ccccc5,Ki,=,95.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,95.0
13744,CHEMBL3409250,NC(=O)c1ccccc1OCCCN2CCN(CC2)c3cccc4c3ccn4Cc5ccccc5F,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,21.0
13745,CHEMBL3409251,NC(=O)c1ccccc1OCCCN2CCN(CC2)c3cccc4c3ccn4Cc5cccc(F)c5,Ki,=,45.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,45.0
13746,CHEMBL3409252,NC(=O)c1ccccc1OCCCN2CCN(CC2)c3cccc4c3ccn4Cc5ccc(F)cc5,Ki,=,44.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,44.0
13747,CHEMBL3409253,NC(=O)c1ccccc1OCCCN2CCN(CC2)c3cccc4c3ccn4Cc5cccc(Cl)c5,Ki,=,76.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,76.0
13748,CHEMBL3409254,O=C1CCc2ccc(OCCCN3CCN(CC3)c4cccc5c4ccn5S(=O)(=O)c6ccccc6)cc2N1,Ki,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,23.0
13750,CHEMBL3409256,NC(=O)c1ccccc1OCCCN2CCN(CC2)c3cccc4c3ccn4S(=O)(=O)c5ccccc5,Ki,=,6.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,6.3
13751,CHEMBL3409256,NC(=O)c1ccccc1OCCCN2CCN(CC2)c3cccc4c3ccn4S(=O)(=O)c5ccccc5,Kb,=,3.7,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity against human recombinant dopmaine D2L receptor expressed in CHOK1 cells assessed as reduction in apomorphine-induced increase in intracellular Ca2+ levels by aequorin based radiometric and luminescence plate counting method,B,3.7
13752,CHEMBL3409256,NC(=O)c1ccccc1OCCCN2CCN(CC2)c3cccc4c3ccn4S(=O)(=O)c5ccccc5,EC50,=,54.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopmaine D2L receptor expressed in CHOK1 cells assessed as intracellular Ca2+ levels by aequorin based radiometric and luminescence plate counting method,B,27.0
13753,CHEMBL3409256,NC(=O)c1ccccc1OCCCN2CCN(CC2)c3cccc4c3ccn4S(=O)(=O)c5ccccc5,Ki,=,6.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human D2S receptor expressed in HEK293 cells,B,6.3
13754,CHEMBL3409257,NC(=O)c1ccccc1OCCCCN2CCN(CC2)c3cccc4c3ccn4S(=O)(=O)c5ccccc5,Ki,=,78.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,78.0
13758,CHEMBL3409261,O=S(=O)(c1ccccc1)n2ccc3c(cccc23)N4CCN(CCCCOc5ccccc5)CC4,Ki,=,62.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,62.0
13759,CHEMBL3409262,Fc1ccc(OCCCN2CCN(CC2)c3cccc4c3ccn4S(=O)(=O)c5ccccc5)cc1,Ki,=,67.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,67.0
13760,CHEMBL3409263,Fc1ccc(OCCCCN2CCN(CC2)c3cccc4c3ccn4S(=O)(=O)c5ccccc5)cc1,Ki,=,47.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,B,47.0
13773,CHEMBL3423332,CN1C(=O)N(C)c2nc3n(CCCCN4CCN(CC4)c5ccccc5O)c(cn3c2C1=O)c6ccccc6,Ki,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,B,4.0
13780,CHEMBL3423333,CN1C(=O)N(C)c2nc3n(CCCCCN4CCN(CC4)c5ccccc5O)c(cn3c2C1=O)c6ccccc6,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,B,24.0
13790,CHEMBL3423337,CN1C(=O)N(C)c2nc3n(CCCCN4CCN(CC4)c5ccc(Cl)cc5)c(cn3c2C1=O)c6ccccc6,Ki,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,B,23.0
13791,CHEMBL3423338,CN1C(=O)N(C)c2nc3n(CCCCCN4CCN(CC4)c5ccc(Cl)cc5)c(cn3c2C1=O)c6ccccc6,Ki,=,9.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,B,9.0
13796,CHEMBL3423339,CN1C(=O)N(C)c2nc3n(CCCCN4CCN(CC4)c5cccc(C)c5C)c(C)cn3c2C1=O,Ki,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,B,27.0
13803,CHEMBL3423340,CN1C(=O)N(C)c2nc3n(CCCCCN4CCN(CC4)c5ccc(Cl)c(Cl)c5)c(C)cn3c2C1=O,Ki,=,59.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,B,59.0
13819,CHEMBL3423378,CN1C(=O)N(C)c2nc3N(CCCCN4CCN(CC4)c5ccc(Cl)cc5)C(=O)C=Cn3c2C1=O,Ki,=,68.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,B,68.0
13856,CHEMBL3526391,C1CN(CCN1)C2=Nc3ccccc3Sc4ccccc24,Ki,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding Assay: The ability of test compounds to displace 3H-raclopride at the D2s receptor can be determined on membranes from D2s-transfected CHO cells (Bmax 13 pmol/mg protein). An assay can use a standard 96-well glass-fiber filter plate to retain radioligand bound by the receptor. Retained 3H can be determined in a TopCount scintillation plate counter following the addition of a liquid scintillant to each well. Compounds can be evaluated for their potency using competition curve analysis, resulting in calculated Ki values.",B,37.0
13861,CHEMBL3577342,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@H]3COC(=CC3)C#C)nn1,Ki,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,B,1.6
13862,CHEMBL3577342,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@H]3COC(=CC3)C#C)nn1,Ki,=,2.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,B,2.9
13863,CHEMBL3577342,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@H]3COC(=CC3)C#C)nn1,EC50,=,110.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity at human dopamine D2S receptor expressed in HEK293 cells co-transfected with Galpha0i assessed as [35S]GTPgammaS binding after 30 mins by [35S]GTPgammaS incorporation assay,B,55.0
13867,CHEMBL3577342,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@H]3COC(=CC3)C#C)nn1,EC50,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity at human dopamine D2L receptor expressed in HEK293 cells co-transfected with Galpha0i assessed as [35S]GTPgammaS binding after 30 mins by [35S]GTPgammaS incorporation assay,B,26.0
13869,CHEMBL3577342,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@H]3COC(=CC3)C#C)nn1,EC50,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity at human dopamine D2L receptor expressed in HEK293 cells co-transfected with Galphai2 assessed as [35S]GTPgammaS binding after 30 mins by [35S]GTPgammaS incorporation assay,B,14.0
13873,CHEMBL3577343,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@@H]3COC(=CC3)C#C)nn1,Ki,=,4.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,B,4.9
13874,CHEMBL3577343,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@@H]3COC(=CC3)C#C)nn1,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,B,10.0
13879,CHEMBL3577343,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@@H]3COC(=CC3)C#C)nn1,EC50,=,90.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity at human dopamine D2L receptor expressed in HEK293 cells co-transfected with Galpha0i assessed as [35S]GTPgammaS binding after 30 mins by [35S]GTPgammaS incorporation assay,B,45.0
13885,CHEMBL3577344,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)CCc3ccc(O)c4NC(=O)C=Cc34)nn1,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,B,24.0
13886,CHEMBL3577344,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)CCc3ccc(O)c4NC(=O)C=Cc34)nn1,Ki,=,53.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,B,53.0
13895,CHEMBL3577344,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)CCc3ccc(O)c4NC(=O)C=Cc34)nn1,EC50,=,140.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ARMS2-PK2-tagged human dopamine D2S receptor expressed in HEK293 cells co-expressing (EA)-tagged beta arrestin fusion protein assessed as recruitment of beta-arrestin-2 after 5 hrs by chemiluminescence assay,B,70.0
13897,CHEMBL3577345,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@@H]3CCc4c(O)cccc4C3)nn1,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,B,18.0
13898,CHEMBL3577345,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@@H]3CCc4c(O)cccc4C3)nn1,Ki,=,30.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,B,30.0
13907,CHEMBL3577345,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@@H]3CCc4c(O)cccc4C3)nn1,EC50,=,30.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ARMS2-PK2-tagged human dopamine D2S receptor expressed in HEK293 cells co-expressing (EA)-tagged beta arrestin fusion protein assessed as recruitment of beta-arrestin-2 after 5 hrs by chemiluminescence assay,B,15.0
13909,CHEMBL3577346,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)nn1,Ki,=,0.47,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,B,0.47
13910,CHEMBL3577346,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)nn1,Ki,=,0.54,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,B,0.54
13911,CHEMBL3577346,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)nn1,EC50,=,2.1,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity at human dopamine D2S receptor expressed in HEK293 cells co-transfected with Galpha0i assessed as [35S]GTPgammaS binding after 30 mins by [35S]GTPgammaS incorporation assay,B,1.05
13913,CHEMBL3577346,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)nn1,EC50,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity at human dopamine D2S receptor expressed in HEK293 cells co-transfected with Galphai2 assessed as [35S]GTPgammaS binding after 30 mins by [35S]GTPgammaS incorporation assay,B,2.0
13915,CHEMBL3577346,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)nn1,EC50,=,3.1,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity at human dopamine D2L receptor expressed in HEK293 cells co-transfected with Galpha0i assessed as [35S]GTPgammaS binding after 30 mins by [35S]GTPgammaS incorporation assay,B,1.55
13917,CHEMBL3577346,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)nn1,EC50,=,2.9,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity at human dopamine D2L receptor expressed in HEK293 cells co-transfected with Galphai2 assessed as [35S]GTPgammaS binding after 30 mins by [35S]GTPgammaS incorporation assay,B,1.45
13919,CHEMBL3577346,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)nn1,EC50,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ARMS2-PK2-tagged human dopamine D2S receptor expressed in HEK293 cells co-expressing (EA)-tagged beta arrestin fusion protein assessed as recruitment of beta-arrestin-2 after 5 hrs by chemiluminescence assay,B,0.7
13924,CHEMBL3581319,O=C(N[C@@H]1CC[C@@H](CCN2CCc3ccccc3C2)CC1)c4cc5ccccc5[nH]4,Kb,=,87.0,nM,Dopamine D2 receptor,Homo sapiens,Negative allosteric modulator activity at wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as ERK1/2 phosphorylation measured as equilibrium dissociation constant after 30 mins,B,87.0
13951,CHEMBL3581326,COc1ccccc1N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)c4cc5ccccc5[nH]4)CC2,Kb,=,3.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as equilibrium dissociation constant after 3 hrs by MicroBeta counting analysis,B,3.4
13952,CHEMBL3581326,COc1ccccc1N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)c4cc5ccccc5[nH]4)CC2,Kb,=,0.257,nM,Dopamine D2 receptor,Homo sapiens,Negative allosteric modulator activity at wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as ERK1/2 phosphorylation measured as equilibrium dissociation constant after 30 mins,B,0.257
13955,CHEMBL3581327,Clc1cccc(N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)c4cc5ccccc5[nH]4)CC2)c1Cl,Kb,=,5.25,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as equilibrium dissociation constant after 3 hrs by MicroBeta counting analysis,B,5.25
13956,CHEMBL3581327,Clc1cccc(N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)c4cc5ccccc5[nH]4)CC2)c1Cl,Kb,=,1.38,nM,Dopamine D2 receptor,Homo sapiens,Negative allosteric modulator activity at wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as ERK1/2 phosphorylation measured as equilibrium dissociation constant after 30 mins,B,1.38
13964,CHEMBL3581329,O=C(NCCCCN1CCc2ccc(cc2C1)C#N)c3cc4ccccc4[nH]3,Kb,=,81.2,nM,Dopamine D2 receptor,Homo sapiens,Negative allosteric modulator activity at wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as ERK1/2 phosphorylation measured as equilibrium dissociation constant after 30 mins,B,81.2
13972,CHEMBL3581331,O=C(NCCCCCCN1CCc2ccc(cc2C1)C#N)c3cc4ccccc4[nH]3,Kb,=,30.1,nM,Dopamine D2 receptor,Homo sapiens,Negative allosteric modulator activity at wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as ERK1/2 phosphorylation measured as equilibrium dissociation constant after 30 mins,B,30.1
13976,CHEMBL3581332,CN([C@@H]1CC[C@@H](CCN2CCc3ccc(cc3C2)C#N)CC1)C(=O)c4cc5ccccc5[nH]4,Kb,=,91.2,nM,Dopamine D2 receptor,Homo sapiens,Negative allosteric modulator activity at wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as ERK1/2 phosphorylation measured as equilibrium dissociation constant after 30 mins,B,91.2
13980,CHEMBL3581333,O=C(N[C@@H]1CC[C@@H](CCN2CCc3ccc(cc3C2)C#N)CC1)c4oc5ccccc5c4,Kb,=,18.2,nM,Dopamine D2 receptor,Homo sapiens,Negative allosteric modulator activity at wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as ERK1/2 phosphorylation measured as equilibrium dissociation constant after 30 mins,B,18.2
13984,CHEMBL3581334,O=C(N[C@@H]1CC[C@@H](CCN2CCc3ccc(cc3C2)C#N)CC1)c4oc5ccccc5n4,Kb,=,18.2,nM,Dopamine D2 receptor,Homo sapiens,Negative allosteric modulator activity at wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as ERK1/2 phosphorylation measured as equilibrium dissociation constant after 30 mins,B,18.2
13988,CHEMBL3581335,O=C(N[C@@H]1CC[C@@H](CCN2CCc3ccc(cc3C2)C#N)CC1)C4=Cc5ccccc5C4,Kb,=,22.9,nM,Dopamine D2 receptor,Homo sapiens,Negative allosteric modulator activity at wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as ERK1/2 phosphorylation measured as equilibrium dissociation constant after 30 mins,B,22.9
13992,CHEMBL3581336,Cn1c(cc2ccccc12)C(=O)N[C@@H]3CC[C@@H](CCN4CCc5ccc(cc5C4)C#N)CC3,Kb,=,72.4,nM,Dopamine D2 receptor,Homo sapiens,Negative allosteric modulator activity at wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as ERK1/2 phosphorylation measured as equilibrium dissociation constant after 30 mins,B,72.4
13995,CHEMBL3581439,O=C(N[C@@H]1CC[C@@H](CCN2CCc3ccc(cc3C2)C#N)CC1)c4nc5ccccc5[nH]4,Kb,=,81.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as equilibrium dissociation constant after 3 hrs by MicroBeta counting analysis,B,81.3
13999,CHEMBL3581440,O=C(N[C@@H]1CC[C@@H](CCN2CCc3ccc(cc3C2)C#N)CC1)c4cc5cccnc5[nH]4,Kb,=,45.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as equilibrium dissociation constant after 3 hrs by MicroBeta counting analysis,B,45.7
14000,CHEMBL3581440,O=C(N[C@@H]1CC[C@@H](CCN2CCc3ccc(cc3C2)C#N)CC1)c4cc5cccnc5[nH]4,Kb,=,23.4,nM,Dopamine D2 receptor,Homo sapiens,Negative allosteric modulator activity at wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as ERK1/2 phosphorylation measured as equilibrium dissociation constant after 30 mins,B,23.4
14003,CHEMBL3581441,O=C(N[C@@H]1CC[C@@H](CCN2CCc3ccc(cc3C2)C#N)CC1)c4ccc[nH]4,Kb,=,57.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as equilibrium dissociation constant after 3 hrs by MicroBeta counting analysis,B,57.5
14004,CHEMBL3581441,O=C(N[C@@H]1CC[C@@H](CCN2CCc3ccc(cc3C2)C#N)CC1)c4ccc[nH]4,Kb,=,3.31,nM,Dopamine D2 receptor,Homo sapiens,Negative allosteric modulator activity at wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as ERK1/2 phosphorylation measured as equilibrium dissociation constant after 30 mins,B,3.31
14008,CHEMBL3581442,O=C(N[C@@H]1CC[C@@H](CCN2CCc3ccc(cc3C2)C#N)CC1)[C@H]4CCCN4,Kb,=,45.7,nM,Dopamine D2 receptor,Homo sapiens,Negative allosteric modulator activity at wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as ERK1/2 phosphorylation measured as equilibrium dissociation constant after 30 mins,B,45.7
14011,CHEMBL3581443,O=C(N[C@@H]1CC[C@@H](CCN2CCc3ccc(cc3C2)C#N)CC1)[C@@H]4CCCN4,Kb,=,23.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as equilibrium dissociation constant after 3 hrs by MicroBeta counting analysis,B,23.4
14012,CHEMBL3581443,O=C(N[C@@H]1CC[C@@H](CCN2CCc3ccc(cc3C2)C#N)CC1)[C@@H]4CCCN4,Kb,=,27.5,nM,Dopamine D2 receptor,Homo sapiens,Negative allosteric modulator activity at wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as ERK1/2 phosphorylation measured as equilibrium dissociation constant after 30 mins,B,27.5
14014,CHEMBL3585363,Cl.CCCNCCc1cccc2NC(=O)Cc12,EC50,=,85.11,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,42.555
14015,CHEMBL3585363,Cl.CCCNCCc1cccc2NC(=O)Cc12,EC50,=,85.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,42.5
14017,CHEMBL3585364,CCCN(CCCC(=O)OCC)CCc1cccc2NC(=O)Cc12,EC50,=,54.95,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,27.475
14018,CHEMBL3585364,CCCN(CCCC(=O)OCC)CCc1cccc2NC(=O)Cc12,EC50,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,27.5
14026,CHEMBL3585367,CCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2NC(=O)Cc12,EC50,=,41.69,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,20.845
14027,CHEMBL3585367,CCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2NC(=O)Cc12,EC50,=,42.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,21.0
14029,CHEMBL3585368,CCCN(CCCNC(=O)CCC(=O)NCCCN(CCC)CCc1cccc2NC(=O)Cc12)CCc3cccc4NC(=O)Cc34,EC50,=,28.18,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,14.09
14030,CHEMBL3585368,CCCN(CCCNC(=O)CCC(=O)NCCCN(CCC)CCc1cccc2NC(=O)Cc12)CCc3cccc4NC(=O)Cc34,EC50,=,28.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,14.0
14032,CHEMBL3585369,CCCN(CCCNC(=O)CCCCCCC(=O)NCCCN(CCC)CCc1cccc2NC(=O)Cc12)CCc3cccc4NC(=O)Cc34,EC50,=,22.39,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,11.195
14033,CHEMBL3585369,CCCN(CCCNC(=O)CCCCCCC(=O)NCCCN(CCC)CCc1cccc2NC(=O)Cc12)CCc3cccc4NC(=O)Cc34,EC50,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,11.0
14035,CHEMBL3585370,CCCN(CCCNC(=O)CCCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2NC(=O)Cc12)CCc3cccc4NC(=O)Cc34,EC50,=,3.89,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,1.945
14037,CHEMBL3585370,CCCN(CCCNC(=O)CCCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2NC(=O)Cc12)CCc3cccc4NC(=O)Cc34,EC50,=,3.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,1.95
14038,CHEMBL3585371,CCCN(CCCNC(=O)CCCCCCCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2NC(=O)Cc12)CCc3cccc4NC(=O)Cc34,EC50,=,6.166,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,3.083
14041,CHEMBL3585371,CCCN(CCCNC(=O)CCCCCCCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2NC(=O)Cc12)CCc3cccc4NC(=O)Cc34,EC50,=,6.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,3.1
14042,CHEMBL3585372,CCCN(CCCNC(=O)CCCCCCCCCCCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2NC(=O)Cc12)CCc3cccc4NC(=O)Cc34,EC50,=,14.13,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,7.065
14045,CHEMBL3585372,CCCN(CCCNC(=O)CCCCCCCCCCCCCCCCCCC(=O)NCCCN(CCC)CCc1cccc2NC(=O)Cc12)CCc3cccc4NC(=O)Cc34,EC50,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,7.0
14050,CHEMBL3588913,COc1ccccc1N2CCN(CCCCc3cn(nn3)c4ccc5ccccc5c4)CC2,Ki,=,31.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,31.5
14051,CHEMBL3588914,COc1ccccc1N2CCN(CCCCc3cn(nn3)c4ccc5c(Cc6ccccc56)c4)CC2,Ki,=,57.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,57.2
14052,CHEMBL3588915,COc1ccccc1N2CCN(CCCCc3cn(nn3)c4ccc5[nH]ccc5c4)CC2,Ki,=,51.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,51.8
14053,CHEMBL3588916,COc1ccccc1N2CCN(CCCCc3cn(nn3)c4ccc5cnccc5c4)CC2,Ki,=,83.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,83.4
14054,CHEMBL3588917,Clc1cccc(N2CCN(CCCCc3cn(nn3)c4ccc5ccccc5c4)CC2)c1Cl,Ki,=,80.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,80.8
14056,CHEMBL3588919,Clc1cccc(N2CCN(CCCCc3cn(nn3)c4ccc5[nH]ccc5c4)CC2)c1Cl,Ki,=,46.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,46.6
14057,CHEMBL3588920,COc1ccccc1N2CCN(CCCCn3cc(nn3)c4ccc5ccccc5c4)CC2,Ki,=,23.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,23.3
14058,CHEMBL3588921,COc1ccccc1N2CCN(CCCCn3cc(nn3)c4ccc5c(Cc6ccccc56)c4)CC2,Ki,=,50.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,50.1
14059,CHEMBL3588981,COc1ccccc1N2CCN(CCCCn3cc(nn3)c4ccc5[nH]ccc5c4)CC2,Ki,=,43.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,43.7
14060,CHEMBL3588982,COc1ccccc1N2CCN(CCCCn3cc(nn3)c4ccc5ncccc5c4)CC2,Ki,=,42.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,42.5
14061,CHEMBL3588983,COc1ccccc1N2CCN(CCCCn3cc(nn3)c4ccc(cc4)c5ccccc5)CC2,Ki,=,69.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,69.0
14064,CHEMBL3588986,Clc1cccc(N2CCN(CCCCn3cc(nn3)c4ccc5[nH]ccc5c4)CC2)c1Cl,Ki,=,56.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,56.1
14065,CHEMBL3588987,Clc1cccc(N2CCN(CCCCn3cc(nn3)c4ccc5ncccc5c4)CC2)c1Cl,Ki,=,53.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,53.9
14077,CHEMBL3589575,CCCN(CCNC(=O)\N=N\c1ccc(F)cc1)C2Cc3ccccc3C2,Ki,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,B,5.0
14078,CHEMBL3589575,CCCN(CCNC(=O)\N=N\c1ccc(F)cc1)C2Cc3ccccc3C2,Ki,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,B,4.0
14079,CHEMBL3589576,CCCN(CCNC(=O)\N=N\c1ccc(F)c(F)c1)C2Cc3ccccc3C2,Ki,=,3.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,B,3.9
14080,CHEMBL3589576,CCCN(CCNC(=O)\N=N\c1ccc(F)c(F)c1)C2Cc3ccccc3C2,Ki,=,8.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,B,8.5
14082,CHEMBL3589577,CCCN(CCNC(=O)\N=N\c1cc(F)c(F)c(F)c1)C2Cc3ccccc3C2,Ki,=,73.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,B,73.0
14086,CHEMBL3589652,OC(CCNC(=O)c1ccc2Cc3ccccc3c2c1)CN4CCN(CC4)c5cccc(Cl)c5Cl,Ki,=,54.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,54.7
14091,CHEMBL3590077,COc1ccccc1N2CCN(CCCCNC(=O)\N=N\c3ccc(F)cc3)CC2,Ki,=,38.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,B,38.0
14092,CHEMBL3590077,COc1ccccc1N2CCN(CCCCNC(=O)\N=N\c3ccc(F)cc3)CC2,Ki,=,34.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,B,34.0
14093,CHEMBL3590078,COc1ccccc1N2CCN(CCCCNC(=O)\N=N\c3ccc(F)c(F)c3)CC2,Ki,=,7.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,B,7.5
14094,CHEMBL3590078,COc1ccccc1N2CCN(CCCCNC(=O)\N=N\c3ccc(F)c(F)c3)CC2,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,B,12.0
14095,CHEMBL3590079,COc1ccccc1N2CCN(CCCCNC(=O)\N=N\c3cc(F)c(F)c(F)c3)CC2,Ki,=,6.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,B,6.6
14096,CHEMBL3590079,COc1ccccc1N2CCN(CCCCNC(=O)\N=N\c3cc(F)c(F)c(F)c3)CC2,Ki,=,9.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,B,9.5
14097,CHEMBL3590080,CCCN(CCCCNC(=O)\C=C\c1ccc(F)cc1)C2Cc3ccccc3C2,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,B,19.0
14098,CHEMBL3590080,CCCN(CCCCNC(=O)\C=C\c1ccc(F)cc1)C2Cc3ccccc3C2,Ki,=,2.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,B,2.9
14099,CHEMBL3590081,CCCN(CCCCNC(=O)\N=N\c1ccc(F)cc1)C2Cc3ccccc3C2,Ki,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,B,23.0
14100,CHEMBL3590081,CCCN(CCCCNC(=O)\N=N\c1ccc(F)cc1)C2Cc3ccccc3C2,Ki,=,36.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,B,36.0
14101,CHEMBL3590082,CCCN(CCCCNC(=O)\N=N\c1ccc(F)c(F)c1)C2Cc3ccccc3C2,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,B,25.0
14102,CHEMBL3590082,CCCN(CCCCNC(=O)\N=N\c1ccc(F)c(F)c1)C2Cc3ccccc3C2,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,B,13.0
14103,CHEMBL3590083,CCCN(CCCCNC(=O)\N=N\c1cc(F)c(F)c(F)c1)C2Cc3ccccc3C2,Ki,=,40.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,B,40.0
14104,CHEMBL3590083,CCCN(CCCCNC(=O)\N=N\c1cc(F)c(F)c(F)c1)C2Cc3ccccc3C2,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,B,12.0
14105,CHEMBL3590084,CCCN(CCNC(=O)\C=C\c1ccc(F)cc1)C2Cc3ccccc3C2,Ki,=,43.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,B,43.0
14106,CHEMBL3590084,CCCN(CCNC(=O)\C=C\c1ccc(F)cc1)C2Cc3ccccc3C2,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,B,13.0
14108,CHEMBL3590086,Cc1ccc(Cl)c(c1)N2CCN(CCCCNC(=O)c3ccc4OC(=O)Nc4c3)CC2,Ki,=,46.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells,B,46.9
14114,CHEMBL3597635,O=C(NCCCCN1CCN(CC1)c2cccc3ccccc23)c4cnc5ccccc5c4,Ki,=,15.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,B,15.8
14115,CHEMBL3597635,O=C(NCCCCN1CCN(CC1)c2cccc3ccccc23)c4cnc5ccccc5c4,EC50,=,170.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as stimulation of quinpirole-stimulated mitogenesis,B,85.0
14117,CHEMBL3597635,O=C(NCCCCN1CCN(CC1)c2cccc3ccccc23)c4cnc5ccccc5c4,IC50,=,29.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,B,14.5
14122,CHEMBL3597637,COc1c(Cl)cccc1N2CCN(CCCCNC(=O)c3cnc4ccccc4c3)CC2,Ki,=,43.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,B,43.1
14125,CHEMBL3597637,COc1c(Cl)cccc1N2CCN(CCCCNC(=O)c3cnc4ccccc4c3)CC2,IC50,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,B,31.5
14127,CHEMBL3597639,Fc1ccc2ncc(cc2c1)C(=O)NCCCCN3CCN(CC3)c4cccc(Cl)c4Cl,Ki,=,39.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,B,39.2
14129,CHEMBL3597641,COc1c(Cl)cccc1N2CCN(CCCCNC(=O)c3cc4ccccc4[nH]3)CC2,Ki,=,53.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,B,53.0
14130,CHEMBL3597642,COc1c(Cl)cccc1N2CCN(CCCCNC(=O)c3oc4ccccc4c3)CC2,Ki,=,72.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,B,72.3
14131,CHEMBL3597643,O=C(NCCCCN1CCN(CC1)c2cccc3ccccc23)c4cc5ccccc5[nH]4,Ki,=,12.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,B,12.9
14132,CHEMBL3597643,O=C(NCCCCN1CCN(CC1)c2cccc3ccccc23)c4cc5ccccc5[nH]4,EC50,=,76.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as stimulation of quinpirole-stimulated mitogenesis,B,38.0
14134,CHEMBL3597643,O=C(NCCCCN1CCN(CC1)c2cccc3ccccc23)c4cc5ccccc5[nH]4,IC50,=,87.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,B,43.5
14135,CHEMBL3597644,COc1ccc2[nH]c(cc2c1)C(=O)NCCCCN3CCN(CC3)c4cccc5ccccc45,Ki,=,13.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,B,13.8
14136,CHEMBL3596212,O=C(NCCCCN1CCN(CC1)c2cccc3ccccc23)c4oc5ccccc5c4,Ki,=,14.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,B,14.8
14137,CHEMBL3597645,O=C(NCCCCN1CCN(CC1)c2cccc3ccccc23)c4cc5ccccc5s4,Ki,=,8.37,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,B,8.37
14139,CHEMBL3597647,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc4cc(F)ccc4n3)CC2,Ki,=,68.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,B,68.2
14145,CHEMBL3597650,COc1ccccc1N2CCN(CCCCNC(=O)c3cnc4ccc(F)cc4c3)CC2,Ki,=,34.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,B,34.1
14213,CHEMBL3613873,COc1ccccc1N2CCN(CCCc3cn(nn3)c4ccn5nccc5c4)CC2,Ki,=,81.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,B,81.0
14219,CHEMBL3613874,Clc1cccc(N2CCN(CCCc3cn(nn3)c4ccn5ncc(C=O)c5c4)CC2)c1Cl,Ki,=,6.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,6.7
14220,CHEMBL3613874,Clc1cccc(N2CCN(CCCc3cn(nn3)c4ccn5ncc(C=O)c5c4)CC2)c1Cl,Ki,=,3.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,B,3.8
14221,CHEMBL3613874,Clc1cccc(N2CCN(CCCc3cn(nn3)c4ccn5ncc(C=O)c5c4)CC2)c1Cl,EC50,=,190.55,nM,Dopamine D2 receptor,Homo sapiens,Activity at dopamine D2S receptor (unknown origin) expressed in HEK293 cell membranes co-expressing Galpha protein subunit Galphao1 by [35S]GTPgammaS binding assay,B,95.275
14227,CHEMBL3613875,Clc1cccc(N2CCN(CCCCc3cn(nn3)c4ccn5ncc(C=O)c5c4)CC2)c1Cl,Ki,=,51.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,B,51.0
14233,CHEMBL3613876,Clc1cccc(N2CCN(CCc3cn(nn3)c4ccn5ncc(C=O)c5c4)CC2)c1Cl,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,11.0
14234,CHEMBL3613876,Clc1cccc(N2CCN(CCc3cn(nn3)c4ccn5ncc(C=O)c5c4)CC2)c1Cl,Ki,=,8.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,B,8.0
14235,CHEMBL3613876,Clc1cccc(N2CCN(CCc3cn(nn3)c4ccn5ncc(C=O)c5c4)CC2)c1Cl,EC50,=,199.53,nM,Dopamine D2 receptor,Homo sapiens,Activity at dopamine D2S receptor (unknown origin) expressed in HEK293 cell membranes co-expressing Galpha protein subunit Galphao1 by [35S]GTPgammaS binding assay,B,99.765
14240,CHEMBL3613877,COc1ccccc1N2CCN(CCc3cn(nn3)c4ccn5ncc(C=O)c5c4)CC2,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,18.0
14241,CHEMBL3613877,COc1ccccc1N2CCN(CCc3cn(nn3)c4ccn5ncc(C=O)c5c4)CC2,Ki,=,9.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,B,9.4
14247,CHEMBL3613878,Clc1cccc(N2CCN(CCc3cn(nn3)c4ccn5nccc5c4)CC2)c1Cl,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,22.0
14248,CHEMBL3613878,Clc1cccc(N2CCN(CCc3cn(nn3)c4ccn5nccc5c4)CC2)c1Cl,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,B,10.0
14255,CHEMBL3613879,Clc1cccc(N2CCN(CCCc3cn(nn3)c4ccn5nccc5c4)CC2)c1Cl,Ki,=,54.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,B,54.0
14261,CHEMBL3613880,Clc1cccc(N2CCN(CCCCc3cn(nn3)c4ccn5nccc5c4)CC2)c1Cl,Ki,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,B,23.0
14262,CHEMBL3613880,Clc1cccc(N2CCN(CCCCc3cn(nn3)c4ccn5nccc5c4)CC2)c1Cl,Ki,=,7.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,B,7.3
14273,CHEMBL3622097,Brc1ccc(NCCN2CCN(CCc3c[nH]c4ccccc34)CC2)cc1,Ki,=,53.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,B,53.0
14275,CHEMBL3622097,Brc1ccc(NCCN2CCN(CCc3c[nH]c4ccccc34)CC2)cc1,Ki,=,48.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,B,48.0
14277,CHEMBL3622099,CCCN(CCN1CCN(CCc2c[nH]c3ccccc23)CC1)c4ccc(Br)cc4,Ki,=,58.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,B,58.0
14279,CHEMBL3622099,CCCN(CCN1CCN(CCc2c[nH]c3ccccc23)CC1)c4ccc(Br)cc4,Ki,=,51.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,B,51.0
14434,CHEMBL3646149,Fc1ccc2Sc3ccccc3N=C(N4CCNCC4)c2c1,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding Assay: The ability of test compounds to displace 3H-raclopride at the D2s receptor can be determined on membranes from D2s-transfected CHO cells (Bmax 13 pmol/mg protein). An assay can use a standard 96-well glass-fiber filter plate to retain radioligand bound by the receptor. Retained 3H can be determined in a TopCount scintillation plate counter following the addition of a liquid scintillant to each well. Compounds can be evaluated for their potency using competition curve analysis, resulting in calculated Ki values.",B,11.0
14435,CHEMBL3646150,Clc1ccc2Sc3ccccc3N=C(N4CCNCC4)c2c1,Ki,=,0.7,nM,Dopamine D2 receptor,Homo sapiens,"Binding Assay: The ability of test compounds to displace 3H-raclopride at the D2s receptor can be determined on membranes from D2s-transfected CHO cells (Bmax 13 pmol/mg protein). An assay can use a standard 96-well glass-fiber filter plate to retain radioligand bound by the receptor. Retained 3H can be determined in a TopCount scintillation plate counter following the addition of a liquid scintillant to each well. Compounds can be evaluated for their potency using competition curve analysis, resulting in calculated Ki values.",B,0.7
14436,CHEMBL3646151,CN1CCN(CC1)C2=Nc3ccccc3Sc4ccc(F)cc24,Ki,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,"Binding Assay: The ability of test compounds to displace 3H-raclopride at the D2s receptor can be determined on membranes from D2s-transfected CHO cells (Bmax 13 pmol/mg protein). An assay can use a standard 96-well glass-fiber filter plate to retain radioligand bound by the receptor. Retained 3H can be determined in a TopCount scintillation plate counter following the addition of a liquid scintillant to each well. Compounds can be evaluated for their potency using competition curve analysis, resulting in calculated Ki values.",B,1.1
14437,CHEMBL3647673,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccc(F)cc6)NC1=O)NCCC[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7,Ki,=,10.8,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,10.8
14438,CHEMBL3647674,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccc(F)cc6)NC1=O)NCCCC[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7,Ki,=,6.9,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,6.9
14439,CHEMBL3647675,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccc(F)cc6)NC1=O)NCCCCC[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7,Ki,=,45.2,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,45.2
14441,CHEMBL3647677,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccc(F)cc6)NC1=O)NC[C@H](Cc7ccc(O)cc7)NC(=O)CSC[C@@H]8C[C@H]9[C@@H](Cc%10c[nH]c%11cccc9c%10%11)N(C)C8,Ki,=,28.5,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,28.5
14443,CHEMBL3647679,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccc(F)c(F)c6)NC1=O)NCCSC[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7,Ki,=,16.9,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,16.9
14444,CHEMBL3647680,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6cc(F)cc(F)c6)NC1=O)NCCSC[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7,Ki,=,25.4,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,25.4
14445,CHEMBL3647681,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6cccc(F)c6)NC1=O)NCCSC[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7,Ki,=,30.3,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,30.3
14446,CHEMBL3647682,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccccc6F)NC1=O)NCCSC[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7,Ki,=,31.8,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,31.8
14447,CHEMBL3647683,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6c(F)c(F)c(F)c(F)c6F)NC1=O)NCCSC[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7,Ki,=,40.4,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,40.4
14448,CHEMBL3647684,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccncc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccc(O)cc6)NC1=O)NCCSC[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7,Ki,=,34.3,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,34.3
14450,CHEMBL3647686,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccncc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccccc6)NC1=O)NC[C@H](CCCCNC(=O)CSC[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7)NC(=O)CSC[C@@H]%11C[C@H]%12[C@@H](Cc%13c[nH]c%14cccc%12c%13%14)N(C)C%11,Ki,=,39.2,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,39.2
14451,CHEMBL3647687,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccc(F)cc6)NC1=O)NCCS(=O)(=O)C[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7,Ki,=,56.4,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,56.4
14453,CHEMBL3647688,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccncc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccc(O)cc6)NC1=O)NCC[S@@+]([O-])C[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7,Ki,=,31.6,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,31.6
14454,CHEMBL3647689,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccc(F)cc6)NC1=O)NC[C@H](Cc7ccc(O)cc7)NC(=O)C[S+]([O-])C[C@@H]8C[C@H]9[C@@H](Cc%10c[nH]c%11cccc9c%10%11)N(C)C8,Ki,=,32.5,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,32.5
14455,CHEMBL3647690,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccc(F)cc6)NC1=O)NCC[S+]([O-])C[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7,Ki,=,76.5,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,76.5
14457,CHEMBL3647692,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccncc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccc(O)cc6)NC1=O)NC[C@H](CCCCNC(=O)C[S+]([O-])C[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7)NC(=O)C[S+]([O-])C[C@@H]%11C[C@H]%12[C@@H](Cc%13c[nH]c%14cccc%12c%13%14)N(C)C%11,Ki,=,22.5,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,22.5
14458,CHEMBL3647693,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccncc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccccc6)NC1=O)NC[C@H](CCCCNC(=O)C[S+]([O-])C[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7)NC(=O)C[S+]([O-])C[C@@H]%11C[C@H]%12[C@@H](Cc%13c[nH]c%14cccc%12c%13%14)N(C)C%11,Ki,=,67.6,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,67.6
14468,CHEMBL3647703,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccc(F)cc6)NC1=O)N(CCCN(C[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7)C(=O)C)C(=O)C,Ki,=,39.9,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,39.9
14469,CHEMBL3647704,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccc(F)cc6)NC1=O)NC[C@@H](Cc7ccc(O)cc7)NCCCN(C[C@@H]8C[C@H]9[C@@H](Cc%10c[nH]c%11cccc9c%10%11)N(C)C8)C(=O)C,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,14.0
14471,CHEMBL3647706,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccc(F)cc6)NC1=O)NCCCN(C[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7)C(=O)C,Ki,=,46.8,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,46.8
14472,CHEMBL3647707,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccccc6)NC1=O)NC[C@H](Cc7ccc(O)cc7)NC(=O)CSC[C@@H]8C[C@H]9[C@@H](Cc%10c[nH]c%11cccc9c%10%11)N(C)C8,Ki,=,24.2,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,24.2
14473,CHEMBL3647707,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccccc6)NC1=O)NC[C@H](Cc7ccc(O)cc7)NC(=O)CSC[C@@H]8C[C@H]9[C@@H](Cc%10c[nH]c%11cccc9c%10%11)N(C)C8,Ki,=,44.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,44.0
14474,CHEMBL3647708,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCNC(=O)[C@H](Cc6ccccc6)NC1=O)NC[C@H](Cc7ccc(O)cc7)NC(=O)CSC[C@@H]8C[C@H]9[C@@H](Cc%10c[nH]c%11cccc9c%10%11)N(C)C8,Ki,=,38.6,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,38.6
14475,CHEMBL3647709,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccc(O)cc6)NC1=O)NC[C@H](Cc7ccc(O)cc7)NC(=O)CSC[C@@H]8C[C@H]9[C@@H](Cc%10c[nH]c%11cccc9c%10%11)N(C)C8,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,15.0
14478,CHEMBL3647712,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccccc6)NC1=O)NC(=O)[C@@H](Cc7ccc(O)cc7)NC(=O)CSC[C@@H]8C[C@H]9[C@@H](Cc%10c[nH]c%11cccc9c%10%11)N(C)C8,Ki,=,25.3,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,25.3
14482,CHEMBL3650453,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccccc6)NC1=O)NC[C@@H](Cc7ccc(O)cc7)NC(=O)CSC[C@@H]8C[C@H]9[C@@H](Cc%10c[nH]c%11cccc9c%10%11)N(C)C8,Ki,=,8.5,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,8.5
14485,CHEMBL3650456,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccc(F)cc6)NC1=O)NC[C@H](CCCCNC(=O)CSC[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7)NC(=O)CSC[C@@H]%11C[C@H]%12[C@@H](Cc%13c[nH]c%14cccc%12c%13%14)N(C)C%11,Ki,=,84.2,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,84.2
14486,CHEMBL3650457,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccc(F)cc6)NC1=O)NCCCS(=O)(=O)C[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7,Ki,=,19.4,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,19.4
14556,CHEMBL3664882,O=S(=O)(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3cccc4OCOc34)CC1)c5ccccc5,Ki,=,63.45,nM,Dopamine D2 receptor,Homo sapiens,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,63.45
14561,CHEMBL3664887,CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3cccc4OCOc34)CC1,Ki,=,52.74,nM,Dopamine D2 receptor,Homo sapiens,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,52.74
14566,CHEMBL3676846,CC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,50.4,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,50.4
14567,CHEMBL3676847,COCCC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,71.18,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,71.18
14568,CHEMBL3676848,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)C5CCOCC5,Ki,=,37.32,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,37.32
14569,CHEMBL3676849,O=C(CC1CCOCC1)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2,Ki,=,77.56,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,77.56
14570,CHEMBL3676850,CCC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,48.1,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,48.1
14571,CHEMBL3676851,COCC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,80.1,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,80.1
14572,CHEMBL3676852,CS(=O)(=O)CC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,50.8,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,50.8
14573,CHEMBL3676853,O=C(CC1COCCO1)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2,Ki,=,85.9,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,85.9
14574,CHEMBL3676854,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)c5ccccc5,Ki,=,32.32,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,32.32
14575,CHEMBL3676855,Cc1cc(CC(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2)on1,Ki,=,83.59,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,83.59
14576,CHEMBL3676856,OCC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,46.52,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,46.52
14577,CHEMBL3676857,FC(F)(F)CC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,42.66,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,42.66
14579,CHEMBL3676859,CC(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,39.54,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,39.54
14580,CHEMBL3676860,CC(C)CC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,43.49,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,43.49
14581,CHEMBL3676861,CC(C)(O)C(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,53.71,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,53.71
14582,CHEMBL3676862,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)C5CCOC5,Ki,=,52.97,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,52.97
14583,CHEMBL3676863,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)C5CCCO5,Ki,=,81.48,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,81.48
14584,CHEMBL3676864,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)c5ccnc6ccccc56,Ki,=,96.68,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,96.68
14585,CHEMBL3676865,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)C5CCC5,Ki,=,38.05,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,38.05
14586,CHEMBL3676866,OCCC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,62.94,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,62.94
14587,CHEMBL3676867,OC1(CC1)C(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2,Ki,=,47.49,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,47.49
14588,CHEMBL3676868,O=C(CC#N)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,41.51,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,41.51
14589,CHEMBL3676869,Fc1ccc(cc1)C(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2,Ki,=,68.89,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,68.89
14590,CHEMBL3676870,O=C(CC1CC1)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2,Ki,=,33.71,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,33.71
14591,CHEMBL3676871,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)C5CCCOC5,Ki,=,37.09,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,37.09
14592,CHEMBL3676872,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)C5CC5,Ki,=,22.68,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,22.68
14593,CHEMBL3676873,CC(C)(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,37.96,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,37.96
14594,CHEMBL3676874,O=C(CC1CCCO1)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2,Ki,=,52.86,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,52.86
14595,CHEMBL3676875,FC1(F)CC1C(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2,Ki,=,28.11,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,28.11
14596,CHEMBL3676876,CCC(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,46.02,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,46.02
14597,CHEMBL3676877,OC(C(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)C(F)(F)F,Ki,=,46.39,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,46.39
14598,CHEMBL3676878,CCCC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,45.27,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,45.27
14599,CHEMBL3676879,CC(C)(O)CC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,41.33,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,41.33
14600,CHEMBL3676880,O[C@H](CC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)C(F)(F)F,Ki,=,50.42,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,50.42
14601,CHEMBL3676881,CS(=O)(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,47.35,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,47.35
14602,CHEMBL3676882,CCS(=O)(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,47.99,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,47.99
14603,CHEMBL3676883,Cc1ccc(cc1)S(=O)(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2,Ki,=,58.62,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,58.62
14604,CHEMBL3676884,FC(F)(F)C(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,37.47,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,37.47
14605,CHEMBL3676885,CC(C)(C)CC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,53.03,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,53.03
14606,CHEMBL3676886,Cc1cc(on1)C(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2,Ki,=,36.41,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,36.41
14607,CHEMBL3676887,CN(C)C(=O)CCC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,92.3,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,92.3
14608,CHEMBL3676888,CN(C)S(=O)(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,47.02,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,47.02
14609,CHEMBL3676889,FC(F)(F)CCC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,61.16,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,61.16
14610,CHEMBL3676890,CC(C)CCC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,65.98,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,65.98
14611,CHEMBL3676891,CC[C@@H](O)CC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,55.43,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,55.43
14612,CHEMBL3676892,CC[C@H](O)CC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,33.75,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,33.75
14613,CHEMBL3676893,O=C(CC1CCC1)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2,Ki,=,58.22,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,58.22
14614,CHEMBL3676894,Clc1ccc(cc1)C(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2,Ki,=,25.8,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,25.8
14617,CHEMBL3676897,COC(CC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)OC,Ki,=,48.85,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,48.85
14618,CHEMBL3676898,CC(=CC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)C,Ki,=,18.01,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,18.01
14619,CHEMBL3676899,C\C=C\CC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,57.95,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,57.95
14620,CHEMBL3676900,CC#CC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,25.62,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,25.62
14621,CHEMBL3676901,O=CN[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,38.76,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,38.76
14622,CHEMBL3676902,CCCCC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1,Ki,=,65.71,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,65.71
14623,CHEMBL3676903,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)c5ccc6OCOc6c5,Ki,=,28.63,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,28.63
14624,CHEMBL3676904,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)c5ccc(cc5)n6cccn6,Ki,=,46.9,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,46.9
14627,CHEMBL3676907,CN1CCN(CC1)c2ccc(cc2)C(=O)N[C@@H]3CC[C@@H](CCN4CCC(CC4)c5coc6ccccc56)CC3,Ki,=,50.09,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,50.09
14628,CHEMBL3676908,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)c5ccc(cc5)c6ccccc6,Ki,=,22.11,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,22.11
14629,CHEMBL3676909,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)c5ccc(cc5)c6cccnc6,Ki,=,16.72,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,16.72
14630,CHEMBL3676910,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)c5ccc(nc5)N6CCOCC6,Ki,=,51.8,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,51.8
14631,CHEMBL3676911,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)c5ccc(cc5)N6CCS(=O)(=O)CC6,Ki,=,19.22,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,19.22
14633,CHEMBL3676913,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)c5ccc(cc5)n6cccc6,Ki,=,34.26,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,34.26
14634,CHEMBL3676914,Cc1ccc(cn1)C(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2,Ki,=,28.13,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,28.13
14635,CHEMBL3676915,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3coc4ccccc34)CC1)c5ccc(cc5)C#N,Ki,=,15.19,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,15.19
14637,CHEMBL3676917,CO[C@@H]1CC[C@@H](CC(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2)CC1,Ki,=,67.41,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,67.41
14638,CHEMBL3676919,O=C(Cc1ccc2OCOc2c1)N[C@@H]3CC[C@@H](CCN4CCC(CC4)c5coc6ccccc56)CC3,Ki,=,92.47,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,92.47
14639,CHEMBL3676920,CS(=O)(=O)c1ccc(s1)C(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2,Ki,=,60.84,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,60.84
14640,CHEMBL3676921,O=C(CC1COC1)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2,Ki,=,34.19,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,34.19
14643,CHEMBL3676924,FC(F)(F)C1CCC(CC1)C(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2,Ki,=,72.97,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,72.97
14649,CHEMBL3676931,CS(=O)(=O)c1ccc(cc1)C(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2,Ki,=,79.51,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,79.51
14650,CHEMBL3676932,Clc1ccc(C(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2)c(Cl)c1,Ki,=,38.17,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,38.17
14651,CHEMBL3676933,CC(C)(C)c1ccc(cc1)S(=O)(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2,Ki,=,70.03,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,70.03
14661,CHEMBL3695362,CCC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3cccc4occc34)CC1,Ki,=,91.9,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,91.9
14686,CHEMBL3695387,Clc1ccc(cc1)C(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4cccc5OCCc45)CC2,Ki,=,71.9,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,71.9
14687,CHEMBL3695388,Fc1ccc(cc1)C(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4cccc5OCCc45)CC2,Ki,=,73.7,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,73.7
14734,CHEMBL3695436,CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3cccc4OCCc34)CC1,Ki,=,69.9,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,69.9
14735,CHEMBL3695437,CC(=CC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3cccc4OCCc34)CC1)C,Ki,=,73.9,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,73.9
14741,CHEMBL3695443,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3cccc4OCCc34)CC1)c5ccc(cc5)n6cccc6,Ki,=,85.1,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,85.1
14743,CHEMBL3695445,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3cccc4OCCc34)CC1)c5ccc(cc5)c6cccnc6,Ki,=,99.8,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,99.8
14747,CHEMBL3697951,CC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1,Ki,=,67.35,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,67.35
14753,CHEMBL3697957,CCC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1,Ki,=,74.48,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,74.48
14758,CHEMBL3697962,COC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1,Ki,=,68.55,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,68.55
14760,CHEMBL3697964,O=C(CC#N)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1,Ki,=,75.98,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,75.98
14762,CHEMBL3697966,FC(F)(F)CC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1,Ki,=,91.22,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,91.22
14773,CHEMBL3697977,CC(C)(O)CC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1,Ki,=,76.78,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,76.78
14774,CHEMBL3697978,OC1(CC(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4cccc5OCOc45)CC2)CCC1,Ki,=,94.57,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,94.57
14775,CHEMBL3697979,OC1(CC1)C(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4cccc5OCOc45)CC2,Ki,=,61.45,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,61.45
14781,CHEMBL3697985,OC1(CCC1)C(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4cccc5OCOc45)CC2,Ki,=,84.94,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,84.94
14785,CHEMBL3697989,CC(C)[C@@H](O)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1,Ki,=,90.15,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,90.15
14786,CHEMBL3697990,CC(C)[C@H](O)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1,Ki,=,73.41,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,73.41
14788,CHEMBL3697992,C[C@@H](O)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1,Ki,=,89.81,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,89.81
14792,CHEMBL3697996,Fc1ccc(cc1)C(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4cccc5OCOc45)CC2,Ki,=,82.51,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,82.51
14794,CHEMBL3697998,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1)c5cccnc5,Ki,=,88.19,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,88.19
14798,CHEMBL3698002,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1)C5CCS(=O)(=O)C5,Ki,=,58.95,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,58.95
14800,CHEMBL3698004,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1)C5CCC5,Ki,=,91.14,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,91.14
14801,CHEMBL3698005,CS(=O)(=O)CC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1,Ki,=,95.38,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,95.38
14803,CHEMBL3698007,CN1CCC(CC1)C(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4cccc5OCOc45)CC2,Ki,=,62.94,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,62.94
14804,CHEMBL3698008,CC1(COC1)C(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4cccc5OCOc45)CC2,Ki,=,81.08,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,81.08
14806,CHEMBL3698010,ClC1CC(C1)C(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4cccc5OCOc45)CC2,Ki,=,81.06,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,81.06
14807,CHEMBL3698011,CN1CCN(CC(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4cccc5OCOc45)CC2)CC1,Ki,=,38.06,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,38.06
14808,CHEMBL3698012,COC1(CC1)C(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4cccc5OCOc45)CC2,Ki,=,86.54,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,86.54
14810,CHEMBL3698014,CO[C@H](C(C)C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1,Ki,=,89.5,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,89.5
14812,CHEMBL3698016,FC(F)(F)CS(=O)(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1,Ki,=,73.84,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,73.84
14813,CHEMBL3698017,O=S(=O)(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1)c5ccccc5,Ki,=,72.43,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,72.43
14814,CHEMBL3698018,Fc1ccc(cc1)S(=O)(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4cccc5OCOc45)CC2,Ki,=,46.18,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,46.18
14815,CHEMBL3698019,Cn1cnc(c1)S(=O)(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4cccc5OCOc45)CC2,Ki,=,55.32,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,55.32
14818,CHEMBL3698021,CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1,Ki,=,30.42,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,30.42
14823,CHEMBL3698026,O=S(=O)(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1)N5CCOCC5,Ki,=,62.99,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ¿g protein/well (D2, D3) and 15 ¿g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ¿l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 ¿M-0.1 nM for 1 h at RT.",B,62.99
14864,CHEMBL3740041,CCCN(CCN1CCN(CC1)c2ccc3cc[nH]c3c2Cl)[C@H]4CCc5nc(N)sc5C4.OC(=O)C(F)(F)F,EC50,=,3.23,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,B,1.615
14866,CHEMBL3740286,CCCN(CCN1CCN(CC1)c2c(Cl)ccc3[nH]ccc23)[C@H]4CCc5nc(N)sc5C4.OC(=O)C(F)(F)F,EC50,=,32.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,B,16.35
14868,CHEMBL3740778,Nc1nc2CC[C@@H](Cc2s1)N(CCN3CCN(CC3)c4ccc5[nH]ccc5c4Cl)CC#N.OC(=O)C(F)(F)F,EC50,=,21.6,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,B,10.8
14875,CHEMBL3742140,Nc1nc2CC[C@@H](Cc2s1)N(CCN3CCN(CC3)c4ccc5cc[nH]c5c4Cl)CC#N.OC(=O)C(F)(F)F,EC50,=,39.4,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,B,19.7
14877,CHEMBL3742076,CC(C)c1ccccc1OCCN2CCC(CC2)NS(=O)(=O)c3ccccc3F,Ki,=,51.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr by microplate reader based assay,B,51.0
14883,CHEMBL3740055,Clc1cccc(c1)S(=O)(=O)NC2CCN(CCOc3ccccc3c4ccccc4)CC2,Ki,=,85.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr by microplate reader based assay,B,85.0
14884,CHEMBL3747052,CC(C)c1ccccc1OCCN2CCC(CC2)N(C)S(=O)(=O)c3ccccc3,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,B,60.0
14885,CHEMBL3747114,CC(C)c1ccccc1OCCN2CCC(CC2)N(C)S(=O)(=O)c3cccc(F)c3,Ki,=,45.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,B,45.0
14886,CHEMBL3747071,CC(C)c1ccccc1OCCN2CCC(CC2)N(C)S(=O)(=O)c3ccc(F)cc3,Ki,=,50.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,B,50.0
14887,CHEMBL3747459,CC(C)c1ccccc1OCCN2CCC(CC2)N(C)S(=O)(=O)c3cnn(C)c3,Ki,=,46.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,B,46.0
14893,CHEMBL3746713,CN(C1CCN(CCOc2ccccc2c3ccccc3)CC1)S(=O)(=O)c4ccccc4,Ki,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,B,52.0
14894,CHEMBL3745815,CN(C1CCN(CCOc2ccccc2c3ccccc3)CC1)S(=O)(=O)c4ccc(F)cc4,Ki,=,54.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,B,54.0
14895,CHEMBL3747003,CN(C1CCN(CCOc2ccccc2c3ccccc3)CC1)S(=O)(=O)c4cnn(C)c4,Ki,=,35.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,B,35.0
14897,CHEMBL3747148,CC(C)c1ccccc1OCCN2CCC(CC2)N(CC3CC3)S(=O)(=O)c4cccc(F)c4,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,B,15.0
14898,CHEMBL3747744,CC(C)c1ccccc1OCCN2CCC(CC2)N(CC3CC3)S(=O)(=O)c4ccc(F)cc4,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,B,20.0
14899,CHEMBL3745882,CC(C)c1ccccc1OCCN2CCC(CC2)N(CC3CC3)S(=O)(=O)c4cnn(C)c4,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,B,18.0
14903,CHEMBL3745853,Fc1ccc(cc1)S(=O)(=O)N(CC2CC2)C3CCN(CCOc4ccccc4c5ccccc5)CC3,Ki,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,B,37.0
14904,CHEMBL3747240,Cn1cc(cn1)S(=O)(=O)N(CC2CC2)C3CCN(CCOc4ccccc4c5ccccc5)CC3,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,B,16.0
14913,CHEMBL3752512,CN1CCc2ccccc2Cc3sccc3CC1,Ki,=,45.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned D2 dopamine receptor incubated for 90 mins by radioligand binding assay,B,45.0
14917,CHEMBL3753266,CN1CCc2ccccc2Cc3sc4ccccc4c3CC1,Ki,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned D2 dopamine receptor incubated for 90 mins by radioligand binding assay,B,1.5
14921,CHEMBL3759205,CC(C)c1cccc(OCCN2C3CCC2CC(C3)NS(=O)(=O)c4ccc(F)cc4)c1,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells after 1 hr,B,60.0
14922,CHEMBL3759819,Clc1cccc(c1)S(=O)(=O)NC2CC3CCC(C2)N3CCOc4cccc(c4)c5ccccc5,Ki,=,94.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells after 1 hr,B,94.0
14931,CHEMBL3759865,O=C(NCCCCN1CCN(CC1)c2cccc3[nH]ccc23)c4ccc5ccccc5c4,Ki,=,95.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,B,95.0
14932,CHEMBL3759441,O=C(NCCCCN1CCN(CC1)c2cccc3NC(=O)Cc23)c4ccc5ccccc5c4,Ki,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,B,52.0
14934,CHEMBL3758610,CS(=O)(=O)Nc1cccc(c1)N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2,Ki,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,B,55.0
14936,CHEMBL3758991,COc1ccccc1N2CCN(CCCCNC(=O)Nc3cccc(Cl)c3)CC2,Ki,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,B,13.0
14941,CHEMBL3758368,COc1ccccc1N2CCN(CCCCCOc3ccc4ccccc4c3)CC2,Ki,=,34.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,B,34.0
15007,CHEMBL3775226,Cc1ncoc1c2nnc(SCCCN3CC4CCN(C4C3)c5ccc(cc5F)C(F)(F)F)n2C,Ki,=,50.12,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of dopamine-mediated Ca+2 stimulation pretreated for 10 mins followed by addition of dopamine by fluo-4 AM dye-based FLIPR assay,B,50.12
15008,CHEMBL3775226,Cc1ncoc1c2nnc(SCCCN3CC4CCN(C4C3)c5ccc(cc5F)C(F)(F)F)n2C,Ki,=,63.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,63.1
15014,CHEMBL3775534,Cc1ncoc1c2nnc(SCCCN3CC4CCN(C4C3)c5cccc(c5)C#N)n2C,Ki,=,50.12,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,50.12
15015,CHEMBL3775534,Cc1ncoc1c2nnc(SCCCN3CC4CCN(C4C3)c5cccc(c5)C#N)n2C,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,31.62
15017,CHEMBL3775338,Cc1ncoc1c2nnc(SCCCN3CC4CCN(C4C3)c5cc(Cl)cc(Cl)c5)n2C,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,10.0
15020,CHEMBL3775872,Cc1ncoc1c2nnc(SCCCN3CC4CCN(C4C3)c5ccccc5OC(F)(F)F)n2C,Ki,=,19.95,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,19.95
15024,CHEMBL3774425,Cn1c(SCCCN2CC3CCN(C3C2)c4cccc(c4)C(F)(F)F)nnc1c5cnccn5,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,31.62
15039,CHEMBL3774621,Cn1c(SCCCN2CC3CCN(C3C2)c4ccccc4OC(F)(F)F)nnc1c5cnccn5,Ki,=,31.62,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,31.62
15097,CHEMBL3774431,Cn1c(SCCCN2CC3CCN(C3C2)c4ccc(F)cc4)nnc1C5CCCCC5,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,39.81
15107,CHEMBL3780506,CCCOc1ccc2CC3N(CCc4cc(OC)c(O)cc34)Cc2c1OC,Ki,=,99.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,99.0
15113,CHEMBL3780184,COc1cc2CCN3Cc4c(CC3c2cc1O)ccc(OCC5CC5)c4OC,Ki,=,54.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,54.0
15160,CHEMBL3800165,CCCN[C@H]1CN2C(=O)N(CCC)c3cccc(C1)c23,Ki,=,8.08,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,8.08
15162,CHEMBL3800165,CCCN[C@H]1CN2C(=O)N(CCC)c3cccc(C1)c23,EC50,=,68.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,B,34.0
15164,CHEMBL3800165,CCCN[C@H]1CN2C(=O)N(CCC)c3cccc(C1)c23,EC50,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,B,6.5
15166,CHEMBL3797740,CCCN(C)[C@H]1CN2C(=O)Nc3cccc(C1)c23,Ki,=,12.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,12.5
15168,CHEMBL3797740,CCCN(C)[C@H]1CN2C(=O)Nc3cccc(C1)c23,EC50,=,29.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,B,14.5
15170,CHEMBL3797740,CCCN(C)[C@H]1CN2C(=O)Nc3cccc(C1)c23,EC50,=,18.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,B,9.05
15172,CHEMBL3797209,CCCN(CCC)[C@H]1CN2C(=O)N(CCC)c3cccc(C1)c23,Ki,=,2.59,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,2.59
15174,CHEMBL3797209,CCCN(CCC)[C@H]1CN2C(=O)N(CCC)c3cccc(C1)c23,EC50,=,33.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,B,16.95
15176,CHEMBL3797209,CCCN(CCC)[C@H]1CN2C(=O)N(CCC)c3cccc(C1)c23,EC50,=,13.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,B,6.85
15179,CHEMBL3797209,CCCN(CCC)[C@H]1CN2C(=O)N(CCC)c3cccc(C1)c23,EC50,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as cAMP inhibition by BRET assay,B,0.5
15180,CHEMBL3797209,CCCN(CCC)[C@H]1CN2C(=O)N(CCC)c3cccc(C1)c23,EC50,=,20.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,B,10.25
15182,CHEMBL3797209,CCCN(CCC)[C@H]1CN2C(=O)N(CCC)c3cccc(C1)c23,IC50,=,157.8,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,78.9
15184,CHEMBL3797209,CCCN(CCC)[C@H]1CN2C(=O)N(CCC)c3cccc(C1)c23,EC50,=,16.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,B,8.4
15188,CHEMBL3797209,CCCN(CCC)[C@H]1CN2C(=O)N(CCC)c3cccc(C1)c23,EC50,=,0.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,B,0.45
15190,CHEMBL3797209,CCCN(CCC)[C@H]1CN2C(=O)N(CCC)c3cccc(C1)c23,IC50,=,98.9,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,B,49.45
15192,CHEMBL3799157,CCCN1C(=O)N2C[C@@H](Cc3cccc1c23)NC,Ki,=,13.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,13.2
15194,CHEMBL3799157,CCCN1C(=O)N2C[C@@H](Cc3cccc1c23)NC,EC50,=,38.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,B,19.35
15198,CHEMBL3798803,CCCCN1C(=O)N2C[C@@H](Cc3cccc1c23)NC,Ki,=,12.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,12.8
15200,CHEMBL3798803,CCCCN1C(=O)N2C[C@@H](Cc3cccc1c23)NC,EC50,=,30.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,B,15.25
15202,CHEMBL3798803,CCCCN1C(=O)N2C[C@@H](Cc3cccc1c23)NC,EC50,=,83.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,B,41.5
15204,CHEMBL3800633,CN(CCCCNC(=O)c1oc2ccccc2c1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,Ki,=,15.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,15.5
15206,CHEMBL3800633,CN(CCCCNC(=O)c1oc2ccccc2c1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,EC50,=,43.3,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,B,21.65
15208,CHEMBL3800633,CN(CCCCNC(=O)c1oc2ccccc2c1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,EC50,=,19.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,B,9.75
15211,CHEMBL3800633,CN(CCCCNC(=O)c1oc2ccccc2c1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,EC50,=,65.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as cAMP inhibition by BRET assay,B,32.95
15214,CHEMBL3800633,CN(CCCCNC(=O)c1oc2ccccc2c1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,EC50,=,163.3,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,B,81.65
15216,CHEMBL3800633,CN(CCCCNC(=O)c1oc2ccccc2c1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,EC50,=,78.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,B,39.1
15218,CHEMBL3798179,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,Ki,=,5.78,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,5.78
15220,CHEMBL3798179,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,EC50,=,22.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,B,11.35
15222,CHEMBL3798179,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,EC50,=,27.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,B,13.85
15225,CHEMBL3798179,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,EC50,=,0.3,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as cAMP inhibition by BRET assay,B,0.15
15226,CHEMBL3798179,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,EC50,=,154.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,B,77.25
15228,CHEMBL3798179,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,EC50,=,124.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,B,62.35
15230,CHEMBL3798179,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,EC50,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,B,0.55
15232,CHEMBL3799626,CN(CCCCNC(=O)c1ccc2c(Cc3ccccc23)c1)[C@H]4CN5C(=O)Nc6cccc(C4)c56,Ki,=,5.47,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,5.47
15234,CHEMBL3799626,CN(CCCCNC(=O)c1ccc2c(Cc3ccccc23)c1)[C@H]4CN5C(=O)Nc6cccc(C4)c56,EC50,=,109.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor transfected in HEK293T cells by BRET based G0 activation assay,B,54.5
15236,CHEMBL3799626,CN(CCCCNC(=O)c1ccc2c(Cc3ccccc23)c1)[C@H]4CN5C(=O)Nc6cccc(C4)c56,EC50,=,102.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at recombinant human D2 receptor expressing in CHOp cells assessed as receptor mediated stimulation of mitogenesis measured as [3H]thymidine incorporation after 24 hrs by scintillation spectrometry,B,51.0
15248,CHEMBL3799603,Clc1cccc(N2CCN(CCCCNC(=O)Oc3ccccc3)CC2)c1Cl,EC50,=,37.6,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor short isoform transfected in HEK293 cells measured for 10 mins by spectroscopic analysis,B,18.8
15261,CHEMBL3797651,COc1ccc(cc1)c2cc(nc3c2ccn3S(=O)(=O)CC(C)C)N4CCN(C)CC4,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,B,22.0
15262,CHEMBL3800150,CC(C)CS(=O)(=O)n1ccc2c(cc(nc12)N3CCN(C)CC3)c4ccc(OCc5ccccc5)cc4,Ki,=,86.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,B,86.0
15273,CHEMBL3799120,CC(C)S(=O)(=O)n1ccc2c(cc(nc12)N3CCN(C)CC3)c4ccc(cc4)C(F)(F)F,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,B,25.0
15276,CHEMBL3798490,COCCS(=O)(=O)n1ccc2c(cc(nc12)N3CCN(C)CC3)c4ccc(cc4)C(F)(F)F,Ki,=,52.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,B,52.0
15291,CHEMBL3799455,COc1cc(CCNCCc2ccc(O)c3NC(=O)C=Cc23)ccc1OCCCc4ccccc4,Ki,=,64.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,64.0
15293,CHEMBL3799455,COc1cc(CCNCCc2ccc(O)c3NC(=O)C=Cc23)ccc1OCCCc4ccccc4,EC50,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2S receptor expressed in HEK293 cells cotransfected with Gqi5 protein assessed as [3H]IP3 accumulation after 120 mins by scintillation counting assay in presence of myo-[3H]-inositol,B,8.5
15298,CHEMBL3800303,COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc3ccccc3,Ki,=,67.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,67.0
15308,CHEMBL3800636,COc1cc(CCNCCc2ccc(O)c(O)c2)ccc1OCCCc3ccccc3,Ki,=,63.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,63.0
15310,CHEMBL3800636,COc1cc(CCNCCc2ccc(O)c(O)c2)ccc1OCCCc3ccccc3,EC50,=,110.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2S receptor expressed in HEK293 cells cotransfected with Gqi5 protein assessed as [3H]IP3 accumulation after 120 mins by scintillation counting assay in presence of myo-[3H]-inositol,B,55.0
15315,CHEMBL3798748,COc1cc(CCNC[C@H](O)c2ccc(O)c3NC(=O)COc23)ccc1OCCCc4ccccc4,Ki,=,65.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,65.0
15316,CHEMBL3798748,COc1cc(CCNC[C@H](O)c2ccc(O)c3NC(=O)COc23)ccc1OCCCc4ccccc4,EC50,=,98.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2S receptor expressed in HEK293 cells cotransfected with Gqi5 protein assessed as [3H]IP3 accumulation after 120 mins by scintillation counting assay in presence of myo-[3H]-inositol,B,49.0
15321,CHEMBL3797205,COc1cc(CCNC[C@@H](O)c2ccc(O)c3NC(=O)COc23)ccc1OCCCc4ccccc4,Ki,=,96.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,96.0
15322,CHEMBL3797205,COc1cc(CCNC[C@@H](O)c2ccc(O)c3NC(=O)COc23)ccc1OCCCc4ccccc4,EC50,=,7.3,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2S receptor expressed in HEK293 cells cotransfected with Gqi5 protein assessed as [3H]IP3 accumulation after 120 mins by scintillation counting assay in presence of myo-[3H]-inositol,B,3.65
15326,CHEMBL3800341,COc1cc(CCNCCc2ccc(O)c3NC(=O)COc23)ccc1OCCCc4ccccc4,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,12.0
15327,CHEMBL3800341,COc1cc(CCNCCc2ccc(O)c3NC(=O)COc23)ccc1OCCCc4ccccc4,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,17.0
15328,CHEMBL3800341,COc1cc(CCNCCc2ccc(O)c3NC(=O)COc23)ccc1OCCCc4ccccc4,EC50,=,2.6,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2S receptor expressed in HEK293 cells cotransfected with Gqi5 protein assessed as [3H]IP3 accumulation after 120 mins by scintillation counting assay in presence of myo-[3H]-inositol,B,1.3
15334,CHEMBL3797876,COc1ccccc1OCCNC[C@H](O)c2ccc(O)c(O)c2,EC50,=,170.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2S receptor expressed in HEK293 cells cotransfected with Gqi5 protein assessed as [3H]IP3 accumulation after 120 mins by scintillation counting assay in presence of myo-[3H]-inositol,B,85.0
15343,CHEMBL3797758,COc1ccccc1OCCNCCc2ccc(O)c(O)c2,Ki,=,85.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,85.0
15344,CHEMBL3797758,COc1ccccc1OCCNCCc2ccc(O)c(O)c2,Ki,=,48.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,48.0
15345,CHEMBL3797758,COc1ccccc1OCCNCCc2ccc(O)c(O)c2,EC50,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2S receptor expressed in HEK293 cells cotransfected with Gqi5 protein assessed as [3H]IP3 accumulation after 120 mins by scintillation counting assay in presence of myo-[3H]-inositol,B,12.5
15348,CHEMBL3799986,CCCN[C@@H]1CCC2N=C(N)SC2C1,Ki,=,60.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,60.0
15349,CHEMBL3799125,COc1ccccc1OCCNC[C@H](O)COc2cccc3[nH]c4ccccc4c23,Ki,=,49.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,49.0
15350,CHEMBL3798017,COc1ccccc1OCCNC[C@@H](O)COc2cccc3[nH]c4ccccc4c23,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,26.0
15351,CHEMBL3805600,CC(=O)Nc1cccc(OCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)c1,IC50,=,98.4,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,49.2
15352,CHEMBL3805077,CNC(=O)c1cccc(OCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)c1,IC50,=,32.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,16.0
15353,CHEMBL3806169,NC(=O)c1cccc(OCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)c1,IC50,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,27.5
15354,CHEMBL3805772,CCNC(=O)c1cccc(OCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)c1,IC50,=,116.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,58.0
15355,CHEMBL3805826,CCCCCNC(=O)c1cccc(OCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)c1,IC50,=,16.8,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,8.4
15356,CHEMBL3805120,CNC(=O)c1cc(OCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)ccc1C,IC50,=,9.8,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,4.9
15357,CHEMBL3805884,CNC(=O)c1cc(OCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)ccc1F,IC50,=,39.4,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,19.7
15359,CHEMBL3804943,CNC(=O)c1ccc(OC)c(OCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)c1,IC50,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,6.0
15360,CHEMBL3806224,CNC(=O)c1cc(OCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)ccc1Cl,IC50,=,34.9,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,17.45
15361,CHEMBL3806047,CNC(=O)c1cc(C)cc(OCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)c1,IC50,=,89.8,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,44.9
15362,CHEMBL3805434,CNC(=O)c1cc(OCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)cc(c1)C(=O)C,IC50,=,37.7,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,18.85
15363,CHEMBL3805327,CNC(=O)c1ccc(Cl)c(OCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)c1,IC50,=,58.5,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,29.25
15366,CHEMBL3805046,CNC(=O)c1cccc(OCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)c1F,IC50,=,171.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,85.5
15367,CHEMBL3804954,CNC(=O)c1ccccc1OCCCCN2CCN(CC2)c3cccc(Cl)c3Cl,IC50,=,167.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,83.5
15368,CHEMBL3805376,CNC(=O)c1ccc(OCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)cc1,IC50,=,70.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,35.0
15369,CHEMBL3805559,CNC(=O)c1cccc(OCCCCN2CCC(CC2)c3noc4cc(F)ccc34)c1,IC50,=,8.5,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,4.25
15370,CHEMBL3805518,CNC(=O)c1cc(OCCCCN2CCC(CC2)c3noc4cc(F)ccc34)ccc1F,IC50,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,11.5
15371,CHEMBL3805860,CNC(=O)c1cccc(OCCCCN2CCN(CC2)c3nsc4ccccc34)c1,IC50,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,5.0
15372,CHEMBL3805099,CNC(=O)c1cc(OCCCCN2CCN(CC2)c3nsc4ccccc34)ccc1F,IC50,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,6.0
15373,CHEMBL3805704,CNC(=O)c1cccc(OCCCCN2CCN(CC2)c3cccc4sccc34)c1,IC50,=,91.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,45.5
15374,CHEMBL3805649,CNC(=O)c1cc(OCCCCN2CCN(CC2)c3cccc4sccc34)ccc1F,IC50,=,43.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,21.5
15375,CHEMBL3805165,CNC(=O)c1cccc(OCCCCN2CCN(CC2)c3cccc4OC(F)(F)Oc34)c1,IC50,=,4.1,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,2.05
15376,CHEMBL3804965,CNC(=O)c1cc(OCCCCN2CCN(CC2)c3cccc4OC(F)(F)Oc34)ccc1F,IC50,=,30.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,15.0
15380,CHEMBL3819567,O=C1NCN(c2ccccc2)C13CCN(CCCCc4nc5ccccc5s4)CC3,Ki,=,24.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,B,24.0
15381,CHEMBL3819567,O=C1NCN(c2ccccc2)C13CCN(CCCCc4nc5ccccc5s4)CC3,Ki,=,23.99,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,B,23.99
15382,CHEMBL3818124,Clc1ccc2sc(CCCCN3CCC4(CC3)N(CNC4=O)c5ccccc5)nc2c1,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,B,18.0
15383,CHEMBL3818124,Clc1ccc2sc(CCCCN3CCC4(CC3)N(CNC4=O)c5ccccc5)nc2c1,Ki,=,18.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,B,18.2
15384,CHEMBL3818935,O=C1NCN(c2ccccc2)C13CCN(CCCCc4oc5ccccc5n4)CC3,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,B,10.0
15385,CHEMBL3818935,O=C1NCN(c2ccccc2)C13CCN(CCCCc4oc5ccccc5n4)CC3,Ki,=,10.23,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,B,10.23
15386,CHEMBL3818478,O=C1NCN(c2ccccc2)C13CCN(CCCCc4c[nH]c5ccccc45)CC3,Ki,=,22.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,B,22.0
15387,CHEMBL3818478,O=C1NCN(c2ccccc2)C13CCN(CCCCc4c[nH]c5ccccc45)CC3,Ki,=,22.39,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,B,22.39
15390,CHEMBL3819153,Clc1ccc2N(C3CCN(CCCCc4oc5ccccc5n4)CC3)C(=O)Nc2c1,Ki,=,95.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,B,95.0
15391,CHEMBL3819153,Clc1ccc2N(C3CCN(CCCCc4oc5ccccc5n4)CC3)C(=O)Nc2c1,Ki,=,95.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,B,95.5
15401,CHEMBL3819434,Cl.OC1(CC2CCC(C1)N2CCCCc3nc4ccccc4s3)c5ccc(Cl)cc5,Ki,=,44.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,B,44.0
15402,CHEMBL3819434,Cl.OC1(CC2CCC(C1)N2CCCCc3nc4ccccc4s3)c5ccc(Cl)cc5,Ki,=,44.67,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,B,44.67
15418,CHEMBL3818994,Fc1ccc(cc1)C(=O)CCCN2CCc3ccccc3C2,Ki,=,49.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,B,49.0
15437,CHEMBL3885419,CC(C)(C)[C@]1(O)CCN2C[C@@H]3c4ccccc4CCc5cccc([C@@H]2C1)c35,IC50,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methyl-spiperone from human recombinant dopamine D2S receptor expressed in HEK293 cells measured after 60 mins by scintillation counting method,B,0.55
15442,CHEMBL3890178,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c4ccc(cc4)C(F)(F)F)C2)nnc1c5ccccc5C(=O)N,Ki,=,39.81,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,39.81
15445,CHEMBL3891542,CCOc1ccccc1N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,Ki,=,4.1,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,4.1
15446,CHEMBL3891542,CCOc1ccccc1N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,4.3,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,2.15
15447,CHEMBL3891773,N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1,Ki,=,4.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,4.6
15449,CHEMBL3892440,CS(=O)(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1,Ki,=,8.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,8.9
15458,CHEMBL3895540,CN([C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1)S(=O)(=O)c5cccs5,Ki,=,0.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,0.3
15462,CHEMBL3896746,Clc1cccc(N2CCN(C\C=C\COc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,15.0
15463,CHEMBL3896746,Clc1cccc(N2CCN(C\C=C\COc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,13.0
15464,CHEMBL3896937,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1)Nc5cccnc5,Ki,=,0.51,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,0.51
15472,CHEMBL3898054,Clc1cccc(C2CCN(CCCCOc3ccc4CCNC(=O)c4c3)CC2)c1Cl,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,20.0
15473,CHEMBL3898054,Clc1cccc(C2CCN(CCCCOc3ccc4CCNC(=O)c4c3)CC2)c1Cl,EC50,=,64.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,32.0
15478,CHEMBL3899117,CC(=O)Nc1cc(OCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)ccc1C,Ki,=,72.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,72.0
15479,CHEMBL3899117,CC(=O)Nc1cc(OCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)ccc1C,EC50,=,9.2,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,4.6
15484,CHEMBL3899336,Cc1ncoc1c2nnc(SCCCN3CC[C@]4(C[C@@H]4c5cc(Cl)cc(Cl)c5)C3)n2C,Ki,=,61.66,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,61.66
15487,CHEMBL3900752,CC(C)N(C(C)C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1,Ki,=,0.72,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,0.72
15493,CHEMBL3902496,CCC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,18.0
15499,CHEMBL3903560,COCC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1,Ki,=,9.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,9.6
15504,CHEMBL3905247,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1)c5cc6ccccc6[nH]5,Ki,=,0.43,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,0.43
15509,CHEMBL3906408,O=C(CCCCCN1CCN(CC1)c2ccccc2c3ccccc3)NCc4ccc(OCCCN5CCOCC5)cc4,Ki,=,64.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,B,64.0
15525,CHEMBL3909821,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1)N5CCOCC5,Ki,=,2.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,2.2
15532,CHEMBL3912435,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4cccc5OCCOc45)nc2N1,Ki,=,0.45,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,0.45
15533,CHEMBL3912435,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4cccc5OCCOc45)nc2N1,EC50,=,0.4,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,0.2
15534,CHEMBL3912435,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4cccc5OCCOc45)nc2N1,EC50,=,0.6,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,0.3
15543,CHEMBL3913691,FC(F)(F)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1,Ki,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,1.7
15548,CHEMBL3914241,CCOC(=O)N1CCC(CCN2CCN(CC2)c3nsc4ccccc34)CC1,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,10.0
15551,CHEMBL3915863,Clc1cccc(N2CCCN(CCCOc3ccc4NC(=O)Nc4c3)CC2)c1Cl,Ki,=,4.5,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,4.5
15552,CHEMBL3915863,Clc1cccc(N2CCCN(CCCOc3ccc4NC(=O)Nc4c3)CC2)c1Cl,EC50,=,8.5,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,4.25
15553,CHEMBL3916047,Clc1cccc(N2CCCN(CCCOc3ccc4C=CC(=O)Nc4c3)CC2)c1Cl,Ki,=,3.4,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,3.4
15554,CHEMBL3916047,Clc1cccc(N2CCCN(CCCOc3ccc4C=CC(=O)Nc4c3)CC2)c1Cl,EC50,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,6.5
15555,CHEMBL3916047,Clc1cccc(N2CCCN(CCCOc3ccc4C=CC(=O)Nc4c3)CC2)c1Cl,EC50,=,2.2,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,1.1
15562,CHEMBL3918282,OC(CN1CCN(CC[S+]([O-])C(c2ccc(F)cc2)c3ccc(F)cc3)CC1)Cc4ccccc4,Ki,=,78.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2R expressed in HEK293 cell membranes incubated for 1 hr by radioligand binding assay,B,78.6
15564,CHEMBL3918755,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1)Nc5ccccc5,Ki,=,0.63,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,0.63
15565,CHEMBL3918805,Clc1cccc(N2CCCN(CCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,8.3,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,8.3
15566,CHEMBL3918805,Clc1cccc(N2CCCN(CCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,6.1,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,3.05
15567,CHEMBL3918805,Clc1cccc(N2CCCN(CCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,3.1,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,1.55
15568,CHEMBL3918805,Clc1cccc(N2CCCN(CCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,=,6.0,nM,Dopamine D2 receptor,Homo sapiens,"pERK High-Content Assay: Cell Culture: Chinese Hamster Ovary (CHO) cells stably expressing the hD2L dopamine receptor (Urban et al., Neuropsychopharmacology 32:67 (2007)) were maintained in Ham's F12 medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, 100 ug/mL streptomycin, and 0.5 ug/ml G418. On day 1 of the assay, cells were seeded onto black clear-bottom tissue culture-treated 96-well plates (Greiner, BioOne). On day 2 of the assay, cells were washed with serum-free medium (Ham's F-12, penicillin and streptomycin) and incubated in 100 uL serum-free medium overnight.Immunofluorescence: Automatic multichannel pipetters were used for liquid handling and multichannel vacuum manifolds for aspirations. Each tested concentration was typically measured in triplicate or quadruplicate. For concentration curves, half-log-dilutions were used. Drug dilutions were prepared in stimulation medium (serum-free medium, 100 mg/L ascorbic acid).",B,3.0
15572,CHEMBL3920252,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1)c5ccccc5,Ki,=,0.33,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,0.33
15573,CHEMBL3920432,CCCS(=O)(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1,Ki,=,1.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,1.9
15577,CHEMBL3921903,CC(C)Oc1ccccc1N2CCCN(CCCCOc3ccc4C=CC(=O)Nc4c3)CC2,Ki,=,0.93,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,0.93
15578,CHEMBL3921903,CC(C)Oc1ccccc1N2CCCN(CCCCOc3ccc4C=CC(=O)Nc4c3)CC2,EC50,=,0.1,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,0.05
15579,CHEMBL3921903,CC(C)Oc1ccccc1N2CCCN(CCCCOc3ccc4C=CC(=O)Nc4c3)CC2,EC50,=,4.2,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,2.1
15586,CHEMBL3923240,CCOC(=O)N[C@@H]1CC[C@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1,Ki,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,4.0
15592,CHEMBL3926847,Cc1ncoc1c2nnc(SCCCN3CC[C@@]4(C[C@H]4c5ccc(F)cc5F)C3)n2C,Ki,=,66.07,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,B,66.07
15597,CHEMBL3929168,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1)C5CCCCC5,Ki,=,0.94,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,0.94
15598,CHEMBL3929710,COc1ccccc1N2CCCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2,Ki,=,5.7,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,5.7
15600,CHEMBL3929710,COc1ccccc1N2CCCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2,EC50,=,6.1,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,3.05
15605,CHEMBL3932186,Clc1ccc2c(nsc2c1)N3CCN(C[C@@H]4CC[C@@H](CNC(=O)c5occc5)CC4)CC3,Ki,=,2.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,2.1
15607,CHEMBL3933256,O=S(=O)(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1)c5cccnc5,Ki,=,0.35,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,0.35
15608,CHEMBL3934712,Clc1cccc(N2CCN(CCCOc3ccc4NC(=O)Nc4c3)CC2)c1Cl,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,25.0
15610,CHEMBL3934712,Clc1cccc(N2CCN(CCCOc3ccc4NC(=O)Nc4c3)CC2)c1Cl,EC50,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,12.5
15611,CHEMBL3935170,CCOc1ccccc1N2CCCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2,Ki,=,4.4,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,4.4
15612,CHEMBL3935170,CCOc1ccccc1N2CCCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2,EC50,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,2.0
15615,CHEMBL3935692,Cc1ncoc1c2nnc(SCCCN3CC[C@]4(C[C@@H]4c5ccc(cc5)C(F)(F)F)C3)n2C,Ki,=,74.13,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,B,74.13
15623,CHEMBL3937643,COc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2,Ki,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,1.7
15624,CHEMBL3937643,COc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2,EC50,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,5.5
15625,CHEMBL3937643,COc1ccccc1N2CCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2,EC50,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,8.5
15627,CHEMBL3938210,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1)c5ccc[nH]5,Ki,=,0.21,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,0.21
15630,CHEMBL3940712,O=C(NCc1ccccc1)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4nsc5ccccc45)CC2,Ki,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,1.4
15633,CHEMBL3941190,Nc1ccc2c(nsc2c1)N3CCN(CC[C@@H]4CC[C@H](CC4)NC(=O)c5occc5)CC3,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,14.0
15636,CHEMBL3941529,C[C@H](NC(=O)CCCCCN1CCN(CC1)c2ccccc2c3ccccc3)c4ccccc4,Ki,=,53.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,B,53.0
15641,CHEMBL3942236,O=C(N1CCC(CCN2CCN(CC2)c3nsc4ccccc34)CC1)c5occc5,Ki,=,15.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,15.0
15642,CHEMBL3943838,Clc1cccc(N2CCCN(CCCCOc3ccc4CCNC(=O)c4c3)CC2)c1Cl,Ki,=,4.6,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,4.6
15644,CHEMBL3943838,Clc1cccc(N2CCCN(CCCCOc3ccc4CCNC(=O)c4c3)CC2)c1Cl,EC50,=,6.2,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,3.1
15645,CHEMBL3944009,CCOc1ccccc1N2CCCN(CCCCOc3ccc4C=CC(=O)Nc4c3)CC2,Ki,=,3.6,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,3.6
15646,CHEMBL3944009,CCOc1ccccc1N2CCCN(CCCCOc3ccc4C=CC(=O)Nc4c3)CC2,EC50,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,13.5
15647,CHEMBL3944009,CCOc1ccccc1N2CCCN(CCCCOc3ccc4C=CC(=O)Nc4c3)CC2,EC50,=,4.8,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,2.4
15656,CHEMBL3945856,CCCCCOc1c(O)ccc2C[C@@H]3N(CCc4cc(OC)c(O)cc34)Cc12,Ki,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,A,23.0
15660,CHEMBL3946995,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1)c5occc5,Ki,=,2.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,2.9
15664,CHEMBL3946995,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1)c5occc5,IC50,=,61.45,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at D2 receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 assessed as inhibition of dopamine-induced calcium flux by fluo-4 dye based FLIPR assay,B,30.725
15668,CHEMBL3948056,Cc1ccc(cc1)S(=O)(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4nsc5ccccc45)CC2,Ki,=,0.42,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,0.42
15679,CHEMBL3950977,O=C(N[C@@H]1CC[C@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1)c5occc5,Ki,=,6.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,6.3
15683,CHEMBL3952761,CC(C)Oc1ccccc1N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,Ki,=,0.87,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,0.87
15684,CHEMBL3952761,CC(C)Oc1ccccc1N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,4.2,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,2.1
15688,CHEMBL3953773,CN(C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1)c5ccccc5,Ki,=,2.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,2.4
15690,CHEMBL3954123,CS(=O)(=O)c1ccc2Sc3ccccc3N(CCCN4CCC(CC4)C(=O)O)c2c1,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The pharmacological profile of metopimazine, metopimazine acid (MPZA), domperidone, and metoclopramide were assessed by radioligand binding and by a functional antagonist assay. For the radioligand binding assay, cell membranes of dopamine D2 receptor expressing cells were incubated with [3H]spiperone and competing drugs in buffer. The assay was terminated by rapid filtration, and the bound radioactive signal was determined by liquid scintillation counting.",B,14.0
15693,CHEMBL3954556,CCCOc1c(O)ccc2C[C@@H]3N(CCc4cc(OC)c(O)cc34)Cc12,Ki,=,41.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,A,41.0
15697,CHEMBL3955505,Cc1ncoc1c2nnc(SCCCN3CC[C@@]4(C[C@H]4c5ccc(cc5F)C(F)(F)F)C3)n2C,Ki,=,25.7,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,B,25.7
15701,CHEMBL3956720,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1)C5CC5,Ki,=,0.85,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,0.85
15703,CHEMBL3957278,COc1ccccc1N2CCCN(CCCCOc3ccc4C=CC(=O)Nc4c3)CC2,Ki,=,2.1,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,2.1
15705,CHEMBL3957278,COc1ccccc1N2CCCN(CCCCOc3ccc4C=CC(=O)Nc4c3)CC2,EC50,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,1.25
15722,CHEMBL3959698,O=C(NC[C@@H]1CC[C@@H](CN2CCN(CC2)c3nsc4ccccc34)CC1)c5occc5,Ki,=,8.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,8.9
15727,CHEMBL3960785,CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1,Ki,=,0.53,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,0.53
15734,CHEMBL3962525,CCCC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1,Ki,=,2.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,2.8
15739,CHEMBL3963783,Cc1ncoc1c2nnc(SCCCN3CC[C@@]4(C[C@H]4c5ccc(F)cc5)C3)n2C,Ki,=,57.54,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,B,57.54
15750,CHEMBL3966842,O=S(=O)(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1)c5cccs5,Ki,=,0.43,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,0.43
15751,CHEMBL3966956,O=C1Nc2cc(OCCCCN3CCN(CC3)c4cccc5OCCOc45)ccc2C=C1,Ki,=,0.4,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,0.4
15752,CHEMBL3966956,O=C1Nc2cc(OCCCCN3CCN(CC3)c4cccc5OCCOc45)ccc2C=C1,EC50,=,0.9,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,0.45
15754,CHEMBL3967779,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1)c5cccnc5,Ki,=,0.85,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,0.85
15757,CHEMBL3968569,CN(C)Cc1ccc(CNC(=O)CCCCCN2CCN(CC2)c3ccccc3c4ccccc4)cc1,Ki,=,75.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,B,75.0
15763,CHEMBL3970746,[O-][N+](=O)c1ccc2c(nsc2c1)N3CCN(CC[C@@H]4CC[C@H](CC4)NC(=O)c5occc5)CC3,Ki,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,26.0
15770,CHEMBL3971907,CCN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1,Ki,=,0.51,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,0.51
15773,CHEMBL3973357,COc1ccccc1N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,Ki,=,4.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,4.0
15774,CHEMBL3973357,COc1ccccc1N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,163.0,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,81.5
15775,CHEMBL3973357,COc1ccccc1N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2,EC50,=,4.6,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,2.3
15776,CHEMBL3973487,CC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,25.0
15779,CHEMBL3975989,Cc1ncoc1c2nnc(SCCCN3CC[C@@]4(C[C@@H]4c5ccccc5C(F)(F)F)C3)n2C,Ki,=,63.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,63.1
15781,CHEMBL3976282,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1)c5cccs5,Ki,=,0.19,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,0.19
15785,CHEMBL3976659,CCCOc1c(O)cc(Br)c2C[C@@H]3N(CCc4cc(OC)c(O)cc34)Cc12,Ki,=,70.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,A,70.0
15789,CHEMBL3978288,CC(C)Oc1ccccc1N2CCCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2,Ki,=,1.29,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,1.29
15790,CHEMBL3978288,CC(C)Oc1ccccc1N2CCCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2,EC50,=,0.2,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,0.1
15791,CHEMBL3978288,CC(C)Oc1ccccc1N2CCCN(CCCCOc3ccc4CCC(=O)Nc4n3)CC2,EC50,=,4.6,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,2.3
15803,CHEMBL3982215,COCCOc1c(O)ccc2C[C@@H]3N(CCc4cc(OC)c(O)cc34)Cc12,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,A,18.0
15804,CHEMBL3982360,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4cccc5OCCOc45)cc2N1,Ki,=,0.3,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,0.3
15805,CHEMBL3982360,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4cccc5OCCOc45)cc2N1,EC50,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,0.75
15806,CHEMBL3982486,CCOC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1,Ki,=,0.71,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,B,0.71
15807,CHEMBL3983121,Cc1ncoc1c2nnc(SCCCN3CC[C@]4(C[C@H]4c5cc(Cl)cc(Cl)c5)C3)n2C,Ki,=,66.07,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,66.07
15809,CHEMBL3983588,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4cccc5NC(=O)COc45)cc2N1,Ki,=,0.47,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",B,0.47
15810,CHEMBL3983588,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4cccc5NC(=O)COc45)cc2N1,EC50,=,1.8,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,0.9
15811,CHEMBL3983588,O=C1CCc2ccc(OCCCCN3CCN(CC3)c4cccc5NC(=O)COc45)cc2N1,EC50,=,0.4,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of ß-arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing ß-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 ¿g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 ¿l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 ¿l/well of reference agonist (6 ¿M) or D2 test ligand (6 ¿M)±reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 ¿M, final DMSO concentration was 3%).",B,0.2
15820,CHEMBL3985152,COCOc1ccc(CNC(=O)CCCCCN2CCN(CC2)c3ccccc3c4ccccc4)cc1,Ki,=,36.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,B,36.0
15829,CHEMBL4059581,CCCN[C@H]1CN2C(=O)N(CCCCOCCCCc3ccccc3)c4cccc(C1)c24,EC50,=,25.6,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as cAMP inhibition by BRET assay,B,12.8
15830,CHEMBL4059581,CCCN[C@H]1CN2C(=O)N(CCCCOCCCCc3ccccc3)c4cccc(C1)c24,Ki,=,37.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,B,37.2
15831,CHEMBL4059581,CCCN[C@H]1CN2C(=O)N(CCCCOCCCCc3ccccc3)c4cccc(C1)c24,EC50,=,196.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,B,98.4
15833,CHEMBL4059581,CCCN[C@H]1CN2C(=O)N(CCCCOCCCCc3ccccc3)c4cccc(C1)c24,EC50,=,194.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,B,97.25
15835,CHEMBL4059581,CCCN[C@H]1CN2C(=O)N(CCCCOCCCCc3ccccc3)c4cccc(C1)c24,EC50,=,24.6,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,B,12.3
15839,CHEMBL4060403,Clc1cccc(N2CCN(CCCC(=O)Nc3ccn4ncc(C=O)c4c3)CC2)c1Cl,Ki,=,0.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.3
15840,CHEMBL4060403,Clc1cccc(N2CCN(CCCC(=O)Nc3ccn4ncc(C=O)c4c3)CC2)c1Cl,Ki,=,0.41,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.41
15841,CHEMBL4060403,Clc1cccc(N2CCN(CCCC(=O)Nc3ccn4ncc(C=O)c4c3)CC2)c1Cl,EC50,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,6.5
15846,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,Ki,=,1.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,1.2
15847,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,Ki,=,0.72,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.72
15848,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,EC50,=,3.4,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,1.7
15852,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,EC50,=,3.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,B,1.85
15854,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,EC50,=,5.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,B,2.85
15856,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,EC50,=,5.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,B,2.85
15858,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,EC50,=,1.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,B,0.9
15860,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,EC50,=,2.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,B,1.05
15870,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,EC50,=,3.388,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,1.694
15874,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,Ki,=,0.16,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.16
15875,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,Ki,=,0.094,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.094
15876,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,EC50,=,0.74,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,0.37
15878,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,EC50,=,117.49,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,58.745
15880,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,EC50,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,B,2.5
15882,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,EC50,=,5.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,B,2.9
15884,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,EC50,=,6.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,B,3.1
15886,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,EC50,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,B,1.25
15888,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,EC50,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,B,1.0
15899,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,EC50,=,120.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,60.0
15900,CHEMBL4060461,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(\C=N\O)c4c3)CC2,EC50,=,0.7413,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,0.37065
15902,CHEMBL4060649,Cc1cccc(c1)S(=O)(=O)NCCCN2CCC(=CC2)c3c[nH]c4ccc(F)cc34,Ki,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,17.0
15903,CHEMBL4060678,CC1=C(CCN2CCN(CC2)c3nsc4ccccc34)C(=O)N5CCCC(O)C5=N1,IC50,=,5.1,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,2.55
15907,CHEMBL4061068,CC1=C(CCN2CCN(CC2)c3nsc4ccccc34)C(=O)N5CCCC(C)(O)C5=N1,IC50,=,2.4,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,1.2
15912,CHEMBL4061986,Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c5cccnc15,Ki,=,33.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,B,33.0
15913,CHEMBL4061986,Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c5cccnc15,Ki,=,25.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,B,25.0
15921,CHEMBL4062602,Fc1ccc2c(noc2c1)C3CCN(CCCN4C(=O)COc5ccccc45)CC3,Ki,=,3.236,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,B,3.236
15924,CHEMBL4062602,Fc1ccc2c(noc2c1)C3CCN(CCCN4C(=O)COc5ccccc45)CC3,Ki,=,3.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,B,3.2
15925,CHEMBL4062602,Fc1ccc2c(noc2c1)C3CCN(CCCN4C(=O)COc5ccccc45)CC3,Kb,=,1.2,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in F1pIn CHO cells assessed as inhibition of ERK1/2 phosphorylation incubated for 5 mins by AlphaScreen assay,B,1.2
15926,CHEMBL4062817,Fc1ccc2[nH]cc(C3=CCN(CCCCNS(=O)(=O)c4ccc5ccccc5c4)CC3)c2c1,Ki,=,0.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,0.3
15927,CHEMBL4062936,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCC(F)C5=N1,IC50,=,6.2,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,3.1
15928,CHEMBL4062992,CC1=C(CCN2CCN(CC2)c3nsc4ccccc34)C(=O)N5CCCC(F)(F)C5=N1,IC50,=,5.2,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,2.6
15929,CHEMBL4063145,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4ccc(O)c5NC(=O)COc45)cc12,Ki,=,0.91,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,B,0.91
15930,CHEMBL4063145,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4ccc(O)c5NC(=O)COc45)cc12,Ki,=,0.67,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,B,0.67
15931,CHEMBL4063145,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4ccc(O)c5NC(=O)COc45)cc12,EC50,=,110.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,B,55.0
15936,CHEMBL4063145,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4ccc(O)c5NC(=O)COc45)cc12,Ki,=,0.98,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,B,0.98
15937,CHEMBL4063145,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4ccc(O)c5NC(=O)COc45)cc12,Ki,=,0.95,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,B,0.95
15938,CHEMBL4063145,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4ccc(O)c5NC(=O)COc45)cc12,EC50,=,110.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,B,55.0
15944,CHEMBL4063235,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(C#N)c4c3)CC2,Ki,=,0.25,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.25
15945,CHEMBL4063235,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(C#N)c4c3)CC2,Ki,=,0.16,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.16
15946,CHEMBL4063235,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(C#N)c4c3)CC2,EC50,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,6.5
15951,CHEMBL4063235,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(C#N)c4c3)CC2,EC50,=,12.88,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,6.44
15952,CHEMBL4063282,COc1ccccc1N2CCN(CCCC(=O)Nc3ccn4nccc4c3)CC2,Ki,=,46.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,46.0
15953,CHEMBL4063282,COc1ccccc1N2CCN(CCCC(=O)Nc3ccn4nccc4c3)CC2,Ki,=,36.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,36.0
15959,CHEMBL4064186,Oc1ccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5cccnc15,Ki,=,3.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,B,3.4
15960,CHEMBL4064186,Oc1ccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5cccnc15,Ki,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,B,1.5
15967,CHEMBL4064742,Oc1ccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5OCC(=O)Nc15,Ki,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,B,1.6
15968,CHEMBL4064742,Oc1ccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5OCC(=O)Nc15,Ki,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,B,1.6
15971,CHEMBL4064742,Oc1ccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5OCC(=O)Nc15,EC50,=,78.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2S receptor expressed in HEK293T cell membranes coexpressing Galphao1 assessed as induction of nucleotide exchange preincubated for 30 mins followed by addition of [35S]GTPgammaS measured after 30 mins by [35S]GTPgammaS binding assay,B,39.0
15980,CHEMBL4064974,FCCOc1ccccc1N2CCN(CCCCNC(=O)c3cc4ccccn4n3)CC2,Ki,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2-long receptor expressed in CHO cell membranes,B,39.0
15981,CHEMBL4064974,FCCOc1ccccc1N2CCN(CCCCNC(=O)c3cc4ccccn4n3)CC2,Ki,=,21.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2-short receptor expressed in CHO cell membranes,B,21.0
15982,CHEMBL4065353,CCCN[C@H]1CN2C(=O)N(CCCCNC(=O)c3cc4ccccc4[nH]3)c5cccc(C1)c25,Ki,=,18.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,B,18.5
15985,CHEMBL4065510,NC(=O)c1cccc(c1)c2ccc(OC(=O)NC\C=C\CN3CCN(CC3)c4cccc(Cl)c4Cl)cc2,EC50,=,147.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor-short expressed in CHO-K1 cells assessed as reduction in adenylyl cyclase activator NKH 477 induced cAMP accumulation preincubated for 10 mins followed by NKH 477 addition by HTRF assay,B,73.5
15987,CHEMBL4065568,Cc1cccc(c1)S(=O)(=O)NCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,Ki,=,3.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,3.3
15990,CHEMBL4065568,Cc1cccc(c1)S(=O)(=O)NCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,EC50,=,56.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2S receptor expressed in HEK-293 cells by cellular dielectric spectroscopy,B,28.0
15992,CHEMBL4065568,Cc1cccc(c1)S(=O)(=O)NCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,Kb,=,2.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2S receptor expressed in HEK-293 cells by cellular dielectric spectroscopy,B,2.1
15993,CHEMBL4065710,CC1=C(CCN2CCN(CC2)c3cccc4sccc34)C(=O)N5CCCC(C)(O)C5=N1,IC50,=,31.5,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,15.75
15995,CHEMBL4065797,CCCN1CCCN(CC1)c2ccc(O)c3NC(=O)COc23,Ki,=,56.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,B,56.0
16004,CHEMBL4066435,COc1ccccc1N2CCN(CCCN3C(=O)COc4ccccc34)CC2,Ki,=,42.66,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,B,42.66
16007,CHEMBL4066435,COc1ccccc1N2CCN(CCCN3C(=O)COc4ccccc34)CC2,Ki,=,42.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,B,42.7
16008,CHEMBL4066435,COc1ccccc1N2CCN(CCCN3C(=O)COc4ccccc34)CC2,Kb,=,7.8,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in F1pIn CHO cells assessed as inhibition of ERK1/2 phosphorylation incubated for 5 mins by AlphaScreen assay,B,7.8
16009,CHEMBL4066532,Clc1cccc(c1)S(=O)(=O)NCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,Ki,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,23.0
16014,CHEMBL4066971,Oc1cccc(c1)S(=O)(=O)NCCCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,2.5
16015,CHEMBL4067439,COc1ccccc1N2CCN(CCCCOc3ccc4c(C=O)cnn4c3)CC2,Ki,=,7.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,7.8
16016,CHEMBL4067439,COc1ccccc1N2CCN(CCCCOc3ccc4c(C=O)cnn4c3)CC2,Ki,=,7.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,7.7
16017,CHEMBL4067439,COc1ccccc1N2CCN(CCCCOc3ccc4c(C=O)cnn4c3)CC2,EC50,=,5.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,2.95
16019,CHEMBL4067439,COc1ccccc1N2CCN(CCCCOc3ccc4c(C=O)cnn4c3)CC2,EC50,=,154.88,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,77.44
16021,CHEMBL4067439,COc1ccccc1N2CCN(CCCCOc3ccc4c(C=O)cnn4c3)CC2,EC50,=,4.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,B,2.1
16023,CHEMBL4067439,COc1ccccc1N2CCN(CCCCOc3ccc4c(C=O)cnn4c3)CC2,EC50,=,7.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,B,3.85
16025,CHEMBL4067439,COc1ccccc1N2CCN(CCCCOc3ccc4c(C=O)cnn4c3)CC2,EC50,=,10.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,B,5.05
16027,CHEMBL4067439,COc1ccccc1N2CCN(CCCCOc3ccc4c(C=O)cnn4c3)CC2,EC50,=,2.6,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,B,1.3
16029,CHEMBL4067439,COc1ccccc1N2CCN(CCCCOc3ccc4c(C=O)cnn4c3)CC2,EC50,=,2.6,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,B,1.3
16040,CHEMBL4067439,COc1ccccc1N2CCN(CCCCOc3ccc4c(C=O)cnn4c3)CC2,EC50,=,150.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,75.0
16041,CHEMBL4067439,COc1ccccc1N2CCN(CCCCOc3ccc4c(C=O)cnn4c3)CC2,EC50,=,5.888,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,2.944
16044,CHEMBL4067506,CC1=C(CCN2CCN(CC2)c3csc4ccsc34)C(=O)N5CCCC(O)C5=N1,IC50,=,157.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,78.5
16054,CHEMBL4068455,CCCN(CCC)[C@H]1CN2C(=O)N(CCCCNC(=O)c3cc4ccccc4[nH]3)c5cccc(C1)c25,EC50,=,53.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as cAMP inhibition by BRET assay,B,26.9
16055,CHEMBL4068455,CCCN(CCC)[C@H]1CN2C(=O)N(CCCCNC(=O)c3cc4ccccc4[nH]3)c5cccc(C1)c25,Ki,=,86.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,B,86.8
16062,CHEMBL4068455,CCCN(CCC)[C@H]1CN2C(=O)N(CCCCNC(=O)c3cc4ccccc4[nH]3)c5cccc(C1)c25,EC50,=,184.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,B,92.45
16066,CHEMBL4068455,CCCN(CCC)[C@H]1CN2C(=O)N(CCCCNC(=O)c3cc4ccccc4[nH]3)c5cccc(C1)c25,EC50,=,56.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,B,28.45
16070,CHEMBL4068561,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4ccc(O)c5NC(=O)C=Cc45)cc12,Ki,=,3.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,B,3.4
16071,CHEMBL4068561,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4ccc(O)c5NC(=O)C=Cc45)cc12,Ki,=,1.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,B,1.3
16072,CHEMBL4068561,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4ccc(O)c5NC(=O)C=Cc45)cc12,EC50,=,70.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,B,35.0
16074,CHEMBL4068561,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4ccc(O)c5NC(=O)C=Cc45)cc12,EC50,=,58.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2SR expressed in HEK293 cell membranes co-expressing PTX insensitive variant of Galphao1 incubated for 30 mins by [35S]GTP-gammaS binding assay,A,29.0
16077,CHEMBL4068561,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4ccc(O)c5NC(=O)C=Cc45)cc12,Ki,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,B,1.6
16078,CHEMBL4068561,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4ccc(O)c5NC(=O)C=Cc45)cc12,Ki,=,0.54,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,B,0.54
16079,CHEMBL4068561,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4ccc(O)c5NC(=O)C=Cc45)cc12,EC50,=,46.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,B,23.0
16081,CHEMBL4068561,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4ccc(O)c5NC(=O)C=Cc45)cc12,EC50,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2SR expressed in HEK293 cell membranes co-expressing PTX insensitive variant of Galphao1 incubated for 30 mins by [35S]GTP-gammaS binding assay,A,27.5
16088,CHEMBL4068843,O=C(NCC[C@@H]1C[C@H]1CN2CCc3ccc(cc3C2)C#N)c4cc5cccnc5[nH]4,Ki,=,14.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,14.4
16090,CHEMBL4068843,O=C(NCC[C@@H]1C[C@H]1CN2CCc3ccc(cc3C2)C#N)c4cc5cccnc5[nH]4,Kb,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at D2 long receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine induced beta-arrestin recruitment after 90 mins by DiscoveRx PathHunter assay,B,5.0
16095,CHEMBL4069091,O\N=C/c1cnn2ccc(NC(=O)CCCN3CCN(CC3)c4cccc(Cl)c4Cl)cc12,Ki,=,0.57,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.57
16096,CHEMBL4069091,O\N=C/c1cnn2ccc(NC(=O)CCCN3CCN(CC3)c4cccc(Cl)c4Cl)cc12,Ki,=,0.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.5
16100,CHEMBL4069145,COc1ccccc1N2CCN(CCCCOc3ccc4c(\C=N\O)cnn4c3)CC2,Ki,=,4.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,4.2
16101,CHEMBL4069145,COc1ccccc1N2CCN(CCCCOc3ccc4c(\C=N\O)cnn4c3)CC2,Ki,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,1.7
16102,CHEMBL4069145,COc1ccccc1N2CCN(CCCCOc3ccc4c(\C=N\O)cnn4c3)CC2,EC50,=,2.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,1.45
16104,CHEMBL4069145,COc1ccccc1N2CCN(CCCCOc3ccc4c(\C=N\O)cnn4c3)CC2,EC50,=,0.4365,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,0.21825
16106,CHEMBL4069145,COc1ccccc1N2CCN(CCCCOc3ccc4c(\C=N\O)cnn4c3)CC2,EC50,=,6.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,B,3.4
16108,CHEMBL4069145,COc1ccccc1N2CCN(CCCCOc3ccc4c(\C=N\O)cnn4c3)CC2,EC50,=,10.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,B,5.35
16110,CHEMBL4069145,COc1ccccc1N2CCN(CCCCOc3ccc4c(\C=N\O)cnn4c3)CC2,EC50,=,13.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,B,6.55
16112,CHEMBL4069145,COc1ccccc1N2CCN(CCCCOc3ccc4c(\C=N\O)cnn4c3)CC2,EC50,=,2.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,B,1.45
16114,CHEMBL4069145,COc1ccccc1N2CCN(CCCCOc3ccc4c(\C=N\O)cnn4c3)CC2,EC50,=,4.3,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,B,2.15
16125,CHEMBL4069145,COc1ccccc1N2CCN(CCCCOc3ccc4c(\C=N\O)cnn4c3)CC2,EC50,=,0.44,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,0.22
16126,CHEMBL4069145,COc1ccccc1N2CCN(CCCCOc3ccc4c(\C=N\O)cnn4c3)CC2,EC50,=,2.884,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,1.442
16127,CHEMBL4069237,Clc1ccc2[nH]cc(C3=CCN(CCCNS(=O)(=O)c4cccc5ccccc45)CC3)c2c1,Ki,=,2.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,2.8
16129,CHEMBL4069565,NC(=O)c1cccc(c1)c2ccc(OC(=O)NCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)cc2F,EC50,=,13.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor-short expressed in CHO-K1 cells assessed as reduction in adenylyl cyclase activator NKH 477 induced cAMP accumulation preincubated for 10 mins followed by NKH 477 addition by HTRF assay,B,6.85
16131,CHEMBL4070091,COc1ccccc1N2CCN(CCCC(=O)Nc3ccn4ncc(C#N)c4c3)CC2,Ki,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,1.1
16132,CHEMBL4070091,COc1ccccc1N2CCN(CCCC(=O)Nc3ccn4ncc(C#N)c4c3)CC2,Ki,=,0.55,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.55
16133,CHEMBL4070091,COc1ccccc1N2CCN(CCCC(=O)Nc3ccn4ncc(C#N)c4c3)CC2,EC50,=,84.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,42.0
16136,CHEMBL4070196,NC(=O)c1cccc(c1)c2cccc(OC(=O)NCCCN3CCN(CC3)c4cccc(Cl)c4Cl)c2,EC50,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor-short expressed in CHO-K1 cells assessed as reduction in adenylyl cyclase activator NKH 477 induced cAMP accumulation preincubated for 10 mins followed by NKH 477 addition by HTRF assay,B,6.5
16138,CHEMBL4070254,Clc1cccc(c1)S(=O)(=O)NCCCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,1.0
16143,CHEMBL4070715,Clc1ccc(cc1)S(=O)(=O)NCCCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,Ki,=,4.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,4.5
16144,CHEMBL4071121,COc1ccccc1N2CCN(CCCCNC(=O)Oc3ccc4c(c3)[nH]c5ccccc45)CC2,EC50,=,57.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor-short expressed in CHO-K1 cells assessed as reduction in adenylyl cyclase activator NKH 477 induced cAMP accumulation preincubated for 10 mins followed by NKH 477 addition by HTRF assay,B,28.95
16146,CHEMBL4071185,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,Ki,=,2.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,2.4
16147,CHEMBL4071185,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,Ki,=,0.94,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.94
16148,CHEMBL4071185,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.31,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,B,0.155
16150,CHEMBL4071185,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.54,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,B,0.27
16152,CHEMBL4071185,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.72,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,B,0.36
16154,CHEMBL4071185,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.13,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,B,0.065
16156,CHEMBL4071185,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.12,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,B,0.06
16158,CHEMBL4071185,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,17.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-1 recruitment after 15 mins by BRET assay,B,8.85
16160,CHEMBL4071185,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,13.4,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,B,6.7
16162,CHEMBL4071185,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ARMS2-PK2 tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin-2 recruitment incubated for 5 hrs measured after 60 mins by PathHunter assay,B,1.5
16166,CHEMBL4071240,NC(=O)c1cccc(c1)c2cccc(OC(=O)NCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)c2,EC50,=,45.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor-short expressed in CHO-K1 cells assessed as reduction in adenylyl cyclase activator NKH 477 induced cAMP accumulation preincubated for 10 mins followed by NKH 477 addition by HTRF assay,B,22.5
16168,CHEMBL4071243,CN[C@H]1CN2C(=O)N(CCCCCCOCCCCc3ccccc3)c4cccc(C1)c24,Ki,=,60.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,B,60.6
16169,CHEMBL4071451,Fc1ccc2[nH]cc(C3=CCN(CCNS(=O)(=O)c4ccc5ccccc5c4)CC3)c2c1,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,14.0
16172,CHEMBL4071868,CCCN(CCCCOc1ccc2c(\C=N\O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,2.5
16173,CHEMBL4071868,CCCN(CCCCOc1ccc2c(\C=N\O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,Ki,=,0.84,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.84
16174,CHEMBL4071868,CCCN(CCCCOc1ccc2c(\C=N\O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.39,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,B,0.195
16176,CHEMBL4071868,CCCN(CCCCOc1ccc2c(\C=N\O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.6,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,B,0.3
16178,CHEMBL4071868,CCCN(CCCCOc1ccc2c(\C=N\O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.94,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,B,0.47
16180,CHEMBL4071868,CCCN(CCCCOc1ccc2c(\C=N\O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.19,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,B,0.095
16182,CHEMBL4071868,CCCN(CCCCOc1ccc2c(\C=N\O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.16,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,B,0.08
16184,CHEMBL4071868,CCCN(CCCCOc1ccc2c(\C=N\O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,13.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-1 recruitment after 15 mins by BRET assay,B,6.55
16186,CHEMBL4071868,CCCN(CCCCOc1ccc2c(\C=N\O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,12.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,B,6.05
16188,CHEMBL4071868,CCCN(CCCCOc1ccc2c(\C=N\O)cnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ARMS2-PK2 tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin-2 recruitment incubated for 5 hrs measured after 60 mins by PathHunter assay,B,0.75
16193,CHEMBL4072282,COc1ccccc1N2CCN(CCCNC(=O)Oc3ccc(cc3)c4cccc(c4)C(=O)N)CC2,EC50,=,21.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor-short expressed in CHO-K1 cells assessed as reduction in adenylyl cyclase activator NKH 477 induced cAMP accumulation preincubated for 10 mins followed by NKH 477 addition by HTRF assay,B,10.75
16195,CHEMBL4072780,Oc1ccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5OCC(=O)Nc15,Ki,=,0.87,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,B,0.87
16196,CHEMBL4072780,Oc1ccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5OCC(=O)Nc15,Ki,=,0.67,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,B,0.67
16197,CHEMBL4072780,Oc1ccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5OCC(=O)Nc15,EC50,=,92.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,B,46.0
16202,CHEMBL4072821,CCOC(=O)c1cc2cc(OCCCCN3CCN(CC3)c4ccccc4OC)ccn2n1,Ki,=,8.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,8.1
16203,CHEMBL4072821,CCOC(=O)c1cc2cc(OCCCCN3CCN(CC3)c4ccccc4OC)ccn2n1,Ki,=,7.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,7.4
16204,CHEMBL4072821,CCOC(=O)c1cc2cc(OCCCCN3CCN(CC3)c4ccccc4OC)ccn2n1,EC50,=,190.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,95.0
16209,CHEMBL4072821,CCOC(=O)c1cc2cc(OCCCCN3CCN(CC3)c4ccccc4OC)ccn2n1,EC50,=,190.55,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,95.275
16210,CHEMBL4073330,Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c5C=CC(=O)Oc15,Ki,=,40.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,B,40.0
16211,CHEMBL4073330,Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c5C=CC(=O)Oc15,Ki,=,19.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,B,19.0
16220,CHEMBL4074195,Clc1ccc2[nH]cc(C3=CCN(CCCCNS(=O)(=O)c4ccc5ccccc5c4)CC3)c2c1,Ki,=,2.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,2.6
16221,CHEMBL4074326,Cl.CC1=C(CCN2CCN(CC2)c3cccc4sccc34)C(=O)N5CCC=CC5=N1,IC50,=,9.44,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,4.72
16222,CHEMBL4074373,CC1=C(CCN2CCN(CC2)c3nsc4ccccc34)C(=O)N5CCCC(F)C5=N1,IC50,=,7.8,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,3.9
16223,CHEMBL4075144,Fc1cccc(c1)S(=O)(=O)NCCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,Ki,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,1.7
16225,CHEMBL4075673,Cc1cccc(c1)S(=O)(=O)NCCCCN2CCC(=CC2)c3c[nH]c4ccc(F)cc34,Ki,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,3.0
16231,CHEMBL4076129,CN[C@H]1CN2C(=O)N(CCCCCCCCCCOCCCCc3ccccc3)c4cccc(C1)c24,Ki,=,23.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,B,23.8
16246,CHEMBL4076408,Clc1cccc(c1)N2CCN(CCC3CCN(CC3)S(=O)(=O)c4cccc5ncccc45)CC2,Ki,=,76.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,B,76.0
16255,CHEMBL4077006,Cl.CC1=C(CCN2CCN(CC2)c3cccc4OC(F)(F)Oc34)C(=O)N5CCCCC5=N1,IC50,=,36.6,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,18.3
16256,CHEMBL4077040,Cc1cccc(c1)S(=O)(=O)NCCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,Ki,=,5.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,5.5
16271,CHEMBL4077430,CN[C@H]1CN2C(=O)N(CCCCOc3ccc4CCC(=O)Nc4c3)c5cccc(C1)c25,EC50,=,104.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,B,52.25
16275,CHEMBL4077536,Clc1cccc(N2CCN(C[C@@H]3C[C@H]3CNC(=O)c4cc5ccccc5[nH]4)CC2)c1Cl,Ki,=,8.41,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,8.41
16280,CHEMBL4077702,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCC(=O)C5=N1,IC50,=,9.1,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,4.55
16281,CHEMBL4077937,Fc1ccc(cc1)S(=O)(=O)NCCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,Ki,=,3.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,3.5
16282,CHEMBL4078348,CCCN(CCCCOc1ccn2nccc2c1)[C@H]3CCc4c(O)cccc4C3,Ki,=,2.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,2.1
16283,CHEMBL4078348,CCCN(CCCCOc1ccn2nccc2c1)[C@H]3CCc4c(O)cccc4C3,Ki,=,0.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.7
16284,CHEMBL4078348,CCCN(CCCCOc1ccn2nccc2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,4.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,2.45
16286,CHEMBL4078348,CCCN(CCCCOc1ccn2nccc2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,54.95,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,27.475
16288,CHEMBL4078348,CCCN(CCCCOc1ccn2nccc2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.3,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,B,0.15
16290,CHEMBL4078348,CCCN(CCCCOc1ccn2nccc2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.65,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,B,0.325
16292,CHEMBL4078348,CCCN(CCCCOc1ccn2nccc2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,B,0.4
16294,CHEMBL4078348,CCCN(CCCCOc1ccn2nccc2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.12,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,B,0.06
16296,CHEMBL4078348,CCCN(CCCCOc1ccn2nccc2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.12,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,B,0.06
16298,CHEMBL4078348,CCCN(CCCCOc1ccn2nccc2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,14.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-1 recruitment after 15 mins by BRET assay,B,7.25
16300,CHEMBL4078348,CCCN(CCCCOc1ccn2nccc2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,10.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,B,5.25
16302,CHEMBL4078348,CCCN(CCCCOc1ccn2nccc2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,1.3,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ARMS2-PK2 tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin-2 recruitment incubated for 5 hrs measured after 60 mins by PathHunter assay,B,0.65
16305,CHEMBL4078348,CCCN(CCCCOc1ccn2nccc2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,55.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,27.5
16306,CHEMBL4078348,CCCN(CCCCOc1ccn2nccc2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,4.898,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,2.449
16307,CHEMBL4078379,CCCN1C(=O)N2C[C@@H](Cc3cccc1c23)N(C)CCCCNC(=O)c4cc5ccccc5[nH]4,Ki,=,21.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,B,21.8
16308,CHEMBL4078409,Cl.CC1=C(CCN2CCC(CC2)c3cccc4sccc34)C(=O)N5CCCCC5=N1,IC50,=,10.4,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,5.2
16309,CHEMBL4078873,Cc1cccc(c1)S(=O)(=O)NCCN2CCC(=CC2)c3c[nH]c4ccc(F)cc34,Ki,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,20.0
16310,CHEMBL4079093,Cl.Clc1cccc(N2CCN(CCCCNC(=O)Oc3ccc(cc3)c4ccccc4)CC2)c1Cl,EC50,=,135.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor-short expressed in CHO-K1 cells assessed as reduction in adenylyl cyclase activator NKH 477 induced cAMP accumulation preincubated for 10 mins followed by NKH 477 addition by HTRF assay,B,67.5
16312,CHEMBL4079251,CC1=C(CCN2CCN(CC2)c3cccc4sccc34)C(=O)N5CCCC(Cl)C5=N1,IC50,=,5.49,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,2.745
16313,CHEMBL4079301,COc1ccccc1N2CCN(CCCCOc3ccn4nc(cc4c3)C#N)CC2,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,12.0
16314,CHEMBL4079301,COc1ccccc1N2CCN(CCCCOc3ccn4nc(cc4c3)C#N)CC2,Ki,=,12.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,12.0
16321,CHEMBL4079365,CC1=C(CCN2CCN(CC2)c3nccc4sccc34)C(=O)N5CCCCC5=N1,IC50,=,37.6,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,18.8
16322,CHEMBL4079375,Oc1ccc(N2CCN(CCCCOc3ccn4ncc(C=O)c4c3)CC2)c5OCC(=O)Nc15,Ki,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,B,1.1
16323,CHEMBL4079375,Oc1ccc(N2CCN(CCCCOc3ccn4ncc(C=O)c4c3)CC2)c5OCC(=O)Nc15,Ki,=,0.73,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,B,0.73
16324,CHEMBL4079375,Oc1ccc(N2CCN(CCCCOc3ccn4ncc(C=O)c4c3)CC2)c5OCC(=O)Nc15,EC50,=,68.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,B,34.0
16332,CHEMBL4079637,O=C(NC[C@@H]1C[C@H]1CCN2CCc3ccc(cc3C2)C#N)c4cc5cccnc5[nH]4,Kb,=,65.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at D2 long receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine induced beta-arrestin recruitment after 90 mins by DiscoveRx PathHunter assay,B,65.0
16335,CHEMBL4079972,Cc1[nH]c2ccc(Cl)cc2c1C3=CCN(CCCCNS(=O)(=O)c4ccc5ccccc5c4)CC3,Ki,=,99.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,99.0
16337,CHEMBL4080369,Cc1cccc(c1)S(=O)(=O)NCCCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,Ki,=,2.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,2.5
16341,CHEMBL4080399,Oc1cccc(c1)S(=O)(=O)NCCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,Ki,=,2.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,2.6
16343,CHEMBL4080762,COc1ccccc1N2CCN(CCCCOc3ccn4nccc4c3)CC2,Ki,=,18.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,18.0
16344,CHEMBL4080762,COc1ccccc1N2CCN(CCCCOc3ccn4nccc4c3)CC2,Ki,=,14.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,14.0
16345,CHEMBL4080762,COc1ccccc1N2CCN(CCCCOc3ccn4nccc4c3)CC2,EC50,=,42.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,21.0
16347,CHEMBL4080762,COc1ccccc1N2CCN(CCCCOc3ccn4nccc4c3)CC2,EC50,=,186.21,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,93.105
16349,CHEMBL4080762,COc1ccccc1N2CCN(CCCCOc3ccn4nccc4c3)CC2,EC50,=,190.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,95.0
16350,CHEMBL4080762,COc1ccccc1N2CCN(CCCCOc3ccn4nccc4c3)CC2,EC50,=,41.69,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,20.845
16353,CHEMBL4081780,COc1ccccc1N2CCN(CCCNC(=O)Oc3cccc(c3)c4cccc(c4)C(=O)N)CC2,EC50,=,54.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor-short expressed in CHO-K1 cells assessed as reduction in adenylyl cyclase activator NKH 477 induced cAMP accumulation preincubated for 10 mins followed by NKH 477 addition by HTRF assay,B,27.1
16355,CHEMBL4081987,Cc1cccc(c1)S(=O)(=O)NCCCN2CCC(=CC2)c3c(C)[nH]c4ccc(Cl)cc34,Ki,=,67.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,67.0
16356,CHEMBL4082084,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCC(C)(O)C5=N1,IC50,=,80.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,40.0
16358,CHEMBL4082195,Oc1ccccc1OCCNCC2COCC(O2)(c3ccccc3)c4ccccc4,Ki,=,15.49,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from recombinant human D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting method,A,15.49
16361,CHEMBL4082456,Clc1cccc(N2CCN(CCC3CCN(CC3)S(=O)(=O)c4cccc5ncccc45)CC2)c1Cl,Ki,=,36.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,B,36.0
16365,CHEMBL4083239,Oc1ccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5C=CC(=O)Nc15,Ki,=,0.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,B,0.89
16366,CHEMBL4083239,Oc1ccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5C=CC(=O)Nc15,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,B,1.0
16367,CHEMBL4083239,Oc1ccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5C=CC(=O)Nc15,EC50,=,93.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,B,46.5
16370,CHEMBL4083333,CC1=C(CCN2CCN(CC2)c3cccc4sccc34)C(=O)N5CCCCC5=N1,IC50,=,2.61,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,1.305
16373,CHEMBL4083727,Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c5OCCOc15,Ki,=,68.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,B,68.0
16380,CHEMBL4083903,Clc1cccc(N2CCN(C[C@@H]3C[C@H]3CNC(=O)c4ccnc5ccccc45)CC2)c1Cl,Ki,=,19.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,19.9
16382,CHEMBL4083903,Clc1cccc(N2CCN(C[C@@H]3C[C@H]3CNC(=O)c4ccnc5ccccc45)CC2)c1Cl,Kb,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at D2 long receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine induced beta-arrestin recruitment after 90 mins by DiscoveRx PathHunter assay,B,17.0
16387,CHEMBL4084492,Clc1ccc2[nH]cc(C3=CCN(CCNS(=O)(=O)c4ccc5ccccc5c4)CC3)c2c1,Ki,=,44.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,44.0
16388,CHEMBL4084663,CC1=C(CCN2CCN(CC2)c3nsc4ccccc34)C(=O)N5CCCC(=O)C5=N1,IC50,=,7.6,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,3.8
16390,CHEMBL4084690,Oc1ccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5C=CC(=O)Oc15,Ki,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,B,37.0
16395,CHEMBL4084690,Oc1ccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5C=CC(=O)Oc15,EC50,=,130.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 and GRK2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,B,65.0
16402,CHEMBL4085282,CN[C@H]1CN2C(=O)N(CCOCCOCCOCCCCc3ccccc3)c4cccc(C1)c24,Ki,=,34.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,B,34.7
16405,CHEMBL4085282,CN[C@H]1CN2C(=O)N(CCOCCOCCOCCCCc3ccccc3)c4cccc(C1)c24,EC50,=,139.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,B,69.5
16413,CHEMBL4085282,CN[C@H]1CN2C(=O)N(CCOCCOCCOCCCCc3ccccc3)c4cccc(C1)c24,EC50,=,88.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,B,44.35
16417,CHEMBL4085752,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4ccc(O)c5OCCOc45)cc12,Ki,=,29.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,B,29.0
16418,CHEMBL4085752,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4ccc(O)c5OCCOc45)cc12,Ki,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,B,16.0
16419,CHEMBL4085752,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4ccc(O)c5OCCOc45)cc12,EC50,=,170.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,B,85.0
16424,CHEMBL4085752,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4ccc(O)c5OCCOc45)cc12,Ki,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,B,1.7
16425,CHEMBL4085752,O\N=C\c1cnn2ccc(OCCCCN3CCN(CC3)c4ccc(O)c5OCCOc45)cc12,Ki,=,1.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,B,1.1
16432,CHEMBL4085802,Clc1ccc(cc1)S(=O)(=O)NCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,Ki,=,11.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,11.0
16441,CHEMBL4086613,CCCCN1CCN(CC1)c2cccc(c2)C#N,Kb,=,75.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at D2 long receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine induced beta-arrestin recruitment after 90 mins by DiscoveRx PathHunter assay,B,75.0
16444,CHEMBL4086894,OCCSSCCOc1ccc(cc1)C(=O)CCCN2CCC(O)(CC2)c3ccc(Cl)cc3.OC=O,Ki,=,73.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cell membranes by radioligand binding assay,B,73.0
16445,CHEMBL4086944,NC(=O)c1cccc(c1)c2ccc(OC(=O)NC\C=C\CN3CCN(CC3)c4cccc(Cl)c4Cl)cc2F,EC50,=,66.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor-short expressed in CHO-K1 cells assessed as reduction in adenylyl cyclase activator NKH 477 induced cAMP accumulation preincubated for 10 mins followed by NKH 477 addition by HTRF assay,B,33.1
16448,CHEMBL4087132,Cl.CC1=C(CCN2CCN(CC2)c3cccc4sccc34)C(=O)N5CCCC(F)(F)C5=N1,IC50,=,3.51,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,1.755
16449,CHEMBL4087187,COc1ccccc1N2CCN(CCCCOc3ccn4nc(C=O)cc4c3)CC2,Ki,=,5.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,5.1
16450,CHEMBL4087187,COc1ccccc1N2CCN(CCCCOc3ccn4nc(C=O)cc4c3)CC2,Ki,=,5.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,5.5
16451,CHEMBL4087187,COc1ccccc1N2CCN(CCCCOc3ccn4nc(C=O)cc4c3)CC2,EC50,=,88.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,44.0
16456,CHEMBL4087187,COc1ccccc1N2CCN(CCCCOc3ccn4nc(C=O)cc4c3)CC2,EC50,=,87.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,43.55
16458,CHEMBL4087217,CCCN1CCN(CC1)c2ccc(O)c3NC(=O)COc23,Ki,=,35.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,B,35.0
16459,CHEMBL4087217,CCCN1CCN(CC1)c2ccc(O)c3NC(=O)COc23,EC50,=,130.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,B,65.0
16464,CHEMBL4087246,CC1=C(CCN2CCN(CC2)c3cccc4SCCc34)C(=O)N5CCCC(O)C5=N1,IC50,=,11.8,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,5.9
16469,CHEMBL4087852,Fc1cccc(c1)S(=O)(=O)NCCCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,Ki,=,1.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,1.8
16470,CHEMBL4088249,Fc1ccc(cc1)S(=O)(=O)NCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,10.0
16474,CHEMBL4088639,COc1ccccc1N2CCN(CCCC(=O)Nc3ccn4ncc(C=O)c4c3)CC2,Ki,=,1.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,1.4
16475,CHEMBL4088639,COc1ccccc1N2CCN(CCCC(=O)Nc3ccn4ncc(C=O)c4c3)CC2,Ki,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,1.5
16476,CHEMBL4088639,COc1ccccc1N2CCN(CCCC(=O)Nc3ccn4ncc(C=O)c4c3)CC2,EC50,=,150.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,75.0
16486,CHEMBL4090208,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]3CCc4c(O)cccc4C3,Ki,=,2.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,2.3
16487,CHEMBL4090208,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]3CCc4c(O)cccc4C3,Ki,=,0.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.9
16488,CHEMBL4090208,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.39,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,B,0.195
16490,CHEMBL4090208,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.71,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,B,0.355
16492,CHEMBL4090208,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.74,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,B,0.37
16494,CHEMBL4090208,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.11,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,B,0.055
16496,CHEMBL4090208,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.11,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,B,0.055
16498,CHEMBL4090208,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,12.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-1 recruitment after 15 mins by BRET assay,B,6.25
16500,CHEMBL4090208,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,12.4,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,B,6.2
16502,CHEMBL4090208,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,2.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ARMS2-PK2 tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin-2 recruitment incubated for 5 hrs measured after 60 mins by PathHunter assay,B,1.45
16505,CHEMBL4090568,O=C1COc2ccccc2N1CCCN3CCN(CC3)c4nsc5ccccc45,Ki,=,17.78,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,B,17.78
16508,CHEMBL4090568,O=C1COc2ccccc2N1CCCN3CCN(CC3)c4nsc5ccccc45,Ki,=,17.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,B,17.7
16509,CHEMBL4090568,O=C1COc2ccccc2N1CCCN3CCN(CC3)c4nsc5ccccc45,Kb,=,7.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in F1pIn CHO cells assessed as inhibition of ERK1/2 phosphorylation incubated for 5 mins by AlphaScreen assay,B,7.0
16511,CHEMBL4090872,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCC(Cl)C5=N1,IC50,=,2.87,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,1.435
16513,CHEMBL4091064,Clc1cccc(N2CCN(CCCC(=O)Nc3ccn4ncc(C#N)c4c3)CC2)c1Cl,Ki,=,0.91,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.91
16514,CHEMBL4091064,Clc1cccc(N2CCN(CCCC(=O)Nc3ccn4ncc(C#N)c4c3)CC2)c1Cl,Ki,=,0.52,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.52
16518,CHEMBL4091155,Clc1cccc(N2CCN(CCCC(=O)Nc3ccn4nccc4c3)CC2)c1Cl,Ki,=,8.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,8.1
16519,CHEMBL4091155,Clc1cccc(N2CCN(CCCC(=O)Nc3ccn4nccc4c3)CC2)c1Cl,Ki,=,7.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,7.8
16523,CHEMBL4091193,Clc1cccc(c1)S(=O)(=O)NCCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,Ki,=,5.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,5.6
16525,CHEMBL4091498,NC(=O)c1cccc(c1)c2ccc(OC(=O)NCCCN3CCN(CC3)c4cccc(Cl)c4Cl)cc2,EC50,=,39.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor-short expressed in CHO-K1 cells assessed as reduction in adenylyl cyclase activator NKH 477 induced cAMP accumulation preincubated for 10 mins followed by NKH 477 addition by HTRF assay,B,19.95
16527,CHEMBL4091507,Oc1ccc(N2CCCN(CCCCOc3ccn4nccc4c3)CC2)c5C=CC(=O)Nc15,Ki,=,78.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,B,78.0
16528,CHEMBL4091507,Oc1ccc(N2CCCN(CCCCOc3ccn4nccc4c3)CC2)c5C=CC(=O)Nc15,Ki,=,46.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,B,46.0
16531,CHEMBL4091507,Oc1ccc(N2CCCN(CCCCOc3ccn4nccc4c3)CC2)c5C=CC(=O)Nc15,EC50,=,90.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2S receptor expressed in HEK293T cell membranes coexpressing Galphao1 assessed as induction of nucleotide exchange preincubated for 30 mins followed by addition of [35S]GTPgammaS measured after 30 mins by [35S]GTPgammaS binding assay,B,45.0
16536,CHEMBL4091933,Oc1ccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5OCCOc15,Ki,=,2.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,B,2.9
16537,CHEMBL4091933,Oc1ccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5OCCOc15,Ki,=,2.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,B,2.2
16541,CHEMBL4092052,NC(=O)c1cccc(c1)c2ccc(OC(=O)NCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)cc2,EC50,=,13.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor-short expressed in CHO-K1 cells assessed as reduction in adenylyl cyclase activator NKH 477 induced cAMP accumulation preincubated for 10 mins followed by NKH 477 addition by HTRF assay,B,6.5
16543,CHEMBL4092243,Fc1ccc2[nH]cc(C3=CCN(CCCNS(=O)(=O)c4ccc5ccccc5c4)CC3)c2c1,Ki,=,0.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,0.7
16544,CHEMBL4092441,Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c5C=CC(=O)Nc15,Ki,=,8.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,B,8.3
16545,CHEMBL4092441,Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c5C=CC(=O)Nc15,Ki,=,3.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,B,3.7
16558,CHEMBL4092928,CC[C@H](O)CN1CCN(CC1)c2cccc(Cl)c2Cl,Ki,=,93.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,B,93.1
16559,CHEMBL4093223,CCCN[C@H]1CN2C(=O)N(CCCCCCOCCCCc3ccccc3)c4cccc(C1)c24,Ki,=,54.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,B,54.8
16562,CHEMBL4093477,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@H]3CN4C(=O)N(CCC)c5cccc(C3)c45,Ki,=,8.43,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,B,8.43
16580,CHEMBL4093656,Clc1cccc(N2CCN(CCCCNC(=O)c3cnc4ccccc4c3)CC2)c1Cl,Ki,=,10.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,B,10.0
16581,CHEMBL4093971,Clc1cccc(N2CCN(CCC3CCN(CC3)S(=O)(=O)c4cncc5ccccc45)CC2)c1Cl,Ki,=,30.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,B,30.0
16587,CHEMBL4093980,Clc1cccc(N2CCN(CCCN3C(=O)COc4ccccc34)CC2)c1Cl,Kb,=,99.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in F1pIn CHO cells assessed as inhibition of ERK1/2 phosphorylation incubated for 5 mins by AlphaScreen assay,B,99.0
16595,CHEMBL4094794,Cc1ccccc1N2CCN(CCCCNC(=O)Oc3ccc(cc3)c4cccc(c4)C(=O)N)CC2,EC50,=,49.3,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor-short expressed in CHO-K1 cells assessed as reduction in adenylyl cyclase activator NKH 477 induced cAMP accumulation preincubated for 10 mins followed by NKH 477 addition by HTRF assay,B,24.65
16597,CHEMBL4094825,CC1=C(CCN2CCN(CC2)c3cccc4sccc34)C(=O)N5C=CC=CC5=N1,IC50,=,3.29,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,1.645
16598,CHEMBL4094869,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]3CCc4c(O)cccc4C3,Ki,=,96.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,96.0
16599,CHEMBL4094869,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]3CCc4c(O)cccc4C3,Ki,=,39.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,39.0
16600,CHEMBL4094869,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]3CCc4c(O)cccc4C3,EC50,=,5.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,B,2.6
16602,CHEMBL4094869,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]3CCc4c(O)cccc4C3,EC50,=,8.4,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,B,4.2
16604,CHEMBL4094869,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]3CCc4c(O)cccc4C3,EC50,=,9.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,B,4.9
16606,CHEMBL4094869,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]3CCc4c(O)cccc4C3,EC50,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,B,0.75
16608,CHEMBL4094869,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]3CCc4c(O)cccc4C3,EC50,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,B,0.85
16610,CHEMBL4094869,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]3CCc4c(O)cccc4C3,EC50,=,48.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-1 recruitment after 15 mins by BRET assay,B,24.0
16612,CHEMBL4094869,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]3CCc4c(O)cccc4C3,EC50,=,54.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,B,27.0
16614,CHEMBL4094869,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]3CCc4c(O)cccc4C3,EC50,=,161.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ARMS2-PK2 tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin-2 recruitment incubated for 5 hrs measured after 60 mins by PathHunter assay,B,80.5
16618,CHEMBL4094926,CC1=C(CCN2CCC(CC2)c3cccc4sccc34)C(=O)N5CCCC(O)C5=N1,IC50,=,75.4,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,37.7
16641,CHEMBL4095555,Fc1cccc(c1)S(=O)(=O)NCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,Ki,=,2.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,2.4
16644,CHEMBL4095881,Oc1ccc(N2CCN(CCCCOc3ccn4ncc(C=O)c4c3)CC2)c5OCCOc15,Ki,=,5.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,B,5.7
16645,CHEMBL4095881,Oc1ccc(N2CCN(CCCCOc3ccn4ncc(C=O)c4c3)CC2)c5OCCOc15,Ki,=,2.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,B,2.9
16651,CHEMBL4095979,Fc1ccc(cc1)S(=O)(=O)NCCCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,Ki,=,4.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,4.4
16655,CHEMBL4096353,COc1ccccc1N2CCN(CCCC(=O)Nc3ccn4ncc(\C=N/O)c4c3)CC2,Ki,=,0.97,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.97
16656,CHEMBL4096353,COc1ccccc1N2CCN(CCCC(=O)Nc3ccn4ncc(\C=N/O)c4c3)CC2,Ki,=,0.52,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.52
16661,CHEMBL4096422,CN(CCCCOc1ccc2CCC(=O)Nc2c1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,EC50,=,3.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as cAMP inhibition by BRET assay,B,1.55
16662,CHEMBL4096422,CN(CCCCOc1ccc2CCC(=O)Nc2c1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,Ki,=,40.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,B,40.1
16664,CHEMBL4096422,CN(CCCCOc1ccc2CCC(=O)Nc2c1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,EC50,=,74.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,B,37.0
16666,CHEMBL4096422,CN(CCCCOc1ccc2CCC(=O)Nc2c1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,EC50,=,188.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,B,94.4
16668,CHEMBL4096422,CN(CCCCOc1ccc2CCC(=O)Nc2c1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,EC50,=,157.8,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,B,78.9
16670,CHEMBL4096467,Cl.CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCC(F)(F)C5=N1,IC50,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,2.5
16671,CHEMBL4096479,Clc1ccc2[nH]cc(C3=CCN(CCCCNS(=O)(=O)c4cccc5ccccc45)CC3)c2c1,Ki,=,2.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,2.3
16675,CHEMBL4096866,Clc1cccc(c1)N2CCN(CCC3CCN(CC3)S(=O)(=O)c4cncc5ccccc45)CC2,Ki,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,B,37.0
16677,CHEMBL4097330,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]3CCc4c(O)cccc4C3,Ki,=,0.63,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.63
16678,CHEMBL4097330,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]3CCc4c(O)cccc4C3,Ki,=,0.75,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.75
16679,CHEMBL4097330,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,1.0
16681,CHEMBL4097330,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,25.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,12.85
16683,CHEMBL4097330,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.3,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,B,0.15
16685,CHEMBL4097330,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.61,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,B,0.305
16687,CHEMBL4097330,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.81,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,B,0.405
16689,CHEMBL4097330,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.13,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,B,0.065
16691,CHEMBL4097330,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.11,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,B,0.055
16693,CHEMBL4097330,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,13.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-1 recruitment after 15 mins by BRET assay,B,6.85
16695,CHEMBL4097330,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,15.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,B,7.95
16697,CHEMBL4097330,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,3.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ARMS2-PK2 tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin-2 recruitment incubated for 5 hrs measured after 60 mins by PathHunter assay,B,1.5
16700,CHEMBL4097330,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,26.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,13.0
16701,CHEMBL4097330,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,2.042,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,1.021
16702,CHEMBL4097395,CC1=C(CCN2CCN(CC2)c3nccc4sccc34)C(=O)N5CCCC(O)C5=N1,IC50,=,20.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,10.0
16708,CHEMBL4097572,CN[C@H]1CN2C(=O)N(CCCCCCCCOCCCCc3ccccc3)c4cccc(C1)c24,Ki,=,38.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,B,38.7
16726,CHEMBL4098236,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(C=O)c4c3)CC2,Ki,=,1.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,1.8
16727,CHEMBL4098236,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(C=O)c4c3)CC2,Ki,=,2.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,2.3
16728,CHEMBL4098236,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(C=O)c4c3)CC2,EC50,=,17.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,8.5
16730,CHEMBL4098236,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(C=O)c4c3)CC2,EC50,=,15.85,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,7.925
16732,CHEMBL4098236,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(C=O)c4c3)CC2,EC50,=,16.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,8.0
16733,CHEMBL4098236,COc1ccccc1N2CCN(CCCCOc3ccn4ncc(C=O)c4c3)CC2,EC50,=,17.38,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,8.69
16735,CHEMBL4098594,CC1=C(CCN2CCN(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCC(O)C5=N1,IC50,=,9.65,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,4.825
16737,CHEMBL4098803,COc1ccccc1N2CCN(CCCCOc3ccc4ccnn4c3)CC2,Ki,=,1.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,1.8
16738,CHEMBL4098803,COc1ccccc1N2CCN(CCCCOc3ccc4ccnn4c3)CC2,Ki,=,0.74,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.74
16739,CHEMBL4098803,COc1ccccc1N2CCN(CCCCOc3ccc4ccnn4c3)CC2,EC50,=,4.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,2.05
16741,CHEMBL4098803,COc1ccccc1N2CCN(CCCCOc3ccc4ccnn4c3)CC2,EC50,=,22.91,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,11.455
16743,CHEMBL4098803,COc1ccccc1N2CCN(CCCCOc3ccc4ccnn4c3)CC2,EC50,=,2.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,B,1.05
16745,CHEMBL4098803,COc1ccccc1N2CCN(CCCCOc3ccc4ccnn4c3)CC2,EC50,=,4.4,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,B,2.2
16747,CHEMBL4098803,COc1ccccc1N2CCN(CCCCOc3ccc4ccnn4c3)CC2,EC50,=,5.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,B,2.5
16749,CHEMBL4098803,COc1ccccc1N2CCN(CCCCOc3ccc4ccnn4c3)CC2,EC50,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,B,0.75
16751,CHEMBL4098803,COc1ccccc1N2CCN(CCCCOc3ccc4ccnn4c3)CC2,EC50,=,1.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,B,0.95
16762,CHEMBL4098803,COc1ccccc1N2CCN(CCCCOc3ccc4ccnn4c3)CC2,EC50,=,23.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,11.5
16763,CHEMBL4098803,COc1ccccc1N2CCN(CCCCOc3ccc4ccnn4c3)CC2,EC50,=,4.074,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,2.037
16764,CHEMBL4098859,CCCN(CCCCOc1ccn2ncc(\C=N/O)c2c1)[C@H]3CCc4c(O)cccc4C3,Ki,=,2.2,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,2.2
16765,CHEMBL4098859,CCCN(CCCCOc1ccn2ncc(\C=N/O)c2c1)[C@H]3CCc4c(O)cccc4C3,Ki,=,0.87,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,0.87
16766,CHEMBL4098859,CCCN(CCCCOc1ccn2ncc(\C=N/O)c2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.49,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,B,0.245
16768,CHEMBL4098859,CCCN(CCCCOc1ccn2ncc(\C=N/O)c2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.67,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,B,0.335
16770,CHEMBL4098859,CCCN(CCCCOc1ccn2ncc(\C=N/O)c2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.96,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,B,0.48
16772,CHEMBL4098859,CCCN(CCCCOc1ccn2ncc(\C=N/O)c2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.21,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,B,0.105
16774,CHEMBL4098859,CCCN(CCCCOc1ccn2ncc(\C=N/O)c2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,0.17,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,B,0.085
16776,CHEMBL4098859,CCCN(CCCCOc1ccn2ncc(\C=N/O)c2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,11.9,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-1 recruitment after 15 mins by BRET assay,B,5.95
16778,CHEMBL4098859,CCCN(CCCCOc1ccn2ncc(\C=N/O)c2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,13.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,B,6.6
16780,CHEMBL4098859,CCCN(CCCCOc1ccn2ncc(\C=N/O)c2c1)[C@H]3CCc4c(O)cccc4C3,EC50,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ARMS2-PK2 tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin-2 recruitment incubated for 5 hrs measured after 60 mins by PathHunter assay,B,0.85
16783,CHEMBL4099236,Cl.COc1ccccc1N2CCN(CCCCNC(=O)Oc3ccc(cc3)c4cccc(c4)C(=O)N)CC2,EC50,=,53.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor-short expressed in CHO-K1 cells assessed as reduction in adenylyl cyclase activator NKH 477 induced cAMP accumulation preincubated for 10 mins followed by NKH 477 addition by HTRF assay,B,26.5
16789,CHEMBL4099666,Oc1ccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5C=CC(=O)Oc15,Ki,=,4.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,B,4.8
16790,CHEMBL4099666,Oc1ccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5C=CC(=O)Oc15,Ki,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,B,2.0
16793,CHEMBL4099711,COc1ccccc1N2CCN(CCCCOc3ccn4nc(CO)cc4c3)CC2,Ki,=,6.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,6.0
16794,CHEMBL4099711,COc1ccccc1N2CCN(CCCCOc3ccn4nc(CO)cc4c3)CC2,Ki,=,5.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,5.8
16795,CHEMBL4099711,COc1ccccc1N2CCN(CCCCOc3ccn4nc(CO)cc4c3)CC2,EC50,=,73.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,36.5
16800,CHEMBL4099711,COc1ccccc1N2CCN(CCCCOc3ccn4nc(CO)cc4c3)CC2,EC50,=,72.44,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing GalphaoA incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,36.22
16801,CHEMBL4099798,COc1ccccc1N2CCN(CCCCNC(=O)Oc3cccc(c3)c4cccc(c4)C(=O)N)CC2,EC50,=,56.4,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor-short expressed in CHO-K1 cells assessed as reduction in adenylyl cyclase activator NKH 477 induced cAMP accumulation preincubated for 10 mins followed by NKH 477 addition by HTRF assay,B,28.2
16803,CHEMBL4099997,Cc1cccc(c1)S(=O)(=O)NCCCCN2CCC(=CC2)c3c(C)[nH]c4ccc(Cl)cc34,Ki,=,56.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,56.0
16804,CHEMBL4100152,CC1=C(CCN2CCN(CC2)c3cccc4OC(F)(F)Oc34)C(=O)N5CCCC(O)C5=N1,IC50,=,27.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,13.5
16805,CHEMBL4100183,Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c5OCC(=O)Nc15,Ki,=,2.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,B,2.0
16806,CHEMBL4100183,Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c5OCC(=O)Nc15,Ki,=,0.86,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,B,0.86
16807,CHEMBL4100183,Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c5OCC(=O)Nc15,EC50,=,62.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,B,31.0
16849,CHEMBL4100951,Clc1ccc2[nH]cc(C3=CCN(CCCNS(=O)(=O)c4ccc5ccccc5c4)CC3)c2c1,Ki,=,3.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,3.7
16850,CHEMBL4101115,CC1=C(CCN2CCN(CC2)c3nsc4ccccc34)C(=O)N5CCCC(Cl)C5=N1,IC50,=,8.29,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,4.145
16852,CHEMBL4102561,CC1=C(CCN2CCN(CC2)c3cccc4sccc34)C(=O)N5C=CC=C(O)C5=N1,IC50,=,26.7,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,13.35
16854,CHEMBL4102616,CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]3CCc4c(O)cccc4C3,Ki,=,48.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,48.0
16855,CHEMBL4102616,CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]3CCc4c(O)cccc4C3,EC50,=,5.5,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai1 after 10 mins by BRET assay,B,2.75
16857,CHEMBL4102616,CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]3CCc4c(O)cccc4C3,EC50,=,8.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai2 after 10 mins by BRET assay,B,4.35
16859,CHEMBL4102616,CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]3CCc4c(O)cccc4C3,EC50,=,9.6,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged Galphai3 after 10 mins by BRET assay,B,4.8
16861,CHEMBL4102616,CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]3CCc4c(O)cccc4C3,EC50,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoA after 10 mins by BRET assay,B,0.85
16863,CHEMBL4102616,CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]3CCc4c(O)cccc4C3,EC50,=,2.2,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells coexpressing renilla luciferase 2-tagged GalphaoB after 10 mins by BRET assay,B,1.1
16865,CHEMBL4102616,CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]3CCc4c(O)cccc4C3,EC50,=,98.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-1 recruitment after 15 mins by BRET assay,B,49.0
16867,CHEMBL4102616,CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]3CCc4c(O)cccc4C3,EC50,=,61.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at N-terminal flag-tagged D2S receptor (unknown origin) expressed in HEK293 cells assessed as induction of renilla luciferase 2-tagged beta-arrestin-2 recruitment after 15 mins by BRET assay,B,30.5
16871,CHEMBL4102620,COc1ccccc1N2CCN(CCCCNC(=O)Oc3ccc(c(OC)c3)c4cccc(c4)C(=O)N)CC2,EC50,=,10.4,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor-short expressed in CHO-K1 cells assessed as reduction in adenylyl cyclase activator NKH 477 induced cAMP accumulation preincubated for 10 mins followed by NKH 477 addition by HTRF assay,B,5.2
16873,CHEMBL4102628,Oc1ccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5C=CC(=O)Nc15,Ki,=,1.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,B,1.6
16874,CHEMBL4102628,Oc1ccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5C=CC(=O)Nc15,Ki,=,0.81,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,B,0.81
16875,CHEMBL4102628,Oc1ccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5C=CC(=O)Nc15,EC50,=,190.0,nM,Dopamine D2 receptor,Homo sapiens,Partial agonist activity at human D2SR expressed in HEK293T cells co-expressing (EA)beta-arrestin2 assessed as induction of beta-arrestin2 recruitment after 5 hrs by chemiluminescence assay,B,95.0
16877,CHEMBL4102628,Oc1ccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5C=CC(=O)Nc15,EC50,=,67.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2S receptor expressed in HEK293T cell membranes coexpressing Galphao1 assessed as induction of nucleotide exchange preincubated for 30 mins followed by addition of [35S]GTPgammaS measured after 30 mins by [35S]GTPgammaS binding assay,B,33.5
16888,CHEMBL4102670,CC1=C(CCN2CCN(CC2)c3cccc4sccc34)C(=O)N5CCCC(O)C5=N1,IC50,=,3.31,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,1.655
16889,CHEMBL4103339,Clc1cccc(N2CCN(CCCNC(=O)Oc3ccc(cc3)c4ccccc4)CC2)c1Cl,EC50,=,14.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor-short expressed in CHO-K1 cells assessed as reduction in adenylyl cyclase activator NKH 477 induced cAMP accumulation preincubated for 10 mins followed by NKH 477 addition by HTRF assay,B,7.35
16891,CHEMBL4103509,CC1=C(CCN2CCN(CC2)c3cccc4sccc34)C(=O)N5CCCC(=O)C5=N1,IC50,=,40.5,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,20.25
16892,CHEMBL4103639,Oc1ccc(N2CCN(CCCCOc3ccn4ncc(C=O)c4c3)CC2)c5C=CC(=O)Nc15,Ki,=,1.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,B,1.0
16893,CHEMBL4103639,Oc1ccc(N2CCN(CCCCOc3ccn4ncc(C=O)c4c3)CC2)c5C=CC(=O)Nc15,Ki,=,0.58,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,B,0.58
16894,CHEMBL4103639,Oc1ccc(N2CCN(CCCCOc3ccn4ncc(C=O)c4c3)CC2)c5C=CC(=O)Nc15,EC50,=,51.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2SR expressed in HEK293 cells incubated for 5 hrs by beta-Arrestin 2 recruitment assay,B,25.5
16899,CHEMBL4103725,Clc1ccc(cc1)S(=O)(=O)NCCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,Ki,=,2.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,2.7
16901,CHEMBL4104013,O=C1Nc2cccc(N3CCN(CCCN4C(=O)COc5ccccc45)CC3)c2O1,Ki,=,1.7380000000000002,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,B,1.7380000000000002
16903,CHEMBL4104013,O=C1Nc2cccc(N3CCN(CCCN4C(=O)COc5ccccc45)CC3)c2O1,EC50,=,0.0955,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in F1pIn CHO cells assessed as increase in forskolin-mediated cAMP accumulation incubated for 30 mins by AlphaScreen assay,B,0.04775
16906,CHEMBL4104013,O=C1Nc2cccc(N3CCN(CCCN4C(=O)COc5ccccc45)CC3)c2O1,EC50,=,0.631,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in F1pIn CHO cells assessed as induction of ERK1/2 phosphorylation incubated for 5 mins by AlphaScreen assay,B,0.3155
16907,CHEMBL4104013,O=C1Nc2cccc(N3CCN(CCCN4C(=O)COc5ccccc45)CC3)c2O1,Ki,=,1.7,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,B,1.7
16908,CHEMBL4104013,O=C1Nc2cccc(N3CCN(CCCN4C(=O)COc5ccccc45)CC3)c2O1,EC50,=,0.096,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in F1pIn CHO cells assessed as increase in forskolin-mediated cAMP accumulation incubated for 30 mins by AlphaScreen assay,B,0.048
16909,CHEMBL4104013,O=C1Nc2cccc(N3CCN(CCCN4C(=O)COc5ccccc45)CC3)c2O1,EC50,=,0.64,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in F1pIn CHO cells assessed as induction of ERK1/2 phosphorylation incubated for 5 mins by AlphaScreen assay,B,0.32
16910,CHEMBL4104216,Clc1ccc2[nH]cc(C3=CCN(CCNS(=O)(=O)c4cccc5ccccc45)CC3)c2c1,Ki,=,37.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,37.0
16913,CHEMBL4104261,CC1=C(CCN2CCN(CC2)c3cccc4sccc34)C(=O)N5CCCC(F)C5=N1,IC50,=,3.32,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,1.66
16916,CHEMBL4104622,Oc1cccc(c1)S(=O)(=O)NCCN2CCC(=CC2)c3c[nH]c4ccc(Cl)cc34,Ki,=,1.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,B,1.5
16919,CHEMBL4105030,COc1ccccc1N2CCN(CCCCOc3ccn4nc(\C=N\O)cc4c3)CC2,Ki,=,3.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,3.3
16920,CHEMBL4105030,COc1ccccc1N2CCN(CCCCOc3ccn4nc(\C=N\O)cc4c3)CC2,Ki,=,1.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,B,1.9
16935,CHEMBL4110066,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccncc4)NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc6ccc(O)cc6)NC1=O)NCC[S@+]([O-])C[C@@H]7C[C@H]8[C@@H](Cc9c[nH]c%10cccc8c9%10)N(C)C7,Ki,=,79.7,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",B,79.7
